<?xml version="1.0" encoding="utf-8"?>
<add>
	<doc>
		<field name="docid">BR-TU.13327</field>
		<field name="filename">19291_tese.pdf</field>
		<field name="filetype">PDF</field>
		<field name="text">
Universidade de Aveiro 
2016  

Departamento de Engª de Materiais e Cerâmica 

Paula Maria  
da Costa Torres 
 

Cimentos injetáveis à base de fosfatos de cálcio 
para vertebroplastia 
 

 

  
 

   



 
Universidade de Aveiro 
2016  

Departamento de Engª de Materiais e Cerâmica 

Paula Maria  
da Costa Torres 
 
 

Cimentos injetáveis à base de fosfatos de cálcio 
para vertebroplastia 
 

 Tese apresentada à Universidade de Aveiro para cumprimento dos requisitos 
necessários à obtenção do grau de Doutor em Ciência e Engenharia de 
Materiais, realizada sob a orientação científica do Professor Doutor José Maria 
da Fonte Ferreira, Professor Associado com Agregação do Departamento de 
Engenharia de Materiais e Cerâmica da Universidade de Aveiro e da Doutora 
Susana Maria Henriques Olhero, Investigadora Auxiliar do Departamento de 
Engenharia de Materiais e Cerâmica da Universidade de Aveiro. 

 

  
 

Apoio financeiro da FCT e do 
POPH/FSE no âmbito do III Quadro 
Comunitário de Apoio. 
SFRH/BD/62021/2009 
 
 
 



 

  

  
 

 
 

 
                                         
 
 
 
 
 
 
 
 
 
 
 
 
                                                   
 
 
 
 
 
 
 
                                                 Aos meus amores Tomás e Paulo… 
                                                                       
                                                 Aos meus pais… 
                                             
                                                 À minha família e amigos… 
 

 



 

  
 

 
 
 

 
 

o júri   
 

presidente Prof. Doutor Carlos Fernandes da Silva 
professor catedrático do Departamento de Educação da Universidade de Aveiro 

  
 

 Prof. Doutora Ana Francisca de Campos Simão Bettencourt 
professor auxiliar da Faculdade de Farmácia da Universidade de Lisboa 

  
 

 Prof. Doutor Alberto Eduardo Morão Cabral Ferro 
professor auxiliar do Departamento de Engenharia Mecânica do Instituto Superior Técnico 

  
 

 Prof. Doutor João Carlos Tomás Ramos 
professor auxiliar da Faculdade de Medicina da Universidade de Coimbra 

  
 

 Prof. Doutora Maria Elisabete Jorge Vieira da Costa 
professor auxiliar do Departamento de Engenharia de Materiais e Cerâmica da Universidade de 
Aveiro 

  
 

 Prof. Doutor José Maria da Fonte Ferreira 
professor associado com agregação do Departamento de Engenharia de Materiais e Cerâmica  
da Universidade de Aveiro 

  
 

  
 
 
 



 

  

  
 

agradecimentos 
 

Quero agradecer ao Professor Doutor José Maria F. Ferreira pelo seu apoio 
científico, sagacidade dos seus comentários, paciência e resiliência. As longas 
horas de discussões e correcções, enriquecedoras, animadas, por vezes 
difíceis e cansativas, pontuadas por acesas trocas de argumentos e por temas 
diversos como politica e livros, nunca serão esquecidas.  

À minha co-orientadora e amiga, Doutora Susana Olhero. A sua contribuição 
foi fundamental para conseguir finalizar esta tese. Meu eterno bem-haja, Susie, 
por todo o apoio que me deste: cientifico, emocional, e pelo suporte financeiro 
nesta última fase.  

À FCT, pela bolsa de doutoramento concedida. 

À UA, ao DEMAC e ao CICECO, pelos meios colocados à minha disposição; 
aos seus funcionários e técnicos. Um especial bem-haja aos Professores
Joaquim Vieira, Augusto Lopes e Ana Barros, à Sandra Magina, Rosário, 
Marta, Bruno, Maria João, Celeste, Dra. Alexandra, Luísa, Paulo, Ana, Célia, 
Sr. Jacinto e Octávio. 

À Sandra Pina, pela disponibilidade, pela amizade e por me ter encaminhado 
para este interessante mundo dos cimentos de fosfato de cálcio injectáveis.  

À Ana Marote, Regina Cerqueira, Sandra Vieira, António Calado e Odete Cruz, 
pelo trabalho desenvolvido, apoio científico, gentileza e disponibilidade.  

Ao João Abrantes, pela sua preciosa contribuição nas numerosas análises de 
DRX por refinamento de Rietveld, pela sua simpatia, disponibilidade e 
paciência.  

À Sónia Gouveia, pela sua fundamental contribuição no tratamento de dados, 
pela sua calma, perspicácia e boa disposição. Mergulhada e quase afogada 
nos dados, fui salva por si! 

Ao Marc Bohner e ao Nicola Döbelin, pelos conhecimentos transmitidos, trocas 
de ideias e comentários pertinentes que levaram a uma melhoria do trabalho 
desenvolvido.  

Ao Hospital Infante D. Pedro de Aveiro, especialmente à equipa envolvida no 
processo de esterilização de amostras. Um bem-haja às enfermeiras Áurea
Simões e Margarida Vilarinho. 

Aos meus amigos e colegas de trabalho Catarina, Avito, Hugo, Ajay e Anurag 
e também à Marisa Costa, pela amizade, boa disposição, apoio e pela partilha 
de momentos bons e menos bons que contribuíram para um enriquecimento 
pessoal e profissional.  

A todos os meus colegas, amigos e familiares que, de alguma forma, 
prestaram o seu apoio. 

Aos meus pais e à minha irmã Té que sempre me apoiaram e animaram em 
todos os momentos mais difíceis do meu trajecto.  
À Glória, pela força, determinação, coragem, calma e carinho que me tem 
dado. 
Ao Paulo e ao meu filho Tomás, pelo seu amor, cumplicidade, ajuda e 
paciência. 



 

  
 
 
 
 
 
 
 
 
 
 

  

palavras-chave 
 

Cimentos de fosfatos cálcio, brushite, pós de ?? e ??TCP, iões dopantes, 
distribuição de tamanho de partícula, sucrose como agente retardador, 
injectabilidade, presa, resistência mecânica, regeneração óssea 
 

resumo 
 
 

O principal objectivo desta investigação foi o desenvolvimento cimentos de 
fosfatos de cálcio com injetabilidade melhorada e propriedades mecânicas 
adequadas para aplicação em vertebroplastia. 

Os pós de fosfato de tricálcico (TCP) não dopados e dopados (Mg, Sr e Mn) 
usados neste estudo foram obtidos pelo processo de precipitação em meio 
aquoso, seguidos de tratamento térmico de forma a obter as fases 
pretendidas, ?? e ??TCP. A substituição parcial de iões Ca por iões dopantes 
mostrou ter implicações em termos de estabilidade térmica da fase ??TCP. Os 
resultados demonstraram que as transformações de fase alotrópicas 
????TCP são fortemente influenciadas por variáveis experimentais como a 
taxa de arrefecimento, a presença de impurezas de pirofosfato de cálcio e a 
extensão do grau de dopagem com Mg. 

Os cimentos foram preparados através da mistura de pós, ??TCP (não 
dopados e dopados) e fosfato monocálcico monidratado (MCPM), com meios 
líquidos diferentes usando ácido cítrico e açucares (sucrose e frutose) como 
agentes retardadores de presa, e o polietilenoglicol, a
hidroxipropilmetilcelulose e a polivinilpirrolidona como agentes gelificantes. 
Estes aditivos, principalmente o ácido cítrico, e o MCPM aumentam 
significativamente a força iónica do meio, influenciando a injetabilidade das 
pastas. Os resultados também mostraram que a distribuição de tamanho de 
partícula dos pós é um factor determinante na injetabilidade das pastas 
cimentícias.  

A combinação da co-dopagem de Mn e Sr com a adição de sucrose no líquido 
de presa e com uma distribuição de tamanho de partícula dos pós adequada 
resultou em cimentos de brushite com propriedades bastante melhoradas em 
termos de manuseamento, microestrutura, comportamento mecânico e 
biológico: (i) o tempo inicial de presa passou de ~3 min to ~9 min; (ii) as pastas 
cimentícias foram totalmente injectadas para uma razão liquido/pó de 0.28 mL 
g?1 com ausência do efeito de “filter-pressing” (separação de fases líquida e 
sólida); (iii) após imersão numa solução durante 48 h, as amostras de cimento 
molhadas apresentam uma porosidade total de ~32% e uma resistência a 
compressão de ~17 MPa, valor muito superior ao obtido para os cimentos sem 
açúcar não dopados (5 MPa) ou dopados só com Sr (10 MPa); e (iv) o 
desempenho biológico, incluindo a adesão e crescimento de células 
osteoblásticas na superfície do cimento, foi muito melhorado. Este conjunto de 
propriedades torna os cimentos excelentes para regeneração óssea e 
engenharia de tecidos, e muito promissores para aplicação em vertebroplastia. 

 
 



 

 
 
 
 
 
 
 
 

 
 
 
 
 
 
 
 
 
 
 

  

keywords 
 

Calcium phosphates cements, brushite, ?? and ??TCP powders, dopant ions, 
particle size distribution, sucrose as retardant, injectability, self-setting, 
mechanical strength, bone regeneration 
 

abstract 
 

The main objective of this research was the development of cements based on 
calcium phosphates with improved injectability and mechanical properties 
suitable for being used in vertebroplasty. 

The tricalcium phosphate powders (TCP) undoped and doped (Mg, Sr and Mn) 
used in this study were obtained through aqueous precipitation process, 
followed by heat treatment in order to obtain appropriate phases, ?? and 
??TCP. The partial substitution of Ca ions by doping ions shown to have 
implications in terms of thermal stability of ??TCP phase. The results showed 
that ????TCP allotropic phase transformations are strongly influenced by 
experimental variables like cooling rate, the presence of calcium 
pyrophosphate impurities and the Mg-doping extent. 

The cements were prepared by mixing the ??TCP and monocalcium phosphate 
monohydrate (MCPM) powders with different liquids, using citric acid and 
sugars (sucrose and fructose) as setting retarders, and polyethylene glycol, 
hydroxypropyl methylcellulose and polyvinylpyrrolidone as gelling agents. 
These additives, especially the citric acid, and MCPM significantly increase the 
ionic strength of the medium, affecting the injectability of cement pastes. The 
results also showed that the particle size distribution of the powders used is a 
determinant factor in the injectability of cement pastes. 

The combination of co-doping of Sr and Mn with the addition of sucrose in the 
setting liquid and with a suitable particle size distribution of the powders 
resulted in brushite based cements with overall greatly improved properties in 
terms of handling, microstructure, mechanical and biological behaviours: (i) the 
initial setting time increased from ~3 min to ~9 min; (ii) the cement pastes were 
fully injected for a liquid powder ratio of 0.28 mL g?1 with absence of filter 
pressing effects; (iii) after immersion for 48 hours in a solution, wet cement 
samples exhibit a total porosity of ~32% and a compressive strength of ~17 
MPa, much higher than those registered for sugar-free CPCs derived from non-
doped ??TCP (5 MPa) or from Sr-doped ??TCP (10 MPa); and (iv) the 
biological performance, including adhesion and growth of osteoblastic cells in 
cement surface, was much improved. This set of properties turns these 
cements excellent for bone regeneration and tissue engineering, and very 
promising for application in vertebroplasty.  

 

 



 

 i 

Índice 

 

Introdução Geral ..................................................................................................................... 1 

Referências bibliográficas .............................................................................................................. 6 

Capítulo 1 

Composição, estrutura e metabolismo do osso, e a importância dos cimentos de fosfato de 

cálcio como material substituto do tecido ósseo: noções gerais e objetivos deste estudo .......... 9 

1. Estrutura, composição e propriedades do osso....................................................................... 11 

1.1 Macroestrutura do osso ..................................................................................................... 12 

1.2 Microestrutura do osso ...................................................................................................... 14 

1.2.1 Composição e propriedades do osso ......................................................................... 14 

1.2.2 Células ósseas............................................................................................................. 16 

1.3 Remodelação e autorreparação óssea............................................................................... 18 

2. Materiais de substituição óssea ............................................................................................... 19 

3. Fosfatos de cálcio como substitutos ósseos ............................................................................ 20 

3.1 Fosfatos de cálcio ............................................................................................................... 21 

3.2 Substituição iónica em fosfatos de cálcio .......................................................................... 26 

4. Cimentos ósseos....................................................................................................................... 27 

4.1 Cimentos à base de PMMA ................................................................................................ 28 

4.2 Cimentos de sulfato de cálcio ............................................................................................ 28 

4.3 Cimentos de fosfato de cálcio ............................................................................................ 29 

4.3.1 Processo de presa e endurecimento.......................................................................... 29 

4.3.1.1 Tempo de presa e endurecimento ....................................................................... 30 

4.3.2 Tipos de cimentos ...................................................................................................... 32 

4.3.3 Reacções químicas envolvidas na presa dos cimentos .............................................. 33 

4.3.4 Principais diferenças entre cimentos de apatite e de brushite ................................. 35 

4.3.5 Flexibilidade dos CPCs em termos de desenhos das suas propriedades ................... 39 

4.3.5.1 Injetabilidade........................................................................................................ 40 

4.3.5.2 Comportamento mecânico .................................................................................. 44 

4.3.5.3 Biocompatibilidade e ressorção ........................................................................... 46 

4.3.5.4 Incorporação de iões presentes no osso.............................................................. 48 



 

 ii 

5. Metas e objetivos ..................................................................................................................... 48 

6. Referências bibliográficas ........................................................................................................ 51 

Capítulo 2 

Influência da dopagem de magnésio, das impurezas de pirofosfato de cálcio e da taxa de 

arrefecimento sobre as transformações de fase alotrópicas ???????????? do fosfato tricálcico ............ 65 

Abstract ........................................................................................................................................ 68 

1. Introduction.............................................................................................................................. 69 

2. Materials and methods ............................................................................................................ 71 

2.1 Powder synthesis................................................................................................................ 71 

2.2 Powders characterization................................................................................................... 73 

3. Results ...................................................................................................................................... 77 

3.1 Influence of Mg-doping on the characteristics of starting powders.................................. 77 

3.2 Thermal behaviour of Mg0TCP........................................................................................... 80 

3.3 Influence of Mg-doping on thermal behaviour.................................................................. 85 

4. Discussion................................................................................................................................. 87 

4.1 Influence of Mg-doping on the characteristics of the Mg0?5TCP powders ...................... 87 

4.2 The thermal behaviour of Mg0TCP .................................................................................... 88 

4.3 Influence of Mg-doping on thermal behaviour.................................................................. 93 

5. Conclusions............................................................................................................................... 95 

Acknowledgements...................................................................................................................... 97 

References.................................................................................................................................... 97 

Capítulo 3 

Injectabilidade de pastas de fosfato de cálcio: Efeitos do tamanho da partícula e estado de 

agregação de pós de ?-fosfato tricálcico ................................................................................105 

Abstract ...................................................................................................................................... 108 

1. Introduction............................................................................................................................ 109 

2. Materials and methods .......................................................................................................... 111 

2.1 Powder preparation and characterisation ....................................................................... 111 

2.2 Granule preparation and characterisation....................................................................... 112 

2.3 Injectability evaluation ..................................................................................................... 113 

2.3.1 Preparation of the pastes......................................................................................... 113 

2.3.2 Injectability tests ...................................................................................................... 114 

2.4 Zeta potential and electrical conductivity in different electrolyte solutions................... 115 



 

 iii 

2.5 Influence of preparation conditions on the flow behaviour of pastes ............................ 115 

2.6 Statistical methods and data analysis .............................................................................. 116 

3. Results .................................................................................................................................... 117 

3.1 Characterisation of starting powders............................................................................... 117 

3.2 Characterisation of the Sr?TCP granules .......................................................................... 121 

3.3 Injectability and filter pressing effect of pastes ............................................................... 122 

3.3.1 Non-reactive systems............................................................................................... 122 

3.3.2 Reactive systems ...................................................................................................... 125 

3.3.3 Powder blends in reactive systems .......................................................................... 129 

3.4 Influence of dispersing/reactive liquids on zeta potential and rheology......................... 132 

4. Discussion............................................................................................................................... 134 

5. Conclusions............................................................................................................................. 139 

Acknowledgments...................................................................................................................... 140 

References.................................................................................................................................. 141 

Capítulo 4 

Efeitos da dopagem do manganês na estrutura e nas propriedades biológicas do fosfato 

?????tricálcico ...........................................................................................................................147 

Abstract ...................................................................................................................................... 150 

1. Introduction............................................................................................................................ 151 

2. Materials and methods .......................................................................................................... 153 

2.1 Powders preparation........................................................................................................ 153 

2.2 Powders characterization................................................................................................. 155 

2.3 MC3T3-E1 cell culture ...................................................................................................... 156 

2.4 Cytotoxicity and cell proliferation assays in Mn-doped ?-TCP powders ......................... 156 

2.5 Antibodies and Fluorescing Chemicals............................................................................. 157 

2.6 Immunoblot analyses of Type-I collagen protein expression and media secretion ........ 157 

2.7 Confocal microscopy analyses of Type-I collagen protein distribution ........................... 158 

2.8 Statistical analysis............................................................................................................. 158 

3. Results .................................................................................................................................... 159 

3.1 Influence of Mn-doping on the structure of ?-TCP.......................................................... 159 

3.2. Biological properties........................................................................................................ 164 

3.2.1 Mn0.5-1TCP powders increase MC3T3 cellular proliferation .................................. 164 



 

 iv 

3.2.2 MnTCP powders greatly decrease intracellular procollagen (I) levels and increase its 

maturation and secretion ................................................................................................. 166 

3.2.3 Mn1TCP induces osteoblastic differentiation .......................................................... 168 

4. Discussion............................................................................................................................... 170 

4.1 Influence of Mn-doping on the structure of ?-TCP.......................................................... 170 

4.2 Biological properties......................................................................................................... 172 

5. Conclusions............................................................................................................................. 173 

Acknowledgements.................................................................................................................... 174 

References.................................................................................................................................. 175 

Capítulo 5 

Cimentos ósseos formados por brushite adoçados e dopados com estrôncio e manganês: a 

receita para fomentar a injectabilidade e o desempenho biológico in vitro ............................181 

Abstract ...................................................................................................................................... 184 

1. Introduction............................................................................................................................ 185 

2. Materials and Methods .......................................................................................................... 187 

2.1 Preparation of starting powders and cements ................................................................ 187 

2.1.1 Preparation and characterisation of the powders ................................................... 187 

2.1.2 Preparation of cement pastes.................................................................................. 188 

2.2 Characterisation of cement pastes .................................................................................. 189 

2.2.1 Setting time .............................................................................................................. 189 

2.2.2 Injectability............................................................................................................... 190 

2.2.3 Mechanical properties and porosity ........................................................................ 190 

2.2.4 X-ray diffraction and structural analysis by the Rietveld refinement method ........ 191 

2.3 Characterisation of cement/osteoblastic-like cells interactions...................................... 191 

2.3.1 Cultures of MG63 cells with cements ...................................................................... 191 

2.3.2 Viability and proliferation assays ............................................................................. 192 

2.3.3 Chemical and phase composition of cements after 28DIV with MG63 cells ........... 192 

2.3.4 Immunoblot analyses of type-I collagen .................................................................. 193 

2.3.5 Confocal microscopy and scanning electron microscopy analyses of cells ............. 193 

2.4 Statistical analysis............................................................................................................. 194 

3. Results .................................................................................................................................... 195 

3.1 Characterisation of ?-TCP powders ................................................................................. 195 

3.2 Characterisation of cement pastes .................................................................................. 197 



 

 v 

3.3 Characterisation of in vitro osteoconductive properties ................................................. 205 

3.3.1 Effects of Mn- and Sr-doping on cell viability and type-I collagen secretion........... 205 

3.3.2 Mn0.5Sr5CPC potential to be an osteoconductive scaffold .................................... 207 

4. Discussion............................................................................................................................... 212 

4.1. Effects of MnSr-doping and sugars addition on the properties of cements ................... 212 

4.2 Effects of MnSr-doping and adding sucrose on the in vitro biological behaviour ........... 218 

5. Conclusions............................................................................................................................. 220 

Acknowledgments...................................................................................................................... 221 

References.................................................................................................................................. 222 

Capítulo 6 

Conclusões gerais e perspetivas futuras ................................................................................233 

Perspetivas futuras..................................................................................................................... 237 

Anexos .................................................................................................................................239 

Anexo 1. Diagrama de equilíbrio de fases do sistema Mg3(PO4)2-Ca3(PO4)2 .............................. 241 

Anexo 1.1 Segundo Enderle et al. .......................................................................................... 241 

Anexo 1.2 Segundo Carrodeguas et al. .................................................................................. 242 

Anexo 2. Diagrama de equilíbrio de fases do sistema CaO-P2O5 ............................................... 243 

Anexo 3. Diagrama de equilíbrio de fases do sistema CaO-P2O5-H2O........................................ 244 

 

 

 

 

 

 

 

 

 



 

 vi 

 

 

 

 

 

 

 

 



 

 vii 

Lista de Abreviaturas 

 

A Líquido de presa A: solução aquosa com 5 wt.% CA + 10 wt.% PEG + 
0.5% wt.% HPMC 

Setting liquid A 

AS Líquido de presa contendo sacarose, AS: solução aquosa com 5 wt.% CA 
+ 10 wt.% PEG) + 0.5% wt.% HPMC + 10wt.% S 

Setting liquid AS 

AF Líquido de presa contendo frutose, AF: solução aquosa com 5 wt.% CA + 
10 wt.% PEG + 0.5% wt.% HPMC + 10wt.% F 

Setting liquid AF 

AP Apatite 

Apatite 

BET Método de Brunauer–Emmett–Teller  

Brunauer–Emmett–Teller method 

BSA Albumina de soro bovino 

Bovine serum albumin 

CA Ácido cítrico 

Citric acid 

CaP Fosfato de cálcio 

Calcium phosphate  

CDHA Hidroxiapatite não-estequiométrica deficiente em cálcio 

Calcium deficient hydroxyapatite 

CP Pasta reativa ou pasta cimentícia  

Reactive paste 

CPC Cimento de fosfato de cálcio 

Calcium phosphate cement 

CPP Pirofosfato de cálcio 

Calcium pyrophosphate 

  



 

 viii 

DCPA Fosfato dicálcico ou monetite CaHPO4 

Dicalcium phosphate anhydrous 

DCPD Fosfato dicálcico dihidratado ou brushite CaHPO4·2H2O 

Dicalcium phosphate dihydrate 

Div Dias in vitro 

Days in vitro  

DSC Calorimetria diferencial de varrimento ou calorimetria exploratória 
diferencial 

Differential scanning calorimeter 

EBSS  Solução salina equilibrada de Earl 

Earle’s Balanced Salt Solution 

ECL  Quimioluminescência aumentada 

Enhanced chemiluminescence 

ECM  Matriz extracelular 

Extracellular matrix 

F Frutose  

Fructose 

FBS  Soro fetal bovino 

Fetal bovine serum 

FITC Isotiocianato de fluoresceína 

Fluorescein isothiocyanate 

FST Tempo final de presa  

Final setting time 

FT-IR Espectroscopia no infravermelho por transformada de Fourier 

Fourier Transform Infrared Spectrometry 

G Grânulos 

Granules 

HA Hidroxiapatite 

Hydroxyapatite 

HPMC Hidroxipropilmetilcelulose 

Hydroxypropyl methylcellulose 



 

 ix 

HT-XRD Difracção de raios X de alta temperatura 

high-temperature X-ray powder diffraction 

ICP-OES Espectrometria de emissão óptica por plasma acoplado indutivamente 

Inductively coupled plasma optical emission spectrometry 

IST Tempo inicial de presa  

Initial setting time  

LPR Razão líquido-pó 

Liquid-to-powder ratio 

MCPM Fosfato monocálcico monidratado 

Monocalcium phosphate monohydrate 

MgTCP Pó de TCP dopados com Mg 

Mg doped TCP powder 

MnCPC CPC dopado com Mn 

CPC doped with Mn 

MnTCP, 
Mn-TCP 

Pó de TCP dopados com Mn 

Mn doped TCP powder 

MnSrCPC CPC co-dopado com Mn e Sr 

CPC co-doped with Mn and Sr 

OCP Fosfato octacálcico 

Octacalcium phosphate   

O.D.  Densidade óptica 

Optical density 

O.D.f  Densidade óptica final. 

Final optical density 

P Pasta não reativa 

Non-reactive paste 

PBS Tampão fosfato-salino 

Phosphate-buffered saline 

PEG Polietilenoglicol 

Polyethylene glycol 



 

 x 

PMMA Polimetilmetacrilato 

Polymethylmethacrylate 

PS Tamanho de particular 

Particle size 

PSD Distribuição de tamanho de partícula 

Particle size distribution 

PVP polivinilpirrolidona 

polyvinylpyrrolidone 

RT Temperatura ambiente 

Room Temperature 

S Sacarose 

Sucrose 

SBS Dodecil sulfato de sódio 

Sodium dodecyl sulfate 

SEM 

 

Microscopia electrónica de varrimento 

Scanning Electron Microscopy 

SrCPC CPC dopado com Sr 

CPC doped with Sr 

Sr-TCP Pó de TCP dopados com Sr 

Sr doped TCP powder 

SSA Área superficial específica 

Specific surface area 

TCP Fosfato tricálcico 

Tricalcium phosphate 

TTCP Fosfato tetracálcico 

Tetracalcium phosphate 

XRD Difracção de raios X 

X-ray powder diffraction 

 



 

 1 

Introdução Geral 

 

O envelhecimento da população e o consequente aumento da incidência de 

doenças ósseas, tais como a osteoporose, osteomielite e tumores malignos, e de 

acidentes traumáticos, entre outros, têm gerado uma procura crescente de 

materiais de preenchimento e de reparação óssea [1, 2]. Para fazer face à essa 

multiplicidade de patologias e de traumatismos que necessitam de respostas 

adequadas, grandes têm sido os esforços de investigação nesta área com vista 

ao desenvolvimento de uma grande variedade de substitutos ósseos.  

Em geral, existem 206 ossos no esqueleto humano adulto e cerca de 300 ossos 

no de uma criança. O osso, material compósito natural, é um tecido dinâmico em 

contínua remodelação ao longo da vida por ação de uma importante atividade 

metabólica das células ósseas. A atividade conjunta destas células contribui para 

a degradação de áreas lesadas ou envelhecidas do osso (osteoclastos), a sua 

regeneração (osteoblastos) e sua manutenção (osteócitos) [3]. No entanto, este 

processo biológico pode ser demasiado longo ou não ser suficiente, 

especialmente no caso de perda óssea significativa de origem traumática ou 

patológica. A osteoporose, por exemplo, que afeta um número crescente de 

pacientes, muito devido ao aumento da esperança média de vida, requer o 

preenchimento de lesões, por vezes, de difícil acesso. Para superar os vários 

problemas, diversos procedimentos cirúrgicos foram desenvolvidos para a 

implantação de enxertos ósseos de diferentes origens. Os enxertos autógenos 

(utilização de osso do mesmo paciente) estão entre os mais bem-sucedidos, mas 

deparam-se com limitações óbvias no que respeita à fraca disponibilidade de 

tecido recolhido, morbidez, e complicações no local da colheita. Os enxertos 

alógenos (osso de cadáver de indivíduo da mesma espécie) e xenógenos (osso 

de espécie diferente da do recetor) apresentam também vários inconvenientes, 

entre as quais a grande probabilidade de rejeição e de transmissão de doenças 

infeciosas [4]. Tendo em conta os maiores riscos de infeção e de contaminação  



Introdução Geral 

 2 

dos materiais de origem biológica, o desenvolvimento de substitutos ósseos 

sintéticos tem vindo a ganhar cada vez mais importância nos últimos anos. Entre 

os últimos materiais desenvolvidos encontram-se os cimentos minerais 

hidráulicos, nomeadamente, os cimentos de fosfatos de cálcio, usados para o 

enchimento de cavidades ósseas e dentárias. Estes cimentos apresentam a 

vantagem de ser biocompatíveis, bioativos e biomiméticos permitindo uma ótima 

integração do material no local implantado [1, 5, 6]. De facto, o tecido ósseo é 

constituído por ~60% de fase mineral, sendo a hidroxiapatite deficiente em cálcio, 

a fase dominante. As propriedades osteocondutoras e potencialmente 

osteoindutoras destes cimentos, e a sua potencial biodegradabilidade são outras 

características atrativas para o seu uso. Além disso, apresentando-se sob a forma 

de uma pasta que endurece in situ, eles dão estabilidade a defeitos com qualquer 

geometria sendo particularmente adequados para técnicas cirúrgicas 

minimamente invasivas, desde que as suas propriedades de fluxo sejam 

adequadas [6]. Infelizmente esta condição nem sempre é alcançada com 

sucesso, devido principalmente a fenómenos de separação de fases sólida-líquida 

durante a extrusão da pasta e ao consequente entupimento das agulhas ou 

cânulas de injeção [7-9]. Em termos de propriedades mecânicas, eles 

apresentam-se muitas vezes frágeis e a sua cinética de ressorção após 

implantação nem sempre é ajustada ao da neoformação óssea. O desajuste 

iónico dos cimentos em relação à composição óssea é também um fator que 

limita o seu desempenho biológico. Estas deficiências, consensualmente 

reconhecidas por médicos, justificam o contínuo esforço de investigação 

recentemente dedicado aos cimentos de fosfato de cálcio [2, 5, 6, 10-14]. 

O trabalho apresentado nesta tese visou o desenvolvimento de cimentos de 

fosfatos de cálcio ácidos e reabsorvíveis à base de brushite, nos quais o cálcio foi 

parcialmente substituído por outros elementos, tais como o estrôncio (Sr) e o 

manganês (Mn), com propriedades melhoradas em termos de injectabilidade e de 

resistência mecânica, desejavelmente adequadas para aplicações em 

vertebroplastia. Este é um procedimento cirúrgico minimamente invasivo para 

reparar fraturas de vertebras osteoporóticas que colapsam sob os esforços de 

compressão. Para esse fim, o cimento ósseo terá de apresentar um conjunto 



Introdução Geral 

 3 

muito exigente de propriedades: (i) um adequado comportamento ao fluxo através 

da agulha da seringa, incluindo viscosidade e coesão apropriadas a um 

manuseamento fácil e a uma injectabilidade completa, a par de uma capacidade 

de endurecimento rápido (em alguns minutos) em contacto com os fluidos e 

tecidos biológicos; (ii) atingir, depois de implantado, uma resistência mecânica 

comparável à do osso; (iii) rápido crescimento de novo osso e remodelação do 

defeito ósseo de modo a reduzir o risco de falha do implante. Com a incorporação 

de pequenas quantidades de elementos dopantes nos pós de partida, esperam-se 

efeitos positivos relacionados com os processos biológicos e de integração do 

cimento ósseo nos tecidos circundantes. 

A obtenção de um cimento com tais características é uma tarefa muito ambiciosa 

uma vez que as variáveis que as determinam exercem muitas vezes efeitos 

antagónicos quer no que respeita ao manuseamento quer às suas propriedades 

funcionais. Se as propriedades mecânicas do implante forem similares às do 

osso, o risco de falha estrutural do implante é mais reduzido. No entanto, uma 

resistência mecânica elevada é frequentemente associada a uma fração de 

porosidade baixa, a qual, por sua vez, condiciona o crescimento ósseo através do 

implante. Além disso, neste procedimento cirúrgico a pasta cimentícia é injetada e 

a injectabilidade varia diretamente com a razão entre os componentes líquido e 

sólido (pó) usados na sua preparação. Assim, quanto maior for a razão líquido-pó 

usada, menor será a resistência mecânica dos cimentos. A solução passará 

portanto por um compromisso entre estas características.  

Esta tese está estruturada em seis capítulos. No Capítulo 1 são apresentadas 

algumas noções gerais e algumas referências bibliográficas que permitem situar 

este trabalho no domínio dos cimentos ósseos à base de fosfatos de cálcio. Este 

inclui portanto várias secções que abordam, com algum detalhe, generalidades 

que vão desde a composição e estrutura do osso até ao uso dos cimentos de 

fosfatos de cálcio como substitutos ósseos. As metas e os objetivos desta tese 

estão apresentados no final deste capítulo. 

Nas introduções dos capítulos seguintes (capítulos 2 a 5) encontram-se revisões 

bibliográficas mais orientadas para uma melhor compreensão das motivações que 



Introdução Geral 

 4 

levaram à realização dos vários estudos que compõem esta tese e dos 

respectivos resultados que foram obtidos.  

O Capítulo 2 está relacionado com dois tipos de pós precursores, ??fosfato 

tricálcico e ??fosfato tricálcico, usados em muitas composições de cimentos de 

fosfatos de cálcio. A obtenção de pós de ?? fosfato tricálcico puros, não dopados 

ou dopados em laboratório, continua a não ser fácil e as influências de factores 

experimentais na transformação entre estes dois polimorfos ainda não estão bem 

clarificadas. De facto ? e ?  são fases alotrópicas e o trabalho apresentado neste 

capítulo traz um aporte de informação complementar sobre a estabilidade térmica 

destas fases, em presença de impurezas de pirofosfato de cálcio e de magnésio 

como dopante. Apesar das composições dopadas com magnésio não terem sido 

usadas nos estudos seguintes, esclarecer o papel deste ião na estabilidade 

térmica da fase ?? fosfato tricálcico foi considerado essencial para uma melhor 

compreensão dos efeitos dos outros iões dopantes usados neste trabalho. Esta 

escolha ficou ainda a dever-se ao facto de existirem vários estudos na literatura 

referentes às transformações de fase ? ? ?  de fosfato tricálcico dopado com 

magnésio. Para isso foram sintetizados e caracterizados pós de ?-fosfato 

tricálcico dopados com teores diferentes de magnésio e sujeitos a diferentes 

condições de tratamento térmico. É de salientar que os resultados obtidos neste 

estudo influenciaram de certa forma o tipo de pó usado no Capítulo 3. 

No Capítulo 3 é explorada a influência do tamanho e distribuição de tamanho de 

partículas de pós de ?-fosfato tricálcicos e do seu estado de agregação na 

injectabilidade de sistemas não reativos e reativos. Para o efeito foram 

preparados e usados pós de ?-fosfato tricálcicos dopados com Sr. Este elemento 

foi introduzido para aumentar a estabilidade térmica do ?-fosfato tricálcico e, pelas 

suas propriedades de ião biologicamente ativo e de agente rádio opacificante.  

O Capítulo 4 descreve a síntese e a caracterização físico-química de pós de 

?-fosfato tricálcico dopados com vários teores de Mn e a sua resposta biológica 

in vitro. Assim, este estudo permitiu avaliar o interesse da incorporação de Mn (e 



Introdução Geral 

 5 

em que teores) no desempenho biológico de cimentos de fosfatos de cálcio 

preparados no capítulo 5.  

O Capítulo 5 reporta resultados de investigação levados a cabo com base nos 

resultados obtidos nos dois capítulos anteriores, nomeadamente, envolvendo a 

preparação e caracterização diversos pós ?-fosfato tricálcico dopados com Sr e 

Mn. Neste caso, para além do líquido reativo normal, foram também preparados 

cimentos com líquidos contendo açúcares (sucrose, também denominada por 

sacarose, e frutose) e avaliados os seus efeitos em termos de manuseamento 

(tempo de início de presa e injectabilidade), propriedades físicas (resistência a 

compressão e porosidade) e do seu desempenho biológico in vitro. 

No Capítulo 6 estão apresentadas as conclusões gerais que puderam ser 

retiradas das discussões de todos os resultados apresentados ao longo da tese, 

bem como algumas perspetivas interessantes para trabalhos futuros. 

Finalmente, em Anexos estão apresentados alguns diagramas de fases 

referênciados no capítulo 2, com o intuito de auxiliar o leitor facultando-lhe uma 

consulta rápida. 

 

É de referir que nos capítulos de 2 a 5 estão apresentados os artigos publicados 

(capítulos 2 a 4) ou submetidos para publicação (capítulo 5) em jornais do 

Science Citation Index, relativos aos estudos realizados. Estes capítulos são 

apresentados em inglês, ao contrário das restantes partes da tese que estão 

escritas em português. No capítulo 5, as informações suplementares do artigo 

foram colocadas ao longo do texto, e não em anexo, para facilitar a sua leitura e 

compreensão. À excepção do trabalho experimental envolvendo testes biológicos, 

a autora deu os seguintes contributos relevantes para a elaboração experimental 

e escrita dos seguintes estudos: 

Capitulo 2 - Maior parte do planeamento e do trabalho experimental. Maior parte 

da escrita. 



Introdução Geral 

 6 

Capitulo 3 - Parte do planeamento e maior parte do trabalho experimental. Maior 

parte da escrita. 

Capitulo 4 - Maior parte do planeamento, todo o trabalho experimental e 

preparação dos materiais para os testes biológicos. Maior parte da escrita. 

Capitulo 5 - Maior parte do planeamento, todo o trabalho experimental e 

preparação dos materiais para os testes biológicos. Parte da escrita. 

 

Referências bibliográficas  

[1] S.V. Dorozhkin, Calcium orthophosphates cements for biomedical application, 

J. Mater. Sci: Mater. Med. 43 (2008) 3028-57. 

[2] M. Bohner, U. Gbureck, J.E. Barralet, Technological issues for the 

development of more efficient calcium phosphate bone cements: a critical 

assessment, Biomaterials. 26 (2005) 6423-9. 

[3] R.R. Seeley, T.D. Stephens, P. Tate, Anatomia e fisiologia, Lusodidádica, 

Anatomia &amp;amp; fisiologia, 2001. 

[4] A.R. Amini, C.T. Laurencin, S.P. Nukavarapu, Bone Tissue Engineering: 

Recent Advances and Challenges, Crit. Rev. Biomed. Eng. 40 (2012) 363-408. 

[5] M Bohner, Reactivity of calcium phosphate cements, J. Mater. Chem. 17 

(2007) 3980-6. 

[6] S. Dorozhkin, Self-Setting Calcium Orthophosphate Formulations, J Funct. 

Biomater. 4 (2013) 209-311. 

[7] M. Habib, G. Baroud, F. Gitzhofer, M. Bohner, Mechanisms underlying the 

limited injectability of hydraulic calcium phosphate paste, Acta Biomater. 4 (2008) 

1465-71. 



Introdução Geral 

 7 

[8] M. Habib, G. Baroud, F. Gitzhofer, M. Bohner, Mechanisms underlying the 

limited injectability of hydraulic calcium phosphate paste. Part II: Particle 

separation study, Acta Biomater. 6 (2010) 250-6. 

[9] M. Bohner, G. Baroud, Injectability of calcium phosphate pastes, Biomaterials. 

26 (2005) 1553-63. 

[10] E.F. Burguera, H.H.K. Xu, L.M. Sun, Injectable calcium phosphate cement: 

Effects of powder-to-liquid ratio and needle size 9, J. Biomed. Mater. Res. B Appl. 

Biomater. 84B (2008) 493-502. 

[11] H.L. Alves, L.A. Dos Santos, C.P. Bergmann, Injectability evaluation of 

tricalcium phosphate bone cement, J. Mater. Sci. Mater. Med. 19 (2008) 2241-6. 

[12] S. Pina, S.M. Olhero, S. Gheduzzi, A.W. Miles, JM. Ferreira, Influence of 

setting liquid composition and liquid-to-powder ratio on properties of a Mg-

substituted calcium phosphate cement, Acta Biomater. 5 (2009) 1233-40. 

[13] S. Pina, P.M. Torres, J.M. Ferreira, Injectability of brushite-forming Mg-

substituted and Sr-substituted alpha-TCP bone cements, J Mater Sci Mater 

medicine. 21 (2010) 431-8. 

[14] S. Pina, Vieira SI, P.M. Torres, Goetz-Neunhoeffer F, J. Neubauer, O.A. da 

Cruz e Silva, et al. In vitro performance assessment of new brushite-forming Zn- 

and ZnSr-substituted beta-TCP bone cements, J. Biomed. Mater. Res. B, Appl. 

Biomater. 94 (2010) 414-20. 

 
 

 



  

 8 

 

 

 

 

 

 

 

 

 



  

 9 

 

 

Capítulo 1 

 

Composição, estrutura e metabolismo do 

osso, e a importância dos cimentos de 

fosfato de cálcio como material substituto do 

tecido ósseo: noções gerais e objetivos deste 

estudo 

 



  

 10 

 



Capítulo 1 

 11 

O tecido ósseo é um material vivo que tem uma fascinante habilidade de se auto 

remodelar. Altamente adaptável, ele remodela-se para atender a necessidades 

relacionadas com suas funções específicas; por exemplo, ele reabsorve quando 

pouca ou nenhuma força externa é aplicada por um longo período de tempo, ou 

reconstrói quando for necessária uma maior dureza ou resistência. Essa 

facilidade de renovação concede ao osso a capacidade de auto reparação 

permitindo a regeneração de um defeito ósseo (de pequena dimensão) sem 

deixar cicatriz. Mas em alguns casos, a remodelação só por si não é suficiente e é 

necessário recorrer à implantação de um biomaterial de enchimento (natural ou 

sintético) para substituir o osso em falta e, se possível, servir de suporte a uma 

remodelação do próprio biomaterial com o objetivo de formar novo osso. Além de 

apresentar algumas noções gerais sobre este tema, este capítulo dará uma 

atenção especial a uma classe de biomateriais, os cimentos de fosfato de cálcio, 

o foco do presente estudo. 

 

1. Estrutura, composição e propriedades do osso 

O corpo humano adulto é constituído por cerca de 206 ossos. De tamanho, forma, 

composição e estrutura complexa e diversificada, estes materiais compósitos 

desempenham diferentes funções. Juntamente com os músculos, eles constituem 

os alicerces do corpo humano tendo portanto uma função estrutural. O esqueleto 

serve de ponto de fixação para tendões e apoio aos tecidos moles entre os quais 

se encontram os músculos e os ligamentos. Além disso, em algumas partes do 

corpo, eles têm também a função de proteger órgãos vitais, como por exemplo, o 

cérebro através da caixa craniana, o coração e os pulmões através da caixa 

torácica, a bexiga e vísceras pélvicas através da pélvis e a espinal medula que é 

protegida pelas vértebras. A matriz óssea representa também o maior reservatório 

de iões minerais do organismo, particularmente de cálcio e fósforo. 99% do cálcio 

e 90% do fósforo no nosso corpo estão armazenados nos ossos, cartilagem e 

dentes. Todos os ossos têm uma participação ativa na manutenção da 

homeostase do cálcio mas somente alguns (essencialmente, osso esterno, ossos 

ilíacos, vértebras e costelas) mantêm sua função hematopoiética no corpo adulto: 



Capítulo 1 

 12 

eles participam no processo de formação de células do sangue, nomeadamente 

pela medula óssea vermelha, que produz os glóbulos vermelhos, os glóbulos 

brancos e as plaquetas do sangue. 

 

1.1 Macroestrutura do osso 

Os ossos podem ser classificados quanto à sua forma em osso longos (como o 

fémur, radio, úmero, tíbia), curtos (como o carpo e o tarso), planos (como o 

esterno, frontal, parietais, omoplata) e irregulares (como as vertebras).  

A Fig. 1 apresenta uma estrutura típica de um osso longo. Ele é composto por 

duas partes principais: a diáfise, parte central e cilíndrica, e as epífises proximal e 

distal, suas extremidades.  

 

 

 

 

 

 

 

 

 

 

Fig. 1. Desenho representativo da estrutura de um osso longo (a) e ampliações da estrutura da 

epífise proximal (b) e de uma secção da diáfise (c) (adaptado de [1]). 

Diáfise

Epífise
distale

Epífise
proximale

Cavidade 
medular

Osso cortical

Cartilagem
articular 

Osso
trabecular

Cartilagem
articular 

Osso trabecular

Osso cortical

Osso cortical

(a) (c)

(b)
medula óssea 

amarela

endósteo

periósteo

periósteo

Linha 
epifisial

Artérias 
nutrientes

perfurantes 
(fibras de 
Sharpey).

Diáfise
ósteons

Canal 
de Havers

Diáfise

Epífise
distale

Epífise
proximale

Cavidade 
medular

Osso cortical

Cartilagem
articular 

Osso
trabecular

Cartilagem
articular 

Osso trabecular

Osso cortical

Osso cortical

(a) (c)

(b)
medula óssea 

amarela

endósteo

periósteo

periósteo

Linha 
epifisial

Artérias 
nutrientes

perfurantes 
(fibras de 
Sharpey).

DiáfiseDiáfise

Epífise
distale

Epífise
proximale

Cavidade 
medular

Osso cortical

Cartilagem
articular 

Osso
trabecular

Cartilagem
articular 

Osso trabecular

Osso cortical

Osso cortical

(a) (c)

(b)
medula óssea 

amarela

endósteo

periósteo

periósteo

Linha 
epifisial

Artérias 
nutrientes

perfurantes 
(fibras de 
Sharpey).

Diáfise
ósteonsósteons

Canal 
de Havers



Capítulo 1 

 13 

O tecido ósseo da diáfise é composto por osso compacto também denominado 

por osso cortical ou lamelar. Este prolonga-se sobre toda a periferia do osso, 

protegendo a sua parte interna. No interior da diáfise, dentro da cavidade 

medular, encontra-se a medula óssea amarela constituída principalmente por 

tecido adiposo. No interior das extremidades existe outro tipo de tecido ósseo, 

osso esponjoso também conhecido como osso trabecular, de porosidade muito 

superior à do osso cortical. A recobrir as epífises está uma fina camada de 

cartilagem articular que permite reduzir a fricção e amortizar os choques.  

O osso cortical é composto por fibras de colagénio sobre as quais se 

desenvolvem cristais do mineral ósseo. Estas fibras estão coladas paralelamente 

umas às outras e organizadas em lamelas concêntricas formando os ósteons 

(Fig. 1c). Estes são atravessados por uma rede tridimensional de nervos e de 

vasos sanguíneos. A organização compacta dos ósteons permite ao osso cortical 

desempenhar um papel predominante no suporte mecânico (resistência e rigidez) 

e na função de proteção do esqueleto. Enquanto o osso cortical tem uma 

estrutura densa e microporosa (~10% de porosidade de diâmetro de poro de 1 a 

10 µm), o osso trabecular é formado por uma estrutura macro porosa (~55-70% 

de porosidade interligada [2] de 200 a 400 µm [3]), originando uma importante 

superfície de trocas com os fluidos biológicos que lhe confere propriedades 

funcionais e estruturais diferentes, nomeadamente funções metabólicas tais como 

a homeostase do cálcio. 

As superfícies do osso são recobertas por membranas de tecidos conjuntivos, o 

periósteo e o endósteo (Fig. 1c). Ambos possuem a função de nutrição e 

fornecimento de novos osteoblastos para o crescimento e regeneração do osso. 

O periósteo reveste a superfície externa não articulada do osso. Este é 

constituído por: (i) uma camada externa que consiste num tecido conjuntivo 

fibroso denso, rico em fibras de colagénio e alguns fibroblastos, e (ii) uma camada 

interna composta por células osteoprogenitoras com a capacidade de se dividir 

por mitose e se diferenciar em osteoblastos. O periósteo fixa-se ao tecido ósseo 

através das fibras de sharpney (fibras de colagénio especialmente do tipo I) 

(Fig. 1c). O periósteo possui vasos sanguíneos e nervos que transportam sangue 



Capítulo 1 

 14 

até ao interior do osso para entrega de nutrientes, através dos canais de 

Volkmann. O endósteo consiste numa membrana que reveste interiormente a 

superfície do tecido ósseo que forma a cavidade medular, formada por células 

osteoprogenitoras e osteoblastos, e por uma pequena quantidade de tecido 

conjuntivo.  

 

1.2 Microestrutura do osso 

1.2.1 Composição e propriedades do osso  

O osso é formado por células ósseas e por um material extracelular (~90% do 

peso ósseo total), chamado de matriz óssea. Esta matriz extracelular é constituída 

por ~65% de uma matriz mineral à base de fosfato de cálcio, ~5% de água e 

~30% de uma matriz orgânica [4-6]. Esta última, composta por cerca de 90% de 

fibras de colagénio do tipo I e por uma substância basal contendo proteoglicanos 

e glicoproteínas, é a primeira a ser sintetizada aquando da formação do osso, 

sendo posteriormente mineralizada por minerais de fosfato de cálcio. O carácter 

compósito do tecido ósseo confere-lhe propriedades excecionais, nomeadamente 

mecânicas. A componente orgânica do osso dá flexibilidade e resiliência ao osso, 

enquanto a matriz inorgânica traz dureza e rigidez. 

Devido ao facto do osso ser um tecido altamente adaptável, as suas propriedades 

mecânicas variam entre os indivíduos, com a idade, de acordo com o local no 

corpo, devido a doenças. Valores aproximados de algumas propriedades 

mecânicas e porosidade do osso podem ser encontrados na Tabela 1, mostrando 

as diferenças entre os dois tipos de tecidos ósseos. 

Tabela 1. Propriedades mecânicas e porosidade do osso 

Resistência mecânica à 
compressão  

Módulo de Young Porosidade 
Tipo de osso 

(MPa) (GPa) (%) 

Cortical [5-12] 130-300 0,5-40 5-13 

Trabecular [7, 8, 13, 14] 0,6-12 0,05-0.9 30-90 

 



Capítulo 1 

 15 

A parte mineral do osso é composta por uma apatite. A apatite forma uma 

alargada família de minerais do grupo dos fosfatos cuja fórmula química geral dos 

compostos estequiométricos é: 

Me10(XO4)6Y2 

em que Me é um metal divalente (Ca2+, Sr2+, Ba2+); XO4 um anião trivalente 

(PO4
3?, VO4

3?, AsO4
3?) e o Y um anião monovalente (OH?, F?, Cl?) [15]. As apatites 

cristalizam no sistema hexagonal (grupo espacial P63/m), e esta estrutura tem a 

capacidade de aceitar muitas substituições atómicas de diferentes valências em 

Me, XO4 e Y, e, lacunas em Me e Y. Entre elas encontra-se a hidroxiapatite 

estequiométrica (Ca10(PO4)6(OH)2, HA), um dos fosfatos de cálcio mais estáveis 

do ponto de vista termodinâmico. Mas a apatite que compõe a parte mineral do 

osso, longe de ser estequiométrica, é muito mais complexa que a HA. É uma 

apatite deficiente em cálcio, poli-substituída, carbonatada, contendo iões HPO4
2?, 

e que pode ser muito pouco hidroxilizada (OH?). Ela pode ser descrita pela 

fórmula geral [16] a seguir apresentada, mas tendo em atenção que a composição 

do osso varia entre indivíduos e consoante a localização, idade, sexo, a existência 

de doenças e regime alimentar: 

 

Ca8,3 ?1.7 (PO4)4,3 (CO3)1,0 (HPO4)0,7 (CO3,OH)0,3 ?1,7 

         Me2+       XO4
3?            Y? 

em que ? indica uma lacuna na estrutura . 

 

A carbonatação pode ser de dois tipos, A e B, que podem ocorrer em simultâneo. 

Quando os iões carbonato (CO3
2?) substituem os iões hidroxilo (OH?), a 

carbonatação diz-se do tipo A. Ela é do tipo B quando eles substituem os iões 

fosfato (PO4
3?) e esta substituição é acompanhada pela criação de uma lacuna de 

ca2+ e de uma de OH? numa proximidade imediata a fim de manter a 

eletroneutralidade de cargas. Além da carbonatação, a apatite óssea apresenta 



Capítulo 1 

 16 

também substituições de iões PO4
3? por iões hidrogenofosfato HPO4

2?. O conjunto 

destas substituições conduz a uma apatite deficiente em cálcio e fracamente 

hidroxilizada [17] com um grau de cristalinidade baixo [18] (também devido ao 

tamanho nanométrico dos cristais). A extensão da carbonatação depende dos 

indivíduos, da localização do osso e da idade, havendo uma tendência para 

aumentar ao longo da vida [16].  

Além disso, os nano cristais, que constituem a apatite biológica, apresentam à 

superfície uma camada hidratada, estruturada mas frágil, que contem iões (Ca2+, 

HPO4
2?, CO3

2?) suscetíveis de interagir com os fluidos circundantes [19]. Este 

fator é um dos principais responsáveis pela reatividade excecional deste 

composto, nomeadamente no que respeita a trocas iónicas e, absorção de iões e 

de moléculas biológicas (proteínas) [19, 20]. 

 

1.2.2 Células ósseas  

O tecido ósseo é constituído por quatro tipos de células ósseas: células 

osteoprogenitoras, os osteoblastos, os osteócitos e os osteoclastos. As células 

ósseas têm origem nas células estaminais, mais especificamente nas células 

estaminais mesenquimatosas que se podem diferenciar em vários tipos de 

células. Dependendo das condições de meio celular envolvente, estas podem ser 

células osteoprogenitoras, células indiferenciadas, que têm a capacidade de se 

diferenciar em osteoblastos. Estas células estão localizadas, como já referido na 

secção 2.1.1, no periósteo e no endósteo. No caso dos osteoclastos, elas derivam 

das células estaminais hematopoiéticas (provenientes da medula óssea 

vermelha).  

As células osteoprogenitoras são células indiferenciadas. Elas permanecem 

nesse estado indiferenciado até receberem um estímulo adequado, 

diferenciando-se então em osteoblastos.  

Os osteoblastos são células diferenciadas mononucleares responsáveis pela 

formação de matriz óssea. Situadas na periferia do osso em formação, estas 



Capítulo 1 

 17 

células são responsáveis pela síntese e deposição nas superfícies ósseas de uma 

matriz proteica de novo material intercelular (incluindo colagénio do tipo I) 

denominada osteoide (matriz óssea ainda não calcificada) que vai sendo 

mineralizada formando novo osso. A mineralização da matriz avança 

gradualmente em direcção à última camada de osteoide secretado. Iões cálcio e 

fosfato e ainda algumas enzimas são acumuladas em vesículas que vão sendo 

secretadas pelas células contribuído para a progressiva mineralização. A 

fosfatase alcalina, uma das enzimas produzidas, cliva o pirofosfato removendo a 

sua influência estabilizadora e, ao mesmo tempo, aumenta o fosfato local 

disponível para a cristalização. 

Os osteócitos (células maduras) são provenientes dos osteoblastos que ficaram 

presos e cercados por matriz óssea produzida por eles próprios. Ocupando 

lacunas ósseas, estas células comunicam entre si e com as células da superfície 

óssea, através de uma rede de canalículos, que contêm os seus numerosos 

prolongamentos citoplasmáticos permitindo a passagem de nutrientes e de muitas 

outras substâncias. Eles têm um papel fundamental na manutenção da 

integridade da matriz óssea. Estas células captam as alterações da matriz óssea 

e os estímulos mecânicos que atuam sobre o osso (mecanossensores) e 

transmitem estas informações às células da superfície para que estas possam 

ativar os processos de remodelação óssea, sempre que estes sejam necessários 

Os osteoclastos são células polinucleadas de grandes dimensões e que se 

localizam nas superfícies ósseas, principalmente no endósteo e, ocasionalmente, 

na superfície do periósteo. Eles são responsáveis pela reabsorção óssea através 

de um processo sequencial, químico e enzimático. A primeira fase consiste num 

processo de acidificação (produção de protões H+) que provoca a dissolução da 

fase mineral da matriz óssea. Numa segunda fase, tem lugar a degradação 

completa da fase orgânica por ação de numerosas enzimas proteolíticas, sendo a 

colagenase uma das principais.  

 

 



Capítulo 1 

 18 

1.3 Remodelação e autorreparação óssea  

O osso é um tecido em constante mudança pois ele tem a capacidade de se 

remodelar continuamente durante toda a vida. A remodelação óssea é um 

processo dinâmico resultante de um equilíbrio entre a reabsorção e neo-formação 

óssea. Ela envolve portanto a remoção de osso velho e a formação de osso novo 

através da ação dos osteoclastos e dos osteoblastos, respetivamente. Este 

processo permite ao tecido ósseo adaptar-se às mudanças nas tensões e forças 

mecânicas a que está sujeito, prevenir a degeneração óssea, regular a 

concentração de iões (especialmente de cálcio) nos fluidos biológicos, 

conferindo-lhe a capacidade de se autorreparar desde que o tamanho do defeito 

seja inferior a um certo valor crítico [21].  

Em geral, o processo, constituído por várias fases, inicia-se com a formação de 

um hematoma à volta do local fraturado, acompanhado por uma reação 

inflamatória. De seguida, o hematoma é substituído gradualmente por uma 

substância fibrosa (calo fibroso): os fibroblastos invadem o hematoma levando a 

formação de um complexo de fibrina. Com o desenvolvimento de vasos 

sanguíneos, a presença de osteoblastos, a formação de colagénio e a deposição 

de cálcio dá-se a formação de cartilagem (calo fibrocartilagíneo). Os osteoclastos 

vão reabsorvendo o osso morto e promovendo a ossificação do calo que sofre 

posterior remodelação. Os osteoblastos restabelecem o sistema ósseo original, 

que só é possível se não houver mais tecido fibroso no espaço [21].  

É de notar que a consolidação óssea de uma fratura é dependente de fatores 

diretamente relacionados com o indivíduo (idade, sexo, fatores hormonais, 

nutricionais, mecânicos, entre outros) e com as características inerentes à fratura 

(tamanho, capacidade de vascularização, o tipo de tecido ósseo) [21]. 

Normalmente, as células ósseas podem promover a reparação de osso danificado 

após fratura ou cirurgia. Mas, como mencionado na secção anterior, se o defeito 

exceder um tamanho crítico (~1 cm), a reconstrução óssea não ocorre com 

rapidez suficiente, formando-se tecido fibroso em vez de osso dentro do defeito. 



Capítulo 1 

 19 

Uma das formas de prevenir isso é preenchendo o defeito com um substituto 

ósseo. 

 

2. Materiais de substituição óssea 

Os substitutos ósseos podem ser biodegradáveis, desaparecem do local da 

implantação após determinado período de tempo, ou não biodegradáveis 

(inertes), que residem dentro do defeito por tempo indefinido. O uso de substitutos 

biodegradáveis é muitas vezes vantajoso visto que o tecido ósseo pode substituir 

o biomaterial implantado à medida que este se degrada. A taxa de ressorção do 

biomaterial deve ser adequada à taxa de formação do novo osso para assim 

assegurar uma transição harmoniosa entre eles e evitar o risco de crescimento de 

tecido fibroso.  

Relativamente aos implantes biodegradáveis, existem vários aspetos importantes 

a ter em conta tais como as propriedades de manuseamento, as capacidades 

osteocondutoras e osteoindutoras, a taxa de degradação e, dependendo do local, 

as propriedades mecânicas. A degradação de um implante pode ocorrer através 

de mecanismos que envolvem um processo de dissolução (processo físico-

químico e dependente da solubilidade do material) e/ou processos biológicos que 

são mediados por agentes biológicos (como enzimas e células) [22, 23].  

É importante referir que a taxa de degradação está fortemente relacionada com a 

porosidade do material. De facto, o aumento da porosidade leva geralmente a um 

aumento da área superficial exposta ao meio envolvente, onde a dissolução e/ou 

a degradação mediada pelas células e enzimas podem ocorrer, levando assim a 

um aumento da taxa de degradação.  

Existem muitos tipos de substitutos ósseos, que podem ser classificados em duas 

grandes famílias, os naturais e os sintéticos. Como já referido na Introdução 

Geral, as limitações dos naturais levaram a um aumento substancial da 

investigação na área dos biomateriais sintéticos. Estes permitem obter substitutos 

ósseos de forma reprodutível, em quantidade praticamente ilimitada, com menos 



Capítulo 1 

 20 

riscos de contaminações. Estes podem ser constituídos por diferentes tipos de 

materiais (metais, ligas, polímeros, cerâmicos) podendo apresentarem-se sob 

diversas formas (blocos maciços ou porosos, grânulos porosos, pós, géis, 

cimentos, etc.). 

Nas últimas décadas, muitos biomateriais quando implantados em locais 

heterotópicos demonstraram possuir aptidão para induzir a formação de osso, 

capacidade que se designa de osteoindução [24]. Espera-se portanto que a 

implantação de um biomaterial com propriedades osteoindutoras num defeito 

ósseo aumente a taxa de formação de osso, permitindo uma degradação e 

remodelação mais rápida. Apesar de muitos estudos já terem mostrado a 

capacidade osteoindutora de vários tipos de biomateriais (sobretudo biomateriais 

à base de fosfato de cálcio), o mecanismo biológico subjacente a este fenómeno 

ainda não está bem compreendido [24]. Mas os substitutos de preenchimento 

ósseo à base de fosfatos de cálcio, conhecidos por serem bioativos em termos de 

osteocondutividade, mostram serem também potencialmente osteoindutivos [24]. 

 

3. Fosfatos de cálcio como substitutos ósseos 

Os compostos de fosfato de cálcio (CaP, calcium phosphate) têm sido estudados 

como substitutos ósseos já há cerca de 100 anos [25]. O interesse por estes 

compostos químicos deve-se à sua similaridade química com a parte inorgânica 

da maior parte dos tecidos duros (ossos, dentes, chifres de veados, etc.) normais 

ou com patologia dos mamíferos [26]. Estes compostos, como já referido 

anteriormente, podem ser naturais ou sintéticos. O primeiro estudo sobre um 

fosfato de cálcio sintético utilizado in vivo foi publicado em 1920 por Fred Albee e 

Harold Morrison para reparação de fratura óssea em coelhos [27]. 

Biocompatíveis, eles estão disponíveis sob diversas formas como blocos densos 

ou porosos, granulados, cimentos, revestimentos de próteses metálicas, entre 

outros [22].  

 



Capítulo 1 

 21 

3.1 Fosfatos de cálcio 

Derivados de neutralizações sucessivas do ácido fosfórico, estes compostos 

podem ser classificados em três principais grupos: os ortofosfatos baseados em 

PO4
3?, os metafosfatos baseados em PO3

? e os pirofosfatos P2O7
4?.  

Os ortofosfatos de cálcio, comummente denominados por fosfatos de cálcio 

(termo usado ao longo desta tese) são os mais usados nas composições dos 

cimentos de fosfato de cálcio, apesar dos pirofosfatos de cálcio estarem a ter 

cada vez mais interesse [28, 29]. Encontram-se listados na Tabela 2 alguns dos 

mais relevantes fosfatos de cálcio.  

Tabela 2. Fosfatos de cálcio mais comuns [26]. 

Composto 
Abreviatura 

(termos  
em inglês) 

Fórmula Ca/P 

Fosfato monocálcico monidratado 
(Monocalcium phosphate monohydrate) 

MCPM Ca(H2PO4)2.H2O 0,5 

Fosfato monocálcico anidro 
(Monocalcium phosphate anhydrous) 

MCPA Ca(H2PO4)2 0,5 

Fosfato dicálcico diidratado ou brushite 
(Dicalcium phosphate dihydrate or 
brushite) 

DCPD CaHPO4.2 H2O 1 

Fosfato dicálcico anidro ou monetite 
(Dicalcium phosphate anhydrous or 
monetite) 

DCPA CaHPO4 1 

Fosfato octacálcico 
(Octacalcium phosphate) 

OCP Ca8(HPO4)2(PO4)4.5H2O 1,33 

Fosfato de cálcio amorfo 
(Amorphous calcium phosphate) 

ACP 
CaxHy(PO4)z.nH2O 

n=3 – 4.5 
1,2 – 2,2 

Alfa-fosfato tricálcico 
(Alpha-tricalcium phosphate) 

?-TCP Ca3(PO4)2 1,5 

Beta-fosfato tricálcico 
(Beta-tricalcium phosphate) 

?-TCP Ca3(PO4)2 1,5 

Hidroxiapatite deficiente em cálcio 
(Calcium deficient hydroxyapatite) 

CDHA 
Ca10-x(HPO4)x(PO4)6-x(OH)2-x 

0 &amp;lt;x ? 1 
1,5 – 1,67 

Hidroxiapatite 
(Hydroxyapatite) 

HA Ca10(PO4)6(OH)2 1,67 

Fosfato tetracálcico 
(Tetracalcium phosphate) 

TTCP Ca4(PO4)2O 2 

 



Capítulo 1 

 22 

A sua solubilidade é apresentada na Fig. 2, onde se pode observar que a 

hidroxiapatite (HA) é o composto menos solúvel em pH neutros a básicos, 

enquanto os fosfatos de dicálcio (DCPA e DCPD) são os menos solúveis a pH 

ácidos [30].  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fig. 2. Solubilidade do Ca (a) e do P (b) de vários compostos de fosfatos de cálcio [30] (sendo 

HAP - hidroxiapatite). 

(a) 

(b) 



Capítulo 1 

 23 

Desta grande variedade de fosfatos de cálcio, apenas serão destacados os 

envolvidos neste estudo: 

???? O fosfato monocálcico monoidratado (MCPM) é o fosfato de cálcio mais ácido e 

o mais solúvel para quase todos os valores de pH (Fig. 2, [30]). Devido a esses 

dois fatores, este composto não é biocompatível, não podendo, portanto, ser 

utilizado sozinho como substituto ósseo. Combinado com outros compostos de 

fosfato de cálcio, o MCPM entra na composição de muitos CPCs [31].  

???? O fosfato dicálcico diidratado (DCPD, brushite) é um cristal monoclínico com 

uma estrutura muito semelhante ao do gesso do sulfato de cálcio [32]. É um 

composto de carácter ácido que cristaliza geralmente sob a forma de plaquetas, 

mas também pode apresentar-se sob a forma de agulhas. Além disso, é o 

composto menos solúvel a pH ácido (Fig. 2, [30]). Os seus cristais de estrutura 

monoclínica podem ser facilmente obtidos a partir de soluções aquosas. 

Relativamente à sua forma desidratada (monetite), a brushite é a principal fase 

que precipita à temperatura ambiente, embora seja metastável nessas condições. 

A menor energia superficial (energia livre interfacial) da brushite, comparada com 

a da monetite [33], e a elevada energia necessária para desidratação de iões 

cálcio em solução [34], favorecem a formação da forma hidratada em vez da 

anidra. DCPD foi detetada em calos ósseos e em algumas calcificações 

patológicas (cálculos renais, cálculos dentários) [35]. Como material de 

substituição óssea, este composto tem sido usado na forma de cimento por ser 

biocompatível, biodegradável e osteocondutor, sendo in vivo facilmente convertido 

em hidroxiapatite (HA) [31]. É importante referir que a monetite (DCPA) raramente 

é obtida por precipitação a partir de uma solução aquosa à temperatura ambiente 

[36]. Este composto é geralmente obtido por aquecimento da brushite a 

temperaturas entre 120ºC e 170ºC. Da mesma forma, os processos de hidratação 

destes compostos são geralmente eficazes a temperaturas superiores a 50ºC 

[36]. 

? O fosfato tricálcico (TCP, Ca3(PO4)2) é um dos compostos de fosfatos de cálcio 

que tem sido cada vez mais utilizado, tanto na sua forma ? como ?, como 



Capítulo 1 

 24 

matéria-prima para materiais de reparação óssea, estando disponível sob várias 

formas, tais como grânulos, blocos e cimento de fosfato de cálcio [31, 37]: 

• O ?-fosfato tricálcico (?-TCP), fase de baixa temperatura, é estável desde a 

temperatura ambiente até 1125ºC. Dentro de uma gama de temperaturas 

entre 1125ºC a 1430ºC, ele transforma-se na fase ?-TCP que pode ser 

mantida à temperatura ambiente como fase metastável. Por ser mais 

rapidamente degradado no organismo do que a HA, o ?-TCP tem sido 

extensivamente utilizado como substituto ósseo, quer na forma de 

grânulos, blocos ou mesmo como cimentos de fosfatos de cálcio [22]. O 

?-TCP também tem sido usado com HA formando materiais de fosfato de 

cálcio bifásico HA + ?-TCP, sendo ambos amplamente utilizados como 

materiais biocerâmicos de substituição óssea [22]. O controlo da razão 

HA/?-TCP permite ajustar a velocidade de ressorção consoante o tipo de 

aplicação no organismo  

• O ?-fosfato tricálcico (?-TCP), fase de alta temperatura, é geralmente 

preparado a partir de fase ?-TCP tratado termicamente acima de 1125ºC 

seguida geralmente de uma têmpera para impedir a transformação inversa. 

As transformações de fase  ? ? ?-TCP serão tratadas em maior detalhe no 

Capítulo 2. As fases ? e ?-TCP têm exactamente a mesma composição 

química, mas possuem estruturas cristalográficas (monoclínica e 

romboédrica, respectivamente) e solubilidades distintas (Fig. 2). ?-TCP é 

biocompatível e mais solúvel e biodegradável do que ?-TCP. Por essa 

razão, o ?-TCP é mais reactivo em sistemas aquosos e pode ser 

hidrolisado com uma mistura de outros fosfatos de cálcio, razão porque 

nunca ocorre em ossificações biológicas e porque é frequentemente usado 

em cimentos de fosfatos de cálcio [25, 38-40].  

???? O fosfato octacálcico (Ca8(HPO4)2(PO4)4.5H2O, OCP) é mais solúvel (Fig. 2) e 

menos estável em condições fisiológicas do que a HA. A hidrólise do OCP para 

HA é termodinamicamente favorecida e procede espontaneamente e de forma 

irreversível [41, 42]. Resultados obtidos por Legeros [41] sugerem que essa 

transformação ocorre através de um processo de dissolução do OCP e da 



Capítulo 1 

 25 

subsequente precipitação na forma de apatite deficiente em cálcio, incorporando 

espécies iónicas presentes em solução (CO3
2?, HPO4

2? or F?), e indicam que a 

estabilidade do OCP em calcificações patológicas pode ser devida à presença de 

iões Mg2+, citratos e/ou P2O7
4? e/ou baixas concentrações dos iões CO3

2?, F?, 

Ca2+, HPO4
2? nos fluidos biológicos. As características de osteocondução e 

possivelmente osteoindutoras do OCP [43-46] aumentaram o interesse na 

preparação de substitutos ósseos que contenham OCP na sua composição [47]. 

O OCP pode ser obtido como produto de reacção de cimentos de fosfatos de 

cálcio obtidos com mistura de dois ou mais pós (por exemplo, mistura de ??TCP e 

brushite ou de ?-TCP e monetite [47]). A sua formação a partir de pós de brushite 

imersos em meio de Eagle modificado por Dulbecco (Dulbecco's modified Eagle 

médium, DMEM) à temperatura de 36,6ºC foi também detectada por Mandel e 

Tas [48] ao fim de cerca de uma semana. 

 

De acordo com a solubilidade, os fosfatos de cálcio podem ser classificados por 

ordem crescente da taxa de degradação, da seguinte forma:  

MCPM &gt; TTCP ? ?-TCP &gt; DCPD &gt; OCP &gt; ?-TCP &gt; HA 

Assim, dependendo da sua composição química e porosidade, estes podem ser 

mais ou menos degradáveis in vivo. Materiais à base de HA são considerados 

praticamente inertes se forem densos (com porosidade baixa). Os restantes 

fosfatos cálcicos são geralmente considerados como sendo degradáveis [35, 40]. 

Considerados portanto, em geral, ressorvíveis, eles são também bioativos. Um 

material bioativo é um material que tem a capacidade de reagir positivamente com 

o corpo acelerando processos de reparação tecidual. E, de facto, os compostos 

de fosfato de cálcio têm a propriedade especial de formar uma forte ligação 

química com o osso defeituoso, estabelecendo uma união entre o implante e o 

tecido ósseo circundante, assegurando assim a biointegração do material. No 

entanto, as suas fracas propriedades mecânicas não lhes permitem serem usados 

em zonas sujeitas a cargas mecânicas. 



Capítulo 1 

 26 

3.2 Substituição iónica em fosfatos de cálcio 

As apatites biológicas (apatites carbonatadas) contêm uma quantidade 

significativa de outros iões na sua composição. As composições minerais dos 

tecidos duros, osso, esmalte e dentina, estão apresentadas na Tabela 3 [49]. 

Tabela 3. Composição inorgânica do osso, esmalte e dentina humana [49]. 

Elementos Osso Esmalte Dentina 

(wt.%)    

Ca 36,6 37,6 40,3 

P 17,1 18,3 18,6 

CO2 4,8 3,0 4,8 

Na 1,0 0,70 0,1 

K 0,07 0,05 0,07 

Mg 0,6 0,2 1,1 

Sr 0,05 0,03 0,04 

Cl 0,1 0,4 0,27 

F 0,1 0,01 0,07 

    

(ppm)    

Zn 39 263 173 

Ba  125 129 

Fe  118 93 

Al  86 69 

Ag  0,6 2 

Cr 0,33 1 2 

Co&amp;lt;0,025 0,1 1 

Sb  1 0,7 

Mn 0,17 0,6 0,6 

Au  0,1 0,07 

Br  34 114 

Si 500   

    

Ca/P 1,65 1,59 1,67 

 



Capítulo 1 

 27 

Cada um dos elementos acima mencionados desempenha uma parte essencial 

no processo biológico. Por exemplo, Mg desempenha um papel chave no 

metabolismo ósseo, uma vez que influencia a actividade dos osteoblastos e 

osteoclastos, e, assim, o crescimento ósseo. Quanto ao Sr, ele tem efeitos 

benéficos no tratamento da osteoporose devido à prevenção da perda óssea, 

através de um mecanismo de inibição da ressorção óssea e manutenção da 

formação óssea [50]. O Mn Influencia a regulação da remodelação óssea e o seu 

défice causa redução da síntese da matriz orgânica e atrasos da osteogênese 

endocondral, aumentando a possibilidade de anomalias ósseas como a 

diminuição da espessura do osso ou comprimento [51]. O suplemento oral de Mn 

verificou-se ser um inibidor eficaz da perda de massa óssea após ovariectomia 

[52]. A Influência dos elementos Mn e do Sr como dopantes será abordada de 

forma detalhada nos Capítulos 4 (Mn) e 5 (Mn e Sr).  

Devido ao seu interesse biológico, a incorporação de iões tem despertado muito 

interesse. A sua presença na estrutura de apatites sintéticas pode alterar uma 

série de propriedades dos fosfatos de cálcio tanto estruturais como 

físico-químicas (como parâmetros de rede, cristalinidade, solubilidade, dissolução, 

ressorção óssea, bioatividade, entre outros) [50, 53-56]. Sob esta perspectiva, a 

incorporação de iões como Mg, Sr, Zn, Mn, Na, K, F entre outros, e carbonatos 

tem sido e continua a ser o alvo de muitos estudos de síntese de pós de fosfatos 

de cálcio. Contudo, o mesmo nível de atenção relativamente aos efeitos causados 

pelas diversas substituições iónicas na rede dos fosfatos de cálcio não tem sido 

dispensado no caso de cimentos ósseos à base destes materiais. Isso justifica a 

ênfase dada no âmbito desta tese ao estudo dos efeitos de alguns dos dopantes 

mais relevantes em termos de desempenho biológico.  

 

4. Cimentos ósseos  

Os cimentos ósseos são biomateriais sintéticos compostos por uma fase sólida 

em pó e uma fase líquida que, após mistura nas proporções adequadas, fazem 

presa e endurecem. Excluindo os cimentos usados apenas para uso odontológico, 



Capítulo 1 

 28 

os cimentos ósseos mais usados são à base de polimetilmetacrilato (PMMA) e os 

cimentos cerâmicos à base de sulfatos cálcio, ou de fosfatos de cálcio. 

Contrariamente aos dois primeiros tipos de cimentos que serão abordados de 

seguida de forma muito superficial, os cimentos de fosfatos de cálcio são o foco 

desta tese, nomeadamente, os cimentos de brushite.  

 

4.1 Cimentos à base de PMMA 

Os cimentos à base de PMMA têm maior resistência mecânica do que os seus 

homólogos cerâmicos, com valores de resistência compressão na gama dos 

70-120 MPa, e de resistência à tracção até 50 MPa [57]. No entanto, estes 

cimentos não são biodegradáveis e podem causar necrose extensa devido à 

elevada exotermicidade da reacção de presa baseada na polimerização de 

radicais livres do monómero de metilmetacrilato (MMA). A incapacidade biológica 

para remodelar ou integrar o osso circundante, a excessiva rigidez, a contracção 

volúmica do cimento durante a polimerização, a fraca resistência à fadiga e a 

toxicidade dos monómeros, são outros dos inconvenientes deste tipo de cimentos 

[58]. Apesar disso, graças às suas propriedades mecânicas, ainda é dos mais 

usados numa grande variedade de aplicações. Os cimentos de PMMA são 

comummente utilizados na fixação de próteses e como enchimento de defeitos 

em cirurgias envolvendo remoção óssea como no caso de tumores, ou em 

procedimentos minimamente invasivos como a vetebroplastia e a cifoplastia 

[25, 40]. 

 

4.2 Cimentos de sulfato de cálcio 

Os cimentos de sulfato de cálcio têm uma longa história clínica como substituto 

ósseo. Pela primeira vez em 1892, o sulfato de cálcio foi usado como enchimento 

de cavidade óssea por Dreesman et al. [59, 60]. Este tipo de cimento degrada-se 

através de um processo de dissolução e não de ressorção mediada por células. 

Além disso, a taxa de degradação é muito maior do que a dos cimentos de fosfato 



Capítulo 1 

 29 

de cálcio, e a maioria deste tipo de implantes é completamente dissolvida em 

poucos meses [60]. Essa rápida dissolução pode ser problemática se a sua taxa 

de degradação for superior à taxa de crescimento do osso novo, ficando a 

cavidade óssea ainda não preenchida por osso novo no final do processo de 

dissolução do implante.  

 

4.3 Cimentos de fosfato de cálcio 

A possibilidade de obter um cerâmico monolítico de fosfato de cálcio, à 

temperatura ambiente ou à temperatura corporal, através de uma reação de 

cimentação, foi apresentada no início dos anos de 1980 [25, 40, 61, 62]. A 

descoberta destes cimentos, conhecidos por cimentos de fosfato de cálcio (CPC, 

calcium phosphate cement), abriu uma nova era nos substitutos ósseos para 

aplicações médicas.  

 

4.3.1 Processo de presa e endurecimento 

Os CPCs são preparados a partir de um pó (uma mistura de pó amorfo e/ou 

cristalino de fosfato(s) de cálcio) e de uma solução aquosa. A presa ocorre 

através de um processo de dissolução-precipitação, em que um ou mais 

compostos de fosfato de cálcio solúveis são dissolvidos na solução aquosa e 

precipitados numa fase menos solúvel, fazendo com que a pasta cimentícia vá 

perdendo as suas propriedades viscoelásticas e se transforme num corpo sólido 

[63]. Num primeiro momento, a pasta cimentícia aparenta não evoluir fisicamente 

e permanece muito maleável. Quimicamente, as partículas do pó percursor 

começam a dissolver-se no líquido, e à medida que este processo avança, a 

solução aquosa fica sobressaturada em espécies que tendem a precipitar como 

nova(s) fase(s), formando núcleos que vão crescendo e dão origem à formação 

de cristais cada vez maiores. À medida que os cristais se desenvolvem e mais 

núcleos são formados, os cristais começam a interagir e emaranhar-se entre eles, 

resultando num material sólido [25]. A este segundo momento dá-se o nome de 



Capítulo 1 

 30 

presa do cimento, que é caracterizada por um tempo inicial de presa (IST, inicial 

setting time) e um tempo final de presa (FST, final setting time). Acompanhada 

por um aumento da viscosidade da pasta, a presa atinge o seu fim quando a 

pasta já não é deformavél e se transforma num material rígido. Segue-se a última 

fase que é de endurecimento, onde as reações químicas prosseguem 

aumentando as propriedades mecânicas dos cimentos. Dependendo da química 

do cimento, do tamanho de partícula do pó precursor e das condições de reacção, 

este processo poderá levar desde alguns segundos a algumas semanas.  

 

4.3.1.1 Tempo de presa e endurecimento 

O tempo de presa não deve ser demasiado curto, pois deverá permitir ao cirurgião 

implantar facilmente o cimento, por moldagem ou injecção, no local pretendido. 

Também não deve ser demasiado longo de modo a que o cirurgião possa fechar 

o defeito imediatamente após a sua colocação. Assim, os dois tempos de presa 

acima mencionados devem ser convenientemente ajustados, sendo contados a 

partir do início da mistura pó-líquido. O IST é o tempo a partir do qual o material 

não deve continuar a ser manuseado de modo a evitar danos estruturais [64]; 

enquanto o FST define o tempo a partir do qual o material fica endurecido. Mas 

tipicamente, o endurecimento completo só é alcançado após vários dias [65]. 

Tanto o IST como o FST são avaliados utilizando o mesmo princípio: uma agulha, 

com um determinado diâmetro e com um peso associado, é colocada sobre a 

superfície da amostra em intervalos regulares de tempo, em ambiente húmido e à 

temperatura de 37ºC. Mas o diâmetro da extremidade da agulha e o peso 

associado diferem. As agulhas utilizadas para medir o IST são mais leves e 

podem ter um diâmetro de ponta maior do que as usadas para medir o FST. Estas 

medições podem ser feitas por dois métodos tradicionais padronizados: o método 

da agulha de Vicat (ASTM C191-92) [66] e o método das agulhas de Gilmore 

(ASTM C266-89) [67]. Enquanto o instrumento de Vicat apresenta uma só agulha 

que pode ser adequada para determinar o IST ou o FST, o de Gilmore é 

constituído por duas agulhas possibilitando a obtenção dos dois tempos de presa. 



Capítulo 1 

 31 

Neste estudo, tal como em alguns estudos anteriores [39, 68], usou-se o método 

da agulha de Vicat para a determinação do IST (Capítulo 5).  

O significado clínico destes tempos de presa (IST e FST) é que a pasta 

cimentícea deve ser implantada antes do IST e a ferida deve ser fechada após o 

FST conforme está representado na Fig. 3, na qual ainda estão referidos os vários 

parâmetros de manuseamento sugeridos para os CPCs [69, 70]. 

 

 

 

 

 

 

Fig. 3. O diagrama dos parâmetros de presa relevantes para os CPCs (adaptado de [64]). 

 

Para que o cirurgião tenha pelo menos 1 min para aplicar e moldar o material, o 

tempo de coesão (CT, cohesion time), que é o tempo a partir do qual já não se 

verifica desintegração do cimento quando em contacto com algum fluido, deve ser 

pelo menos 1 min antes do IST [70]. Como o tempo de mistura pó-líquido é de 

aproximadamente 1 min, o tempo de coesão mais curto que é permitido é de 

aproximadamente 2 min. Assim, o cirurgião tem pelo menos 1 min para recolher a 

pasta e colocá-la (ou injectá-la) no local da ferida depois do CT e antes do IST 

(Fig. 3) [64, 70]. Para aplicações dentárias, o IST deve estar perto dos 3 min, 

enquanto para aplicações ortopédicas deverá estar próximo de 8 min. Além disso, 

é sugerido que FSTs superiores a 15 min não seriam bem aceites na prática 

clínica, uma vez que a ferida deve ser fechada após o FST [64, 70]. Contudo, esta 

necessidade de fechamento da ferida depois do FST não é consensual. Sarda et 

al. [71] sugeriram que o cimento provavelmente atinge uma resistência mecânica 

0    CT 3    IST 8     FST 15

PRESAPRESA

Tempo (min)

Fecho da ferida

intervalo de 
implantação

Implantação não 
permitida

3 min ? IST &amp;lt;8 min

CT – tempo de coesão;

IST – tempo de presa inicial;

FST – tempo de presa final.

IST- CT ? 1min (intervalo de implantação)

FST ? 15 min



Capítulo 1 

 32 

suficiente para resistir à pressão exercida durante o fecho da ferida bem antes do 

FST. 

Vários estudos sobre o efeito da distribuição de tamanho de partículas dos TCPs 

na cinética de reação dos CPCs estão disponíveis na literatura [72, 73]. Todos 

eles relataram que a presença de aglomerados de partículas e/ou de fase amorfa 

modificam a cinética da reação. Sabe-se que a diminuição do tamanho de 

partícula do pó precursor acelera as reações de presa e reduz o IST e o FST, mas 

os efeitos nas propriedades mecânicas não são claros [61]. O uso de agentes 

gelificantes também pode ser usado para controlar a reação de presa. Por 

exemplo, a adição de polietilenoglicol (PEG) e hidroxipropilmetilcelulose (HPMC), 

usados como agentes de gelificação, mostraram provocar um aumento do tempo 

de presa, sendo menos pronunciada no caso do PEG, em comparação com 

HPMC [74]. Estes agentes são polímeros hidrofílicos que formam uma estrutura 

de rede com as moléculas de água, que se tornam menos livres para reagir com 

os CaPs. Por outro lado, as espécies poliméricas podem ser adsorvidas na 

superfície das partículas de CaPs, atrasando assim os processos de 

dissolução/precipitação. Este fenómeno é mais pronunciado para polímeros de 

elevado peso molecular, tal como HPMC, o que poderia explicar a aumento mais 

acentuado do tempo de presa na presença deste aditivo, em comparação com as 

pastas de cimento com adição de PEG [74]. Alguns estudos mostraram que a 

presença de Sr, de Zr e Mg como iões dopantes em pós de ?? e ??TCP [68, 75], 

assim como a adição de silicato tricálcico [76], aumentou a tempo de presa dos 

cimentos. 

 

4.3.2 Tipos de cimentos 

Após mistura dos dois componentes, sólido e líquido, e da obtenção de uma pasta 

suficientemente viscosa e moldável (com coesão adequada), esta pode ser 

colocada num defeito ósseo como substituto da parte danificada do osso, onde 

endurece in situ na sala de operações após alguns minutos. As fases 

predominantes formadas durante a presa destes cimentos podem ser a 



Capítulo 1 

 33 

hidroxiapatite (HA), a hidroxiapatite deficiente em cálcio (CDHA), ou a brushite 

(DCPD), a par de outras eventuais fases minoritárias. 

Assim, de acordo com a fase predominante que compõe os CPCs endurecidos, a 

qual depende do pH das pastas cimentícias durante a presa, os cimentos podem 

ser classificados em dois principais grupos [25, 40, 62]: (1) cimentos de apatite 

(HA ou CDHA) e (2) cimentos de brushite (DCPD) embora alguns cimentos 

tenham monetite como produto final. Os cimentos de apatite são formados acima 

de pH 4,2, enquanto que os cimentos de brushite são preferencialmente formados 

a pH &amp;lt;4,2, embora por razões cinéticas este limite possa subir um pouco mais 

para pH 6,5 [40, 77]. 

Os primeiros estudos em cimentos apatíticos foram publicados em 1982 por 

LeGeros et al. [78] e em 1983 por Brown e Chow [79]. Só alguns anos mais tarde, 

em 1989, é que Mirchi et al. [80] publicaram pela primeira vez um estudo com 

cimentos de brushite. 

 

4.3.3 Reacções químicas envolvidas na presa dos cimentos 

As reacções químicas que ocorrem durante a presa dependem muito da 

composição química dos CPCs. No entanto, elas podem ser de dois tipos: 

1. Reacção de ácido-base, onde uma fonte de fosfato de cálcio ácida e outra 

alcalina reagem formando um produto neutro. Dois exemplos muito comuns de 

reacção de ácido-base são: 

i. Fosfato tetracálcico (TTCP, básico) reage com monetite (DCPA, levemente 

ácida) numa solução aquosa, precipitando hidroxiapatite pouco cristalizada 

(HA, levemente alcalina) [79] (equação 1), resultando assim num cimento de 

apatite: 

2Ca4 (PO4)2 O + 2CaHPO4 ? Ca10 (PO4)6 (OH)2  (1) 

Vários desvios da equação 1 foram estudados em detalhe [81]. Foi mostrado 

que apenas os primeiros núcleos são constituídos por HA quase 



Capítulo 1 

 34 

estequiométrica e que o seu crescimento subsequente ocorre 

prefencialmente sob a forma de CDHA [82], e que a HA estequiométrica 

inicialmente formada reage com o DCPD remanescente para formar CDHA 

[83]. 

ii. ?-TCP (ligeiramente básico) reage com MCPM (ácido) formando brushite 

(levemente ácida) [75, 84] (equação 2): 

? - Ca3 (PO4)2 + Ca (H2PO4)2 H2O + 7 H2O ? 4CaHPO4 2H2O  (2) 

Nesta equação, o MCMP pode ser substituído por ácido fosfórico (H3PO4) ou 

MCPA, e o ?-TCP por ?-TCP, por CDHA ou ainda por Ca(OH)2 e CaO [85]. 

De facto, os cimentos de brushite contêm sempre uma fonte de cálcio 

alcalina e uma fonte de fósforo ácida. O componente alcalino tem uma razão 

Ca/P&gt; 1 (por exemplo, hidróxido de cálcio (Ca(OH)2), TTCP, HA, ?-TCP, ou 

?-TCP). Mas devido à elevada energia requerida para a produção da maior 

parte dos fosfatos de cálcio mencionados, o ?-TCP é o mais frequentemente 

usado [36]. A fonte ácida de fosfato deve ter uma razão Ca/P&amp;lt;1, e os 

compostos mais utilizados são o ácido fosfórico [86], o MCPM [75], ou o 

fosfato monocálcico anidro (MCPA) [87]. Nesta tese, todos os cimentos são 

baseadas no sistema ?-TCP / MCPM (equação 2).  

2. O segundo tipo de reacção pode ser definido como a hidrólise de CaPs 

metastáveis em meio aquoso. É uma simples reacção de dissolução-precipitação 

onde o pó percursor e a fase formada têm a mesma razão Ca/P, mas diferentes 

solubilidades. Por exemplo, a pH neutro, o ?-TCP (solubilidade relativamente 

elevada) tende a formar CDHA [88] (Equação 3): 

? - Ca3 (PO4)2 + H2O ? Ca9 (HPO4)2 (PO4)5 OH (3) 

Cimentos formados por reacção entre uma solução aquosa e os compostos ?-

TCP, ACP, ou TTCP, que re-cristalizam na forma de CDHA quando em contacto 

com a água ou fluídos fisiológicos são outros exemplos deste tipo de reacção [85].  



Capítulo 1 

 35 

Ao contrário dos cimentos de PMMA que endurecem através de reacções de 

polimerização altamente exotérmica acompanhadas de uma certa retracção 

volúmica [89], os CPCs apresentam reacções de presa fracamente exotérmicas 

libertando uma pequena quantidade de calor, durante as quais o cimento 

praticamente não retrai, isto é, o volume do cimento permanece quase constante 

ao longo do processo de presa [39, 85, 90, 91]. 

 

4.3.4 Principais diferenças entre cimentos de apatite e de brushite 

Devido aos diferentes precursores e fases finais nos cimentos de apatite e de 

brushite, existem algumas diferenças entre estes dois tipos de cimentos que vale 

a pena serem mencionadas. Os cimentos de apatite apresentam maior resistência 

mecânica, mas taxas mais lentas de ressorção in vivo que interferem com o 

processo de regeneração óssea. Mas pelo facto de a CDHA ter uma composição 

química similar à do osso, eles têm sido os mais extensivamente investigados e 

produzidos comercialmente. De facto, a maioria dos cimentos de fosfato de cálcio 

comercialmente disponíveis são cimentos apatíticos, como se mostra na Tabela 4.  

No entanto, estudos in vivo e in vitro revelaram que os cimentos de brushite 

apresentam maiores taxas de degradação passiva (dissolução) e ativa (mediadas 

por células) do que os cementos de apatite [92, 93], facto que tem vindo a 

despertar um interesse crescente neste tipo de cimentos. Segundo um estudo de 

Ohura et al. [94], a taxa de degradação do cimento de brushite endurecido é de 

cerca de 0.25 mm/semana. Admite-se que esta rápida e linear degradação pode 

levar à formação de osso imaturo, problema que poderia ser mitigado pela 

incorporação de grânulos de ??TCP no cimento, pois estes podem agir como 

pontos de ancoragem óssea e promover a formação de osso maduro [94, 95]. 

 

 

 



Capítulo 1 

 36 

Tabela 4. Alguns cimentos de fosfato de cálcio comercialmente disponíveis [31]  

Empresa 
Nome 

comercial do 
produto 

Composição 
Tipo de 
cimento 

aap Implantate 
(GER) 

OsteoCem® 
Pó: fosfatos de cálcio (detalhes não conhecidos); 

Solução: não conhecida 
Apatite 

Cem-OsteticTM 
Pó: fosfatos de cálcio (detalhes não conhecidos); 

Solução: água 
Apatite Berkeley 

Advanced 
Biomaterials 

(U.S.) Tri-Ostetic
TM 

Pó: fosfatos de cálcio (detalhes não conhecidos); 

Solução: água 
Apatite 

Biomatlante 
(FR) 

MCPC 
Pó: maioritariamente ?-TCP, ACP, BCP (HA + ?-
TCP); 

Solução: solução tampão de fosfato 
Apatite 

Biomet (U.S.) 
Interpore (U.S.) 

Calcibon® 
Pó: ?-TCP (61%), DCPA (26%), CaCO3 (10%), 
CDHA (3%); 

Solução: H2O, Na2HPO4 
Apatite 

Walter Lorenz 
Surgical (GER) 

MimixTM 
Pó: TTCP, ?-TCP, citrato trissódico; 

Solução: solução aquosa de acido cítrico 
Apatite 

Calcitec (U.S.) Osteofix 
Pó: pós de fosfatos de cálcio e óxido de cálcio; 

Solução: solução tampão de fosfato 
Apatite 

?-BSM®; 
Embarc; 
Biobon 

Pó: ACP (50%), DCPD (50%); 

Solução: solução salina não tamponada 
Apatite 

?-BSM® 
Composição não conhecida (resistencia a 
compressão e injectabilidade superior ao ?-BSM®) 

Apatite 

?-BSM® Composição não conhecida Apatite 

OssiPro 
Composição não conhecida; cimento macroporoso 
depois de endurecido 

Apatite 

ETEX (U.S.) 

CarriGen 
Composição: fosfatos de cálcio, carboximetilcelulose 
de sódio, bicarbonato de sódio e carbonato de sódio 

Apatite 

Graftys® HBS 
Pó: ?-TCP (78%), DCPD (5%), MCPM (5%), CDHA 
(10%), hidroxipropilmetilcelulose (2%); 

Solução: solução aquosa 5% Na2HPO4 
Apatite 

Graftys (FR) 

Graftys® 
Quickset 

Composição: fosfatos de cálcio e solução com 
hidroxipropilmetilcelulose e fosfatos de cálcio 

Apatite 

Jectos 
Eurobone® 

Pó: ?-TCP (98%), Na2P2O7 (2%); 

Solução: H2O, H3PO4 (3.0 M), H2SO4 (0.1 M) 
Brushite 

Kasios (FR) 

Jectos+ Composição não conhecida Brushite 

Kyphon (U.S.) KyphOsTM 
Pó: ?-TCP (77%), Mg3(PO4)2 (14%), MgHPO4 
(4.8%), SrCO3 (3.6%); 

Solução: H2O, (NH4)2HPO4 (3.5 M) 
Apatite 

Merck (GER) 
Biomet (U.S.) 

Biocement D 
Pó: 58% ?-TCP, 24% DCPA, 8.5% CaCO3, 8.5% 
CDHA; 

Solução: 4 wt% Na2HPO4 em água 
Apatite 

 



Capítulo 1 

 37 

Tabela 4. cont. 

Empresa 
Nome 

commercial 
do produto 

Composição 
Tipo de 
cimento 

Biopex® 

Pó: ?-TCP (75%), TTCP (20%–18%), DCPD (5%),        
HA (0%–2%) 

Solução: H2O, succinato sódico (12%–13%), Sulfato 
sódico de condroitina (5%–5.4%) 

Apatite 
Mitsubishi 

Materials (J) 

Biopex®-R 
Pó: ?-TCP, TTCP, DCPD, HA, Mg3(PO4)2, NaHSO3; 

Solução: H2O, Sulfato sódico de condroitina 
Apatite 

Produits 
Dentaires SA 

(CH) CalciphOs 
(CH) 

VitalOs4 

Solução 1: ?-TCP (1.34 g), Na2H2P2O7 (0.025 g), 
H2O, sais (0.05 M PBS, pH 7.4); 

Solução 2: MCPM (0.78 g), CaSO4·2H2O (0.39 g), 
H2O, H3PO4 (0.05 M) 

Brushite 

Shanghai 
Rebone 

Biomaterials 
Co (CN) 

Rebone 
Pó: TTCP, DCPA; 

Solução: H2O 
Apatite 

CallosTM 
Pó: ?-TCP, CaCO3, MCPM; 

Solução: silicato de sódio 
Apatite 

Callos InjectTM Pó: ?-TCP e compostos não conhecidos Apatite 
Skeletal 

Kinetics (U.S.) 
OsteoVation 

EX Inject 
Composição não conhecida Apatite 

Stryker (U.S.) 
Leibinger 

(GER) 
BoneSourceTM 

Pó: TTCP (73%), DCPD (27%); 

Solução: H2O, mixture of Na2HPO4 and NaH2PO4 
Apatite 

Stryker (U.S.) HydroSetTM 
Pó: TTCP, DCPD, citrato; trisódico 

Solução: H2O, polivinilpirolidona, fosfato de sódio 
Apatite 

Norian® SRS 
Norian® CRS 

Pó: ?-TCP (85%), CaCO3 (12%), MCPM (3%); 

Solução: H2O, Na2HPO4 
Apatite 

Norian® SRS 
Fast Set Putty 
Norian® CRS 
Fast Set Putty 

Composição não conhecida Apatite 

Norian 
Drillable 

Composição: pó de fosfato de cálcio, fibras bio-
ressorvíveis e solução de hialuronato de sódio 

Apatite 

DePuy Synthes 
(U.S.) 

ChronOSTM 

Inject 

Pó: ?-TCP (73%), MCPM (21%), MgHPO4·3H2O 
(5%), MgSO4 (&amp;lt;1%), Na2H2P2O7 (&amp;lt;1%); 

Solução: H2O, hialuronato de sódio (0.5%) 
Brushite 

Cementek® 
Pó: ?-TCP, TTCP, glicerofosfato de sódio;  

Solução: H2O, Ca(OH)2, H3PO4 
Apatite 

Teknimed (FR) 

Cementek® LV 
Pó: ?-TCP, TTCP, glicerofosfato de sódio, 
dimetilsiloxane; 

Solução: H2O, Ca(OH)2, H3PO4 
Apatite 

 

 



Capítulo 1 

 38 

Além disso, a brushite é metastável em condições fisiológicas e os cimentos à 

base de brushite possuem tempos de presa mais curtos [25, 40, 62]. De facto, o 

tempo de presa destes dois tipos de cimentos difere bastante. Os cimentos 

apatíticos (exemplos apresentados nas equações 1 e 3) têm presa lenta e podem 

demorar até algumas semanas para endurecer totalmente. Pelo contrário, os 

cimentos de brushite prendem rapidamente, com tempos de presa que vão desde 

alguns segundos a alguns minutos, dependendo da composição do pó precursor 

(no caso da equação 2, ele varia de 30 a 60 segundos). Para fins clínicos, o 

tempo de presa óptimo sugerido é 10?15 minutos [64]. 

Assim, vários métodos com vista a alterar o tempo de presa dos cimentos têm 

sido testados com algum sucesso. 

Nos cimentos de apatite, as várias abordagens testadas incluem:  

(1) A adição de um agente que acelere a dissolução dos precursores (por 

exemplo, ácido fosfórico, Na2HPO4) [88];  

(2) A diminuição da razão líquido/pó com o intuito de provocar uma saturação 

mais rápida dos iões precipitantes [96];  

(3) A diminuição do tamanho de partícula dos precursores de modo a aumentar a 

velocidade da sua dissolução no líquido de reação [61]. 

Nos cimentos de brushite, a busca das soluções envolveu abordagens opostas:  

(1) A redução da solubilidade do precursor através, por exemplo, da substituição 

do ??TCP por HA. O precursor alcalino usado para cimentos brushite não tem de 

ser tão solúvel como os precursores utilizados nos cimentos de apatite, uma vez 

que a elevada acidez durante a presa dos cimentos de brushite aumenta a 

solubilidade do precursor;  

(2) A diminuição da taxa de dissolução através do aumento do tamanho de 

partículas do pó percursor;  

(3) A adição de aditivos que formem quelatos com os iões precipitantes em 

solução, ou com iões da superfície do cristal em crescimento, podendo assim 

prevenir a formação de núcleos, o crescimento rápido dos cristais, ou agregação 



Capítulo 1 

 39 

de cristais devido à blindagem estérica que é criada. Ácido cítrico, pirofosfatos, 

sulfatos, ácido glicólico, entre outros, têm sido usados para aumentar o tempo de 

presa dos cimentos de brushite [86, 97-100]. Além de aumentar o tempo 

disponível para o manuseamento (tornando as pastas menos viscosas durante 

mais tempo), outra vantagem relacionada com a adição destes retardadores é a 

melhor organização dos cristais devido ao seu crescimento mais lento, resultando 

numa melhor compactação do comento endurecido e numa maior resistência 

mecânica [80, 97, 101]. Assim, a adição deste tipo de aditivos pode contribuir para 

colmatar os aspectos menos positivos dos cimentos de brushite, que travam o seu 

uso clínico (baixa resistência mecânica, tempo de presa demasiado curto e 

consequente rápido aumento da viscosidade limitando o sua injectabilidade 

através de agulhas hipodérmicas). Esta é uma das abordagens perseguidas no 

âmbito desta tese, mais concretamente no Capítulo 5. 

 

4.3.5 Flexibilidade dos CPCs em termos de desenhos das suas propriedades  

Tipicamente, os CPCs apresentam composições químicas e padrões de difração 

de raios X semelhantes aos do osso, possuem biocompatibilidade, bioatividade, 

osteoconductividade e capacidade de serem bioressorvidos e de estabelecerem 

ligações químicas com os ossos hospedeiros; são potencialmente osteoindutores 

e podem ser injectáveis e usados em cirurgias minimamente invasivas [25, 38, 61, 

62, 90, 98, 102, 103]. Para além destas características gerais, a possibilidade de 

manipular outras mais específicas em cada tipo de CPC, tais como os graus de 

cristalinidade e de carbonatação da(s) fase(s) obtidas no cimento endurecido, a 

quantidade de lacunas ou de substituições dos iões Ca ou dos iões OH?, etc., 

oferecem oportunidades de ajuste das suas propriedades características físico-

químicas, incluindo a porosidade, a taxa de degradação/solubilidade e o seu 

comportamento in vivo. Esta elevada flexibilidade acrescenta outros benefícios 

potenciais ao seu uso na correção de fraturas e defeitos ósseos não sujeitos a 

cargas. São também bons candidatos para a libertação de principios activos [104] 

como antibióticos [105,106], anti-inflamatórios [107], medicamentos 

anti-cancerígenos [108], anti-osteoporóticos [109]. Por outro lado, a sua fácil 



Capítulo 1 

 40 

manipulação, a sua adaptação às superfícies teciduais em defeitos ósseos 

(excelente capacidade de se moldar) e a presa in situ à temperatura do corpo, são 

outras vantagens adicionais dos CPCs [40] que fazem destes cimentos 

substitutos ósseos muito mais versáteis e atrativos. 

Contudo, as formulações comercialmente disponíveis continuam a sofrer de 

vários problemas relacionados com o nível insatisfatório de algumas propriedades 

[25, 38, 40, 62], tais como:  

(i) Fraca coesão e injetabilidade  

(ii) Baixa resistência mecânica óssea (priciplamente numa fase inicial após 

implantação); 

(iii) Desajuste iónico em relação à composição óssea; 

(iv) Ressorsão in vivo mais lenta que a formação de osso novo; 

(v) Taxa de crescimento ósseo limitada pela falta de macroporosidade e de 

porosidade interligada. 

 

Estas deficiências, consensualmente reconhecidas pelos profissionais de saúde, 

justificam o continuado esforço de investigação que tem vindo a ser dispensado 

aos CPCs, em vários estágios do seu desenvolvimento [85]. Este trabalho usa 

uma bordagem holística visando a melhoria geral das propriedades mais 

relevantes dos CPCs, nomeadamente, da injectabilidade, propriedades 

mecânicas, ajuste iónico, as quais têm reflexos no seu desempenho in vivo. 

 

4.3.5.1 Injetabilidade 

A injectabilidade é uma das propriedades mais críticas dos CPCs, sendo 

geralmente fraca, independentemente do tipo de cimento. No caso dos cimentos à 

base de brushite, os tempos de presa precisam de ser alongados de modo a 



Capítulo 1 

 41 

permitir o seu manuseamento adequado até serem injetados. Em termos de 

prática clínica, esta capacidade de ser injetável é uma das principais vantagens 

do uso de cimentos, em relação aos cerâmicos pré-fabricados, uma vez que 

permite a sua introdução na cavidade de um defeito através de uma agulha. A 

injectabilidade torna-se de extrema importância no preenchimento de: (i) defeitos 

com acessibilidade limitada e/ou que não podem ser abertos, como é o caso de 

ossos com osteoporose; (ii) cavidades estreitas onde existe necessidade de 

colocação de cimento de forma precisa tais como, por exemplo, na reparação do 

osso peridontal.  

Uma boa injetabilidade, associada a uma boa coesão, moldabilidade e presa 

in situ permitem aos CPCs serem injetados diretamente em fraturas e defeitos 

ósseos, adaptando-se intimamente à cavidade óssea independentemente da sua 

forma, o que faculta a possibilidade de cirurgias minimamente invasivas tal como 

na vertebroplastia percutânea (Fig. 3). Neste caso, a vértebra é consolidada por 

estabilização mecânica, a qual pode ter um efeito analgésico (alivio rápido da 

dor).  

 

 

 

 

 

 

Fig. 3. Tratamento de uma fratura por compressão através do processo de vertebroplastia [110]. 

 

O preenchimento de fissuras e lesões ósseas provocados por osteoporose ou 

tumores também recorrem a procedimentos minimamente invasivos onde a 

injectabilidade é determinante do seu sucesso [38, 40, 102].  

Fratura vertebral  

Cimento ósseo injetado através de uma cânula 



Capítulo 1 

 42 

O uso de técnicas cirúrgicas minimamente invasivas permite a redução do tempo 

de internamento hospitalar, tempo de recuperação do paciente, procedimentos 

menos dolorosos e um aumento global da eficiência do processo [38, 102]. Pelas 

razões acima mencionadas, o desenvolvimento dos CPCs injectáveis é visto com 

cada vez mais interesse. Mas a obtenção de pastas de CPCs com boa 

injectabilidade ainda permanece um grande desafio pelo facto das propriedades 

de fluxo serem afetadas por vários fatores tais como: (i) tamanho médio de 

partícula e distribuição de tamanho de partícula dos pós de partida; (ii) proporção 

e natureza das fases apresentadas; (iii) a presença de partículas fortemente 

ligados (agregados); (iv) a forma das partículas; (v) a razão líquido/pó 

(liquid/powder ratio, LPR); (vi) a presença de modificadores reológicos e/ou 

aditivos com funções específicas [40, 61, 62, 88, 111-115]. A injectabilidade é 

tratada de forma detalhada no Capítulo 3. 

Aparentemente, ainda não existe nenhuma norma que descreva o protocolo a 

seguir para quantificar a injectabilidade de uma pasta cimentícia. As definições 

variam entre grupos de investigação e diferentes dispositivos e protocolos de 

medida da injectabilidade têm sido propostos [102, 114]. Vários autores seguiram 

uma definição que envolve a ausência de segregação líquido/sólido durante a 

extrusão de uma pasta [111, 114, 116]. Assim, a injectabilidade é definida como 

sendo a percentagem de pasta que pode ser extrudida através de uma seringa, 

de uma forma homogénea, sob uma força aplicada [111, 114, 117], equação 4. 

 

( )
seringanateinicialmeninseridapastadevolumeoumassa

seringadaextrudidapastadevolumeoumassa
dadeInjetabili

)(
(%) =      (4) 

 

A Fig. 4 mostra um esquema do aparato experimental usado em testes de 

injectabilidade. 

 



Capítulo 1 

 43 

 

 

 

 

 

 

 

 

Fig. 4. Esquema representativo da configuração experimental usada para medir a injectabilidade 

dos CPCs. 

 

A ocorrência, durante a extrusão, de uma eventual separação de 

fases líquida/sólida (também conhecida como filter pressing effect) piora, ou inibe, 

a injectabilidade. Em tais circunstâncias, a primeira porção de pasta extrudida 

contém mais líquido do que a mistura inicial. A heterogeneidade da pasta tende a 

aumentar a força requerida para a extrusão, podendo mesmo levar ao 

entupimento da cânula e bloquear o processo de extrusão. Nestas circunstâncias, 

a pasta retida na seringa contém um teor de líquido menor do que a mistura 

inicial.  

A separação de fases líquida/sólida provocada pela pressão aplicada à pasta 

durante a injeção/extrusão (filter pressing effect) [40, 61, 62, 111, 116] foi relatada 

em vários trabalhos. Habib et al. [111, 116] mostraram que uma elevada 

velocidade de extrusão, pequeno tamanho de seringa, cânula curta e elevada 

LPR favorecem a injetabilidade. Gbureck et al. [99] obtiveram um resultado 

semelhante para cimentos de brushite e apatite, observando também um aumento 

da injetabilidade com o aumento de LPR. Leroux et al. [112] observaram que o 

pasta

Força aplicada

Seringa

Pasta 
injetada

cânula

pasta

Força aplicada

Seringa

Pasta 
injetada

cânula

pasta

Força aplicada

Seringa

Pasta 
injetada

cânula



Capítulo 1 

 44 

uso de aditivos como glicerofosfato de sódio, ácido lácteo, glicerol e quitosano 

diminuía a força de extrusão e melhorava a injetabilidade. A mesma tendência foi 

observada com o uso de ácido cítrico (CA, citric acid) tanto em pastas cimentícias 

(CP, cement pastes) baseadas em pós de ?-TCP [118] como em CP baseada na 

mistura de pós de ?-TCP com MCPM [119], mostrando ter um efeito retardador 

nas reações de dissolução-precipitação, com consequentes aumentos do IST das 

pastas cimentícias e da resistência à compressão dos cimentos endurecidos. 

Parecendo contrariar essa tendência, Pina et al. [74] mostraram que o aumento 

da concentração de CA em CP baseada em pós de ?-TCP reduz o IST. Os 

resultados apresentados nesse mesmo estudo mostraram que a adição de 

agentes reológicos, como o polietilenoglicol ou o hidroxipropilmetilcelulose, 

aumentaram o IST, permitindo adequar o tempo de presa, as propriedades 

reológicas e de manuseamento das CPs. Sabe-se também que a presença de 

agregados de partículas afeta negativamente a injetabilidade, mas ainda não 

foram estabelecidas correlações claras e consensuais entre o grau de agregação 

de partículas e a injetabilidade [40, 61, 111, 116, 120]. Por todas estas razões, 

vários dos fatores que mais afetam a injectabilidade foram objeto de estudo ao 

longo do Capítulo 3. 

 

4.3.5.2 Comportamento mecânico 

O comportamento mecânico dos cimentos ósseos é de uma importância 

primordial visto serem utilizados como substitutos ósseos e porque a principal 

função do osso é a de suportar o peso corporal. Embora o seu uso tenha até 

agora sido restrito a locais não sujeitos a carga, devido ao fraco desempenho 

mecânico dos cimentos ósseos comercialmente disponíveis, seria desejável 

estender o seu uso a outros locais, tais como vértebras osteoporóticas com 

fraturas compressivas, desde que eles se qualificassem para tal. No mínimo, a 

resistência mecânica requerida para os cimentos ósseos deveria ser pelo menos 

tão elevada como os valores máximos apresentados para o osso trabecular na 

Tabela 1 da secção 1.2.1 (10-12 MPa).  



Capítulo 1 

 45 

As propriedades mecânicas dos CPCs endurecidos são comummente avaliadas 

através da determinação da resistência à compressão (compression strenght, 

CS), ou da resistência à tração. Como os CPCs são frágeis, a CS é a propriedade 

mecânica mais estudada. Esta é a tensão máxima (?max) em MPa que uma 

amostra do material com uma determinada área de secção transversal (A0) pode 

suportar sob esforços de compressão antes de fraturar. Esta medição é 

normalmente feita utilizando uma máquina de ensaio universal, medindo a força 

máxima (Fmax) que pode ser aplicada ao material. Os provetes, geralmente de 

geometria cilíndrica com uma proporção de 1:2 entre o seu diâmetro (6 mm) e 

altura (12 mm) são colocados na posição vertical de acordo com a norma 

ASTM F 451-0891 para cimentos ósseos acrílicos [121]. A tensão de compressão 

é calculada de acordo com a equação 5. 

0

max
max

A

F
=?   (5) 

 

Como em tais materiais frágeis a resistência à tracção é difícil de medir 

directamente, a sua avaliação é geralmente feita através de um método 

alternativo, nomeadamente, por compressão diametral (diametral tensile strengh, 

DTS), apesar de esta técnica dar resultados que subestimam a verdadeira 

resistência à tracção por um factor de 85% [122]. A DTS é medida de forma 

semelhante à CS, mas colocando as amostras cilíndricas na posição horizontal, 

induzindo forças de tracção perpendicular à carga de compressão aplicada. 

Geralmente, o tamanho da amostra é de 6 mm de diâmetro e 3 mm de altura. A 

DTS é calculada através da equação 6, onde d é o diâmetro da amostra e h é a 

altura da amostra. 

dh

F

?
? maxmax

2
=  (6) 

 



Capítulo 1 

 46 

As propriedades mecânicas das diferentes formulações referidas na literatura são 

de muito difícil comparação devido ao facto das medições destas propriedades 

serem feitas com amostras preparadas em condições variadas (amostras obtidas 

com ou sem pressão exercida sobre elas, ensaios feitos com amostras secas ou 

húmidas e após tempos de presa e endurecimento diversos sob temperatura e 

humidade diferentes, etc.). Estes fatores têm grande influência nos valores finais 

medidos. Contudo, os valores mais frequentemente reportados são baixos, e as 

fracas propriedades mecânicas dos CPCs restringem o campo das suas 

potenciais aplicação clínicas. Os valores de resistência à compressão e de tempo 

de presa de alguns CPCs comerciais referidos na Tabela 2 da secção 3.1 são: (i) 

Norian SRS® (~50% porosidade): 33 ± 5 MPa e 8.5 ± 0.5 min; (ii) Cementek®: 

8 ± 2 MPa and 17 ± 1 min; (iii) Biocement D® (~40% porosidade): 83 ± 4 MPa and 

6.5 ± 0.5 min; (iv) ?-BSM® (~80% porosidade): 4 ± 1 MPa and 19 ± 1 min, 

respectivamente [31].  

Praticamente todos os fatores que influenciam a injectabilidade também 

influenciam a CS. Assim, a variação das características dos pós de partida, tais 

como o tamanho das partículas, a proporção e a natureza das fases formadas, a 

LPR, a presença (e/ou variação) de aditivos, pode alterar de forma notória a CS. 

Sabe-se que o aumento da porosidade ou da LPR diminuem a CS dos 

cimentos [62].  

 

4.3.5.3 Biocompatibilidade e ressorção  

A biocompatibilidade expressa a habilidade do material de não causar dano, 

reacções tóxicas ou imunológicas aos tecidos vivos. A biocompatibilidade e a 

capacidade do material estabelecer ligações com os tecidos vivos podem ser 

avaliadas através de teste in vitro e in vivo. Os testes de biocompatibilidade 

in vitro incluem culturas de células disponíveis no mercado [123]. Além disso, 

existe uma vasta gama de métodos repetíveis e reprodutíveis, que são regulados 

por normas nacionais e internacionais para uso comercial e para o 

desenvolvimento científico de novos materiais e produtos. A análise detalhada da 



Capítulo 1 

 47 

superfície de apatite formada em SBF por técnicas como difracção de raios-X 

(DRX), espectroscopia de infravermelho por transformada de Fourier (FTIR), 

microscopia electrónica de varrimento (SEM) e microscopia electrónica de 

transmissão (TEM) revelou que era semelhante ao mineral do osso na sua 

composição e estrutura [124]. Como resultado, foi especulado que os 

osteoblastos podem preferencialmente proliferar e diferenciarem-se para produzir 

apatite e colagénio na sua superfície. A apatite secundária formada é a 

responsável pela ligação entre os cimentos e os tecidos circundantes. Embora os 

estudos in vitro dêem informações sobre as interacções fundamentais importantes 

com biomateriais, eles não podem substituir a avaliação in vivo. Um modelo 

animal é uma forma adequada para identificar um material com bioatividade 

óssea in vivo, tendo sempre em atenção as semelhanças e as diferenças na 

composição e arquitetura entre o osso trabecular do animal e dos seres humanos.  

Fenómenos de troca iónica que ocorrem com os CPCs estão associados a 

reactividade face a ligação óssea. A importância dos oligoelementos na saúde 

óssea está bem documentada. Iões como o zinco, magnésio, manganês, silício, 

estrôncio, etc. têm mostrado aumentar a osteogênese e a neovascularização 

[125]. A presença Sr na composição dos CPCs tem vinda a despertar muito 

interesse devido a sua contribuição no aumento do desempenho biológico in vivo 

destes materiais [50, 126].  

Uma das características mais atraentes de CPCs é a sua capacidade de serem 

ressorvidos in vivo. Após a implantação, estes materiais atuam como suportes 

osteocondutores, degradam-se com o tempo, sendo gradualmente substituídos 

por osso durante o processo de remodelação [3]. A taxa de ressorção pode ser 

influenciada por fatores como a idade, o sexo e a saúde metabólica geral do 

hospedeiro. A ressorção completa dos CPCs pode variar entre 3 a 36 meses 

dependendo da conjunção destes fatores e das características dos cimentos 

(composição química [90], volume implantado, porosidade, grau de cristalinidade 

e tamanho do cristais) [85].  

A incorporação nos cimentos de apatite de compostos mais solúveis, tais como 

CaCO3 e CaSO4, tem vindo a ser explorada com o intuito de acelerar a sua taxa 



Capítulo 1 

 48 

de ressorção [62]. Nesse aspecto, os cimentos de brushite levam vantagem ao 

serem mais rapidamente reabsorvidos em comparação com os de apatite, embora 

a tranformação in vivo da brushite em apatite tenha sido vista como limitadora da 

ressorção do cimento [62]. Por outro lado, a presença de certos iões (tais como 

por exemplo o magnésio [127] e o pirofosfato [128]) que tendem a inibir a 

formação de apatite pode travar essa transformação  

  

4.3.5.4 Incorporação de iões presentes no osso  

A incorporação de elementos vestigiais na estrutura dos cimentos com o intuito de 

obter uma maior correspondência entre a composição dos substitutos ósseos e a 

dos tecidos duros tem sido objeto de vários estudos de investigação [39, 55, 75, 

126,129,130]. Nesta tese, as motivações para o uso de fosfatos de cálcio 

dopados foram ainda além daqueles objetivos, visando não só melhorias ao nível 

do desempenho biológico dos cimentos, mas também de outras das suas 

propriedades mais relevantes, incluindo a facilidade de manuseamento 

(injectabilidade) e das propriedades mecânicas de CPCs [68, 131].  

 

5. Metas e objetivos 

A pesquisa bibliográfica revelou que, apesar do esforço de investigação crescente 

e de alguns progressos verificados nestes últimos anos nesta área, o campo de 

aplicação dos cimentos ósseos à base de fosfatos de cálcio é ainda bastante 

restrito a locais não sujeitos a carga. Realçou ainda que os cimentos comerciais 

possuem fraca habilidade para serem manuseados e injetados. Outra ideia clara 

que ressalta do atual estado da arte é o fraco domínio das características dos pós 

precursores, e a ausência de correlações claras entre essas características e as 

propriedades mais relevantes dos cimentos, incluindo a injectabilidade, e as 

propriedades físicas, químicas e biológicas. Estes aspectos precisam de ser 

aprofundados de modo a trazer um melhor nível de compreensão para esta área 

do conhecimento. 



Capítulo 1 

 49 

Assim, o objetivo central estabelecido para esta tese era o desenvolvimento de 

um cimento ósseo à base de fosfatos de cálcio com injectabilidade e propriedades 

mecânicas melhoradas para aplicações em procedimentos cirúrgicos 

minimamente invasivos. Sendo a vertebroplastia o procedimento cirúrgico 

minimamente invasivo mais exigente no que concerne a estas propriedades 

específicas, esta eventual aplicação foi vista como o nível máximo da fasquia que 

qualquer um gostaria de superar, não devendo ser encarada como um objetivo 

necessariamente alcançável, mas mais como uma motivação inspiradora para 

espíritos insatisfeitos.  

A minimização da razão líquido-pó usada na preparação dos cimentos e o 

aumento da injectabilidade através de uma viscosidade controlada foram os 

pontos-chave para alcançar este objetivo. A incorporação de aditivos na solução 

aquosa reativa (espessantes reológicos, lubrificantes, entre outros) e o uso de pós 

de partida com distribuições de tamanhos de partículas otimizadas de modo a 

maximizar as concentrações de sólidos nas pastas cimentícias foram as vias 

exploradas para atingir essas metas. A melhoria das propriedades mecânicas 

seria, portanto, conseguida às custas de uma diminuição da porosidade do 

cimento, a qual, por sua vez, deverá abrandar a cinética de reabsorção. Nesta 

perspetiva, a opção por cimentos à base de brushite que têm uma taxa de 

reabsorção mais rápida que os cimentos à base de apatite, apresentou-se como a 

forma mais racional para contornar esse problema.  

Como referido na Introdução Geral, os objetivos específicos do estudo 

apresentado no Capítulo 2 eram contribuir para uma melhor compreensão dos 

efeitos da dopagem com Mg e do tratamento térmico nas transformações 

alotrópicas ? ? ??TCP, especialmente em presença de impurezas de pirofosfato 

de cálcio. Os resultados deveriam servir de base para selecionar qual dos dois 

tipos de pós precursores, ??TCP ou ??TCP, seriam usados em estudos 

posteriores de preparação de cimentos de fosfatos de cálcio à base de brushite. 

Ficou demonstrado que o Mg estabiliza a fase ??TCP, dificultando a obtenção de 

??TCP puro, uma tendência comummente observada com outros elementos 

dopantes. Isto justificou a seleção de pós de ?-TCP para os estudos seguintes.  



Capítulo 1 

 50 

No estudo apresentado no Capítulo 3, os objetivos a atingir eram vários: 

(i) entender a influência do tamanho e da distribuição de tamanho de partículas de 

pós de ?-TCP e do seu estado de agregação na injectabilidade de sistemas não 

reativos (pastas não reativas) e reativos (pastas cimentícias); (ii) averiguar se os 

resultados obtidos com os sistemas não-reativos eram transponíveis para os 

sistemas reativos; (iii) investigar os efeitos de alguns aditivos presentes no líquido 

reativo nas pastas cimentícias; (iv) otimizar a distribuição de tamanho de 

partículas a fim de aumentar a injectabilidade das pastas cimentícias com uma 

razão líquido-pó tão baixa quanto possível. Para o efeito foram preparados e 

usados pós de ?-fosfato tricálcicos dopados com Sr. Além das suas propriedades 

de ião biologicamente ativo e de agente radiopacificante, este elemento foi 

introduzido sobretudo para aumentar a estabilidade térmica do ?-TCP permitindo 

a obtenção de grânulos de ?-TCP bem densificados usados também neste 

estudo.  

Com o intuito de aumentar o desempenho biológico dos cimentos, foram 

sintetizados pós de ?-TCP dopados com vários teores de Mn. A caracterização 

físico-química destes pós, assim como a sua resposta biológica in vitro são 

apresentados no Capítulo 4. 

Tendo em atenção os resultados obtidos nos dois capítulos anteriores, no 

Capítulo 5 foram preparados e caracterizados diversos pós de ?-TCP dopados 

com Sr, com Mn e co-dopados com estes dois iões. Por outro lado, 

adicionaram-se açúcares (sucrose, também denominada por sacarose e frutose) 

à composição do líquido reativo. Os vários objetivos parciais estabelecidos para 

este trabalho eram avaliar os efeitos singulares e conjugados dos iões dopantes e 

da presença de açúcares nas seguintes propriedades dos cimentos: 

(i) manuseamento (tempo de início de presa e injectabilidade); (ii) físicas 

(resistência à compressão e porosidade); (iii) desempenho biológico in vitro; 

(iv) obter uma formulação que vá ao encontro do objetivo central desta tese. 

 

 



Capítulo 1 

 51 

6. Referências bibliográficas 

[1] E.N.Marieb, K. Hoehn, Human Anatomy &amp;amp; Physiology, Pearson 2006. 

[2] J.R. Jones, L.L. Hench, Regeneration of trabecular bone using porous 

ceramics, Curr Opin Solid St M. 7 (2003) 301-7. 

[3] R LeGeros, G Daculsi, J LeGeros. Bioactive Bioceramics. In: W Pietrzak, 

editor, Musculoskeletal Tissue Regeneration, Humana Press (2008)153-81. 

[4] Sommerfeldt DW, Rubin CT, Biology of bone and how it orchestrates the form 

and function of the skeleton, Eur Spine J. 10 Suppl 2 (2001) S86-95. 

[5] S.C. Cowin, Bone Mechanics Handbook, Second Edition: Taylor &amp;amp; Francis 

2001. 

[6] J.D. Currey, Bones: Structure and Mechanics, Princeton University Press 2002. 

[7] A.J. Wagoner Johnson,, B.A. Herschler, A review of the mechanical behavior 

of CaP and CaP/polymer composites for applications in bone replacement and 

repair, Acta Biomater. 7 (2011) 16-30. 

[8] D.R. Carter, WC Hayes, Bone compressive strength: the influence of density 

and strain rate, Science 194 (1976) 1174-6. 

[9] T.M. Wright, W.C. Hayes, Tensile testing of bone over a wide range of strain 

rates: effects of strain rate, microstructure and density, Med biol Eng. 14 (1976) 

671-80. 

[10] J.D. Currey, Tensile yield in compact bone is determined by strain, post-yield 

behaviour by mineral content, J Biomech.;37 (2004) 549-56. 

[11] M. Wright, W.C. Hayes, Tensile testing of bone over a wide range of strain 

rates: effects of strain rate, microstructure and density, J biomech. 37 (2004) 

1281-7. 



Capítulo 1 

 52 

[12] J.-Y. Rho, L. Kuhn-Spearing, P. Zioupos, Mechanical properties and the 

hierarchical structure of bone, Med Eng Phys. 20 (1998) 92-102. 

[13] E.B.W. Giesen, M. Ding, M. Dalstra, T.M.G.J. van Eijden, Mechanical 

properties of cancellous bone in the human mandibular condyle are anisotropic, J 

Biomech. 34 (2001) 799-803. 

[14] X. Banse, T.J. Sims, A.J. Bailey, Mechanical properties of adult vertebral 

cancellous bone: correlation with collagen intermolecular cross-links, J Bone 

Miner Res. 17 (2002) 1621-8. 

[15] A. Doat, F. Pellé, N. Gardant, A. Lebugle, Synthesis of luminescent bioapatite 

nanoparticles for utilization as a biological probe, J Solid State Chem. 177 (2004) 

1179-87. 

[16] R. Legros, N. Balmain, G. Bonel, Age-related changes in mineral of rat and 

bovine cortical bone, Calcified Tissue Int. 41 (1987) 137-44. 

[17] C. Rey, J.L. Miquel, L. Facchini, A.P. Legrand, M.J. Glimcher, 

Hydroxyl-groups in bone mineral, Bone. 16 (1995) 583-6. 

[18] L.C. Bonar, A.H. Roufosse, W.K. Sabine, M.D. Grynpas, M.J. Glimcher, X-ray 

diffraction studies of the crystallinity of bone mineral in newly synthesized and 

density fractionated bone, Calcif Tissue Int. 35 (1983) 202-9. 

 [19] S. Cazalbou, D. Eichert, C. Drouet, C. Combes, C. Rey, Minéralisations 

biologiques à base de phosphate de calcium. C R Palevol. 3 (2004) 563-72. 

[20] S. Cazalbou, D. Eichert, X. Ranz, C. Drouet, C. Combes, M.F. Harmand, et 

al., Ion exchanges in apatites for biomedical application, J Mater Sci-Mater M. 16 

(2005) 405-9. 

[21] R.R. Seeley, T.D. Stephens, P. Tate, Anatomia e Fisiologia, Lusodidática, 

Anatomia &amp;amp; fisiologia 2001. 



Capítulo 1 

 53 

[22] M. Bohner, Resorbable biomaterials as bone graft substitutes, Mater Today. 

13 (2010)24-30. 

[23] Y. Luo, G. Engelmayr, D.T. Auguste, Ld.S. Ferreira, J.M. Karp, R. Saigal, et 

al., Chapter Twenty-Five - Three-Dimensional Scaffolds. In: R. Lanza, R. Langer, 

J. Vacanti editors, Principles of Tissue Engineering (Third Edition), Burlington, 

Academic Press (2007) 359-73. 

[24] A.M. Barradas, H. Yuan, C.A. van Blitterswijk, P. Habibovic, Osteoinductive 

biomaterials: current knowledge of properties, experimental models and biological 

mechanisms, Eur Cell Mater. 21 (2011) 407-29. 

[25] M. Bohner, Calcium orthophosphates in medicine: from ceramics to calcium 

phosphate cements, Injury. 31 (2000) 37-47. 

[26] S.V. Dorozhkin, Calcium orthophosphates. J Mater Sci. 42 (2007) 1061-95. 

[27] F.H. Albee, Studies in bone growth triple calcium phosphate as a stimulus to 

osteogenesis, Ann Surg. 71 (1920) 32-9. 

[28] L.M. Grover, A.J. Wright, U. Gbureck, A. Bolarinwa, J. Song, Y. Liu, et al., The 

effect of amorphous pyrophosphate on calcium phosphate cement resorption and 

bone generation, Biomaterials. 34 (2013) 6631-7. 

[29] M.H. Alkhralsat, F.T. Marino, C.R. Rodriguez, LB Jerez, E.L. Cabarcos. 

Combined effect of strontium and pyrophosphate on the properties of brushite 

cements, Acta Biomater. 4 (2008) 664-70. 

[30] K. Ishikawa, Bone substitute fabrication based on dissolution-precipitation 

reactions, Materials. 3 (2010) 1138-55. 

[31] S. Dorozhkin, Self-Setting calcium orthophosphate formulations, J Funct 

Biomater. 4 (2013) 209-311. 



Capítulo 1 

 54 

[32] N.A. Curry, D.W. Jones, Crystal structure of brushite, calcium hydrogen 

orthophosphate dihydrate: a neutron-diffraction investigation, J. Chem. Soc. A. 

(1971) 3725-3729. 

[33] H.E. Lundager Madsen, F. Christensson, Precipitation of calcium phosphate 

at 40°C from neutral solution, J Cryst Growth. 114 (1991) 613-8. 

[34] H.E. Lundager Madsen, G. Thorvardarson, Precipitation of calcium phosphate 

from moderately acid solution, J Cryst Growth. 66 (1984) 369-76. 

[35] R. LeGeros, Calcium phosphates in oral biology and medicine, Monogr Oral 

Sci. 15 (1991) 1-201. 

[36] F Tamimi, Z Sheikh, J Barralet, Dicalcium phosphate cements: Brushite and 

monetite, Acta Biomater. 8 (2012) 474-87. 

[37] M. Bohner, Design of ceramic-based cements and putties for bone graft 

substitution, Eur Cells Mater. 20 (2010) 1-12. 

[38] H.L. Alves, L.A. Dos Santos, C.P. Bergmann. Injectability evaluation of 

tricalcium phosphate bone cement, J Mater Sci-Mater M. 19 (2008) 2241-6. 

[39] S. Pina, P.M. Torres, F. Goetz-Neunhoeffer, J. Neubauer, J.M.F. Ferreira, 

Newly developed Sr-substituted alpha-TCP bone cements, Acta Biomater. 6 

(2010) 928-35. 

[40] S.V. Dorozhkin, Calcium orthophosphates cements for biomedical application, 

J Mater Sci-Mater M. 43 (2008) 3028-57. 

[41] R.Z. LeGeros, G. Daculsi, I. Orly, T. Abergas, W. Torres, Solution-mediated 

transformation of octacalcium phosphate (OCP) to apatite, Scanning Microsc. 3 

(1989) 129-37. 

[42] J.L. Meyer, E.D. Eanes, A thermodynamic analysis of the secondary transition 

in the spontaneous precipitation of calcium phosphate, Calc Tissue Res. 25 

(1978) 209-16. 



Capítulo 1 

 55 

[43] O. Suzuki, S. Kamakura, T. Katagiri, M. Nakamura, B. Zhao, Y. Honda, et al., 

Bone formation enhanced by implanted octacalcium phosphate involving 

conversion into Ca-deficient hydroxyapatite, Biomaterials. 27 (2006) 2671-81. 

[44] P. Habibovic, C.M. van der Valk, C.A. van Blitterswijk, K. De Groot, G. Meijer, 

Influence of octacalcium phosphate coating on osteoinductive properties of 

biomaterials, J Mater Sci-Mater M. 15 (2004) 373-80. 

[45] H Imaizumi, M Sakurai, O Kashimoto, T Kikawa, O Suzuki, Comparative study 

on osteoconductivity by synthetic octacalcium phosphate and sintered 

hydroxyapatite in rabbit bone marrow, Calcif Tissue Int. 2006;78:45-54. 

[46] A. Bigi, B. Bracci, F. Cuisinier, R. Elkaim, M. Fini, I. Mayer, et al., Human 

osteoblast response to pulsed laser deposited calcium phosphate coatings, 

Biomaterials. 26 (2005) 2381-9. 

[47] M. Markovic, L.C. Chow, An Octacalcium Phosphate Forming Cement. 

Journal of research of the National Institute of Standards and Technology. 115 

(2010) 257-65. 

[48] S. Mandel, A.C. Tas, Brushite (CaHPO4 2H2O) to octacalcium phosphate 

(Ca8(HPO4)2(PO4)4•5H2O) transformation in DMEM solutions at 36.5ºC, Mater Sci 

Eng C. 30 (2010) 245-54. 

[49] E. Boanini, M. Gazzano, A Bigi, Ionic substitutions in calcium phosphates 

synthesized at low temperature, Acta Biomater. 6 (2010) 1882-94. 

[50] M. Schumacher, M. Gelinsky, Strontium modified calcium phosphate 

cements - Approaches towards targeted stimulation of bone turnover, J. Mater. 

Chem. B. 3 (2015) 4626-40. 

[51] T. Landete-Castillejos, I. Molina-Quilez, J.A. Estevez, F Ceacero, A.J. Garcia, 

L. Gallego, Alternative hypothesis for the origin of osteoporosis: The role of Mn, 

Front Biosci. E4 (2012) 1385-90. 



Capítulo 1 

 56 

[52] H. Rico, N. Gómez-Raso, M. Revilla, E.R. Hernández, C. Seco, E. Páez, et 

al., Effects on bone loss of manganese alone or with copper supplement in 

ovariectomized rats A morphometric and densitomeric study, Eur. J. Obstet. 

Gynecol. Reprod. Biol. 2000;90:97-101. 

[53] S. Kannan, S.I. Vieira, S.M. Olhero, P.M.C. Torres, S Pina, O.A.B. Da Cruz e 

Silva, et al., Synthesis, mechanical and biological characterization of ionic doped 

carbonated hydroxyapatite/?-tricalcium phosphate mixtures. Acta Biomater. 

7(2011) 1835-43. 

[54] S. Kannan, J.M. Ventura, J.M.F. Ferreira, Aqueous precipitation method for 

the formation of Mg-stabilized ?-tricalcium phosphate: An X-ray diffraction study, 

Ceram Int. 33 (2007) 637-41. 

[55] S. Kannan, S. Pina, J.M.F. Ferreira, Formation of strontium-stabilized 

?-tricalcium phosphate from calcium-deficient apatite, J. Am. Ceram. Soc. 89 

(2006) 3277-80. 

[56] S. Kannan, F. Goetz-Neunhoeffer, J. Neubauer, S. Pina, P.M.C. Torres, 

J.M.F. Ferreira, Synthesis and structural characterization of strontium- and 

magnesium-co-substituted ?-tricalcium phosphate, Acta Biomater. 6 (2010) 571-6. 

[57] G. Lewis, Properties of acrylic bone cement: state of the art review, J. 

Biomed. Mater. Res. 38 (1997) 155-82. 

[58] M.K. Singh, T. Shokuhfar, J.J.A. Gracio, A.C.M. de Sousa, J.M.F. Ferreira, H. 

Garmestani, et al., Hydroxyapatite Modified with Carbon-Nanotube-Reinforced 

Poly(methyl methacrylate): A Nanocomposite Material for Biomedical Applications, 

Adv Funct Mater. 18 (2008) 694-700. 

[59] M. Nilsson, E. Fernandez, S. Sarda, L. Lidgren, J.A. Planell, Characterization 

of a novel calcium phosphate/sulphate bone cement, J. Biomed. Mater. Res. 61 

(2002) 600-7. 



Capítulo 1 

 57 

[60] G. Lewis, Injectable bone cements for use in vertebroplasty and kyphoplasty: 

state-of-the-art review, J. Biomed. Mater. Res. B Appl. Biomater. 76 (2006) 

456-68. 

[61] M. Bohner, Reactivity of calcium phosphate cements, J. Mater. Chem. 17 

(2007) 3980-6. 

[62] M. Bohner, U. Gbureck, J.E. Barralet, Technological issues for the 

development of more efficient calcium phosphate bone cements: a critical 

assessment. Biomaterials. 26 (2005) 6423-9. 

[63] M.P. Ginebra, E. Fernandez, E.A.P. DeMaeyer, R.M.H. Verbeeck, M.G. 

Boltong, J. Ginebra, et al., Setting reaction and hardening of an apatitic calcium 

phosphate cement, J.Dent. Res.;76 (1997) 905-12. 

[64] F.C.M. Driessens, J.A. Planell, M.G. Boltong, I. Khairoun, M.P. Ginebra, 

Osteotransductive bone cements, Proc. Inst. Mech. Eng. Part. H – J. Eng. Med. 

212 (1998) 427-35. 

[65] E. Fernandez, M.P. Ginebra, M.G. Boltong, F.C.M. Driessens, J. Ginebra, 

E.A.P. DeMaeyer, et al., Kinetic study of the setting reaction of a calcium 

phosphate bone cement, J Biomed. Mater. Res. 32 (1996) 367-74. 

[66] ASTM, Standard Test Method for Time of Setting of Hydraulic Cement Paste 

by Vicat Needle; ASTM C191-92; American Society for Testing and Materials: 

Philadelphia, PA, USA, (1993) 158-160. 

[67] ASTM, Standard Test Method for Time of Setting of Hydraulic Cement Paste 

by Gillmore Needles; ASTM C266-89; American Society for Testing and Materials: 

Philadelphia, PA, USA, (1993) 189-191. 

[68] S. Pina, P.M. Torres, J.M. Ferreira, Injectability of brushite-forming Mg-

substituted and Sr-substituted alpha-TCP bone cements, J. Mater. Sci. Mater. M. 

21 (2010) 431-8. 



Capítulo 1 

 58 

[69] M.P. Ginebra, E. Fernández, F.C.M. Driessens, M.G. Boltong, J. Muntasell, J. 

Font, et al., The effects of temperature on the behaviour of an apatitic calcium 

phosphate cement. J. Mater. Sci. Mater. M. 6 (1995) 857-60. 

[70] I. Khairoun, M.G. Boltong, F.C. Driessens, J.A. Planell, Limited compliance of 

some apatitic calcium phosphate bone cements with clinical requirements, J. 

Mater. Sci. Mater. M. 9 (1998) 667-71. 

[71] S. Sarda, E. Fernandez, J. Llorens, S. Martinez, M. Nilsson, J.A. Planell, 

Rheological properties of an apatitic bone cement during initial setting, J. Mater. 

Sci. Mater. M. 12 (2001) 905-9. 

[72] M. Bohner, A.K. Malsy, C.L. Camiré, U. Gbureck, Combining particle size 

distribution and isothermal calorimetry data to determine the reaction kinetics of 

?-tricalcium phosphate-water mixtures, Acta Biomater. 2 (2006) 343-8. 

[73] M.P. Ginebra, F.C.M. Driessens, J.A. Planell, Effect of the particle size on the 

micro and nanostructural features of a calcium phosphate cement: a kinetic 

analysis, Biomaterials. 25 (2004) 3453-62. 

[74] S. Pina, S.M. Olhero, S. Gheduzzi, A.W. Miles, J.M. Ferreira, Influence of 

setting liquid composition and liquid-to-powder ratio on properties of a Mg-

substituted calcium phosphate cement, Acta Biomater. 5 (2009) 1233-40. 

[75] S. Pina, S.I. Vieira, P.M. Torres, F. Goetz-Neunhoeffer, J. Neubauer, O.A. da 

Cruz e Silva, et al. In vitro performance assessment of new brushite-forming Zn- 

and ZnSr-substituted beta-TCP bone cements, J. Biomed. Mater. Res. B. Appl. 

Biomater.;94 (2010)414-20. 

[76] Z.G. Huan, J. Chang. Novel, Bioactive composite bone cements based on the 

beta-tricalcium phosphate-monocalcium phosphate monohydrate composite 

cement system, Acta Biomater. 5 (2009) 1253-64. 

[77] U. Gbureck, S. Dembski, R. Thull, J.E. Barralet, Factors influencing calcium 

phosphate cement shelf-life, Biomaterials. 26 (2005) 3691-7. 



Capítulo 1 

 59 

[78] R Legeros, A Chohayeb, A Shulman, Apatitic calcium phosphates:possible 

dental restorative materials, J. Dent. Res. 61 (1982) 343. 

[79] W.E. Brown, L.C. Chow, A new calcium-phosphate setting cement, J.Dent. 

Res. 62 (1983) 672-672. 

[80] A.A. Mirtchi, J. Lemaitre, N. Terao, Calcium phosphate cements: study of the 

beta-tricalcium phosphate--monocalcium phosphate system, Biomaterials 

10 (1989) 475-80. 

[81] K. Ishikawa, S. Takagi, L.C. Chow, K. Suzuki, Reaction of calcium phosphate 

cements with different amounts of tetracalcium phosphate and dicalcium 

phosphate anhydrous, J. Biomed. Mater. Res. 46 (1999) 504-10. 

[82] P.W. Brown, M. Fulmer, Kinetics of Hydroxyapatite Formation at Low 

Temperature, J. Am. Ceram. Soc. 74 (1991) 934-40. 

[83] K.S. TenHuisen, P.W. Brown, The formation of hydroxyapatite-ionomer 

cements at 38 degrees C, J. Dent. Res. 73 (1994) 598-606. 

[84] J. Engstrand, C. Persson, H. Engqvist, The effect of composition on 

mechanical properties of brushite cements, J Mech Behav Biomed Mater. 

29 (2014) 81-90. 

[85] S. Dorozhkin, Self-Setting calcium orthophosphate formulations, J Funct 

Biomater. 4 (2013) 209-311. 

[86] M. Bohner, J. Lemaitre, T.A. Ring, Effects of Sulfate, Pyrophosphate, and 

Citrate Ions on the Physicochemical Properties of Cements Made of ?-Tricalcium 

Phosphate-Phosphoric Acid-Water Mixtures, J. Am. Ceram. Soc. 79 (1996) 

1427-34. 

[87] J. Engstrand, J. Aberg, H. Engqvist, Influence of water content on hardening 

and handling of a premixed calcium phosphate cement, Mater Sci Eng C. 

33 (2013) 527-31. 



Capítulo 1 

 60 

[88] E.B. Montufar, Y. Maazouz, M.P. Ginebra, Relevance of the setting reaction 

to the injectability of tricalcium phosphate pastes, Acta Biomater. 9 (2013) 

6188-98. 

[89] S. McMahon, G. Hawdon, J. Bare, Y. Sim, N. Bertollo, W.R. Walsh, Thermal 

necrosis and PMMA – a cause for concern? J. Bone Joint. Surg. Br. 94-B (2012) 

64. 

[90] M. Bohner, U. Gbureck, Thermal reactions of brushite cements, J. Biomed. 

Mater. Res. B. Appl. Biomater. 84 (2008) 375-85.  

[91] C. Liu, Y. Huang, J. Chen, The physicochemical properties of the solidification 

of calcium phosphate cement, J Biomed Mater Res B Appl Biomater. 69 (2004) 

73-8. 

[92] C. Grossardt, A. Ewald, L.M. Grover, J.E. Barralet, U. Gbureck, Passive and 

active in vitro resorption of calcium and magnesium phosphate cements by 

osteoclastic cells, Tissue Eng. Part. A. 16 (2010) 3687-95. 

[93] D. Apelt, F. Theiss, A.O. El-Warrak, K. Zlinszky, R. Bettschart-Wolfisberger, 

M. Bohner, et al., In vivo behavior of three different injectable hydraulic calcium 

phosphate cements, Biomaterials. 25 (2004) 1439-51. 

[94] K. Ohura, M. Bohner, P. Hardouin, J. Lemaître, G. Pasquier, B. Flautre, 

Resorption of, and bone formation from, new ?-tricalcium phosphate-monocalcium 

phosphate cements: An in vivo study, J. Biomed. Mater. Res. 30 (1996) 193-200. 

[95] B. Flautre, C. Maynou, J. Lemaitre, P. Van Landuyt, P. Hardouin, Bone 

colonization of beta-TCP granules incorporated in brushite cements, J. Biomed. 

Mater. Res. 63 (2002) 413-7. 

[96] C.S. Liu, H.F. Shao, F.Y. Chen, H.Y. Zheng, Rheological properties of 

concentrated aqueous injectable calcium phosphate cement slurry, Biomaterials. 

27 (2006) 5003-13. 



Capítulo 1 

 61 

[97] J.L. Giocondi, B.S. El-Dasher, G.H. Nancollas, C.A. Orme, Molecular 

mechanisms of crystallization impacting calcium phosphate cements, Philos. 

Trans. A Math. Phys. Eng. Sci. 368 (2010) 1937-61. 

[98] F.T. Marino, J. Torres, M. Hamdan, C.R. Rodriguez, E.L. Cabarcos, 

Advantages of using glycolic acid as a retardant in a brushite forming cement, J. 

Biomed. Mater. Res. B. Appl. Biomater. 83B (2007) 571-9. 

[99] U. Gbureck, J.E. Barralet, K. Spatz, L.M. Grover, R. Thull, Ionic modification 

of calcium phosphate cement viscosity. Part I: hypodermic injection and strength 

improvement of apatite cement, Biomaterials. 25 (2004) 2187-95. 

[100] L.M. Grover, U. Gbureck, A.J. Wright, J.E. Barralet, Cement formulations in 

the calcium phosphate H2O–H3PO4–H4P2O7 system, J. Am. Ceram. Soc. 88 

(2005) 3096-103. 

[101] M. Bohner, H.P. Merkle, P. Van Landuyt, G. Trophardy, J. Lemaitre, Effect of 

several additives and their admixtures on the physico-chemical properties of a 

calcium phosphate cement, J. Mater. Sci. Mater. M. 11 (2000) 111-6. 

[102] E.F. Burguera, H.H.K. Xu, L.M. Sun, Injectable calcium phosphate cement: 

Effects of powder-to-liquid ratio and needle size 9, J. Biomed. Mater. Res. B. Appl. 

Biomater. 84B (2008) 493-502.  

[103] M.P. Hofmann, A.M. Young, U. Gbureck, S.N. Nazhat, J.E. Barralet, FTIR-

monitoring of a fast setting brushite bone cement: effect of intermediate phases, J. 

Mater. Chem. 16 (2006) 3199-206. 

[104] M.P. Ginebra, C. Canal, M. Espanol, D. Pastorino, E.B. Montufar, Calcium 

phosphate cements as drug delivery materials, Adv Drug Deliv Rev. 64 (2012) 

1090-110. 

[105] U. Joosten, A. Joist, T. Frebel, B. Brandt, S. Diederichs, C. von Eiff, 

Evaluation of an in situ setting injectable calcium phosphate as a new carrier 

material for gentamicin in the treatment of chronic osteomyelitis: Studies in vitro 

and in vivo, Biomaterials. 25 (2004) 4287-95. 



Capítulo 1 

 62 

[106] S. Hesaraki, R. Nemati, Cephalexin-loaded injectable macroporous calcium 

phosphate bone cement, J. Biomed. Mater. Res. B. Appl. Biomater. 89B (2009) 

342-52. 

[107] S. Girod Fullana, H. Ternet, M. Freche, J.L. Lacout, F. Rodriguez, Controlled 

release properties and final macroporosity of a pectin microspheres-calcium 

phosphate composite bone cement, Acta Biomater. 6 (2010) 2294-300. 

[108] Y. Tahara, Y. Ishii, Apatite cement containing cis-diamminedichloroplatinum 

implanted in rabbit femur for sustained release of the anticancer drug and bone 

formation, J. Orthop. Sci. 6 (2001) 556-65. 

[109] S. Panzavolta, P. Torricelli, B. Bracci, M. Fini, A. Bigi, Functionalization of 

biomimetic calcium phosphate bone cements with alendronate, J. Inorg. Biochem. 

104 (2010) 1099-106. 

[110] http://www.bristolrad.com/vertebroplasty-radiology-bristol-farmington-ct.html, 

acesso em 18/11/ 2015. 

[111] M. Habib, G. Baroud, F. Gitzhofer, M. Bohner, Mechanisms underlying the 

limited injectability of hydraulic calcium phosphate paste, Acta Biomater. 4 (2008) 

1465-71. 

[112] L. Leroux, Z. Hatim, M. Freche, J.L. Lacout, Effects of various adjuvants 

(lactic acid, glycerol, and chitosan) on the injectability of a calcium phosphate 

cement, Bone. 25 (1999) 31S-4S. 

[113] G. Baroud, E. Cayer, M. Bohner, Rheological characterization of 

concentrated aqueous ?-tricalcium phosphate suspensions: The effect of liquid-to-

powder ratio, milling time, and additives, Acta Biomater. 1 (2005) 357-63. 

[114] M. Bohner, G. Baroud, Injectability of calcium phosphate pastes, 

Biomaterials. 26 (2005) 1553-63. 



Capítulo 1 

 63 

[115] A. Fatimi, J.F. Tassin, J. Bosco, R. Deterre, M.A.V. Axelos, P. Weiss, 

Injection of calcium phosphate pastes: prediction of injection force and 

comparison with experiments, J Mater Sci Mater Med. 23 (2012) 1593-603. 

[116] M Habib, G Baroud, F Gitzhofer, M Bohner, Mechanisms underlying the 

limited injectability of hydraulic calcium phosphate paste. Part II: particle 

separation study, Acta Biomater. 6 (2010) 250-6. 

[117] I. Khairoun, M.G. Boltong, F.C.M. Driessens, J.A. Planell, Some factors 

controlling the injectability of calcium phosphate bone cements, J Mater Sci Mater 

Med. 9 (1998) 425-8. 

[118] S. Sarda, E. Fernandez, M. Nilsson, M. Balcells, J.A. Planell, Kinetic study of 

citric acid influence on calcium phosphate bone cements as water-reducing agent, 

J Biomed Mater Res. 61 (2002) 653-9. 

[119] J.E. Barralet, L.M. Grover, U. Gbureck, Ionic modification of calcium 

phosphate cement viscosity. Part II: hypodermic injection and strength 

improvement of brushite cement, Biomaterials. 25 (2004) 2197-203. 

[120] T.J. Brunner, R.N. Grass, M. Bohner, W.J. Stark, Effect of particle size, 

crystal phase and crystallinity on the reactivity of tricalcium phosphate cements for 

bone reconstruction, J. Mater. Chem. 17 (2007) 4072-8. 

[121] ASTM, Standard Specification for Acrylic Bone Cement. ASTM F451: ASTM 

International, 2008. 

[122] C. Pittet, J. Lemaitre, Mechanical characterization of brushite cements: a 

Mohr circles' approach, J. Biomed. Mater. Res. 53 (2000) 769-80. 

[123] A. Ueno, Y. Miwa, K. Miyoshi, T. Horiguchi, H. Inoue, I. Ruspita, et al., 

Constitutive expression of thrombospondin 1 in MC3T3-E1 osteoblastic cells 

inhibits mineralization, J. Cell. Physiol. 209 (2006) 322-32. 

[124] T. Kokubo, H. Takadama. How useful is SBF in predicting in vivo bone 

bioactivity? Biomaterials. 27 (2006) 2907-15. 



Capítulo 1 

 64 

[125] S. Bose, G. Fielding, S. Tarafder, A. Bandyopadhyay, Understanding of 

dopant-induced osteogenesis and angiogenesis in calcium phosphate ceramics, 

Trends Biotechnol. 31 (2013) 594-605. 

[126] S. Pina, S.I. Vieira, P. Rego, P.M.C. Torres, O.A.B. da Cruz e Silva, E.F. da 

Cruz e Silva, et al., Biological responses of brushite–forming Zn- and ZnSr- 

subtituted beta-tricalcium phosphate bone cements, Eur Cell Mater. 20 (2010) 

162-77. 

[127] K.J. Lilley, U. Gbureck, J.C. Knowles, D.F. Farrar, J.E. Barralet, Cement 

from magnesium substituted hydroxyapatite. J Mater Sci Mater Med.;16 (2005) 

455-60. 

[128] L.M. Grover, U. Gbureck, A.J. Wright, M. Tremayne, J.E. Barralet, 

Biologically mediated resorption of brushite cement in vitro, Biomaterials. 

27 (2006) 2178-85. 

[129] M. Hamdan Alkhraisat, C. Moseke, L. Blanco, J.E. Barralet, E. Lopez-

Carbacos, U. Gbureck, Strontium modified biocements with zero order release 

kinetics, Biomaterials. 29 (2008) 4691-7. 

[130] S. Kannan, F. Goetz-Neunhoeffer, J. Neubauer, J.M.F. Ferreira, Ionic 

substitutions in biphasic hydroxyapatite and beta-tricalcium phosphate mixtures: 

Structural analysis by rietveld refinement, J. Am. Ceram. Soc. 91 (2008) 1-12. 

[131] S. Saint-Jean, C. Camiré, P. Nevsten, S. Hansen, M. Ginebra, Study of the 

reactivity and in vitro bioactivity of Sr-substituted alpha-TCP cements, J Mater Sci 

Mater Med. 16 (2005) 993-1001. 

 



  

 65 

 

 

Capítulo 2 

 

Influência da dopagem de magnésio, das 

impurezas de pirofosfato de cálcio e da taxa 

de arrefecimento sobre as transformações de 

fase alotrópicas ???????????? do fosfato tricálcico 

 

 

 

 

 

 

 

 



  

 66 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



Capítulo 2 

 67 

 

 

 

Influence of Mg-doping, calcium pyrophosphate impurities and 

cooling rate on the allotropic ???????????????? tricalcium phosphate phase 

transformations 

 

P.M.C. Torres a,*, J.C.C. Abrantes a, b, Ajay Kaushal a, S. Pina ª, N. Döbelin c, 

M. Bohner c, J.M.F. Ferreira a 

 

a Department of Materials and Ceramics Engineering, CICECO, University of Aveiro, 

3810-193 Aveiro, Portugal 

b UIDM, ESTG, Polytechnic Institute of Viana do Castelo, 4900 Viana do Castelo, Portugal 

c RMS Foundation, Bischmattstrasse 12, CH-2544 Bettlach, Switzerland 

 

 

Journal of the European Ceramic Society 36 (2016) 817-827 

doi: 10.1016/j.jeurceramsoc.2015.09.037 

 

 

 
*Corresponding author. Tel.: +351 234 370261; fax: +351 234 370204. 

   E-mail address: ptorres@ua.pt (P.M.C. Torres). 
 

 

 

 



Capítulo 2 

 68 

 

 

Abstract 

Alpha and beta-tricalcium phosphates are allotropic phases which play a very 

important role as bone graft substitutes, namely in calcium phosphate cements. 

Despite extensive research efforts, contradictory reports exist on the importance of 

quenching for maintaining ?-TCP purity. The role of calcium pyrophosphate 

impurities derived from a certain calcium-deficiency, hydroxyapatite impurities 

derived from calcium excess, and various ionic substitutions on thermal stability of 

these phases was not yet fully disclosed. The present work reports on the kinetics 

of ???-TCP phase transformations of calcium-deficient TCP powders with 

different Mg-doping extents (0?5 mol%) prepared by precipitation. Mg clearly 

enhanced the thermal stability of ?-TCP. The effect of cooling rate was more 

complex and interdependent on the Mg content and the heat treatment schedule. 

High ?-TCP contents were retained upon cooling at 5ºC min?1 for Mg ? 1 mol% or 

upon quenching from 1550ºC for Mg contents ? 2 mol%.  

 

Keywords: Tricalcium phosphate; Calcium pyrophosphate; Mg substitution; 

Phase transition; Thermal stability  

 



Capítulo 2 

 69 

1. Introduction 

Calcium phosphate (CaP) materials are among the most appropriate bone graft 

substitute materials due to their chemical similarity to the mineral part of bone [1]. 

Specifically, these materials are biocompatible and osteoconductive [2, 3], being 

in most cases degraded by cells such as macrophages and osteoclasts [4, 5]. 

Tricalcium phosphate (TCP, Ca3(PO4)2) is one of the CaP compounds significantly 

used for biomedical applications. It consists of three polymorphs, ?, ?, and ?’ [6] 

depending on the temperature. The low temperature ??TCP phase is stable from 

room temperature (RT) up to 1125ºC and thereafter within the temperature range 

of 1125ºC to 1430ºC transforms reconstructively [7, 8] to stable ?-TCP phase that 

can be maintained at RT as a metastable phase. At temperatures &gt; 1430ºC until 

1765ºC, TCP shows stable ?’-TCP phase that is unable to survive at RT [6, 9]. 

Nowadays, ?-TCP and ?-TCP have received growing attention as raw materials 

for bone repairing, being available in various forms such as granules, blocks and 

hydraulic calcium phosphate cements (CPCs) [10, 11]. Unlike ?-TCP, ?-TCP 

powder is much more soluble in water exhibiting hydraulic behaviour, explaining 

why it is often used in CPCs [12, 13]. 

Literature survey reveals different methods to synthesize ??TCP in laboratory 

(using molar ratio Ca/P ? 1.5) including solid-state reaction method [14-20], or 

thermal transformation of a precursor [21-24]. The thermal ??TCP ? ??TCP phase 

transformation is the most direct way to obtain ?-TCP [25] and is therefore also 

applied in this study. However, the synthesis of pure ??TCP is not easy and still 

not fully understood [26]. Small fractions of other crystalline phases such as 

?-TCP [15, 17, 18, 21, 27] and/or hydroxyapatite (HA) [14, 18, 28] in the final 

product have been reported. The presence of ?-TCP was sometimes attributed to 

a partial reversion during cooling of the already formed ?-TCP [15]. As the 

polymorphic ???-phase transformation is considered to be reconstructive 

[7, 8, 23], the reverse ????TCP transformation would require surpassing a 

considerable activation energy barrier to proceed [23]. Thus, reverting from 

????TCP should only be possible under a very slow cooling rate or a longue 



Capítulo 2 

 70 

dwell at temperature below the transformation temperature [29]. Even recognizing 

the reconstructive character of this transformation, most researchers advocate the 

use of quenching [16, 19, 20, 30] to produce ?-TCP and to avoid the ???-TCP 

reversion, whereas few reports suggest that a moderate cooling rate 

(5ºC min?1 [23, 31] and 10ºC min?1 [23, 32]) is sufficient to maintain ?-TCP purity. 

The incorporation of some ions such as Sr, Zn and Mg in the TCP lattice alters the 

relative stability of the ?- and ?-TCP polymorphs [9, 23, 31, 33-39]. Due to specific 

roles played by these elements in biological processes upon implantation [40-42], 

their presence in TCP is often intentional. The partial substitution of Mg for Ca in 

TCP increases the thermal stability of the ?-phase [9, 23, 31, 35, 39, 43]. 

Recently, Carrodeguas et al. [23, Anexo 1.1] presented a new phase diagram for 

Mg3(PO4)2 ? Ca3(PO4)2 system, different from the previously reported one by 

Enderle et al. [31, Anexo 1.2] in which a single phase boundary line was drawn 

between pure ?-TCP and pure ?-TCP phases. According to this new phase 

diagram [23], a biphasic field ? + ?-TCP exist during thermal transformation of ?-

TCP to ?-TCP at TCP rich zone. Therefore, the presence of a ?-TCP fraction in ?-

TCP sample can be due to a sintering temperature lying in the range of the solid 

solution. The authors showed that for TCP containing up to 1 mol% Mg no 

quenching was required for retaining the pure ?-TCP [23]. However, the solidus 

boundary between ?-TCP and a mixture of ?-TCP and ?-TCP was raised from 

1115 ºC to 1400 ºC upon increasing the Mg content from 0 to 5 mol% [23]. 

Therefore, it is likely that the kinetics of the ?-TCP ? ?-TCP conversion is affected 

by the Mg content. In addition, ?-TCP phase purity has also been reported to be 

affected by small variations of Ca/P ratio during its synthesis. Several phase 

equilibrium diagrams of CaO–P2O5 system have been proposed [44-47]. The most 

recent ones include Kreidler and Hummel [45, Anexo 2] using anhydrous 

conditions and Riboud [46, Anexo 3] in presence of H2O. Accordingly, when 

processed in hydrous condition, a slight variation (positive or negative) in 

stoichiometric ratio (Ca/P = 1.50), involuntary or intentional, lead to formation of 

TCP with minor amounts of HA (positive variation) or calcium pyrophosphate 

(CPP) (negative variation). CPP impurity is known to strongly effect ???-TCP 



Capítulo 2 

 71 

phase transition. Bohner et al. [32] showed that small amounts of CPP reduced 

the ?-TCP purity; Welch and Gutt [44] observed an acceleration on the ??? 

phase transition in the presence of CPP. In these studies, as well as in the 

remaining available literature, no reasonable hypothesis has been advanced to 

explain the effects exerted by the presence of small amounts of CPP in ??? 

phase transition and in the composition of the final products. Therefore, one aim of 

the present study was filling this gap and shedding further light on the influence 

exerted by small amounts of CPP (induced by a certain calcium-deficiency of the 

starting powders [(Ca+Mg)/P ? 1.485?1.490] on the kinetics of the ?-TCP ? ?-

TCP phase transformation. Investigating the effects of cooling rate and of Mg-

doping extent on the thermal stability of ???-TCP phases were other intended 

targets.  

 

2. Materials and methods 

2.1 Powder synthesis 

Mg-substituted ?-Ca3(PO4)2 powders with different Mg contents (0?5 mol%), 

hereafter designated as Mg0?5TCP, were synthesized and investigated. The 

powders were prepared by an aqueous precipitation method described by Kannan 

et al. [48] after some modifications reported elsewhere [49]. The significance of 

the aqueous precipitation method relies on the homogeneous mixture of the final 

product, making this method reliable for the production of powders. Briefly, 

calcium nitrate tetrahydrate [Ca(NO3)?4H2O, Sigma?Aldrich], diammonium 

hydrogen phosphate [(NH4)2HPO4, Sigma?Aldrich] and magnesium nitrate 

hexahydrate [Mg(NO3)2?6H2O, Sigma?Aldrich] were used as starting chemical 

precursors, respectively for calcium, phosphorus and magnesium. The planned 

concentrations of Mg are depicted in Table 1 and the precursors were selected in 

such a way to keep the total molar ratio (Ca+Mg)/P = 1.500 for all compositions.  



 

 

C
a
p
ítu

lo
 2

 

7
2
 

 

 

 

Table 1. The planned and experimentally obtained (from elemental ICP analysis) compositions, quantitative phase analysis, lattice parameters and 

calculated cell volumes obtained by Rietveld refinement for ?-tricalcium phosphate (?-TCP). 95% repeatability limits of the phase quantification should 

be considered to be close to ± 1% [50]. 

 

 

 

  

 

Planned compositions 
Experimental compositions 
(from elemental analysis) 

(± 0.03) 

wt.% of phase 
composition 

(± 1) 

Lattice parameters 
(Å) 

Sample 
Code Ca/P 

molar 
ratio 

(Ca+Mg)/P 
molar 
ratio 

Conc. of 
Mg 

(mol%) 

Ca/P 
molar 
ratio 

(Ca+Mg)/P 
molar  
ratio 

Conc. 
of Mg 
(mol%) 

????-TCP ????-CPP 
a-axis 

(± 0.0004) 
c-axis 

(± 0.0004) 

Cell 
volume 

(Å3) 
(± 0.04) 

Mg0TCP 1.500 1.500 0.00 1.484 1.484 0.04 96.0 4.0 10.4422 37.3952 3531.25 

Mg1TCP 1.480 1.500 1.00 1.476 1.492 1.07 98.2 1.9 10.4300 37.3822 3521.78 

Mg2TCP 1.470 1.500 2.00 1.460 1.491 2.05 97.9 2.1 10.4159 37.3587 3510.04 

Mg5TCP 1.420 1.500 5.00 1.412 1.492 5.36 98.0 2.0 10.3804 37.2720 3478.08 



Capítulo 2 

 73 

The synthesis of the powders was performed at 30ºC and a target pH ~6.5 

(adjusted by adding ammonium hydroxide, NH4OH). The experimental pH values 

ranged within 6-7. The precipitated suspensions were kept under constant stirring 

(700 rpm) for 3 h and then ripened for further 15 h under resting conditions. These 

experimental synthesis conditions (temperature, pH, stirring conditions, maturation 

time) were adjusted to favour the formation of a small amount of CPP [51]. The 

resulting precipitates were vacuum-filtered (without washing) and then dried at 

100ºC during 48 h. The dried cakes were ground to fine powders and sieved 

through a mesh size of 200 µm.  

The as obtained powders were heat treated at 800ºC in a Thermolab furnace 

(Pt30%Rh/Pt6%Rh-thermocouple) with a heating rate of 5ºC min?1 and a dwelling 

time for 2 h to obtain undoped and Mg-doped ?-TCP. This heating schedule was 

shown to be suitable for the intended purposes [48] and the resulting powders, 

hereafter referred to as starting Mg0?5TCP powders, were well ground and sieved 

through a mesh size of 40 µm and stored for further characterization studies. 

 

2.2 Powders characterization 

The powders were submitted to a range of tests including inductively coupled 

plasma spectrometry (ICP-OES), Fourier Transform Infrared Spectrometry (FTIR), 

differential scanning calorimeter (DSC), high-temperature X-ray powder 

diffractometer (HT-XRD), and room-temperature XRD. Table 2 summarises all the 

characterisation experiments performed. More details on the various investigations 

are given in the next paragraphs. 

ICP-OES ? Elemental (Mg, Ca and P) analysis was performed using ICP-OES 

(Jobin Yvon Activa M., USA). For this purpose, the required amount of each 

starting powder was dissolved in nitric acid (HNO3) prior to ICP analysis.  

 

 



 

 

C
a
p
ítu

lo
 2

 

7
4
 

 

 

Table 2. Overview of the heating and cooling experiments performed on the starting powders (heat treated at 800ºC). The powders were characterized 

by ICP and Rietveld refinement (Table 1), XRD (Fig. 1) and FTIR (Fig. 2). The heating rate was fixed at 10ºC min?1 for all samples. Some experiments 

were conducted without dwell time (*). 

Method Powder(s) Calcination Temperature 
(ºC) 

Dwell 
time 
(h) 

Cooling 
(°C min-1) 

Replicates 
Results in 
Fig/Table 

Mg0TCP 1550  * 5, 10, 20  n = 1 Fig. 3 

n = 3 
(heating) DSC 

Mg0?5TCP 1550  * 10  
n = 1 

(cooling) 

Fig. 6 

XRD on DSC 
samples 

(after cooling) 
Mg0?5TCP 1550  * 5, 10, 20  n = 1 Table 3 

HT-XRD Mg0TCP 1350 * 5 n = 3 Fig. 4 

Mg0?5TCP 1550 2 and 24 
Quenching in 
H2O 

n = 3 Fig. 6 

Mg0TCP 1250, 1350,1550 2 5, 13 n = 3 Fig. 5, Fig. 7 
XRD 

Mg0?5TCP 1550 2 5, 13 n = 3 Fig. 7 

 

 



Capítulo 2 

 75 

FTIR ? Infrared spectra were obtained by FT-IR (model Mattson Galaxy S-7000, 

USA). Each starting powder was mixed with KBr in the proportion of 1/150 (by 

weight) for 15 min and pressed into a pellet. Each infrared spectrum was the 

average of 32 scans collected at 2 cm–1 resolution at room temperature (RT).  

DSC ? The thermal behaviour of the starting Mg0?5TCP powders was 

investigated using DSC (Setsys Evolution 16, Setaram) in O2 atmosphere, using a 

sample mass within the range of 20.5–22.5 mg. The samples were tested in 

triplicate on heating from RT up to 1550ºC at 10ºC min?1 to check for 

reproducibility of the results. Without dwell time at the maximum temperature, the 

cooling from 1550 ºC to 200 ºC was carried out at different rates of 5, 10 and 20ºC 

min?1. Based on the good reproducibility of the measurements on heating and 

considering the limited access to the equipment, only one test per sample was 

made on cooling. The as obtained results were complemented with other data 

gathered by other characterization techniques. After DSC experiments, the 

samples were analysed by XRD and quantitative phase analyses. 

HT-XRD ? The Mg0TCP polymorphic transitions were examined by HT-XRD 

(Philips X'Pert, model MPD equipped with Ni-filtered CuK? radiation). The 

instrument was used in the temperature-programmed heating mode within the 

temperature range of 30 ? 1350ºC, at heating and cooling rates of 10ºC min?1 and 

5ºC min?1, respectively. X-ray diffraction patterns were acquired in the 2? range of 

10 ? 115o (step size 0.02o, time per step 1 s) at different temperatures: (1) at 30ºC; 

(2) temperatures in the ranges of 800 ? 1350ºC (heating) and of 1350 ? 600ºC 

(cooling), and at 30ºC after cooling.  

XRD and Rietveld refinement ? Considering the temperature limitations of in situ 

high-temperature X-ray diffraction technique and in order to compare with the 

quantitative analysis of the samples submitted to DSC experiments under similar 

cooling rates, complementary heat treatment tests were carried out to assess the 

phase transformations. Batches of ~0.5 g of undoped (Mg0TCP) and doped 

(Mg1?5TCP) powders were subjected to different heat treatment schedules in a 

Thermolab bottom loading furnace:  



Capítulo 2 

 76 

(i) heating Mg0?5TCP powders at 10ºC min?1 up to 1550ºC, holding at this 

temperature for 2 h and 24 h, and then quenching (putting the crucible containing 

the powder in cold H2O without wetting the powder) to stabilize the phase(s) 

formed at high temperature. As will be later shown and discussed, a dwell time of 

2 h revealed to be enough to stabilize ??phase at 1550ºC. Accordingly, a dwell 

time of 2 h was used in all the remaining heat treatments;  

(ii) heating undoped (Mg0TCP) powder at 10ºC min?1 up to 1250ºC, 1350ºC and 

1550ºC, holding for 2 h at maximum temperatures and then cooling at different 

rates of 5 and 13ºC min?1 for phase quantification analysis. The aim was to 

quantitatively investigate the effects of the maximum temperature and cooling rate 

on the contents of the phases. 

(iii) heating doped (Mg1?5TCP) powders at 10ºC min?1 up to 1550ºC, holding for 

2 h at this temperature, and then cooling under different rates of 5 and 13ºC min?1. 

The aim was to quantitatively investigate the effects of the Mg-doping extent and 

cooling rate on the contents of the obtained phases.  

Qualitative and quantitative phase analyses - Qualitative and quantitative phase 

analyses were performed for Mg0?5TCP powders submitted to different heat 

treatment schedules by combining X-ray diffraction (XRD) with Rietveld 

refinement. A conventional Bragg-Brentano diffractometer (Philips PW 3710, 

Eindhoven, The Netherlands) with Ni-filtered Cu-Ka radiation was used to record 

the X-ray diffraction data within the 2?  range = 4 ? 70o (step size 0.02o and 50 s 

of counting time for each step). The software TOPAS version 4.2 (Bruker AXS, 

Karlsruhe, Germany) with the fundamental parameters approach was used for 

Rietveld refinements using the structural model of ICDD cards numbers of # 

04-014-2292 for ?-TCP, # 04-009-3876 for ?-CPP, # 04-009-2362 for ?-CPP and 

# 040-001-4348 for ?-TCP. The XRD data for Mg0TCP (without any added Mg) 

was refined assuming the space group R3c and structural parameters reported by 

Yashima et al. [52]. The calculated unit cell parameters were a = b = 10.442 Å, 

c = 37.395 Å, ? = ? = 90 º, and ? = 120 º. The refined values for Mg0TCP were 

taken as starting values to refine Mg-substituted ?-TCP powders. Refined 



Capítulo 2 

 77 

parameters were scale factor, specimen displacement, and background as 

Chebyshev polynomial of fifth grade and 1/x function, and lattice parameters. 

Corundum (NIST SRM 676a) was added to all heat treated samples (except the 

ones used in the DSC experiments) as an internal standard for the purpose of 

evaluating the presence of amorphous phase and to quantify it. The mixtures were 

ground in an agate mortar and sieved through a mesh of 40 µm in order to 

homogenize the samples and minimise the problems due to non-random 

orientations. The phase fractions extracted by Rietveld refinements were rescaled 

on the basis of the absolute weight of corundum originally added to their mixtures 

as an internal standard, and therefore, internally renormalized. 

Except for samples derived from DSC tests, the XRD and quantitative phase 

analyses were repeated three times in three independent samples for all the 

investigated compositions. The results of Rietveld phase analysis are expressed 

as means ± standard deviations. 

Statistical analysis – the results were analysed as factorial design of experiments. 

The investigated factors are the cooling rate and the Mg content. Results were 

considered to be significant at p&lt;0.01. 

 

3. Results 

3.1 Influence of Mg-doping on the characteristics of starting powders  

Table 1 presents the planned and experimentally obtained (from elemental ICP 

analysis) (Ca+Mg)/P and Ca/P molar ratios, and the Mg contents of the 

Mg0?5TCP powders. A relatively close match was observed between 

experimental and planned (Ca+Mg)/P and Ca/P molar ratios, the former ones 

tending to be slightly smaller (Table 1). The XRD patterns of the Mg0?5TCP 

powders heat-treated at 800ºC are displayed in Fig. 1.  

 

 



Capítulo 2 

 78 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fig. 1.  (a) X-ray diffraction patterns of undoped (Mg0TCP) and Mg-doped (Mg1?5 TCP) starting ?-

TCP powders (heat treated at 800ºC); (b) Zoomed area of Fig. 1a within the 2? range from 26?32º 

to show the effect of Mg incorporation on shifting the XRD peaks to higher 2? angles. The standard 

JCDD PDF 04-008-8714 of pure ?-TCP is also presented for comparison.  

 

Only ?-TCP diffraction peaks were detected. However, the results of quantitative 

phase analysis presented in Table 1 show that all ?-TCP powders contain the 



Capítulo 2 

 79 

intended traces amounts of ?-CPP. These results are consistent with the FT-IR 

spectra presented in Fig. 2.  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fig. 2. FT-IR spectra of undoped (Mg0TCP) and Mg-doped (Mg1?5 TCP) starting ?-TCP powders 

(heat treated at 800ºC). 

 

The characteristic vibrational modes of PO4 tetrahedra confirm the formation of 

?-TCP phase as the predominant crystalline phase. Other very small absorption 

bands observed at 728 cm–1 at 1210 cm–1 can be attributed to the presence of 

pyrophosphate groups (P2O7
4–) and in particular to P–O–P bonds. Rietveld 

refinement of Mg0?5TCP powders revealed a clear decreasing trend of the lattice 

parameters a-axis and c-axis, and consequently, of the cell volume with increasing 

incorporated amounts of Mg (Table 1). This is consistent with the shift of XRD 

peaks to higher 2? angles with Mg-doping observed in Fig. 1b.  



Capítulo 2 

 80 

3.2 Thermal behaviour of Mg0TCP  

A detailed analysis of the thermal behaviour of non-doped (Mg0TCP) sample is 

essential to then understand the effects of Mg-doping on the 

?-TCP??-TCP??-TCP phase transformation in presence of small content of 

CPP. Table 2 summarizes the characterization techniques and the experimental 

conditions used to assess the thermally induced changes, indicating where data 

are reported. The results DSC analysis collected at a fixed heating rate of 

10ºC min?1 and different cooling rates of 5, 10 and 20ºC min?1 are shown in Fig. 3, 

while the quantitative phase analysis data obtained by XRD and Rietveld 

refinement performed in the samples retrieved from DSC experiments are 

reported in Table 3.  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fig. 3. Normalized thermograms of Mg0TCP obtained at a fixed heating rate of 10ºC min?1 and 

cooled under different rates of 5, 10 and 20ºC min?1. 



Capítulo 2 

 81 

Table 3. Quantitative phase analysis data (wt.%) obtained by Rietveld refinement of Mg0?5TCP 

powder samples collected after DSC experiments in O2 controlled atmosphere: heated up to 

1544ºC at 10ºC min?1 and cooled under different cooling rates (5, 10 and 20ºC min?1). 95% 

repeatability limits of the phase quantification should be considered to be close to ±1% [50]. Values 

below 0.2% were considered as “non-detectable” (n.d.). Amorphous phases were not quantified 

(n.q.). Per condition, three measurements were performed on heating and one on cooling. 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The DSC thermograms show three main endothermic events within the 

temperature range of 1150–1550ºC, namely centred at 1182.4 ± 0.4 ºC, 

1286.1 ± 0.3 ºC and 1476.2 ± 0.4 ºC (Fig. 3). On cooling, the intense exothermic 

peak/band observed at ~1450ºC for the cooling rate of 20ºC min?1 seems to result 

  Cooling rate (ºC min????1) 
Samples 

 
phases 

 5 10 20 

 ????????TCP  3 9 31 

 ????????TCP  96 90 65 

 ????????CPP &amp;lt;1% n.d. 4 

 ????????CPP  n.d. 1 n.d. 

Mg0TCP 

 Amorphous  n.q. n.q. n.q. 

 ????????TCP  71 76 70 

 ????????TCP  27 20 29 

 ????????CPP  2 3 1 

 ????-CPP  n.d. n.d. n.d. 

Mg1TCP 

 Amorphous  n.q. n.q. n.q. 

 ????????TCP  97 96 97 

 ????????TCP  1&amp;lt;1%&amp;lt;1% 

 ????????CPP  2 2 2 

 ????????CPP &amp;lt;1%&amp;lt;1%&amp;lt;1% 

Mg2TCP 

 Amorphous  n.q. n.q. n.q. 

 ????????TCP  91 94 96 

 ????????TCP  2 4 2 

 ????????CPP  4 1&amp;lt;1% 

 ????????CPP  3 n.d. 1 

Mg5TCP 

 Amorphous  n.q. n.q. n.q. 



Capítulo 2 

 82 

from two almost superimposed events. As the cooling rate decreased, these two 

events tended to appear at slightly higher temperatures and with a decreasing 

intensity, features that can be more easily seen in the zooms inserted in Fig. 3. 

Another exothermic broad effect centred at about 1395ºC was registered for the 

cooling rate of 20ºC min?1, which apparently shifted to 1201ºC under cooling at 

10ºC min?1. Only the high temperature peak remained with further decreasing the 

cooling rate to 5ºC min?1.  

Complementary HT-XRD analysis performed within the range of 30?1350ºC 

confirmed that up to 800ºC the Mg0TCP sample consists of ?-TCP (Fig. 4a).  

 

 

 

 

 

 

 

 

 

 

 

 

 

Fig. 4. In situ collected X-ray diffraction patterns of Mg0TCP at different temperatures up to 

1350ºC: (a) under a heating rate of 10ºC min?1; (b) Zoomed diffractograms obtained at 1200, 1300 

and 1350ºC (dotted line box) to better reveal the low intensity peaks; (c) under a cooling rate of 

5ºC min?1. The standard files of pure ??TCP (JCDD PDF 04-008-8714) and pure  ??TCP (JCDD 

PDF 04-010-4348) are also presented for comparison purposes. 



Capítulo 2 

 83 

This ?-TCP phase still predominates at 1150ºC, with ?-TCP appearing as 

secondary phase. Further increasing the temperature to 1200ºC caused a drastic 

change in the XRD spectrum due to the predominance of ?-TCP over the ?-TCP. 

Between 1200 and 1350ºC the sample became enriched in ?-TCP and only a 

small amount of ?-TCP could be detected (Fig. 4b). The above referred phase 

transformations tend to be partially reversed upon cooling as revealed in Fig. 4c. 

To shed further light on the origin of the thermal events observed in Fig. 3 (around 

1200ºC, 1300ºC, and 1450ºC), the Mg0TCP was dwelled for 2 h at 1250ºC, 

1350ºC and 1550ºC and then cooled at either 5ºC min?1 or 13ºC min?1 and 

analysed by XRD analysis (Fig. 5).  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fig. 5. X-ray diffraction patterns of the starting Mg0TCP powder (800ºC), and after further heat 

treatments at 1250ºC, 1350ºC and 1550ºC (heating rate = 10ºC min?1, dwell time of 2 h at 

maximum temperatures followed by cooling under different rates of 5ºC min?1 and 13ºC min?1). The 

standard files of pure ??TCP (JCDD PDF 04-008-8714) and pure ??TCP (JCDD PDF 040-001-

4348) are also presented for comparison purposes. 



Capítulo 2 

 84 

The results of quantitative phase analysis of these samples are displayed in Fig. 6.  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fig. 6. Quantitative phase analysis data (wt.%) obtained by Rietveld refinement of Mg0TCP 

powder heat treated at 10ºC min?1 up to 1250ºC and 1350ºC, and of Mg0?5TCP powders heat 

treated at 10ºC min?1 up to 1550ºC, hold at the maximum temperature for 2 h, followed by 

controlled cooling rates (5 and 13ºC min?1). Similar data were gathered for the same samples 

submitted to the same heating schedule but hold for 2 h and 24 h at the maximum temperature, 

followed by quenching.  

 

It can be seen that upon heat treating at 1250ºC and 1350ºC ?-TCP was partially 

transformed into ?-TCP and an amorphous phase, while the sample heat treated 

at 1550ºC consisted mostly of ?-TCP. There were only remnants of ?-TCP (better 

noticed under faster cooling, Figs. 5 &amp;amp; 6) and small amounts ?-CPP, ?-CPP, and 

amorphous phase (Fig. 6). Higher amount of ?-TCP seems to be retained under a 

faster cooling rate from 1250ºC (p&lt;0.01) while a surprisingly opposite result was 



Capítulo 2 

 85 

obtained upon cooling from 1350 and 1550 ºC (p&lt;0.01), i.e. an increase of cooling 

rate led to a decrease of ?-TCP content. This is also consistent with data obtained 

from DSC experiments (no dwell time) in Table 3. Fig. 6 also displays the 

quantitative phase analyses performed after dwelling the Mg0TCP sample for 2 

and 24 h at 1550ºC, and subsequent quenching. After 2 h at 1550ºC the sample 

consisted of ?-TCP and ~29 % of amorphous phase. The amount of ?-TCP 

decreased and the amorphous phase increased upon prolonging dwelling time to 

24 h.  

 

3.3 Influence of Mg-doping on thermal behaviour 

The DSC thermograms collected upon heating and cooling at 10ºC min?1 of the 

Mg0?5TCP powders are presented in Fig. 7. All samples exhibit small 

endothermic peaks close to 1290ºC and 1480ºC during heating. The peak seen 

for Mg0TCP at ~1182ºC was not observed in the other samples. Upon cooling, 

two exothermic peaks were detected. Their position varied as a function of Mg 

content. Specifically, the temperature of the lowest peak increased from 1201ºC to 

1384 ºC with increasing Mg content, whereas the opposite trend was observed for 

the highest temperature peak, dropping from 1460ºC for Mg0TCP down to 1416ºC 

for Mg5TCP.  

Fig. 6 shows that the phase compositions of the Mg0?2TCP samples quenched 

from 1550ºC after a dwell time of 2 h are very similar, consisting essentially of ?-

TCP and ~26?27% of amorphous phase. After the longer dwelling time (24 h) the 

amount of ?-TCP decreased while the amorphous phase increased. In contrast, 

after a dwell time of 2 h at 1550ºC the Mg5TCP sample is mostly constituted by 

??TCP and amorphous phase, the content of the later further increased at the 

expenses of ??TCP after 24 h dwell time. 

 

 



Capítulo 2 

 86 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fig. 7. Normalized complete thermograms of the studied powders gathered at a heating/cooling 

rate of 10 ºC min?1 in O2 atmosphere. Some parts of heating (black) and cooling (red) branches 

(dotted line boxes) were zoomed up to better illustrate the thermal effects. The peaks observed 

upon heating are also shown in insets (solid line boxes) for better illustrations. The curve of 

Mg0TCP (Fig. 3) is presented again for comparison. 

 



Capítulo 2 

 87 

The XRD Rietveld refinement analysis of the DSC samples after cooling at 5, 10 

or 20ºC min?1 showed that the Mg-free sample (Mg0TCP) consisted mostly of 

?-TCP (Table 3). However, almost 100% ?-TCP was detected with as little as 

2 mol% Mg (Mg2TCP). In Fig. 6, an increase of cooling rate from 5 to 13ºC min?1 

led to a decrease of ?-TCP and amorphous phase content (p&lt;0.01) for the 

samples treated at 1550ºC. Finally, the comparison of the results obtained upon 

quenching and under controlled cooling at 5ºC min?1 and 13ºC min?1 (Fig. 6) 

revealed a very complex interplay between cooling rate and Mg content: at low 

and high Mg contents, the cooling rate hardly affected the outcome, i.e. almost 

pure ?-TCP or ?-TCP were obtained. However, keeping high amount of ?-TCP in 

Mg2TCP sample was only possible upon quenching. Furthermore, cooling 

Mg1TCP sample at 13ºC min?1 minimized the ?-TCP content compared to a lower 

(5ºC min?1) and higher (quenching) cooling rate.  

 

4. Discussion 

4.1 Influence of Mg-doping on the characteristics of the Mg0????5TCP powders  

The predominance of ?-TCP phase in the starting powders (Fig. 1) is in close 

agreement with findings reported in previous studies [48, 49, 53] for aqueous 

precipitated powders. The presence of small amounts of CPP helps explaining the 

non-apparent detection of CPP peaks in the XRD patterns (Fig. 1). Another 

contributing factor is the superposition of its most intense diffraction line at 

2? = 29.6º with a peak of ?-TCP. The second most intense peak of CPP (relative 

intensity 45%) at 2? = 28.9º could no more be observed below 4 wt.% [51, 54]. 

The elementary analysis data presented in Table 1 reveal that Mg was readily 

incorporated into the ?-TCP structure. This is confirmed by the decrease of Ca/P 

molar ratio, while the (Ca+Mg)/P ratio was kept almost constant. Accordingly, 

there is a good coincidence between the planned and the experimentally 

determined values. The small systematic deviation between the planned of 

(Ca+Mg)/P = 1.5 and the measured values near 1.49 can be attributed to slight 



Capítulo 2 

 88 

experimental fluctuations of pH (within the range of 6?7) during the overall 

preparation period (~18 h) of powders at 30ºC. Destainville et al. [51] underlined 

the need of an accurate control of the entire set of experimental parameters during 

TCP synthesis. According to them, at least 10 h maturing must be imposed to 

ensure reproducible synthesis of apatitic precursors of pure TCP at 30ºC, pH = 7. 

Deviations of one pH unit from the ideal value (pH = 7) i.e., pH 6 or pH 8, resulted 

in Ca/P molar ratios of 1.48 or 1.51, respectively. The obtained (Ca+Mg)/P molar 

ratios slightly below the planned stoichiometric value of 1.5 justify the formation of 

CPP traces [45, 46, 51, 54-56], as confirmed by the FT-IR absorption bands at 

728 cm–1 and 1210 cm–1 (Fig. 2) and by the quantitative phase analysis data 

reported in Table 1. The most and the least intense FT-IR bands observed for 

Mg0TCP and Mg1TCP, respectively, are consistent with the calculated higher and 

the smaller amounts of ?-CPP.  

The refinement of XRD data for Mg0TCP (Table 1) is in good agreement with the 

unit cell parameters reported by Yashima et al. [52]. The decreasing trends 

observed for unit cell parameters in doped Mg1?5TCP powders (Table 1) 

constitute further confirmation that Mg was incorporated in Ca sites in ?-TCP 

structure [31, 49]. This can be understood considering the smaller ionic radii of 

Mg2+ (0.72 Å for eightfold coordination with O) in comparison with Ca2+ (1.00 Å for 

eightfold coordination with O) [31, 48, 53, 57].  

 

4.2 The thermal behaviour of Mg0TCP 

The first endothermic event recorded for Mg0TCP upon heating, centred at 

1182.4 ± 0.4 ºC (Fig. 3) may be attributed to the ??? transitions of ?-TCP and ?-

CPP. The ??? phase transition temperatures for CPP and TCP are still 

controversial and might depend on specific preparation conditions. For ?-CPP, the 

transformation has been reported to occur at 1140ºC [44] or at 1181ºC [56], while 

the ???-TCP polymorphic phase transition might occur within a wider range of 

temperatures, 1115ºC [23], 1125ºC [44], 1135ºC [45], 1150ºC [31, 51], 



Capítulo 2 

 89 

1160ºC [58]. Moreover, the presence of CPP delays the ???-TCP phase 

transition to higher temperatures: Ryu et al. [59] showed that 3 wt.% of CPP 

delayed the transition by 50ºC. The existence of a single endothermic peak 

centred at ~1182ºC suggests that the thermal effects of ???  transitions of ?-TCP 

and ?-CPP might be superimposed due to the delayed transformation of 

???-TCP. This is consistent with the presence of ~4% CPP (Table 1). The results 

shown in Fig. 4a demonstrate that most of the ???-TCP phase transformation 

occurred within the range of 1150?1200ºC confirming that the endothermic effect 

registered at ~1182ºC (Fig. 3) is due to ???  transition.  

The second endothermic effect registered upon heating within the temperature 

range of 1280–1300ºC (Fig. 3) consists of a main peak centred at 1286.1 ± 0.3 ºC 

and a small one at 1297 ± 0.6 ºC. The first one coincides with the eutectic 

reported for the TCP–CPP system [45] or in the close neighbourhood (1280ºC 

[51, 56, 59], and 1300ºC [45]) and is likely to represent a melting event. The small 

endothermic peak at about 1297ºC might be due to the crossing of liquidus curve 

as referred to by Maciejewski et al. [56], being corroborated by the presence of 

traces of CPP (Fig. 2 and Table 1). The third endothermic peak centred at 

1476.2 ± 0.4 ºC was preceded by a small shoulder at ~1463.9 ± 0.9 ºC, pointing 

out to two concomitant thermal events. One of them certainly involves the 

monoclinic ?-TCP ? trigonal ?´-TCP polymorphic phase transition [23, 24, 44], 

which has been reported to occur above 1430ºC [44], at 1465ºC [23], at 

1475ºC [46] and between 1458ºC and 1508ºC [24]. The other can be related to 

the formation of a liquid phase. In fact, in the presence of CPP, the peak centred 

at ~1476ºC and the small shoulder at ~1464ºC are most likely linked to the ?-TCP 

+ liquid ? ?´-TCP + liquid transformation reported to occur at 1472 ºC and 

1475ºC according to the TCP?CPP phase diagram published by Welch and 

Gutt [44] and Riboud [46], respectively. 

Upon cooling at 20ºC min?1, two almost superimposed events at ~1450?1453ºC 

appear with a decreasing intensity and at slightly higher temperatures as the 

cooling rate decreases (Fig. 3). These are typical kinetic effects as longer time for 



Capítulo 2 

 90 

temperature equalization between the sample and the standard material is 

allowed as cooling rate decreases. Accordingly, the phase transition occurs at 

higher temperatures, while the signal from DSC is weaker due to a closer 

proximity of the equilibrium conditions. Oppositely, at a higher cooling rate, 

structural rearrangement cannot follow the cooling kinetics and the thermal events 

are shifted to lower temperatures, while the higher deviation from equilibrium 

conditions translates into an enhanced intensity of the exothermic peaks/bands. 

These two events are probably the ?´?? polymorphic phase transition and partial 

crystallization of the liquid into ?-TCP (reversions of the last two events referred 

above).  

The reversion of ?´??-TCP was reported by Carrodeguas et al. [23] to occur at 

~1465ºC in pure ?-TCP under a cooling rate of 5ºC min?1. The maximum intensity 

of the exothermic event observed for the Mg0TCP powder under this cooling rate 

was registered at ~1462ºC (Fig. 3), a similar temperature value. Apparently, no 

other thermal events could be detected upon cooling at 5 ºC min?1, suggesting the 

non-occurrence of phase transformations under these conditions. This is 

reasonably consistent with the small amount of ?-TCP in this sample (~3 wt.%, 

Table 3), meaning that under this cooling rate the structure of ?-TCP remains 

metastable at RT as reported elsewhere [23, 31, 32]. This finding is consistent 

with the reconstructive character of the ??? polymorphic transformation 

[23, 26, 31]. In other words, quenching from high temperature is not the unique 

way to prepare pure or almost pure ?-TCP.  

The broad exothermic effect registered at ~1395ºC under the cooling rate of 

20ºC min?1 was apparently shifted to 1201ºC upon cooling at 10ºC min?1 (Fig. 3). 

This shift coincided with incremental amounts of ?-TCP in comparison to that in 

the sample cooled at 5ºC min?1 (Table 3). Therefore, these peaks are likely due to 

???-TCP phase reversion. This hypothesis is supported by the increments of 

?-TCP from ~9% to ~31% with cooling rate increasing from 10 to 20ºC min?1 

(Table 3) and by the higher amount (~15%) of ?-TCP obtained upon cooling from 

1550ºC under the rate of 13ºC min?1 in comparison to only ~4% at 



Capítulo 2 

 91 

5ºC min?1 (Fig. 6). This suggests that the liquid phase derived from the presence 

of CPP is favouring the ???-phase transformation. It seems reasonable to 

assume that when a given solid phase incongruently changes into a liquid and 

another solid phase, the composition of the remaining solid phase is not the same 

as the starting material. Therefore, changes in chemical activity cannot be 

excluded when moving from one phase to another. This assumption would help 

explaining the present results. Being the ? to ??TCP phase transformation a 

reconstructive structural change as consensually accepted in literature [7,8,23,29], 

some holding time (at a suitable temperature range) is required for it to take place.  

After quenching the Mg0TCP samples from 1550ºC (quenching rate &gt;&gt; 

20ºC min?1) only ?-TCP and an amorphous phase were detected (Fig. 6), 

suggesting that the ???-TCP phase reversion was hindered upon quenching 

(Table 3). Increasing the dwell time from 2 to 24 h, increased the fraction of 

amorphous phase, confirming the formation of a liquid phase and the 

interpretation given above for the higher temperature endothermic effect attributed 

to the ??TCP + liquid ? ?´?TCP + liquid transformation [44, 46].  

The results of XRD (Fig. 5) and phase quantification (Fig. 6) clearly show an 

enrichment in amorphous (from about 3% to ~15%) and in ?-TCP (from about 

~28% to ~44%) phases at expenses of ?-TCP in samples heat treated at 1250ºC 

with cooling rate increasing from 5ºC min?1 to 13ºC min?1. Such significant amount 

of amorphous phase obtained upon cooling at 13ºC min?1 is not likely to derive 

from pre-existing liquid phase, as the eutectic point of CPP is close to 1290ºC. The 

following considerations might shed some light on this surprising result. The 

overall thermal effect depends on the heat treatment schedule (time, temperature), 

meaning that the same chronothermic effect can be obtained at a lower 

temperature by extending the heat treatment time. After 2 h at 1250ºC, ?-TCP was 

the predominant phase (Fig. 4, Fig. 5, and Fig. 6). We could speculate that its 

structural arrangement is likely to be slow and the phase reversion to ?-TCP will 

be incomplete accordingly.  



Capítulo 2 

 92 

In contrast to the above, a decreasing trends were observed for the contents of 

amorphous and ?-TCP phases (and concomitant increasing contents of ?-TCP 

phase) for samples heat treated at higher temperatures and when the cooling rate 

was increased from 5ºC min?1 to 13ºC min?1 (p &amp;lt;0.01). These two distinctive 

trends for the effects of cooling rate on phase composition are consistent with the 

more abundant liquid phase at higher temperatures, catalysing the ???-TCP 

phase reversion.  

The HT-XRD results showed that although most of the ??? phase transformation 

occurred within the range of 1150?1200ºC (Fig. 4a), the remaining part continued 

to occur along a broad temperature range as indicated by the coexistence of 

?-TCP and ?-TCP phases (Fig. 4b). At 1350ºC ?-TCP was the main phase and 

partially transformed to ?-TCP on cooling (5ºC min?1) at temperatures ? 1200ºC 

(Fig. 4c). This means that heat treating at 10ºC min?1 up to 1350ºC did not confer 

to ?-TCP enough structural/thermal stability to hinder phase reversion on cooling 

at both rates tested (Fig. 6) as the RT product consists predominantly of ?-TCP 

phase, especially for the faster cooling rate of 13ºC min?1. 

The results reported in Fig. 5 and Fig. 6 confirm that increasing the heat treatment 

temperature noticeably enhanced the thermal stability of the high temperature 

phase under a slow cooling rate (5ºC min?1). However, such trends are altered for 

the samples heat treated at 1250ºC when increasing the cooling rate to 

13ºC min?1, as mentioned above. This change in the kinetics of phase 

transformation is consistent with the presence of a higher amount of liquid formed 

at temperature above the eutectic point of CPP is at ~1285?1290ºC. The amounts 

of ?-TCP after cooling from 1550ºC at 5ºC min?1 and at 13ºC min?1, were ~79% 

and ~70%, respectively. These changes involved essentially a ???-TCP phase 

reversion, corroborating the trend observed for quantitative crystalline phase 

analysis results of samples derived from the DSC experiments (Table 3).  

 

 



Capítulo 2 

 93 

4.3 Influence of Mg-doping on thermal behaviour 

The thermal stability of Mg-doped powders was considerably enhanced as 

deduced from the shift of the first endothermic peak corresponding to ???-TCP 

phase transition from 1182.4 ± 0.4 ºC (Mg0TCP) to higher temperatures 

(Mg1?5TCP, Fig. 7). This observation corroborates the findings in other literature 

reports [23, 31, 35-37, 43]. In the Mg1TCP sample this phase transition 

approximately coincided with the eutectic temperature in the CPP??-TCP system 

[44-47, 56] detected for Mg0TCP and Mg2?5TCP samples. These observations 

corroborated the presence of traces of CPP detected by FTIR (Fig. 2) and 

quantified by Rietveld refinement (Table 1), and suggest that Mg does not 

interfere with this eutectic transformation. This also means that at the eutectic 

temperature the Mg1TCP system changes from CPP??-TCP ? ?-TCP + ?-TCP + 

liquid. The presence of ?-TCP above the eutectic temperature is confirmed by the 

HT-XRD experiments (Fig. 4b) performed for Mg0TCP. These experiments 

showed that complete phase transformation does not occur suddenly at a 

well-defined temperature but along a temperature range. In other words, the 

observed thermal effects are likely to reflect most of the reaction vigour but do not 

account for the entire phase transformation process. In the Mg2?5TCP samples 

the ???-TCP phase transition occurred above the eutectic, at 1359.8 ± 1.5 ºC 

and at 1473.7 ± 1.2 ºC, respectively (Fig. 7), which consist of ?-TCP + liquid + 

?-TCP relics.  

The last thermal effects observed in DSC thermograms of the Mg1?5TCP samples 

upon heating appear better discriminated than in the case of Mg0TCP and their 

relative intensities changed with increasing amounts of Mg, being reasonably split 

in two peaks (centred at 1464.7 ± 0.5 ºC and at 1485.1 ± 1.0 ºC respectively) for 

the Mg2TCP sample (Fig. 7). Considering that allotropic phase transformations 

require less energy to occur than solid/liquid ones, it seems reasonable to 

hypothesize that the highest thermal effect in each DSC curve might be related 

with a melting event. According to this hypothesis, and considering the noticeable 

amount of ?-TCP (~72%) determined for Mg2TCP quenched after 2 h at 



Capítulo 2 

 94 

1550ºC (Fig. 6), the stronger endothermic effect at 1464.7 ± 0.5 ºC observed for 

this sample is likely to be mostly due to the ???'-TCP phase transformation plus 

further formation of liquid phase. On the other hand, the broad endothermic band 

registered for Mg5TCP, seemingly resulting from the overlap of three thermal 

events, suggests that the enhanced thermal stability of the resulting ?-TCP 

enables this phase to coexist with ?-TCP and eventually ?'-TCP + liquid. This 

would explain why the phase assemblage after quenching consists mostly of 

?-TCP + amorphous phase. Moreover, the kinetics of liquid phase formation 

seems to be relatively slow, explaining the higher amount of amorphous phase 

after 24 h dwell time at the expenses of ?-TCP (Fig. 6). This suggests that at 

1550ºC for Mg5TCP, ?-TCP passes directly to liquid phase instead of being 

transformed into ?-TCP.  

The two exothermic peaks registered on cooling at 10ºC min?1 (red zoomed 

branches, Fig. 7) appear gradually closer to each other and their relative 

intensities changed with increasing added amounts of Mg (Mg1?5TCP). The first 

peak jumped from 1460ºC (Mg0TCP) to 1452ºC (Mg1TCP), 1439ºC (Mg2TCP), 

and 1416ºC (Mg5TCP). This suggests that the enhanced thermal stability of 

?-TCP in Mg5TCP hindered its extensive transformation into ?-TCP, as can be 

deduced from the quenching experiments in Fig. 6. This might explain why the first 

exothermic peak on cooling Mg5TCP is less intense then the second one. 

Accordingly, the second exothermic peak might be partially due to ???-TCP and 

mostly to liquid??-TCP phase transformation and/or solidification of the liquid as 

amorphous phase. This interpretation is supported by the data reported in Fig. 6, 

for samples quenched and cooled under controlled conditions, respectively.  

The content of ?-TCP in Mg2TCP cooled at 10ºC min?1 (DSC experiments) is very 

high (~96%, Table 3). The shorter dwell time (2 h) and cooling at 13ºC min?1 (the 

heat treatment schedule that approaches more the DSC testing conditions) also 

resulted mostly in ?-TCP (~94 %) and small amounts of ?-TCP (~4 %) and 

amorphous phase (~2 %), Fig. 6. This contrasts with the relatively high contents in 

?-TCP (~72%) and amorphous phase (~26%) obtained from the same Mg2TCP 



Capítulo 2 

 95 

sample upon quenching (Fig. 6). An obvious conclusion can be drawn: both 

??TCP and liquid phases transformed into ?-TCP under controlled cooling rate. 

Therefore, the two exothermic peaks registered for Mg2TCP (Fig. 7) are likely due 

to: (i) ?'-TCP + liquid ? ?-TCP and (ii) ???-TCP phase transformation, 

respectively.  

The same arguments could be used to explain the two exothermic peaks 

registered for Mg1TCP upon cooling and the temperatures at which they occur. 

Fig. 6 shows that ?-TCP in Mg1TCP is more stable than in Mg2?5TCP samples. 

Accordingly, a significant high amount of ?-TCP has been retained upon cooling at 

5ºC min?1 (Fig. 6), being consistent with the findings of Carrodeguas et al. [23] in 

the absence of CPP and the partial ???-TCP transformation occurred at a lower 

temperature (exothermic peak centred at 1304ºC) than in the case of Mg2?5TCP 

(1353 and 1354ºC, respectively, Fig. 7). 

The comparison of quantitative phase analysis after DSC experiments (Table 3 – 

absence of dwell time) with the corresponding data after 2 h dwell time at 1550ºC 

(Fig. 6) reveals that: (i) ?-TCP can be retained for Mg0TCP without a dwell time; 

(ii) A significantly smaller fraction of ?-TCP was retained in Mg1TCP due to its 

decreased thermal stability, meaning that a dwell time is necessary to stabilize the 

high temperature phases; (iii) The differences between the data reported in 

Table 3 and Fig. 6 become less evident with increasing Mg contents due to the 

enhanced thermal stability of ?-TCP phase.  

 

5. Conclusions 

The present study aimed at shedding some light on the controversial aspects 

???-TCP phase transformations and on the roles of the most relevant 

experimental variables: cooling rate, the presence of CPP impurities and the 

extent of Mg-doping. The following main conclusions could be drawn:  



Capítulo 2 

 96 

1. Different thermal treatment schedules led to variable fractions of retained 

??TCP. Amorphous phase was formed in all heat treated powders, 

together with small amounts of CPP (except in those quenched from 

1550ºC). 

2. Like in pure TCP systems, the thermal stability of ?-TCP phase was 

significantly enhanced with increasing Mg-doping extents. 

3. The presence of small amount of CPP gave rise to the formation of a 

eutectic at 1286 ± 0.8 ºC. The liquid phase lowered the considerably high 

activation energy for polymorphic ???-TCP transformation to occur in solid 

state reactions, facilitating the ???-TCP phase reversion upon cooling.  

4. Relatively high amounts of ?-TCP phase were retained upon quenching the 

Mg0?2TCP samples from 1550ºC, as well as upon cooling the Mg0?1TCP 

samples at the lowest rate tested (5ºC min?1) from de same temperature.  

5. Concomitant decreases of ?-TCP and amorphous contents for all the 

powders were the most salient effects of an increase of cooling rate from 5 

to 13ºC min?1. The ???-TCP phase reversion was stimulated for the higher 

cooling rate. This apparently counterintuitive result, which was highly 

reproducible in the frame of the present work, has never been reported so 

far. The formation of liquid phase from a starting solid implies a 

corresponding chemical change in the composition of solid phase in contact 

with the liquid and, especially, in chemical activity. These changes are likely 

to strongly interfere with the kinetics of phase transformation, explaining 

why the presence of liquid phase promotes the ???-TCP phase reversion. 

Being the ? to ??TCP phase transformation a reconstructive structural 

change, some holding time (at a suitable temperature range) is required for 

it to take place. Upon quenching, such time is not allowed and the 

transformation is hindered. 

6. The presence of CPP expands the route of preparing ?-TCP-rich powders 

with some contents of amorphous phases for applications in CPC.  



Capítulo 2 

 97 

Acknowledgements 

This work was supported by the European Regional Development Fund (FEDER) 

through the COMPETE, by the Portuguese Government through the Portuguese 

Foundation for Science and Technology (FCT), in the scope of the projects 

UID/CTM/50011/2013 (Aveiro Institute of Materials, CICECO, www.ciceco.ua.pt) 

and by Mathys Ltd Bettlach (Switzerland). P.M.C. Torres (SFRH/BD/62021/2009), 

Ajay Kaushal (SFRH/BPD/77598/2011) and S. Pina (SFRH/BPD/64119/2009) 

acknowledge the respective fellowship Grant by FCT. 

The authors would also like to acknowledge Professor J.J.C. Cruz Pinto A. Barros-

Timmons and Sandra Magina for the Thermal Analysis. Thermal Analysis 

Laboratory was funded by FEDER Funds through Programa Operacional Factores 

de Competitividade – COMPETE and by National Funds through FCT under the 

project REEQ/515/CTM/2005. The XRD facility was funded by FEDER funds 

through QREN-Aviso SAIECT-IEC/2/2010 and Operação NORTE-07-0162-

FEDER-000050. 

 

References 

[1] Legeros RZ. Calcium Phosphate Materials in Restorative Dentistry: a Review. 

Adv Dent Res 1988;2:164-80. 

[2] Hench LL. Bioceramics. J Am Ceram Soc 1998;81:1705-28. 

[3] Greenspan DC. Bioactive ceramic implant materials. Curr Opin Solid State 

Mater Sci 1999;4:389-93. 

[4] Eggli PS, Muller W, Schenk RK. Porous hydroxyapatite and tricalcium 

phosphate cylinders with two different pore size ranges implanted in the 

cancellous bone of rabbits. A comparative histomorphometric and histologic study 

of bone ingrowth and implant substitution. Clin Orthop Relat Res 1988:127-38. 



Capítulo 2 

 98 

[5] Kondo N, Ogose A, Tokunaga K, Ito T, Arai K, Kudo N, et al. Bone formation 

and resorption of highly purified ?-tricalcium phosphate in the rat femoral condyle. 

Biomaterials 2005;26:5600-8. 

[6] Elliott JC. Structure and chemistry of the apatites and other calcium 

orthophosphates. London: Elsevier; 1994. 

[7] Buerger MJ. Phase determination with the aid of implication theory. Phys Rev 

1948;73:927-8. 

[8] Buerger MJ. Some new functions of interest in x-ray crystallography. Proc Natl 

Acad Sci U S A 1953;36:376-82. 

[9] Ando J. Phase Diagrams of Ca3(PO4)2-Mg3(PO4)2 and Ca3(PO4)2-CaNaPO4 

Systems. Bull Chem Soc Jpn 1958;31:201-5. 

[10] Bohner M. Resorbable biomaterials as bone graft substitutes. Mater Today 

2010;13:24-30. 

[11] Bucholz RW. Nonallograft Osteoconductive Bone Graft Substitutes. Clin 

Orthop Relat Res 2002;395:44-52. 

[12] Bohner M. Calcium orthophosphates in medicine: from ceramics to calcium 

phosphate cements. Injury 2000;31:37-47. 

[13] Dorozhkin SV. Calcium orthophosphates cements for biomedical application. 

J Mater Sci: Mater Med 2008;43:3028-57. 

[14] Camiré CL, Gbureck U, Hirsiger W, Bohner M. Correlating crystallinity and 

reactivity in an ?-tricalcium phosphate. Biomaterials 2005;26:2787-94. 

[15] Ginebra MP, Fernandez E, Driessens FCM, Planell JA. Modeling of the 

hydrolysis of ?-tricalcium phosphate. J Am Ceram Soc 1999;82:2808-12. 

[16] Liu W, Zhang J, Rethore G, Khairoun K, Pilet P, Tancret F, et al. A novel 

injectable, cohesive and toughened Si-HPMC (silanized-hydroxypropyl 



Capítulo 2 

 99 

methylcellulose) composite calcium phosphate cement for bone substitution. Acta 

Biomater 2014;10:3335-45. 

[17] Hurle K, Neubauer J, Bohner M, Doebelin N, Goetz-Neunhoeffer F. Effect of 

amorphous phases during the hydraulic conversion of ?-TCP into calcium-

deficient hydroxyapatite. Acta Biomater 2014;10:3931-41. 

[18] Bohner M, Luginbühl R, Reber C, Doebelin N, Baroud G, Conforto E. A 

physical approach to modify the hydraulic reactivity of ?-tricalcium phosphate 

powder. Acta Biomater 2009;5:3524-35. 

[19] Gbureck U, Barralet JE, Radu L, Klinger HG, Thull R. Amorphous alpha-

tricalcium phosphate: Preparation and aqueous setting reaction. J Am Ceram Soc 

2004;87:1126-32. 

[20] Zhang JT, Tancret F, Bouler JM. Fabrication and mechanical properties of 

calcium phosphate cements (CPC) for bone substitution. Mater Sci Eng C 

2011;31:740-7. 

[21] Pina S, Olhero SM, Gheduzzi S, Miles AW, Ferreira JM. Influence of setting 

liquid composition and liquid-to-powder ratio on properties of a Mg-substituted 

calcium phosphate cement. Acta Biomater 2009;5:1233-40. 

[22] Döbelin N, Brunner TJ, Stark WJ, Fisch M, Conforto E, Bohner M. Thermal 

treatment of flame-synthesized amorphous tricalcium phosphate nanoparticles. J 

Am Ceram Soc 2010;93:3455-63. 

[23] Carrodeguas RG, De Aza AH, Turrillas X, Pena P, De Aza S. New approach 

to the ? ? ? polymorphic transformation in magnesium-substituted tricalcium 

phosphate and its practical implications. J Am Ceram Soc 2008;91:1281-6. 

[24] Yashima M, Sakai A. High-temperature neutron powder diffraction study of 

the structural phase transition between ? and ?' phases in tricalcium phosphate 

Ca3(PO4)2. Chem Phys Lett 2003;372:779-83. 



Capítulo 2 

 100 

[25] Kitamura M, Ohtsuki C, Iwasaki H, Ogata S-i, Tanihara M, Miyazaki T. The 

controlled resorption of porous ?-tricalcium phosphate using a 

hydroxypropylcellulose coating. J Mater Sci Mater Med 2004;15:1153-8. 

[26] Carrodeguas RG, De Aza S. ?-Tricalcium phosphate: Synthesis, properties 

and biomedical applications. Acta Biomater 2011;7:3536-46. 

[27] Fernandez E, Ginebra MP, Boltong MG, Driessens FCM, Ginebra J, 

DeMaeyer EAP, et al. Kinetic study of the setting reaction of a calcium phosphate 

bone cement. J Biomed Mater Res 1996;32:367-74. 

[28] Camiré CL, Nevsten P, Lidgren L, McCarthy I. The effect of crystallinity on 

strength development of ?-TCP bone substitutes. J Biomed Mater Res B: Appl 

Biomater 2006;79B:159-65. 

[29] Monma H and Goto M. Behavior of the ??? phase transformation in tricalcium 

phosphate. J Ceram Soc Jpn, 1983;91:473-475. 

[30] Montufar EB, Maazouz Y, Ginebra MP. Relevance of the setting reaction to 

the injectability of tricalcium phosphate pastes. Acta Biomater 2013;9:6188-98. 

[31] Enderle R, Götz-Neunhoeffer F, Göbbels M, Müller FA, Greil P. Influence of 

magnesium doping on the phase transformation temperature of ?-TCP ceramics 

examined by Rietveld refinement. Biomaterials 2005;26:3379-84. 

[32] Bohner M, Lemaître J, Legrand AP, De la Caillerie JBD, Belgrand P. 

Synthesis, X-ray diffraction and solid-state 31P magic angle spinning NMR study 

of ?-tricalcium orthophosphate. J Mater Sci: Mater Med 1996;7:457-63. 

[33] Xue W, Dahlquist K, Banerjee A, Bandyopadhyay A, Bose S. Synthesis and 

characterization of tricalcium phosphate with Zn and Mg based dopants. J Mater 

Sci Mater Med 2008;19:2669-77. 

[34] Cacciotti I, Bianco A. High thermally stable Mg-substituted tricalcium 

phosphate via precipitation. Ceram Int 2011;37:127-37. 



Capítulo 2 

 101 

[35] Famery R, Richard N, Boch P. Preparation of ?- and ?-tricalcium phosphate 

ceramics, with and without magnesium addition. Ceram Int 1994;20:327-36. 

[36] Goetz-Neunhoeffer F, Neubauer J, Göbbels M, Enderle R. Effect of Mg 2+ 

content on lattice parameter and phase transformation temperature of ?-? TCP. 

Eur Cells Mater 2006;11:38. 

[37] Marchi J, Dantas ACS, Greil P, Bressiani JC, Bressiani AHA, Muller FA. 

Influence of Mg-substitution on the physicochemical properties of calcium 

phosphate powders. Mater Res Bull 2007;42:1040-50. 

[38] Matsumoto N, Yoshida K, Hashimoto K, Toda Y. Thermal stability of ?-

tricalcium phosphate doped with monovalent metal ions. Mater Res Bull 

2009;44:1889-94. 

[39] Tardei C, Grigore F, Pasuk I, Stoleriu S. The study of Mg2+/Ca2+ substitution 

of ?-tricalcium phosphate. J Optoelectr Adv Mater 2006;8:568-71. 

[40] Pina S, Vieira SI, Rego P, Torres PMC, da Cruz e Silva OAB, da Cruz e Silva 

EF, et al. Biological responses of brushite-forming Zn- and ZnSr-substituted ?- 

tricalcium phosphate bone cements. Eur Cell Mater 2010;20:162-77. 

[41] Bracci B, Torricelli P, Panzavolta S, Boanini E, Giardino R, Bigi A. Effect of 

Mg2+, Sr2+, and Mn2+ on the chemico-physical and in vitro biological properties of 

calcium phosphate biomimetic coatings. J Inorg Biochem 2009;103:1666-74. 

[42] Boanini E, Gazzano M, Bigi A. Ionic substitutions in calcium phosphates 

synthesized at low temperature. Acta Biomater 2010;6:1882-94. 

[43] Carrodeguas RG, De Aza AH, García-Páez I, De Aza S, Pena P. Revisiting 

the phase-equilibrium diagram of the Ca3(PO4)2-CaMg(SiO3)2 system. J Am 

Ceram Soc 2010;93:561-9. 

[44] Welch JH, Gutt W. High-temperature studies of the system calcium oxide-

phosphorus pentoxide. J Chem Soc 1961:4442-4. 



Capítulo 2 

 102 

[45] Kreidler ER, Hummel FA. Phase relationships in the system SrO-P2O5 and 

the influence of water vapor on the formation of Sr4P2O9. Inorg Chem 1967;6:884-

91. 

[46] Riboud PV. Composition et stabilité des phases à structure d´apatite dans le 

système CaO–P2O5- de fer-H2O à haute temperature. Ann Chim 1973;8:381–90. 

[47] Margot-Marette H, Riboud PV. Study of liquidus temperatures of CaO–P2O5–

SiO2–Iron Oxide System. I. 15% FeO. Mem Sci Rev Metall 1966;63(11):959–67. 

[48] Kannan S, Ventura JM, Ferreira JMF. Aqueous precipitation method for the 

formation of Mg-stabilized ?-tricalcium phosphate: An X-ray diffraction study. 

Ceram Int 2007;33:637-41. 

[49] Torres PMC, Vieira SI, Cerqueira AR, Pina S, da Cruz Silva OAB, Abrantes 

JCC, et al. Effects of Mn-doping on the structure and biological properties of ?-

tricalcium phosphate. J Inorg Biochem 2014;136:57-66. 

[50] Döbelin N. Interlaboratory study on the quantification of calcium phosphate 

phases by Rietveld refinement. Powder Diffr 2015; 30(3):231-41. 

[51] Destainville A, Champion E, Bernache-Assollant D, Laborde E. Synthesis, 

characterization and thermal behavior of apatitic tricalcium phosphate. Mater 

Chem Phys 2003;80:269-77. 

[52] Yashima M, Sakai A, Kamiyama T, Hoshikawa A. Crystal structure analysis of 

?-tricalcium phosphate Ca3(PO4)2 by neutron powder diffraction. J Solid State 

Chem 2003;175:272-7. 

[53] Kannan S, Goetz-Neunhoeffer F, Neubauer J, Pina S, Torres PMC, Ferreira 

JMF. Synthesis and structural characterization of strontium- and magnesium-co-

substituted ?-tricalcium phosphate. Acta Biomater 2010;6:571-6. 

[54] Raynaud S, Champion E, Bernache-Assollant D, Thomas P. Calcium 

phosphate apatites with variable Ca/P atomic ratio I. Synthesis, characterisation 

and thermal stability of powders. Biomaterials 2002;23:1065-72. 



Capítulo 2 

 103 

[55] Descamps M, Hornez JC, Leriche A. Effects of powder stoichiometry on the 

sintering of ?-tricalcium phosphate. J Eur Cera. Soc. 2007;27:2401-6. 

[56] Maciejewski M, Brunner TJ, Loher SF, Stark WJ, Baiker A. Phase transitions 

in amorphous calcium phosphates with different Ca/P ratios. Thermochim Acta 

2008;468:75-80. 

[57] Shannon RD. Revised effective ionic-radii and systematic studies of 

interatomic distances in halides and chalcogenides. Acta Crystallogr A 

1976;32:751-67. 

[58] Gibson IR, Rehman I, Best SM, Bonfield W. Characterization of the 

transformation from calcium-deficient apatite to ?-tricalcium phosphate. J Mater 

Sci Mater Med 2000;11:799-804. 

[59] Ryu HS, Youn HJ, Hong KS, Chang BS, Lee CK, Chung SS. An improvement 

in sintering property of beta-tricalcium phosphate by addition of calcium 

pyrophosphate. Biomaterials 2002;23:909-14. 

 

 



 

 104 

 

 

 



 

 105 

 

 

Capítulo 3 

 

Injectabilidade de pastas de fosfato de cálcio: 

Efeitos do tamanho da partícula e estado de 

agregação de pós de ?-fosfato tricálcico 
 

 

 



 

 106 

 

 



Capítulo 3 

 107 

 

 

 

Injectability of calcium phosphate pastes: Effects of particle size 

and state of aggregation of ?-tricalcium phosphate powders 

 

P. M. C. Torresa,* , S. Gouveiab, S. Olheroa, A. Kaushala, J.M.F. Ferreiraa 

 

a Department of Materials and Ceramics Engineering, CICECO, University of Aveiro, 

3810-193, Portugal 

b Institute of Electronics and Telematics Engineering of Aveiro (IEETA) and Center for 

Research &amp;amp; Development in Mathematics and Applications (CIDMA), University of Aveiro, 

3810-193 Aveiro, Portugal  

 

 

Acta Biomaterialia 21 (2015) 204–216, doi: 10.1016/j.actbio.2015.04.006 

 

 

 

*Corresponding author. Tel.: +351 234 370261; fax: +351 234 370204. 

   E-mail address: ptorres@ua.pt (P.M.C. Torres). 

 

 

 

 

 

 



Capítulo 3 

 108 

 

 

 

Abstract 

The present study discloses a systematic study about the influence of some 

relevant experimental variables on injectability of calcium phosphate cements. 

Non-reactive and reactive pastes were prepared, based on tricalcium phosphate 

doped with 5 mol% (Sr?TCP) that was synthesised by co-precipitation. The varied 

experimental parameters included: (i) the heat treatment temperature within the 

range of 800?1100 ºC; (ii) different milling extents of calcined powders; (iii) the 

liquid-to-powder ratio (LPR); (iv) the use of powder blends with different particle 

sizes (PS) and particle size distributions (PSD); (v) the partial replacement of fine 

powders by large spherical dense granules prepared via freeze granulation 

method to simulate coarse individual particles. The aim was contributing to better 

understanding of the effects of PS, PSD, morphology and state of aggregation of 

the starting powders on injectability of pastes produced thereof. Powders heat 

treated at 800 and 1000ºC with different morphologies but with similar apparent 

PSD curves obtained by milling/blending originated completely injectable reactive 

cement pastes at low LPR. This contrasted with non-reactive systems prepared 

thereof under the same conditions. Hypotheses were put forward to explain why 

the injectability results collected upon extruding non-reactive pastes cannot be 

directly transposed to reactive systems. The results obtained underline the 

interdependent roles of the different powder features and ionic strength in the 

liquid media on determining the flow and injectability behaviours. 

 

Keywords: Calcium phosphates; Bone cements; Injectability; Aggregation state; 

Particle size distribution 

 

 

 



Capítulo 3 

 109 

1. Introduction 

Calcium phosphate bone cements (CPC) have attracted much attention in recent 

years opening up a new era in the medical applications since early 1980s [1, 2]. 

CPC offer numerous attractive advantages including resorbability, 

osteoconductivity, resemblance with chemical bone composition, capability to 

establish chemical bonds with the hard tissues, fast setting time, excellent 

mouldability, outstanding biocompatibility, etc. [3-7]. CPC also provide the 

opportunity for bone grafting using alloplastic materials, which are unlimited in 

quantity and provide no risk for infectious diseases [7]. Injectability and the 

practically isothermal in situ setting offer great opportunities to decrease the 

invasiveness and painfulness of surgeries, reduced recovery time and increase 

the overall benefits for the patient and the medical system [8, 9]. However, the 

commercially available CPC formulations are not completely satisfactory [10, 11]. 

The main shortcomings include insufficient mechanical strength and poor 

injectability. These properties are crucial for bone graft applications in surgical 

procedures for the correction of vertebral compression fractures, usually caused 

by osteoporosis. The currently used polymethylmethacrylate (PMMA) based 

cements injected into the vertebra offer good compressive strength but 

unsatisfactory fatigue resistance [12] and the high exothermicity of the 

polymerisation reactions might cause extensive necrosis [4, 5, 7, 13]. The 

monomer toxicity and the inability to participate in the biological processes of bone 

remodelling constitute other weak points of PMMA based cements [3, 6]. These 

concerns drove the search for CPC with improved flow and mechanical properties 

in the recent years. But achieving CPC pastes with good injectability still remains a 

major challenge as flow properties are affected by several factors such as: (i) 

average particle size (PS) and particle size distributions (PSD) of the starting 

powders; (ii) fraction and nature of the phases presented; (iii) the presence of 

strongly bonded particles (aggregates); (iv) particles shape; (v) liquid-to-powder 

ratio (LPR); (vi) the presence of rheological modifiers and/or additives with specific 

roles [4-6, 14-27].  



Capítulo 3 

 110 

Injectability is expressed as the percentage of paste that can be extruded from a 

syringe, ideally in a homogeneous way under an applied force [17]. The eventual 

occurrence of solid/liquid segregation (also known as filter pressing effect) during 

injection worsens or even hinders injectability [14, 17, 24]. In such circumstances 

the firstly extruded paste contains more liquid than the initial mixture. This paste 

heterogeneity increases extrusion load and might clog the cannula and block the 

process, leaving retained paste in the syringe that contains less amount of liquid 

than the initial mixture. 

Narrow PSD and the presence of aggregates (strongly bonded particles) tend to 

confer a shear thickening behaviour to the pastes and increase their tendency to 

segregate upon extrusion. Increasing the viscosity of mixing liquid is a common 

strategy to decrease the filter pressing effect and enhance injectability, but further 

work is required to better understand how to control the flow behaviour 

[15, 17, 23, 24]. Therefore, drawing firm conclusions about the effects of each 

experimental variable is difficult when several factors are concomitantly changed, 

as it happens in a complex reactive CPC paste made of ill characterised powders. 

Simplifications were attempted in studies carried out with non-reactive systems 

(aqueous suspensions of tricalcium phosphate, ??Ca3(PO4)2 ? ?-TCP) [14, 17, 28], 

but no systematic efforts were made towards discriminating between the size of 

particles and the size of aggregates. The main limitations towards evaluating the 

specific effects of each experimental variable on injectability are: (i) the lack of well 

characterised powders in what concerns PS and PSD; (ii) the frequent confusion 

between PS and aggregates size; and (iii) the limited size range of the practically 

achievable non-aggregates particles.  

Therefore, the main goal of this study is to contribute to a better clarification about 

the effects of particle size and particle size distribution and state of aggregation on 

the injectability and filter pressing effect of CPC pastes. For that, non-setting and 

setting pastes from strontium-doped tricalcium phosphate (Sr-TCP) powders 

calcined at different temperatures (800?1100ºC) and milled for different times (0, 6 

and 12 min), as well as some powder blends, were considered. Furthermore, 

relatively large individual particles (spherical granules) of the same material were 



Capítulo 3 

 111 

prepared and added in controlled amounts to the previous formulations to enlarge 

the PS scope.  

 

2. Materials and methods 

2.1 Powder preparation and characterisation 

The powder selected for the present study was ??TCP doped with 5 mol% of 

strontium (Sr?TCP). Improvements in thermal stability of ??TCP powders [29] as 

well as high performance of CPC derived from Sr?doped TCP [30] were the 

reasons for selecting the strontium-doped powders. The Sr?TCP in the present 

work was prepared by a precipitation method described by Kannan et al. [31] with 

a few minor modifications reported recently [32]. The precipitated powder was 

vacuum filtered, dried, ground and sieved through a mesh size of 200 µm, divided 

into four batches and each portion was then heat-treated at one of the following 

temperatures (800, 900, 1000 and 1100ºC) in air (Thermolab furnace, 

Pt30%Rh/Pt6%Rh-thermocouple). The heat treatment schedule included a heating 

rate of 5ºC min?1, a dwelling time for 2 h at the maximum temperature, followed by 

natural cooling to room temperature [31]. Each of these powders was submitted to 

dry milling for different times (6 and 12 min) in a 250 mL planetary agate mill 

(weight ratio of balls to powder of 3:1). For each calcination temperature, the 

following sub-lots of powders were obtained: (i) non-milled; (ii) milled for 6 min; 

and (iii) milled for 12 min. The codes for powder samples consist of two parts 

separated by a hyphen, the first one relative to temperature (800, 900, 1000, 

1100ºC) and the other to milling time (0, 6, 12 min). For example, 800?0 refers to a 

non-milled powder sample calcined at 800ºC, while and 1100?12 refers to a 

powder sample calcined at 1100ºC and milled for 12 min. All investigated powders 

were passed through a 40 µm sieve. 

The qualitative analyses of crystalline phases presented in the powders 

heat-treated at different temperatures were performed by X-ray powder diffraction 

(XRD) using a high-resolution Rigaku Geigerflex D/Mac, C Series, diffractometer 



Capítulo 3 

 112 

with Cu K? radiation (? = 1.540596 Å). Data sets were recorded in the 2? range 

20 ? 50º with a step size of 0.02º 2? s?1. Elemental analyses of the powders for 

Ca, Sr and P were determined using inductively coupled plasma (ICP) 

spectrometry (ICP-OES Jobin Yvon Activa M., USA). Particle size distributions of 

the Sr?TCP powders were measured in a laser scattering instrument (Coulter 

LS230, Buckinghamshire, UK, Fraunhofer optical model). Specific surface area 

(SSA) of powders were obtained according to the BET method using a 

Micromeritics Gemini 2370 V5.00 (Norcross, USA) through the gas adsorption 

measurements, after degassing the powders in a Micromeritics Flow Prep 060 

(Norcross, USA). The morphology and microstructure of the powders heat-treated 

at different temperatures, before and after milling at different times, were observed 

by Scanning Electron Microscopy (SEM, Hitachi S-4100, Tokyo, Japan). 

 

2.2 Granule preparation and characterisation 

Spherical dense granules might be regarded as individual large particles, thus 

enabling enlarging the range of available particle sizes and extending the scope of 

the studies aiming at assessing the effects of PS and PSD on the flow behaviour 

and injectability. With this purpose, a high concentrated (47 vol.% solids) aqueous 

suspension was prepared from the Sr?TCP powder calcined at 800ºC in presence 

of 0.4 wt.% ammonium salt of polyacrylate dispersant (BK Ladenburg, Germany). 

The suspension was ball milled for several days in order to obtain a well 

deagglomerated system using a weight ratio of zirconia balls to powder of 3:1. The 

as deagglomerated powder exhibited a narrow particle size distribution with two 

particle populations centred at 2.5 µm and 0.05 µm, and an overall D50 ? 0.51 µm. 

The suspension was then sprayed into liquid nitrogen (Power Pro freeze 

granulator LS?2, Gothenburg, Sweden) and the frozen granules were then 

lyophilised (Labconco, LYPH Lock 4.5, Kansas City, MO) [33]. The dried granules 

were subsequently sintered at 1150ºC in air atmosphere for 2 h at 5ºC min?1 

heating rate, and finally separated by size to obtain a size range between 20 and 

40 µm. Differential thermal analysis (DTA, Setaram Labsys, Setaram 



Capítulo 3 

 113 

Instrumentation, Caluire, France) was used to determine the maximum sintering 

temperature in order to obtain Sr-TCP granules of ??TCP phase (without ??TCP 

phase). The evolution of powder morphology with milling time and the 

microstructure of the sintered granules were observed by Scanning Electron 

Microscopy (SEM, Hitachi S-4100, Tokyo, Japan). The density of the granules was 

determined by helium gas pycnometry (Accupyc Quantachrome apparatus, 

Florida, USA) and complemented by SEM observation.  

 

2.3 Injectability evaluation 

2.3.1 Preparation of the pastes  

Non-setting pastes (non-reactive systems that do not harden over time) were 

prepared by mixing 6 g of each Sr?TCP powder sample with an aqueous solution 

of 3 wt.% of polyvinylpyrrolidone (PVP, Sigma?Aldrich, Germany) using liquid to 

powder ratios (LPR) of 0.28, 0.34, 0.4 and 0.6 mL g?1. Setting pastes (reactive 

systems) were also prepared by mixing in a 1:1 wt. ratio, Sr?TCP powders and 

monocalcium phosphate monohydrate (MCPM, Sigma?Aldrich, Germany) in a 

total of 6 g, with an aqueous solution containing 3 wt.% PVP + 15 wt.% citric acid 

(CA, 400, Sigma?Aldrich, Germany) + 0.5 wt.% hydroxyl propyl methylcellulose 

(HPMC, 5 mPa?s at 2% by mass, Sigma?Aldrich, Germany) using different LPR of 

0.28, 0.34, 0.4 mL g?1. The influence of replacing 10 wt.% of Sr?TCP powders by 

large sintered granules on the injectability of both reactive and non-reactive pastes 

was also evaluated. Table 1 summarises all the investigated pastes and their 

respective sample codes. As an example, P?800?6?G denotes a non-reactive 

paste (P), prepared from the 800?6 powder, and containing 10 wt.% of granules 

(G). Sample codes for reactive pastes are similar, substituting P by CP, such as, 

CP?800?6?G.  

 

 



Capítulo 3 

 114 

Table 1. Sample codes (X?T?t) of tested pastes were adopted to simplify their designation. 

Accordingly, X = P stands for non-reactive pastes; X = CP stands for reactive pastes, T stands for 

calcination temperature (ºC), and t for milling time (min). The suffix G is added to the code 

(X?T?t?G) to designate pastes containing granules. 

 

 

 

 

 

 

 

 

2.3.2 Injectability tests 

Injectability tests were performed as described in earlier studies [14, 17, 28, 34-36] 

by using a 10 mL syringe (15 mm diameter and 80 mm in length) fitted with a 

cannula of 2.2 mm inner diameter and 91 mm in length. The paste (6 g powder + 

required amount of liquid) was hand-mixed for 1 min and then placed into the 

syringe. The extrusion set was placed in a suitable homemade fixture device and 

put in a testing machine (Shimadzu Autograph, trapezium 2, Japan). The extrusion 

was performed at room temperature (RT = 20ºC) being always initiated 2 min after 

starting mixing the paste. The crosshead speed and the maximum load were fixed 

at 15 mm min?1 up [23, 24, 35, 36] and 500 N, respectively. This maximum load 

was selected to cover the entire range of applied forces and include all types of 

injection devices (manual, injector guns) and for enlarging the regime of filter 

pressing effect.  

Minimizing LPR values while keeping high injectability levels are the key points to 

develop high strength CPC cements. With this in mind, in the search for an 

optimised PSD, pastes prepared from blends of the most performing powders 

were also tested at the lowest LPR (0.28 mL g?1).  

 Milling time of Sr?TCP powder 
(min) 

Temperature of 
calcination of Sr?TCP 

powder 
(ºC)  0 6 12 

800  X?800?0 X?800?6 X?800?12 

900  X?900?0 X?900?6 X?900?12 

1000  X?1000?0 X?1000?6 X?1000?12 

1100  X?1100?0 X?1100?6 X?1100?12 



Capítulo 3 

 115 

The percentage of injectability was determined as the mass of the paste that could 

be expelled from the syringe divided by the initial mass of the paste inside the 

syringe [17, 35, 36]. Each injectability experiment was repeated three times and 

the average values were calculated. Paste samples were collected every 30 ± 2 s 

counted from the beginning of the extrusion process for evaluating the filter 

pressing effect. Any remaining paste in the syringe (when complete extrusion did 

not occur) was also collected. These samples were weighed before and after 

complete drying at 120ºC for 24 h to determine their LPR values.  

 

2.4 Zeta potential and electrical conductivity in different electrolyte solutions 

The powder blend 800?(50:50) was selected to assess the specific effects of the 

additives in the reacting liquid and ionic strength on zeta potential (ZP) and 

electrical conductivity (EC). The measurements were carried out using a Zeta Sizer 

(Nano ZS, Malvern, Worcestershire, UK) at several pH values. For this, 13 mg of 

powder was ultrasonically dispersed for 15 min into 50 mL of each aqueous 

electrolyte solution tested using 1 mM KCl as background electrolyte. Each dilute 

suspension was divided into two equal parts, one for increasing and the other for 

decreasing pH runs, and the pH values were adjusted by using 0.1 M solutions of 

either 0.1 M NaOH or 0.1 M HCl, respectively. 

 

2.5 Influence of preparation conditions on the flow behaviour of pastes 

To evaluate the influence of the dispersing/reacting liquids on the flow behaviour 

and injectability, the powders 800?6, 800?12 and their 800?(50:50) blend were 

selected. Pastes at various LPR (0.45, 0.40, 0.35, and 0.28 mL g?1) were prepared 

with deionised water, NaCl 3 M, in the complete reacting liquid, and in aqueous 

solutions of each separate additive used in the reacting liquid (0.5 wt.% HPMC, 3 

wt.% PVP, or 15 wt.% CA). Viscosity measurements were performed using a 

rotational Rheometer (Kinexus pro+, Malvern, UK) equipped with a cone and plate 

(2º, 25 mm, and gap of 70 µm) measuring configuration. The flow measurements 



Capítulo 3 

 116 

were conducted between 0.1 and 100 s?1 at 20 ºC. For each test, 2 g of powder 

was mixed with each testing liquid at various LPR for 1 min to form a 

homogeneous paste. The rheological measurement was always initiated 2 min 

after starting mixing the paste to ensure the same rheological history during the 

preparation of all the pastes. 

 

2.6 Statistical methods and data analysis 

Table 1 summarises the codes of pastes prepared from the different powder 

samples. The corresponding PSD curves are displayed in Fig. 2, with distributional 

features/percentiles reported in Table 2. The injectability of the pastes prepared 

from the different powder samples (without and with replacement of 10 wt.% of 

Sr?TCP powder by 10% of granules) was evaluated for non-reactive and reactive 

systems (Figs. 6 and 7, respectively, with data points representing average values 

of three independent experiments). Along the text, injectability data were 

expressed as means ± standard deviations. The filter pressing effect was 

evaluated by the significance of the variations in LPR (three independent 

experiments) undergone upon the extrusion of each paste (Tables 3, 4 and 5) and 

quantified from repeated measures ANOVA with Greenhouse?Geisser correction 

and statistical significance for p&lt;0.05. The pairwise comparisons between the 

chosen/blend powder samples and the reference one (1000?12) considered: 

(i) differences in particle size distributions (Fig. 8, with the evaluation of the 

discrepancy between distributions, D, as the integral of the absolute differences 

between two cumulative distributions); (ii) differences in injectability (Fig. 9 with 

statistical significance for p&lt;0.05 assessed by t-test with Bonferroni correction for 

multiple testing). The conclusions from parametric statistical analysis were 

corroborated in all cases with the non-parametric counterparts, due to the small 

sample size (Friedman test for the repeated measures ANOVA and 

Mann?Whitney U test for the t?test). All statistical analyses were conducted in 

IBM® SPSS® Statistics (Version 21.0) and graphical displays were developed in 

Matlab® (R2006a). ZP and EC were evaluated for the 800?(50:50) powder 



Capítulo 3 

 117 

dispersed in different electrolyte solutions (Fig. 10(a) and (b)). Three 

measurements were performed for each testing condition and the average values 

and standard deviations were calculated. 

 

3. Results 

3.1 Characterisation of starting powders 

The results of ICP analysis revealed that a Sr content of 5.02 mol% was retained 

in the lattice of the Sr?TCP powder, in good agreement with the planned Ca2.85 

Sr0.15 (PO4)2 composition. The XRD patterns of Sr?TCP powder samples heat-

treated at 800 ºC, 900 ºC, 1000 ºC and 1100 ºC displayed in Fig. 1 reveal that all 

samples consist of ??TCP, ??Ca3(PO4)2, ICDD PDF 04-001-7104, also coinciding 

with the standard (Ca2.83Sr0.17)(PO4)2 phase containing 5.6(6) mol% Sr (ICDD PDF 

01-076-8438) [37]. This coincidence means that lattice distortions in ??TCP 

caused by the atomic replacement [31, 38, 39] are too small to be noticed in 

agreement with previous studies [31, 37]. 

The volume based differential PSD curves of the different powder samples are 

displayed in Fig. 2. The most salient features of 800?0 include a quite broad PSD 

with D50 around 6.7 µm, comprising a small population of particles at ~2.4 µm and 

a more intense population of coarser particles centred at ~18 µm. Milling caused 

narrowing of PSD and the upsurge of two distinct populations with varying 

intensities in 800?6. The bimodal features accentuated with milling extent and D50 

decreased to 0.7 µm for sample 800?12, with the most intense population of fine 

particles centred at 0.6 µm and a smaller population of coarser particles centred at 

2.4 µm. These coarser populations presented in 800?6 and 800?12 powders are 

likely to consist more of small aggregates of primary particles than of coarse 

individual ones. 

 



Capítulo 3 

 118 

 

 

 

 

 

 

 

 

 

 

 

 

Fig. 1. X-ray diffraction patterns for the Sr?TCP powders heat treated at different temperatures. 

The diffraction lines of the standard Sr?TCP and ??TCP are also presented for comparison. 

 

 

 

 

 

 

 

 

 

 

Fig. 2. Particle size distributions of Sr?TCP powders calcined at 800ºC, 900ºC, 1000ºC and 1100ºC 

without milling (0 min) and after 6 and 12 min of milling time. 



Capítulo 3 

 119 

The PSD parameters (including D10, D50, and D90, as well as BET SSA) of the 

powders are presented in Table 2. The data enable concluding about a clear 

increase of PS and a concomitant decrease of SSA as calcination temperature 

increased. Moreover, increasing the milling time resulted in a gradual size 

reduction, accompanied by an increase of SSA, confirming the effects expected 

from milling.   

 

Table 2. The features of Sr?TCP powders (particle size, wideness of the distribution and specific 

surface area (SSA)) were affected by calcination temperature and by milling time. Features of 

powders blends used in this work are presented too.  

Calcination 
temperature (ºC) 

milling time 
(min) 

D10
a 

(µµµµm) 
D50

b 
(µµµµm) 

D90
c 

(µµµµm) 

dDmean 
(µµµµm) 

SSA 
(±0.5) 
(m2g????1) 

0 0.8 6.7 24.7 9.9 3.8 

6 0.4 1.3 5.3 2.2 4.5 800ºC 

12 0.4 0.7 2.3 1.0 5.0 

0 0.7 9.8 31.5 13.5 1.3 

6 0.4 1.4 6.8 2.6 2.2 900 ºC 

12 0.4 0.8 3.6 1.4 2.5 

0 0.6 11.1 28.9 13.2 0.1 

6 0.4 1.6 8.7 3.0 0.6 1000ºC 

12 0.4 1.0 2.9 1.4 1.1 

0 1.1 15.6 32.8 16.8 0.1 

6 0.3 4.6 23.6 8.4 0.1 1100ºC 

12 0.3 2.4 14.8 5.2 0.3 

50:50 Blend e 0.4 0.8 2.5 1.1 - 
800ºC 

75:25 Blend f 0.4 0.9 3.0 1.4 - 

a D50 – median particle size: particle size for which 50 vol.% of the particles are finer. 
b D10 – 10 vol.% of the particles are smaller than this value. 
c D90 – 90 vol.% of the particles are smaller than this value. 
d Dmean –“average” size of particles. 
e 50:50 Blend ? blend of 50 wt% 800?6 + 50 wt% 800?12. 
f 75:25 Blend ? blend of 75 wt% 800?6 + 25 wt% 800?12. 
 

 



Capítulo 3 

 120 

Fig. 3 shows the morphological SEM features of non-milled powders heat-treated 

at all temperatures, while Fig. 4 depicts the influence of milling on the morphology 

for the powders heat-treated at 800ºC and 1100ºC. The less magnified SEM 

micrographs of Fig. 3 show overall views of dispersed particles/aggregates 

deposited over the metallic supports, while the higher magnified inserts show clear 

details about the gradual sintering effects upon increasing the heat treatment 

temperature. The micrographs shown in Fig. 4 confirm the strong aggregation 

effect of calcination temperature and the importance of the milling process in 

destroying the aggregates.  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fig. 3. Scanning electron micrographs of Sr?TCP powders heat-treated at different temperatures.  

 

 

 

 

 



Capítulo 3 

 121 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fig. 4. Scanning electron micrographs of Sr?TCP powders heat-treated at 800ºC (a) and 1100ºC 

(b) without milling (a1 and b1), after milling for 6 min (a2 and b2) and 12 min (a3, b3). 
 

3.2 Characterisation of the Sr?TCP granules  

The starting suspension exhibited an appropriate shear thinning behaviour (not 

shown) for the preparation of the granules. The DTA curve (not shown) exhibited 

an exothermic peak centred at 1209 ºC, which was attributed to the ? ? ? phase 

transformation. Based on this result, 1150ºC was selected as the sintering 

temperature for the granules. 



Capítulo 3 

 122 

The morphology of sintered granules can be observed in the SEM micrographs 

presented in Fig. 5, confirming the high degrees of sphericity and density. The 

SEM observation of the internal cross sections of some granules revealed only a 

few small pores. The experimental density achieved upon sintering, was 3.055 ± 

0.06 g cm?3, corresponding to relative density of ~97%.  

 

 

 

 

 

 

 

 

 

 

 

 

Fig. 5. SEM micrographs of the Sr?TCP granules sintered at 1150ºC. 

 

3.3 Injectability and filter pressing effect of pastes 

3.3.1 Non-reactive systems  

The results of injectability of non-setting pastes without and with added 10 wt.% 

granules are present in Fig. 6a and b, respectively. From non-milled powders, 

injectability could be solely performed for LPR = 0.6 mL g?1. Fig. 6a reveals that 

injectability was improved with increasing milling times and LPR. From non-milled 

powders, only the P?1100?0 paste could be partially extruded at the lower LPR 



Capítulo 3 

 123 

values (0.34 and 0.4 mL g?1), achieving 32.8 ± 0.4 % and 48.1 ± 0.2 % of 

injectability, respectively. The increase of LPR to 0.6 mL g?1 allowed the extrusion 

of all the pastes derived from non-milled powders.  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fig. 6. (a) Injectability of non-reactive pastes prepared at different LPR values from powders 

calcined at different temperatures and submitted to different milling times (each data point is the 

average of three independent experiments); non setting pastes (standard deviations ? 1.55); 

(b) the same pastes by replacing 10 wt.% of Sr?TCP powder by 10% of granules 

(standard deviations ? 1.24).  

(a) 

(b) 



Capítulo 3 

 124 

The highest value of injectability (95.8 ± 0.8 %) was obtained for P?1100?0, while 

the lowest one (46.4 ± 1.5 %) was observed for P?800?0. All the pastes prepared 

from powder milled for 12 min could be more extensively extruded in comparison 

to the ones derived from powders non-milled or milled for 6 min. For example, at 

the LPR = 0.34 mL g?1, the injectability values for P?1000?12 and P?1100?12 

were as high as 95.2 ± 1.4 %, and 95.7 ± 0.7 %, respectively. The results 

displayed in Fig. 6a and b also reveal that injectability was enhanced by replacing 

10 wt.% of Sr?TCP powder by the same amount of spherical dense granules that 

simulate larger individual particles. The larger improvements were achieved for the 

powder samples calcinated at 800ºC and 900ºC. The results about the influence of 

the same experimental variables (calcination temperature, milling time and LPR) 

on the extent of filter pressing effect are reported in Table 3. 

 

Table 3. The features of Sr?TCP powders determined by the heat treatment temperature and 

milling time or by adding spherical dense granules, and the liquid-to powder ratio (LPR) affected 

the homogeneity of non-reactive pastes upon extrusion.  

Pastes 
Initial 
LPR 

(mL g-1) 

LPR of A1a 
(mL g????1) 

LPR of A2a 
(mL g????1) 

LPR of A3a 
(mL g????1) 

LPR of  
remaining paste 

not extruded 
(mL g????1) 

p–Value 

P????800????0 0.66 ± 0.01 0.61 ± 0.01 - 0.51 ± 0.02 0.011b 

P????900????0 0.64 ± 0.00 0.60 ± 0.02 - 0.51 ± 0.01 0.003 b 

P????1000????0 0.59 ± 0.01 0.62 ± 0.01 - 0.50 ± 0.01 0.004 b 

P????1100????0 

0.6 

0.57 ± 0.01 0.56 ± 0.01 0.59 ± 0.02 - 0.050 

0.34 0.43 ± 0.01 - - 0.27 ± 0.01 0.002b 

0.4 0.47 ± 0.02 0.39 ± 0.01 - 0.30 ± 0.01 0.002 b P????1100????0 

0.6 0.57 ± 0.01 0.56 ± 0.01 0.59 ± 0.02 - 0.050 

P????800????0 0.66 ± 0.01 0.61 ± 0.01 - 0.51 ± 0.02 0.011 b 

P????800????12 
0.6 

0.58 ± 0.01 0.58 ± 0.01 0.59 ± 0.01 - 0.620 

P????800????6 0.41 ± 0.01 - - 0.36 ± 0.01 0.014b 

P????900????6 0.38 ± 0.01 0.34 ± 0.01 - 0.31 ± 0.01 0.014 b 

P????800????6????G 0.41 ± 0.01 0.38 ± 0.01 0.39 ± 0.01 - 0.026 b 

P????900????6????G 

0.4 

0.39 ± 0.01 0.38 ± 0.01 0.39 ± 0.01 - 0.225 

a A1, A2 and A3 - paste samples collected along the extrusion process. 
b Presence of filter pressing effect (p&lt;0.05). 



Capítulo 3 

 125 

Statistical analysis indicated the occurrence of this phenomenon for most of the 

non-reactive pastes except for the P?1100?0, P?800?12 and P?900?6?G ones. At 

LPR = 0.6 mL g?1, the pastes P?800?0, P?900?0, P?1000?0 and P?1100?0 

revealed enhanced flowability and decreased trend for solid/liquid phase 

separation with the heat treatment temperature increasing. Accordingly, no 

segregation has apparently occurred in P?1100?0, contrarily to the quite visible 

filter pressing effect in the cases of P?800?0, and P?900?0 pastes. The LPR 

values for these last pastes at the beginning of the extrusion (A1) were higher than 

the starting value (0.6 mL g?1). This initial liquid enrichment is consistent with the 

lower LPR values measured for the remaining portion of the paste in the syringe. 

In the case of paste P?1000?0, a less extended filter pressing effect was only 

noticed for the A2 sample. For the pastes P?1100?0, the filter pressing effect 

absent at 0.6 mL g?1, became clearly and gradually noticeable with decreasing 

LPR values. Table 3 also shows that milling for 12 min was enough to prevent the 

filter pressing effect at 0.6 mL g?1 for the paste P?800?12, contrarily to the 

extensive solid/liquid phase separation observed for P?800?0. But milling for 6 min 

was insufficient to eliminate the filter pressing effect at 0.4 mL g?1 for the pastes 

P?800?6 and P?900?6. On the other hand, the filter pressing effect was much 

mitigated for P?800?6?G and completely prevented for P?900?6?G. 

 

3.3.2 Reactive systems  

The injectability results of reactive cement pastes at various LPR values, without 

and with added 10 wt.% granules, are presented in Fig. 7(a) and (b), respectively. 

Some observable features (enhanced injectability by increasing LPR and 

decreasing particle/agglomerate sizes) are common to non-reactive systems [14, 

17]. However, exceptions can also be noticed: (i) the injectability of CP?1100?0 &gt; 

CP?1100?6 &gt; CP?1100?12; (ii) increasing the LPR decreased the injectability of 

CP?1100?6 and CP?1100?12 systems; (iii) at LRP = 0.34 mL g?1, the injectability 

of CP?800?12 (84.5 ± 0.8 %) was lower than that of CP?800?6 (96.9 ± 0.5 %). 



Capítulo 3 

 126 

Pastes from non-milled powders could not be extruded at LRP = 0.28 mL g?1 and 

only partially extruded at LPR = 0.34 mL g?1.  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fig. 7. (a) Injectability of reactive cement pastes prepared at different LPR values from powders 

calcined at different temperatures and submitted to different milling times (each data point is the 

average of three independent experiments); cement pastes; (standard deviations ? 4.49); 

(b) the same pastes by replacing 10 wt.% of Sr?TCP powder by 10% of granules 

(standard deviations ? 3.28). 

(a) 

(b) 



Capítulo 3 

 127 

The higher values of injectability at 0.34 mL g?1 were obtained for CP?800?0 

(24.7 ± 2.0 %) and CP?1100?0 (24.7 ± 2.3 %), and the lower ones were observed 

for CP?900?0 (3.7 ± 0.9 %) and CP?1000?0 (19.5 ± 2.7 %). This tendency was 

maintained at LPR = 0.4 mL g?1 with CP?800?0 and CP?1100?0 reaching 

95.6 ± 2.1 and 97.3 ± 0.2 %, respectively. The pastes derived from powder 

samples milled for 6 min could be partially extruded at LPR = 0.28 mL g?1. The 

highest injectability value (50.9 ± 2.5 %) was obtained for CP?1100?6 while the 

lowest one (1.8 ± 0.3 %) was registered for CP?900?6. Increasing LPR to 

0.40 mL g?1 enhanced the injectability of the systems CP?800?6 (95.6 ± 2.0 %), 

CP?900?6 (97.4 ± 0.7 %) and CP?1000?6 (97.4 ± 0.5 %), while worsen that of 

CP?1100?6 (23.9 ± 1.3 %). For the pastes derived from powder samples milled for 

12 min, the higher injectability values at LPR = 0.28 mL g?1 were obtained for 

CP?800?12 (79.7 ± 4.1 %) and CP?1000?12 (96.0 ± 0.6 %), while the less 

performing systems were CP?900?12 (33.6 ± 2.2 %) and CP?1100?12 

(35.6 ± 2.1 %). 

Comparing the injectability results for the pastes without (Fig. 7a) and with added 

10 wt.% of granules (Fig. 7b), slight increases are observed in just some cases 

when granules are present. This small beneficial effect of granules was more 

evident for CP?900?0?G and CP?1000?0?G at LPR = 0.40 mL g?1. In the 

remaining cases, granules worsened the injectability (Fig. 7b and Table 4). For the 

CP?1100?0?G at LPR = 0.40 mL g?1, injectability decreased from 97.3 ± 0.2 wt.% 

to 35.3 ± 1.8 wt.%. At LPR = 0.28 mL g?1, the liquid was insufficient to wet the non-

milled powders + granules, thus preventing extrusion. 

For reactive pastes, the dependence of filter pressing effect on calcination 

temperature and milling time can be judged from the results presented in Table 4. 

The first set of pastes aimed at evaluating the effect of heat treatment 

temperature, reveals that: (i) at LPR = 0.40 mL g?1 segregation phenomena 

apparently did not occur for CP?1100?0 (p &gt; 0.05), being noticeable for CP?900?0 

and CP?1000?0 ones (p &amp;lt;0.05 for both cases); (ii) the CP?800?0 could be 

completely extruded, but a slight filter pressing effect has occurred.  



Capítulo 3 

 128 

Table 4. The features of Sr?TCP powders determined by the heat treatment temperature and 

milling time or by adding spherical dense granules, and the liquid-to powder ratio (LPR) affected 

the homogeneity of reactive pastes upon extrusion. 

Cement 
Pastes 

Initial 
LPR 

(mL g????1) 

LPR of 
A1a 

(± 0.01) 
(mL g????1) 

LPR of 
A2a 

(± 0.01) 
(mL g????1) 

LPR of 
A3a 

(± 0.01) 
(mL g????1) 

LPR of 
remaining 
paste not 
extruded 
(± 0.01)  
(mL g????1) 

p–
Value 

CP????800????0 0.41  0.37 0.37 - 0.040c 

CP????900????0 0.34  0.53 - 0.19 0.000c 

CP????1000????0 0.33  0.62 - 0.14 0.000c 

CP????1100????0 

0.40 

0.38  0.37 0.37 - 1.000 

0.28 b b b b - 

0.34 0.45 0.39 - 0.29 0.001c CP????1100????0 

0.40 0.38 0.37 0.37 - 1.000 

CP????800????0 0.43 - - 0.19 0.000 c 

CP????800????6 
0.34 

0.33 0.34 0.34 - 0.667 

CP????800????6 0.33 0.34 0.34 - 0.667 

CP????900????6 0.34 0.36 - 0.29 0.000c 

CP????800????6????G 0.34 0.33 0.34 - 0.220 

CP????900????6????G 

0.34 

0.42 0.31 - 0.26 0.001c 

a A1, A2 e A3 - samples of paste injected during the extrusion. 
b The liquid amount was not enough to form a paste. 
c Presence of filter pressing effect (p&lt;0.05). 

 

The second set of experiments aimed at evaluating the effect of LPR in 

CP?1100?0 pastes. At LPR = 0.28 mL g?1 no extrudable pastes could be formed. 

At LPR = 0.34 mL g?1, an evident solid/liquid phase separation occurred; but this 

phenomenon was no more apparent at LPR = 0.40 mL g?1. The third set of 

experiments was aimed at evaluating the effect of milling for 6 min on the filter 

pressing effect upon extruding the CP?800?0 and CP?800?6 pastes. The filter 

pressing effect, clearly evident for the CP?800?0 paste at LPR = 0.34 mL g?1, 

disappeared in the case of CP?800?6, reflecting the beneficial effect of milling. 



Capítulo 3 

 129 

The last set of pastes, prepared from powders milled for 6 min, was intended to 

investigate the influence of heat treatment temperature (800ºC, 900ºC) and of 

adding 10 wt.% of granules on the filter pressing effect at a fixed LPR 

(0.34 mL g?1). Segregation did not occur for CP?800?6 and CP?800?6?G, but 

appeared in the cases of CP?900?6 and CP?900?6?G, being more evident in 

CP?900?6?G.  

 

3.3.3 Powder blends in reactive systems 

Considering that: (i) the high injectability values of CP?1000?12 (96.0 ± 0.6 %) and 

CP?800?12 (79.7 ± 4.1 %) pastes at the lowest LPR (0.28 mL g?1) (Fig. 7a); (ii) 

the jump in injectability of CP?800?6 to 96.9 ± 0.5 % when LPR was increased to 

0.34 mL g?1, it was hypothesised that blends of powders 800?6 and 800?12 could 

be a viable option to mimic the PSD of the sample CP?1000?12 and thus to 

enhance the injectability of the pastes. Accordingly, attempts were made to 

reproduce as much as possible the target PSD of the 1000?12 powder by blending 

two different powder samples. The selection of this pair of powders was based on 

the PSD features reported in Table 2 and in Fig. 2. The blend of powders 

800?6 + 800?12 was found to exhibit features similar to the target. The features of 

the pair 900?6 + 900?12 were not far, except for D90 that was significantly higher 

(Table 2). Powders obtained at 1100ºC deviated from the desired target (Fig. 2) 

and were excluded. Therefore, 5 powders were selected to proceed with this 

study: 1000?12 (1); 800?6 (2); 800?12 (3); and the blends of the powders 

800?6 + 800?12 in the following weight ratios: 50:50 (4) and 75:25 (5). The 

corresponding PSD curves are plotted in Fig. 8a and b. 

Fig. 8b shows that curve 1 (1000?12) is located in between the curves 2 (800?6) 
and 3 (800?12), corroborating the suitability of the pair 800?6 + 800?12 for the 

intended purposes. As a matter of fact, small deviations relative to curve 1 are 

observed for PSD curves 4 and 5, in good agreement with data reported in Table 



Capítulo 3 

 130 

2. The best fit was obtained for blend 75:25 (curve 5) showing only a residual 

discrepancy, D value, between distributions. 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fig. 8. (a) Particle size distributions of Sr?TCP powders: (1) 1000?12; (2) 800?6; (3) 800?12; (4) 

50:50 blend of 800?6 and 800?12; (5) 75:25 blend of 800?6 and 800?12. (b) Pairwise comparison 

of different cumulative distributions with the one obtained for the 1000?12 sample. “D” quantifies 

the integral of the absolute differences between two cumulative distributions. 

(a) 

(b) 



Capítulo 3 

 131 

 

Fig. 9 shows the injectability results of the reactive pastes derived from the 5 

powders selected above at two LPR values. 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fig. 9. Injectability of the cement pastes at two LPR values (0.28 and 0.34 mL g?1): 

(1) CP?1000?12; (2) CP?800?6; (3) CP?800?12; (4) CP?50:50 blend of 800?6 and 800?12; 

(5) 75:25 blend of 800?6 and 800?12. The symbol ‘+’ denotes significant differences of average 

injectability values with respect to the reference CP?1000?12 (p&lt;0.05). 

 

It can be seen that injectability of CP?800?6 was significantly enhanced with LPR 

increasing from 0.28 to 0.34 mL g?1, while the effect was less pronounced for 

CP?1000?12 and CP?800?12 pastes. The pastes derived from powder blends 

could be completely extruded even at the lower LPR = 0.28 mL g?1, confirming the 

wiseness of these selections. The evolution LPR values along the extrusion 

process of the pastes prepared from the 5 selected powders is reported in Table 5.  

 



Capítulo 3 

 132 

Table 5. The features of individual Sr?TCP powders heat treated at 800ºC and milled for different 

times and of their blends affected the homogeneity of reactive cement pastes upon extrusion. 

(1) CP?1000?12, presented for comparison; (2) CP?800?6; (3) CP?800?12; (4) 50:50 

(800?6 + 800?12) blend; and (5) 75:25 (800?6 + 800?12) blend. 

Cement 
pastes 

Initial 
LPR 

(mL g????1) 

LPR of 
A1a 

(± 0.01) 
(mL g????1) 

LPR of 
A2a 

(± 0.01) 
(mL g????1) 

LPR of 
A3a 

(± 0.01) 
(mL g????1) 

LPR of 
remaining 
paste not 
extruded  
(± 0.01)  
(mL g????1) 

P-
Value 

1 0.27 0.29 0.30 - 0.074 

2 0.31 - - 0.26 0.003b 

3 0.28 0.30 - 0.26 0.017b 

4 0.27 0.29 0.29  0.069 

5  

0.28 

0.29 0.29 0.28  0.725 

a A1, A2 e A3 - samples of paste injected during the extrusion. 
b Presence of filter pressing effect (p&lt;0.05). 
 

The filter pressing effect, evident in CP?800?6 and CP?800?12 systems (p &amp;lt;0.05 

for both systems), could not be detected neither in the reference paste 

CP?1000?12 nor in the cement pastes derived from powder blends (4 and 5). 

 

3.4 Influence of dispersing/reactive liquids on zeta potential and rheology 

Since the most significant differences between non-reactive and reactive systems 

were observed for powders heat treated at 800ºC, they were selected to 

investigate the effects of liquids’ composition on their dispersing ability. The plots 

of ZP and EC of dilute 800?(50:50) systems are displayed in Figs. 10a and b, 
respectively. The results for 15 wt.% CA are not shown in Fig. 10a because fast 
dissolution of the particles hindered any reliable measurement, in agreement with 

observations reported elsewhere [21]. The absolute ZP values are close to zero in 

NaCl 3 M, being relatively small in the presence of 3 wt.% PVP and presenting a 

minimum at ~pH 7.5. The other curves show an increasing trend with pH 

increasing, especially in the case of KCl 10-3 M. The EC is highest (~20 S m-1) in 



Capítulo 3 

 133 

NaCl 3 M, followed by the measured for the 15 wt.% CA-containing systems 

(~0.7 S m-1) irrespective of the presence of other additives. The remaining EC 

curves appear almost superimposed and exhibit minima within the neutral pH 

region.  

 

 

 

 

 

 

 

 

Fig. 10. Influence of the different aqueous electrolyte solutions and pH on (a) Zeta potential, and 

(b) Electrical conductivity of P?800?(50:50). Except for molar concentrations (M), the other 

numerical coefficients in the sample codes stand for the concentration (wt.%) of the electrolyte in 

the liquid. The error bars of standard deviations are almost imperceptible in some cases, meaning 

excellent reproducibility of the data. 

 

 

 

 

 

 

 

 

Fig. 11. Flow curves of pastes prepared with different aqueous solutions: (a) non-reactive 

P?800?(50:50) pastes; (b) reactive CP?800?6, CP?800?12 and CP?800?(50:50). The pastes 

were prepared at different LPR (mL g?1): 0.45 (Black); 0.40 (Blue); 0.35 (Red); and 0.28 (Green). 



Capítulo 3 

 134 

The flow curves of non-reactive P?800?(50:50) pastes prepared with different 

aqueous solutions at various LPR are displayed in Fig. 11a. All the systems exhibit 

shear thinning behaviours within the entire shear rate range tested. With CA alone, 

and with the complete reactive liquid (3wt.%PVP + 0.5wt.%HPMC + 15wt.%CA), 

the minima LPR values required to wet the powder and form a paste were 0.35 

and 0.4 mLg?1, respectively. All the other curves (in black) correspond to LPR = 

0.45 mLg?1. In comparison to deionized water: (i) the NaCl 3 M solution forms a 

noticeable less viscous paste; (ii) 3 wt.% PVP solution gives significantly higher 

viscosity values; (iii) the viscosity curve of paste prepared with the less 

concentrated 0.5 wt.% HPMC solution is closer to that of pure water system. The 

least viscous system was obtained for 15 wt.% CA solution. Further adding PVP 

and HPMC binders to CA solution somewhat enhanced the viscosity of the 

resulting paste.  

The shear thinning behaviour is also observed for the reactive systems in Fig. 11b, 

with even smoother flow curves. At LPR = 0.45 mLg?1 the viscosity curve appears 

above those corresponding to non-reactive pastes. The remaining viscosity curves 

at LPR = 0.28 mLg?1 (green) show the following features: (i) CP?800?(50:50) is 

less viscous than CP?800?6 or CP?800?12; (ii) the paste prepared with CA alone 

is slightly more viscous that obtained from the complete reactive liquid (3 wt.%PVP 

+ 0.5 wt.%HPMC + 15 wt.%CA), contrarily to what was observed for non-reactive 

systems.  

 

4. Discussion 

The results of ICP analysis revealed an excellent agreement between the planned 

and the experimentally obtained Sr?TCP compositions. The good match of the 

XRD patterns (Fig. 1) and the standard files of pure and Sr?doped ??TCP (ICDD 

PDF 04-001-7104, and ICDD PDF 01-076-8438, respectively) mean that the lattice 

distortions [31, 38, 39] are too small to be noticed [31, 37].  



Capítulo 3 

 135 

The precipitated primary Sr?TCP particles brought together by capillary forces 

upon drying tend to agglomerate through weak chemical bonds by releasing OH 

surface groups and establishing oxygen bridges. These bonds strengthen and 

necks are gradually formed as the heat-treatment temperature increases, resulting 

in the formation of hard agglomerates or even sintered aggregates [40], as 

illustrated in the SEM micrographs of Figs. 3 and 4. This explains why PSD curves 

displayed in Fig. 2 became gradually broader with increasing the heat-treatment 

temperatures. The as formed aggregates are likely to be at least partially 

destroyed by milling. This process is easier for the powders heat-treated at lower 

temperatures that promote less extended neck formation among the primary 

particles [40]. The SEM micrographs presented in Fig. 4 confirm the strong 

aggregation effect of calcination temperature and the importance of the milling 

process in destroying the aggregates, in good agreement with the results 

displayed in Fig. 2 and Table 2. The SEM micrograph of 800?12 powder 

(Fig. 4, a3) shows assemblages of small particles brought together by capillary 

action upon the evaporation of the dispersing water (soft agglomerates). A first 

glance comparison of these relatively large particle assemblages with the smaller 

ones seen in the SEM micrograph of 1100?12 (Fig. 4, b3) might be misleading. 

Moreover, the coarser aggregates present in the powder calcined at 1100ºC are 

likely to sediment before collecting the dilute suspension droplet onto the metallic 

support used for SEM analysis. The grain growth and the extensive neck formation 

among the primary particles heat treated at 1100ºC confer a more compact and 

cohesive structure to the aggregates (Fig. 3), explaining the smaller specific 

surface area in comparison to the sample calcined at 800ºC (Table 2). These 

powder characteristics are expected to affect their reactivity when in contact with 

the liquid medium.  

The micrographs presented in Fig. 5 reveal that freeze granulation from the 

47 vol.% suspension of 800?0 powder (D50 ? 0.51 µm) was effective for preparing 

spherical granules and sintering the granules at 1150ºC enabled achieving high 

degree of density. The high relative density of ~97%, (3.055 ± 0.06 g cm?3) is 

consistent with the good dispersion of the Sr?TCP powder in the starting 



Capítulo 3 

 136 

suspension. Sintering at a temperature that is 59ºC below the one corresponding 

to the ? ? ? phase transformation (1209ºC, as determined by DTA) also 

accounted for the high level of densification achieved. Considering that pure 

??TCP undergoes ? ? ? phase transformation at ~1125ºC [41-44], these results 

indicate that thermal stability was enhanced for ~84ºC by doping ??TCP with 

5 mol% Sr.  

For non-reactive systems, the pastes prepared from powders heat-treated at lower 

temperatures (800 and 900ºC) required higher LPR to be injected and were more 

prone to undergo solid/liquid phase separation upon extrusion in comparison to 

those derived from powders calcined at higher temperatures (1000 and 1100ºC) 

(Table 3). This is consistent with the higher densification degrees (Fig. 3 and 4) 

and the lower values of SSA (Table 2) of the last powders, which will trap less 

liquid in the intra-agglomerate pores, thus availing more liquid to enhance the flow 

(Fig. 6a). On the other hand, strongly bonded particles moving together will make 

the flow more difficult because of their mutual collisions and risks of clogging the 

cannula. This tendency for hindering the flow and form a slow moving or stopped 

porous paste bed is the well-known filter pressing effect. Therefore, destroying 

rigid particle aggregates that might clog the cannulas is a fundamental step to 

improve injectability of pastes and to mitigate the filter pressing effect. This is 

confirmed by the highest injectability combined with the absence of filter pressing 

effect observed for the P?1100?12 system (Fig. 6a and Table 3). Injectability was 

also significantly enhanced by partially replacing irregularly shaped aggregates by 

spherical granules (Fig. 6b and Table 3) that simulate uniform larger particles 

(Fig. 5). These improvements can be attributed to the regular shape of granules, 

the change in size ratio, and packing ability, and to less liquid trapped in the 

intra-aggregate pore spaces [45]. Therefore, higher LPR will be required to enable 

pastes made of aggregated powders to flow in a homogeneous way. Table 3 

confirms that liquid phase migration upon extrusion occurred preferentially in 

systems with lower LPR. These results are in agreement with the existing 

consensus that increasing LPR facilitates the injectability [16] as observed in 

Fig. 6.  



Capítulo 3 

 137 

In general, increasing LPR and milling time facilitated injectability of both non-

reactive (Fig. 6a and b) and reactive systems (Fig. 7a and b) [14, 17]. The 

extended filter pressing effect observed especially for non-reactive pastes derived 

from powders calcined at lower temperatures became less evident in the case of 

reactive systems (Table 4). Moreover, the noticeable improvements in injectability 

with increasing calcination temperature observed for non-reactive pastes were not 

verified for reactive systems (Fig. 7a). These differences in flow properties 

between reactive and non-reactive systems suggest that the relevance of 

particle/agglomerate size and size distribution is not the same in these different 

systems, supporting the explanatory hypothesis suggested above. Other 

influencing factors come into play in the more complex reactive systems and, 

among the powders’ features particle/aggregate size distribution seems the most 

relevant one, especially at the lower LPR values. On the other hand, the relatively 

high ionic strength of the reacting liquid contributed to mitigate the occurrence of 

filter pressing effect in comparison to non-reactive pastes prepared from powders 

calcined at lower temperatures (Table 4). The overall results suggest that the 

particle/aggregate size distribution is the key factor that mostly determines 

injectability of cement pastes. In fact, powder blends with an overall PSD close to 

that of the standard powder 1000?12 (Fig. 8) performed similarly upon extrusion 

(Fig. 9 and Table 5). Several models [48-52] have been proposed to explain the 

enhanced packing ability of binary, ternary or even multimodal particle size 

systems by mixing in various proportions different sized particles. 

Furnas model [48] is particularly useful for predicting the optimal packing of 

powder blends, with the smaller particles occupying the interstitial spaces among 

the larger ones. Farris [53] explain the viscosity reduction that follows from mixing 

discretely sized particles with sufficiently large size ratios, considering that the 

suspension could be regarded as a coarse fraction suspended in a fluid containing 

the finer particles, with all fractions behaving independently of each other. The 

limited benefits in terms of injectability of reactive pastes containing coarse 

spherical granules (Fig. 7b) can be attributed to the excessively large size 

granule/particle ratio, contrasting with the observations made for non-reactive 

systems in which granules enhanced injectability.  



Capítulo 3 

 138 

The lower viscosity of CP?800?(50:50) in comparison to CP?800?6 or 

CP?800?12, Fig. 11b, reflects the enhanced packing ability of the powder blend in 

agreement with the Furnas [48] and Farris [53] models. Considering the small 

differences between the viscosity curves of CP?800?6 and CP?800?12, the lower 

viscosity of CP?800?(50:50), and the noticeable differences in injectability of these 

systems (Fig. 9), it seems clear that injectability is much more sensitive to 

variations in PSD than viscosity alone.  

One of the most salient differences of reactive systems is the lower amount of 

liquid required for injecting the pastes (Fig. 7) in comparison to non-reactive ones 

(Fig. 6). In fact, all cement pastes, except those prepared with non-milled powders, 

could be partially or totally extruded at LPR = 0.28 mL g?1 (Fig. 7a). This seems 

strange considering the expected increase in viscosity involved in hydraulic setting 

reactions. However, a number of reasons could be alleged to explain the 

enhanced flowing ability of reactive systems: (i) the presence of ionic species 

derived from CA and/or HPMC and PVP in the setting liquid may change the 

interparticle forces and the packing ability. It is known that interparticle forces have 

significant effects on the ability of particles to pack in suspensions or pastes 

[20, 21, 46]; (ii) dissolution reactions that increase the ionic strength of the liquid, 

which in turn tends to collapse the electrical double layers around the particles 

enabling them to approach up to closer distances [47]. This explanatory 

hypothesis is supported by the almost null ZP in the presence of NaCl 3 M (Fig. 

10a), the correspondingly high EC (Fig. 10b), and the noticeably lower viscosity in 

comparison to that of non-reactive paste made with deionised water (Fig. 11a). 

This was further proved by comparing the feasibility of preparing non-reactive 

pastes from 800?6 at LPR = 0.34 mL g?1 using pure water or NaCl 3 M solution. 

The powder was not completely wetted by deionised water, contrasting with a 

flowable paste obtained with NaCl 3 M.  

With CA or (CA + PVP + HPMC) solutions, minima LPR values of 0.35 and 

0.4 mL g?1, respectively, were required for forming (non-necessarily extrudable) 

non-reactive pastes (Fig. 11a). These values are noticeably higher than 

0.28 mL g?1 used to prepare extrudable reactive systems (Fig. 11b). On the other 



Capítulo 3 

 139 

hand, at LPR = 0.45 mL g?1 the non-reactive pastes prepared with 15 wt.% CA or 

(3wt.%PVP + 0.5wt.%HPMC + 15wt.%CA) solutions are noticeably less viscous in 

comparison to the other systems at the same LPR (Fig. 11a). This enhanced 

fluidity of CA-containing pastes is likely to be due to two concomitant and 

concurrent effects: (i) surface adsorption of citrate ions, accentuating the negative 

ZP values [20, 21]; (ii) increase of ionic strength derived from dissolution of ?-TCP 

and the acidic environment. Such significant flow ability differences between non-

reactive and reactive pastes are likely to derive mostly from the huge increase in 

ionic strength derived from the acidic pH values of 15 wt.% CA and 

(3wt.%PVP + 0.5wt.%HPMC + 15wt.%CA) solutions and the partial dissolution of 

MCPM and ??TCP in reactive systems. This is supported by the impossibility of 

measuring any reliable ZP values in CA-containing solutions and by the noticeable 

EC values measured in the presence of 15 wt.% CA and 

(3wt.%PVP + 0.5wt.%HPMC + 15wt.%CA) (Fig. 10b).  

In summary, the most salient differences between reactive and non-reactive 

systems can be explained by the significant increase in ionic strength in the case 

of reactive pastes, collapsing the electrical double layers around the particles. The 

apparent size of the particles decreases and the interactions among them are 

mediated by short range lubricating forces [47]. Another important factor is the 

replacement of 50% of ??TCP by MCPM in reactive systems. Further, real 

complex particle size variations that are hard to describe in detail, are also 

expected from the dissolution/precipitation and setting reactions. Due to 

thermodynamic reasons, the sharpener corners of the particles will firstly undergo 

dissolution. This will favour the particles sliding over each other, also contribution 

to enhance the flowability and injectability of reactive pastes.  

 

5. Conclusions  

This work demonstrates that knowledge acquired upon using non-reactive 

systems regarding the effects of powder features (PS, PSD, state of aggregation) 

cannot be directly transposed to the setting cement pastes prepared from the 



Capítulo 3 

 140 

same powders. The collapse of the electrical double layers around the particles 

and the surge of short range lubricating forces are consistent with injectability tests 

performed under high ionic strength conditions (3 M NaCl), supporting the 

explanatory hypothesis proposed. Accordingly, the overall injectability results for 

reactive systems revealed that under the set of fixed experimental conditions 

used, particle/aggregate size distribution is the most determining factor, as 

confirmed by the excellent injectability of pastes derived from powders with 

significant differences in SSA (CP?1000?12 and CP?50:50 and CP?75:25). 

Partially aggregated particle might behave like individual particles and enhance 

injectability, provided that they are integrated in an overall continuous and 

relatively large PSD.  

The partial replacement of fine and/or insufficiently milled (aggregate) powders by 

regular shaped dense granules might be promising, provided that granules with 

suitable sizes can be prepared to generate blends with proper PSD. Future 

research will be required towards optimising PS and PSD preferentially of 

non-aggregate particles.  

 

Acknowledgments 

This work was supported by the European Regional Development Fund (FEDER) 

through the COMPETE and by the Portuguese Government through the 

Portuguese Foundation for Science and Technology (FCT), in the scope of the 

projects UID/ CTM/50011/2013 (Aveiro Institute of Materials, CICECO, www. 

ciceco.ua.pt), project PEst-OE/EEI/UI0127/2014 and UID/CEC/ 00127/2013 

(Institute of Electronics and Informatics Engineering of Aveiro, IEETA, 

www.ieeta.pt) and project UID/MAT/04106/2013 (Center for Research and 

Development in Mathematics and Applications, CIDMA, www.cidma.mat.ua.pt). 

P.M.C. Torres (SFRH/BD/62021/2009), S. Gouveia (SFRH/BPD/87037/2012), 

S.M. Olhero (SFRH/BPD/87486/2012) and, Ajay Kaushal (SFRH/BPD/ 

77598/2011) acknowledge the respective fellowship Grant by FCT. 



Capítulo 3 

 141 

References 

[1] W.E. Brown, L.C. Chow, A new calcium phosphate setting cement, J. Dent. 

Res. 62 (1983) 672. 

[2] R.Z. LeGeros, A. Chohayeb, A. Shulman, Apatitic calcium phosphates: 

Possible dental restorative materials, J Dent Res. 61(1982) 343. 

[3] M. Bohner, Calcium orthophosphates in medicine: from ceramics to calcium 

phosphate cements, Injury. 31(2000) 37-47. 

[4] M. Bohner, Reactivity of calcium phosphate cements, J. Mater. 

Chem.17 (2007) 3980-6. 

[5] M. Bohner, U. Gbureck, J.E. Barralet, Technological issues for the 

development of more efficient calcium phosphate bone cements: a critical 

assessment, Biomaterials 26 (2005) 6423-9. 

[6] S.V. Dorozhkin, Calcium orthophosphates cements for biomedical 

application, J. Mater. Sci. Mater. Med. 43(2008) 3028-57. 

[7] E. Fernandez, Bioactive bone cements. In: Akay M, editor. Wiley 

encyclopedia of biomedical engineering. New York: John Wiley &amp;amp; Sons, Inc.  2006. 

1–9. 

[8] H. Alves, L. Santos, C. Bergmann, Injectability evaluation of tricalcium 

phosphate bone cement, J. Mater. Sci. Mater. Med. 19 (2008) 2241-6. 

[9] E.F. Burguera Xu HHK, L.M. Sun, Injectable calcium phosphate cement: 

Effects of powder-to-liquid ratio and needle size 9, J. Biomed. Mater. Res. B. 84B 

(2008) 493-502. 

[10] M. Bohner, Design of ceramic-based cements and putties for bone graft 

substitution, Eur Cells Mater. 20 (2010) 1-12. 

[11] S. Dorozhkin, Self-Setting Calcium Orthophosphate Formulations, J. Funct. 

Biomater. 4 (2013) 209-311. 



Capítulo 3 

 142 

[12] MK Singh, T Shokuhfar, J.J.A. Gracio, A.C.M. de Sousa, J.M.F. Ferreira, H. 

Garmestani, S. Ahzi, Hydroxyapatite Modified with Carbon-Nanotube-Reinforced 

Poly(methyl methacrylate): A Nanocomposite Material for Biomedical Applications, 

Adv. Funct. Mater.18 (2008) 694. 

[13] S. Metallidis, D. Topsis, J. Nikolaidis, E. Alexiadou, G. Lazaraki, L. Grovaris, 

A. Theodoridou, P. Nikolaidis, Penetration of moxifloxacin and levofloxacin into 

cancellous and cortical bone in patients undergoing total hip arthroplasty, J 

Chemotherapy. 19 (2007) 682-7. 

[14] M. Habib, G. Baroud, F. Gitzhofer, M. Bohner, Mechanisms underlying the 

limited injectability of hydraulic calcium phosphate paste, Acta Biomater. 4 (2008) 

1465-71. 

[15] L. Leroux, Z. Hatim, M. Freche, J.L. Lacout, Effects of various adjuvants 

(lactic acid, glycerol, and chitosan) on the injectability of a calcium phosphate 

cement, Bone 25 (1999) 31S-34S. 

[16] G. Baroud, E. Cayer, M. Bohner, Rheological characterization of 

concentrated aqueous ?-tricalcium phosphate suspensions: The effect of liquid-to-

powder ratio, milling time, and additives, Acta Biomater. 1 (2005) 357-63. 

[17] M. Bohner, G. Baroud, Injectability of calcium phosphate pastes, 

Biomaterials 26 (2005) 1553-63.  

[18] E.B. Montufar, Y. Maazouz, M.P. Ginebra, Relevance of the setting reaction 

to the injectability of tricalcium phosphate pastes, Acta Biomater. 9 (2013)6188-98. 

[19] A. Fatimi, J.F. Tassin, J. Bosco, R. Deterre, M.A.V. Axelos, P. Weiss, 

Injection of calcium phosphate pastes: prediction of injection force and comparison 

with experiments, J Mater Sci Mater Med. 23 (2012) 1593-603. 

[20] J.E. Barralet, L.M. Grover, U. Gbureck, Ionic modification of calcium 

phosphate cement viscosity. Part II: hypodermic injection and strength 

improvement of brushite cement, Biomaterials 25 (2004)2197-203. 



Capítulo 3 

 143 

[21] U. Gbureck, J.E. Barralet, K. Spatz, L.M. Grover, R. Thull, Ionic modification 

of calcium phosphate cement viscosity. Part I: hypodermic injection and strength 

improvement of apatite cement, Biomaterials 25 (2004) 2187-95. 

[22] U. Gbureck, K. Spatz, R. Thull, J.E. Barralet, Rheological enhancement of 

mechanically activated ?-tricalcium phosphate cements, J. Biomed. Mater. Res. B 

Appl. Biomater. 73 (2005) 1-6. 

[23] M.P. Ginebra, A. Rilliard, E. Fernandez, C. Elvira, J. San Roman, J.A. 

Planell, Mechanical and rheological improvement of a calcium phosphate cement 

by the addition of a polymeric drug, J Biomed Mater Res. 57 (2001) 113-8. 

[24] Khairoun I, Boltong MG, Driessens FCM, Planell JA. Some factors 

controlling the injectability of calcium phosphate bone cements, J Mater Sci Mater 

Med. 9 (1998) 425-8. 

[25] S. Pina, S.M. Olhero, S. Gheduzzi, A.W. Miles, J.M. Ferreira, Influence of 

setting liquid composition and liquid-to-powder ratio on properties of a Mg-

substituted calcium phosphate cement, Acta Biomater. 5 (2009) 1233-40. 

[26] S. Sarda, E. Fernandez, M. Nilsson, M. Balcells, J.A. Planell, Kinetic study 

of citric acid influence on calcium phosphate bone cements as water-reducing 

agent, J. Biomed. Mater. Res. 61 (2002) 653-9. 

[27] S. Tadier, L. Galea, B. Charbonnier, G. Baroud, M. Bohner, Phase and size 

separations occurring during the injection of model pastes composed of 

?-tricalcium phosphate powder, glass beads and aqueous solutions, Acta 

Biomater. 10 (2014) 2259-68. 

[28] M. Habib, G. Baroud, F. Gitzhofer, M. Bohner, Mechanisms underlying the 

limited injectability of hydraulic calcium phosphate paste. Part II: Particle 

separation study, Acta Biomater. 6 (2010) 250-6. 

 



Capítulo 3 

 144 

[29] R.G. Carrodeguas, A.H. De Aza, X. Turrillas, P. Pena, S. De Aza, New 

approach to the beta ? alpha polymorphic transformation in magnesium-

substituted tricalcium phosphate and its practical implications, J. Am. Ceram. Soc. 

91 (2008) 1281-86. 

[30] S. Pina, P.M. Torres, F. Goetz-Neunhoeffer, J. Neubauer, J.M.F. Ferreira, 

Newly developed Sr-substituted alpha-TCP bone cements, Acta Biomater. 

6 (2010) 928-35. 

[31] S. Kannan, S. Pina, J.M.F. Ferreira, Formation of strontium-stabilized 

?-tricalcium phosphate from calcium-deficient apatite, J. Am. Ceram. Soc. 

89 (2006) 3277-280. 

[32] P.M.C. Torres, S.I. Vieira, A.R. Cerqueira, S. Pina, O.A.B. da Cruz Silva, 

J.C.C. Abrantes, J.M.F. Ferreira, Effects of Mn-doping on the structure and 

biological properties of ?-tricalcium phosphate, J Inorg Biochem.136 (2014) 57-66. 

[33] S.M. Olhero, A. Kaushal, J.M.F. Ferreira, Fostering the properties of 

Zr0.8Sn0.2TiO4 (ZST) ceramics via freeze granulation without sintering additives, 

RSC Adv. 4 (2014) 48734-48740. 

[34] X.P. Wang, J.D. Ye, H. Wang, Effects of additives on the rheological 

properties and injectability of a calcium phosphate bone substitute material, J. 

Biomed. Mater. Res. B-Appl. Biomater. 78B (2006) 259-64. 

[35] H.H.K. Xu, M.D. Weir, E.F. Burguera, A.M. Frase, Injectable and 

macroporous calcium phosphate cement scaffold, Biomaterials 27 (2006) 4279-

287. 

[36] S. Pina, P.M. Torres, J.M. Ferreira, Injectability of brushite-forming Mg-

substituted and Sr-substituted alpha-TCP bone cements, J. Mater. Sci. Mater. 

Med. 21 (2010) 431-8. 

[37] G. Renaudin, P. Laquerriere, Y. Filinchuk, E Jallot, J.M. Nedelec, Structural 

characterization of sol-gel derived Sr-substituted calcium phosphates with anti-



Capítulo 3 

 145 

osteoporotic and anti-inflammatory properties, J. Mater. Chem. 18 (2008) 3593-

600. 

[38] A. Bigi, E. Foresti, M. Gandolfi, M. Gazzano, N. Roveri, Isomorphous 

substitutions in ?-tricalcium phosphate: The different effects of zinc and strontium, 

J. Inorg. Biochem. 66 (1997) 259-65. 

[39] S. Kannan, F. Goetz-Neunhoeffer, J. Neubauer, J.M.F. Ferreira, 

Cosubstitution of zinc and strontium in ?-tricalcium phosphate: Synthesis and 

characterization, J. Am. Ceram. Soc. 94 (2011) 230-35. 

[40] S.J.L. Kang, Sintering - Densification, Grain Growth, and Microstructure, 

Oxford, Elsevier Butterworth-Heinemann 2005. 

[41] A.A. Belik, F. Izumi, S.Y. Stefanovich, A.P. Malakho, B.I. Lazoryak, I.A. 

Leonidov, O.N. Leonidova, S.A. Davydov, Polar and centrosymmetric phases in 

solid solutions Ca3-xSrx(PO4)2 (0 ? x ? 16/7), Chem. Mater. 14 (2002) 3197-205. 

[42] B. Dickens, L.W. Schroeder, W.E. Brown, Crystallographic studies of role of 

Mg as a stabilizung impurity in ?-Ca3(PO4)2.1. Crystal struture of pure ?-Ca3(PO4)2, 

J. Solid. State Chem. 10 (1974) 232-48. 

[43] J.C. Elliott, Structure and chemistry of the apatites and other calcium 

orthophosphates, London, Elsevier 1994. 

[44] M. Mathew, L.W. Schroeder, B. Dickens, W.E. Brown, Crystal structure of 

alpha-Ca3(PO4)2, Acta Crystallogr. Sect B: Struct. Sci. 33 (1977) 1325-33.  

[45] K. Ishikawa, S. Matsuya, M. Nakagawa, K. Udoh, K. Suzuki, Basic 

properties of apatite cement containing spherical tetracalcium phosphate made 

with plasma melting method, J. Mater. Sci. Mater. Med. 15 (2004) 13-17. 

[46] B.V. Velamakanni, F.F. Lange, Effect of interparticle potentials and 

sedimentation on particle packing density of bimodal particle distributions during 

pressure filtration, J. Am. Ceram. Soc. 74 (1991) 166-72. 



Capítulo 3 

 146 

[47] F.F. Lange, Shape forming of ceramic powders by manipulating the 

interparticle pair potential, Chem. Eng. Sci. 56 (2001) 3011-20. 

[48] C.C. Furnas, Grading aggregates - I. - Mathematical relations for beds of 

broken solids of maximum density, Ind. Eng. Chem. 23 (1931) 1052-58. 

[49] A.E.R. Westman, H.R. Hugil, The packing of particles, J. Am. Ceram. Soc. 

13 (1930) 767-79. 

[50] H.E. White, S.F. Walton, Particle packing and particle shape, J. Am. Ceram. 

Soc. 20 (1937) 155-66. 

[51] R.K. McGeary, Mechanical packing of spherical particles, J. Am. Ceram. 

Soc. 44 (1961) 513-22. 

[52] R.F. Fedors, R. F. Landel, An empirical method of estimating the void 

fraction in mixtures of uniform particles of different size, Powder Tech. 23 (1979) 

225-231. 

[53] R.J. Farris, Prediction of the Viscosity of Multimodal Suspensions from 

Unimodal Viscosity Data, Trans. Soc. Rheol. 12 (1968) 281-301. 

 

 



 

 147 

 

 

Capítulo 4 

 

Efeitos da dopagem do manganês na 

estrutura e nas propriedades biológicas do 

fosfato ?????tricálcico 
 

 



 

 148 

 

 

 

 

 

 

 

 

 



Capítulo 4 

 149 

 

 

 

Effects of Mn?doping on the structure and biological properties  

of ?????tricalcium phosphate 

 

P. M. C. Torres a,*, S. I. Vieira b,c, A.R. Cerqueira b,c, S. Pina a, O.A.B. da Cruz e 

Silva b,c, J.C.C. Abrantes a,d and J.M.F. Ferreira a 

 

a Department of Materials and Ceramic Engineering, University of Aveiro, CICECO, 

3810-193 Aveiro, Portugal. 

b Department of Biology, Centre for Cellular Biology, University of Aveiro, 3810-193 

Aveiro, Portugal  

c Department of Health Sciences, Centre of Cellular Biology, University of Aveiro, 

3810-193 Aveiro, Portugal 

d UIDM, ESTG, Polytechnic Institute of Viana do Castelo, 4900 Viana do Castelo, Portugal 

 

 

Journal of Inorganic Biochemistry 136 (2014) 57–66, 

doi:10.1016/j.jinorgbio.2014.03.013 

 

 
 
*Corresponding author. Tel.: +351 234 370261; fax: +351 234 370204. 

   E-mail address: ptorres@ua.pt (P.M.C. Torres). 
 

 

 



Capítulo 4 

 150 

 

 

 

Abstract  

Doping calcium phosphates with trace elements that exist in bone tissues is 

beneficial in terms of cell-material interactions and in vivo performance of the bone 

grafts made thereof. Manganese (Mn) is an essential element for normal growth 

and metabolism of bone tissues, but studies reporting the effects of Mn-doping 

calcium phosphates are scarce. The present study investigated the influence of 

Mn-doping on the structure, morphology and biological properties of ??tricalcium 

phosphate [??Ca3(PO4)2] (?-TCP). Mn?doped (MnTCP) powders, with Mn contents 

varying from 0?10 mol%), were obtained through an aqueous precipitation method 

followed by heat treatment at 800ºC. The successful incorporation of Mn into 

??TCP structure was proved through quantitative X-ray diffraction (XRD) phase 

analysis coupled with structural Rietveld refinement. Increasing Mn concentrations 

led to decreasing trends of a- and c-axis lattice parameters, and Mn-doping also 

significantly affected the morphology of ?-TCP powders. In vitro proliferation and 

differentiation assays of MC3T3-E1 osteoblastic-like cells, grown in the presence 

of the powders, revealed that the biological benefits of Mn?doped ??TCP are 

limited to lower Mn incorporation levels and potentially related to their surface 

microstructure. The Mn1??TCP composition revealed the best set of bioactivity 

properties, potentially a good candidate for future applications of ??TCP materials 

in osteoregeneration. 

 

Keywords: ??Tricalcium phosphate, Manganese, Osteoblastic proliferation, 

Osteoblastic differentiation, Extracellular matrix 



Capítulo 4 

 151 

1. Introduction 

The increasing incidence of bone diseases such osteoporosis, osteomyelitis, 

malignant tumours, or traumatic accidents has generated higher demands for 

bone grafting materials [1, 2]. Currently more than 200 million people worldwide 

are affected by osteoporosis, resulting in a high number of fractures such as hip, 

vertebral compression, and Colles’ fractures. An almost fourfold increase in 

incidence of these kinds of fractures is expected to occur over the next 50 

years [3], placing pressure on the development of a versatile bone graft material, 

available in large quantities and bearing no risk to the patient. Bioceramics based 

on calcium phosphates (CaP) fit this need, due to their close chemical similarity to 

the inorganic component of bone and teeth mineral [1, 2, 4]. Doping CaPs with 

trace elements existing in bone composition has been the subject of recent 

widespread investigation, due to specific roles played by these in biological 

processes upon implantation [5-12]. Such approaches aim to obtain a closer 

match between the composition of bone grafts and the composition of hard 

tissues. The doping elements influence the tissue response, including the 

promotion of bone apposition through mechanisms of which our understanding still 

remains limited. Calcium and some trace elements including Mn, detected as 

minor constituents of teeth and bone, are known to play essential roles in the 

normal growth and metabolism of bone tissues [3, 6]. Mn is an important cofactor 

for several enzymes such as the glycosyltransferases (or mucopolysaccharides) 

involved in extracellular matrix (ECM) remodelling, necessary for the synthesis of 

proteoglycans, which is an important constituent of both skeletal and cartilage 

structural matrix [13].  Its deficit impairs the synthesis of cartilaginous organic 

matrix and, in turn, retards endochondral osteogenesis, increasing the possibility 

of bone abnormalities [13, 14]. Mn increases the ligand-binding affinity of integrins, 

a quite large family of receptors that mediate cellular interactions with the ECM, 

and active cell adhesion [15].  

Mn also regulates bone remodelling because its low content in body is connected 

with the increase of the extracellular concentration of calcium, phosphates and 

phosphatase [16]. Reginster et al. [17] suggested a key involvement of Mn in the 



Capítulo 4 

 152 

maintenance of bone mass, pointing out a Mn deficiency in human body as a 

probable cause of osteoporosis. This was strengthened by Rico et al. [17] that 

showed that a Mn supplement was effective in inhibiting the loss of bone mass 

after ovariectomy in rats. Interestingly, in a recent study, Landete-Castillejos et al. 

[18] suggested that calcium loss could be a consequence and not the origin of 

osteoporosis. These authors further believe that a lack of manganese is at the 

genesis of this disease, resulting in the low calcium bone absorption that ultimately 

results in osteoporosis. In a previous study, these authors addressed the 

occurrence of fractures presented in deer antlers [19], and related these to Mn 

changes in the diet. This suggests that a Mn deficiency may prevent the 

incorporation of Ca in bone tissue, thus resulting in antler bone material which is 

less tough and dense, and even more porous than normal [19]. The confirmation 

by the scientific community of this new hypothesis for osteoporosis pathogenesis 

could be a clinical breakthrough.  

Given the role of Mn in osteogenesis and osteoporosis, its incorporation into CaP 

materials for bone repair/regeneration applications, is likely to improve their 

biological performance in terms of bioactivity and acceleration of bone 

mineralization. Previous studies revealed that Mn incorporation in carbonated 

CaP [20] and in CaP coatings on Ti substrates [7] favoured osteoblast 

proliferation, differentiation and mineralization depending of the amount 

incorporated. The Mn incorporation in ceramic materials, including CaP, was also 

shown to affect their surface microstructure and morphology [7, 10, 20-24], which, 

in turn, can influence the resulting biological responses. However, the benefits 

from Mn-doping are likely to be limited to certain Mn incorporation levels. As a 

matter of fact, chronic exposure to toxic levels of Mn leads to manganism, a 

neurodegenerative disorder similar to Parkinson’s disease [25], while Mn 

deficiency may also be associated with diseases of the central nervous system 

such as Alzheimer’s or Parkinson’s disease [18, 26, 27]. A report based on clinical 

data [18] suggests that Mn released from the bone during the remodelling process 

might be available for other prioritized functions, such as brain functions, leading 

to osteoporosis particularly in the elderly population. The lack of consensus 



Capítulo 4 

 153 

relative to the ideal Mn levels in the body might help explain the scarcity of 

published works on Mn-doping of CaP materials for biomedical applications. 

The aim of the present study is to investigate the influence of different amounts of 

Mn on the structure, morphological features and in vitro proliferation and 

differentiation responses of osteoblast-like cells (MC3T3-E1 cell line) to Mn-doped 

??TCP powders. Various biological responses to the biomaterials were assessed, 

including cell viability and Type-I collagen secretion, to evaluate the biological 

potential of the ??TCP materials for repair/regeneration of bone affected by 

osteoporosis or serious traumas. The results are expected to contribute to a better 

understanding of the potential key role of Mn in bone physiology and osteoporosis 

pathogenesis. The resorbable features and excellent osteoconductive properties 

of ??TCP [28] justify the selection of this material.  

 

2. Materials and methods 

2.1 Powders preparation 

??TCP powders doped with different Mn contents (0?10 mol%) were obtained via 

aqueous precipitation. The significance of the aqueous precipitation method relies 

on the homogeneity of the final product. The experimental procedure described by 

Kannan et al. [29, 30] was followed with minor modifications. Briefly, calcium 

nitrate tetrahydrate [Ca(NO3).4H2O, Vaz Pereira-Portugal, Sintra, Portugal], 

diammonium hydrogen phosphate [(NH4)2HPO4, Vaz Pereira-Portugal, Sintra, 

Portugal] and manganese(II) nitrate hydrate [Mn(NO3)2.xH2O, Sigma-Aldrich, 

Darmstadt, Germany], were used as starting chemical precursors, respectively for 

calcium, phosphorus and manganese. The planned concentrations of the 

precursors are depicted in Table 1 and were selected in order to have a total 

(Ca+Mn)/P molar ratio equal to 1.48 for all the compositions to ensure no 

formation of hydroxyapatite [31]. 

 

 



Capítulo 4 

 154 

Table 1. Concentrations of the precursors Ca, P and Mn used in the synthesis. 

 

The synthesis temperature was decreased from 90ºC [29] to 30ºC [32], to reduce 

the amount of toxic ammonia gas released during the removal of the precipitated 

suspension from the reactor. The other experimental synthesis conditions (pH, 

maturation time, stirring conditions) were adjusted accordingly. Synthesis was 

targeted at pH 7, but the experimental values ranged between 6.3?7 by adding the 

required amounts of ammonium hydroxide (NH4OH) solution. Keeping the pH 

value ? 7 is of paramount importance because Mn2 + ions are stable in acidic 

solutions but precipitate as Mn(OH)2 under alkaline conditions (white colour), 

which is then readily oxidized to form MnO(OH)2 (brown colour) [33]. The 

precipitated suspensions were kept for 3 h under constant stirring conditions 

(700 rpm) and ripened for a further 15 h under resting conditions. The resulting 

precipitates were vacuum filtered and then dried at 100ºC during 48 h. The dried 

cakes were ground to fine powders and sieved through a mesh size of 200 µm. 

The resulting powders underwent heat treatment at 800ºC in air in a Thermolab 

furnace (Pt30%Rh / Pt6%Rh-thermocouple) with a heating rate of 5ºC min?1 and a 

dwelling time for 2 h to obtain undoped and Mn?doped ??TCP powders. The 

heat-treated powders were well ground and sieved through a mesh size of 40 µm 

before characterization studies. 

 

Planned compositions 

Molar concentrations 
of the precursors 

Sample 
Code 

 

Ca P Mn 

Ca/P 
 molar ratio 

(Ca+Mn)/P 
molar ratio 

Conc. of 
Mn  

(mol%) 

Mn0TCP  0.888 0.600 0.000 1.480 1.480 0.0 

Mn0.5TCP  0.884 0.600 0.004 1.473 1.480 0.5 

Mn1TCP  0.879 0.600 0.009 1.465 1.480 1.0 

Mn5TCP  0.844 0.600 0.044 1.407 1.480 5.0 

Mn7TCP  0.826 0.600 0.062 1.377 1.480 7.0 

Mn10TCP  0.799 0.600 0.089 1.332 1.480 10.0 



Capítulo 4 

 155 

2.2 Powders characterization  

The qualitative analyses of crystalline phases present on heat-treated powders 

were performed by X-ray powder diffraction (XRD) using a high-resolution Bruker 

D8 Advance DaVinci diffractometer with Cu K? radiation (? = 1.5406 Å) produced 

at 40 kV and 40 mA. Data sets were recorded in the 2? range of 20 ? 80º with a 

step size of 0.015º 2? s-1. Collection of XRD pattern data for Rietveld refinement 

studies was performed using a conventional Bragg-Brentano diffractometer 

(Bruker D8 Advance DaVinci, Karlsruhe, Germany) with Ni-filtered Cu-K? radiation 

by recording X-ray diffraction data within the 2? range = 20 ? 80o (step size 0.015o 

and 0.5 seconds for each step). The software TOPAS version 4.2 (Bruker AXS, 

Karlsruhe, Germany) with the fundamental parameters approach was used for 

Rietveld refinements. Rietveld refinement was performed using the structural 

model of ICSD card numbers of #97500 for ??TCP and #73712 for calcium 

pyrophosphate (Ca2P2O7, CPP). Refined parameters were, scale factor, specimen 

displacement, background as Chebyshev polynomial of fifth grade and 1/x 

function, and lattice parameters.  

Elemental analyses for Mn and Ca were determined for all powders using 

inductively coupled plasma (ICP) spectrometry (ICP-OES Jobin Yvon Activa M., 

USA). For this purpose, required amounts of powders were dissolved in nitric acid 

(HNO3) prior to ICP analysis. Phosphorus contents were determined by 

colorimetry (Single Beam Scanning UV/Visible Spectrophotometer model 

Camspec ?501, United Kingdom, ? = 880 nm) using the ascorbic acid method 

(4500-P E.). 

Infrared spectra of powders were obtained by Fourier Transform Infrared 

Spectrometry (FT-IR model Mattson Galaxy S-7000, USA). For this purpose each 

powder was mixed with KBr in the proportion of 1/150 (by weight) for 15 min and 

pressed into a pellet. Each infrared spectrum was the average of 32 scans 

collected at 2 cm?1 resolution at room temperature. Specific surface areas (SSA) 

of powders were obtained according to the BET method using a Micromeritics 

Gemini 2370 V5.00 (Norcross, USA) through the gas adsorption measurements, 



Capítulo 4 

 156 

after degassing the powders in a Micromeritics Flow Prep 060 (Norcross, USA). 

Particle size distributions of the powders were determined using a light scattering 

instrument (Coulter LS 230, UK, Fraunhofer optical model). The influence of Mn on 

the morphology and microstructure of the powders was observed by Scanning 

Electron Microscopy (SEM, Hitachi SU-70, Tokyo, Japan).  

 

2.3 MC3T3-E1 cell culture  

The osteoblastic cell line MC3T3-E1 (ATCC CRL-2593) was maintained at 37ºC in 

a humidified atmosphere of 5% CO2 in air, in 2 mM Glutamine-containing 

Minimum Essential ?-Medium in EBSS (Eagle’s Balanced Salt Solution) 

supplemented with 10% (v/v) foetal bovine serum (FBS), 1% (v/v) of a 100 U mL?1 

penicillin and 100 mg mL?1 streptomycin solution (Gibco BRL, Invitrogen), and 3.7 

g L?1 NaHCO3. Sub-confluent cultures (at 80?90% confluency) were split 1:5 using 

a 0.25% trypsin/EDTA solution (Gibco BRL, Invitrogen) at 5% CO2, 37ºC.  

 

2.4 Cytotoxicity and cell proliferation assays in Mn-doped ????-TCP powders 

The resazurin metabolic assay [34, 35] was used to determine the powders 

cytotoxicity/biocompatibility to MC3T3-E1 cells. The linear range between 

resazurin reduction to resorufin and MC3T3-E1 viable cells density was previously 

determined by us [34]. Cells were seeded at 1x104 cells cm?2 in 24 well plates and 

cultured in cell media supplemented with 1 mg mL?1 for each powder composition 

(saturated solutions) kept at 37 °C in a humidified 5% CO2 and 95% air 

atmosphere for various days in vitro (div). At the indicated div, cells were 

incubated for 4 h with fresh medium containing 10% of a resazurin solution [0.1 

mg mL?1 resazurin (Sigma Aldrich) in phosphate buffer saline (PBS; Pierce, 

Perbio)]. Resazurin reduction was thereafter spectrophotometrically measured 

(Infinite M200 PRO, Tecan) at 570 and 600 nm. For each time period, a final 

resazurin value (O.D.f) was calculated as the O.D. 570/O.D. 600 nm ratio minus 



Capítulo 4 

 157 

the O.D. 570/O.D. 600 nm ratio of a negative control (resazurin media incubated 

for 4 h in the absence of cells), and the O.D.f plotted against time of incubation in 

div. All experiments were carried out in triplicate and data expressed as 

mean ± standard error of three independent experiments. Prior to cell experiments 

all powders were sterilized by ?-radiation.  

 

2.5 Antibodies and Fluorescing Chemicals 

The primary antibody anti-Type-I Collagen antibody was used (Novus Biologicals, 

Germany) that recognizes Type-I procollagen (monomeric ?1(I) and ?2(I) chains, ? 

chains corresponding to ?/? dimmers, and trimeric ? chains), and various collagen 

forms (tropocollagen, mature trimeric ? chains, microfibrils, and fibrils). Secondary 

antibodies used were fluorescein isothiocyanate (FITC)-conjugated anti-rabbit 

IgGs (Calbiochem) for immunocytochemistry analyses, and horseradish 

peroxidase-linked anti-rabbit IgGs (GE Healthcare, Chalfont St. Giles, UK) for 

enhanced chemiluminescence (ECL) detection for western blot assays. Alexa 

Fluor 568 phalloidin (Molecular Probes, Life technologies) and DAPI [4',6-

diamidino-2-phenylindole, included in the Vectashield antifading reagent (Vector, 

Burlingame, CA, USA)] were two chemicals used to label F-actin and the nucleus, 

respectively. 

 

2.6 Immunoblot analyses of Type-I collagen protein expression and media 

secretion 

At the indicated div, cells conditioned media were collected into 10% SDS-

containing microtubes, and cells were washed with PBS and harvested with a 1% 

SDS boiling solution. Samples were boiled for 10 min and rapidly sonicated in ice. 

100 µL of each cell lysate and media were subjected to reducing 6.5% SDS-PAGE 

in Tris-Glycine buffer and electrophoretically transferred onto nitrocellulose 

membranes. Precision Plus Dual Colour (10?250 kDa, Bio-Rad, Portugal) was 

used as protein standards mix. Immunoblotting of the transferred proteins was 



Capítulo 4 

 158 

performed as previously described [36], where anti-Collagen primary antibody was 

incubated overnight. Detection was achieved using a horseradish peroxidase-

linked secondary antibody and an ECL kit (GE Healthcare, Chalfont St. Giles, UK). 

Ponceau S detection of all proteins was performed as a loading control; briefly, 

prior to immunoblotting procedures, the nitrocellulose membranes were subjected 

to 5 min of reversible Ponceau S staining, washed 2x with water, scanned for 

image acquisition and washed with TBS-T for Ponceau complete distaining.   

 

2.7 Confocal microscopy analyses of Type-I collagen protein distribution  

Control and MC3T3-E1 cells cultured in cell media supplemented with Mn0/ 0.5/ 1/ 

10TCP powders were grown on 35 mm plates-containing pre-treated coverslips. At 

30 div, cells were fixed with a 4% paraformaldehyde in PBS solution for 30 min, 

and permeabilized with a 0.2% Triton PBS solution. Non-specific sites were 

blocked by 1 h incubation with a 3% bovine serum albumin (BSA)-PBS solution, 

and coverslips submitted to immunocytochemistry procedures using the anti-

Collagen antibody diluted in 3% BSA-PBS. Upon three washes with PBS, cells 

were incubated with a solution of PBS 3% BSA containing red fluorescing 

Phalloidin (1:50) and FITC-conjugated secondary antibody (1:300). Coverslips 

were mounted on microscope slides with DAPI-containing Vectashield antifading 

reagent (Vector, Burlingame, CA, USA). Images were acquired in a LSM 510 

META confocal microscope (Zeiss, Göttingen, Germany) with a 40x objective and 

using an Argon laser line of 488 nm (FITC channel), a Diode 405-430 laser (DAPI 

channel) and 561 nm DPSS laser (Alexa 568 channel). 

 

2.8 Statistical analysis 

Statistical significance analysis was conducted using the GraphPad InStat 

software, by one way analysis of variance ANOVA, followed by the Dunnett’s test, 

with the level of statistical significance set at p&lt;0.05. In vitro data are expressed as 

means ± standard error of the mean of three independent experiments.  



Capítulo 4 

 159 

3. Results  

3.1 Influence of Mn-doping on the structure of ? ? ? ?-TCP  

The heat-treated powders presented a colour gradient ranging from white for 

undoped (Mn0TCP) to gradually more intense pink with increasing Mn 

concentrations. This is in agreement with the most stable oxidation state (II) for 

manganese, which has a light pink colour [33]. 

Table 2 presents Ca/P and (Ca+Mn)/P molar ratios and Mn contents obtained from 

elementary analysis for synthesized and heat-treated Mn?doped TCP powders.  

 

Table 2. Physical and chemical characteristics of pure and Mn?doped TCP powders heat-treated at 

800 ºC. (Ca+Mn)/P, Ca/P molar ratios and Mn contents were obtained from ICP (Ca and Mn) and 

from ascorbic acid method (P). 

Particle size distribution  Elemental analysis 

Dx
a (µm)  

Sample 
Code 

SSA 
(±0.5) 
(m2g-1) Mean 

(µm) D10 D50 D90 

Ca/P 
molar 
ratio 

(Ca+Mn)/P 
molar 
ratio 

Conc. of 
Mn 

(±0.03) 
(mol%)  

Mn0TCP 3.6  2.990 0.436 1.551 7.855 1.490 1.490 0.00 

Mn0.5TCP 2.2 1.459 0.408 0.814 3.715 1.485 1.490 0.35 

Mn1TCP 3.6  1.454 0.384 0.781 3.723 1.482 1.494 0.76 

Mn5TCP 4.3  3.032  0.411 1.791 7.866 1.433 1.486 3.54 

Mn7TCP 3.2  2.875 0.414 1.668 7.418 1.397 1.485 5.95 

Mn10TCP 3.8  2.983  0.418 1.823 7.634 1.348 1.482 9.02 

a Dx is the particle diameter at or below which there is the amount x (vol.%) of particles in the 

cumulative (from 0 to 100%) particle size distribution curve. 

 

A good agreement in terms of molar ratios can be observed between the planned 

compositions (Table 1) and the experimentally obtained values. Nonetheless, the 

measured concentrations of Mn varied within the range of 70 and 90% of the 

planned contents.  



Capítulo 4 

 160 

The particle size distribution parameters measured by laser scattering, including 

D10, D50, D90, and the mean, and BET specific surface areas of all the powders are 

also detailed in Table 2. The data show a clear decreasing trend of particle sizes 

with increasing Mn contents up to Mn1TCP, followed by a reverse trend for higher 

added amounts of Mn. In contrast, no clear variation trend is apparent in terms of 

SSA.  

The XRD patterns of the Mn0-10TCP powders heat-treated at 800ºC are displayed 

in Fig. 1a.  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fig. 1. (a) X-ray diffraction patterns for the different Mn-doped ??tricalciumphosphate powders 

(Mn0-10TCP) obtained after heat treatment at 800ºC; (b) Zoomed area of Fig. 1a within the 2? 

range from 28-30 to highlight the presence of  ?-CPP; showing a gradual shift of XRD peaks to 

higher 2? angles with increasing incorporation of Mn; (c) Zoomed area of Fig. 1a within the 2? 

range from 26-32 to show the effect of Mn incorporation on shifting the XRD peaks to higher 2? 

angles for  ?-TCP (also noticed in Fig. 1b). The standard ICDD PDF 04-014-2292 of pure ?-TCP 

and 04-009-3876 of ?-CPP are also presented for comparison. 

 

2 ? (degree) 

(c) 

2 ? (degree) 
26 27 28 29 30 31 32 

Mn0TCP Mn7TCP 

In
te

n
si

ty
 (

a.
u

.)
 

Mn0.5TCP 

Mn10TCP 

(a) 

  

In
te

n
si

ty
 (

a.
u

.)
 

2 ? (degree) 

????-TCP 

????-CPP 

Mn0TCP 

Mn5TCP 

 

Mn1TCP 

Mn7TCP 

20 30 40 50 60 70 80 

????-CPP 

(b) 

????-TCP 

Mn0TCP 

Mn0.5TCP 

Mn5TCP 

Mn10TCP 

Mn1TCP 

Mn7TCP 

In
te

n
si

ty
 (

a.
u

.)
 

28.0 28.5 29.0 29.5 30.0 

????-CPP 
????-TCP 



Capítulo 4 

 161 

It can be seen that all powders apparently consist of pure ?-TCP phase. However, 

with increasing concentrations of Mn in the system (Mn5TCP, Mn7TCP and 

Mn10TCP), the formation of trace amounts of CPP became gradually more 

evident as can be seen in the zoomed areas of the pattern shown in Fig. 1b. For 

low Mn contents, the peaks of ?-CPP and ?-TCP appear more or less overlapped, 

making the discrimination of both phases difficult. The discrimination obtained for 

higher Mn contents is a consequence of the shift of the ?-TCP peak at 2? = 29.63º 

to higher at 2? angles (Fig. 1b and c) [32, 38].  

FT-IR patterns of all the Mn0-10TCP powders, presented in Fig. 2, show the 

characteristic vibrational modes of PO4 tetrahedra, confirming the formation of 

?-TCP as the predominant crystalline phase. 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fig. 2. FT-IR spectra of undoped powder of ?-TCP (Mn0TCP) and Mn2+ -substituted ?-TCP 

powders (Mn0.5-10 TCP) heat-treated at 800ºC. 

  

  

  

T
ra

n
sm

it
ta

n
ce

 (
a.

u
.)

 

Mn1TC
P 

Mn10T
CP 

Mn7TC
P 

500 1000 1500 
P2O7

4- 
 

Wave number (cm-1) 

Mn0TC
P 

Mn0.5T
CP 

 

 

P2O7
4- 

Mn5TC
P 



Capítulo 4 

 162 

With the increasing Mn concentrations other absorption bands at 726 cm?1 and 

1208 cm?1 became gradually more evident, which can be ascribed to 

pyrophosphate groups (P2O7
4–), particularly to P–O–P bonds. This is not 

surprising, considering that CPP is likely formed for Ca/P values lower 

than 1.500 [37, 38]. By the XRD technique, the presence of ?-CPP became more 

easily detected by the gradual shifting (zoomed areas of Fig. 1b-c) of the ??TCP 

peaks at 2? ? 29.57º to higher angles as the Mn content increases (Fig. 1b-c) 

meaning that the lattice parameters of ??TCP tend to decrease with increasing 

amounts of added Mn. The XRD data for Mn0TCP was refined assuming the 

space group R3c and the unit cell and structural parameters reported by 

Yashima et al. [39]. The quantitative phase analysis obtained by Rietveld 

refinement (wt.%) for the studied powders summarized in Table 3 corroborate the 

formation of traces of ?-CPP in all the ?-TCP powders.  

Table 3. Quantitative phase analysis obtained by Rietveld refinement of the studied powders. 

wt% of composition 
determined 

by Rietveld quantification 
Sample 
Code 

?-TCP ?-CPP 

Mn0TCP 97.6 2.4 

Mn0.5TCP 97.6 2.5 

Mn1TCP 98.3 1.7 

Mn5TCP 96.7 3.3 

Mn7TCP 96.4 3.6 

Mn10TCP 95.0 5.0 

 

The ?-TCP unit cell parameters were a = b =10.441(0) Å, c = 37.390(2), 

? = ?= 90 º, and ? = 120 º in the hexagonal setting (space group R3c), in good 

agreement with other literature reports [5, 29]. The refined values for Mn0TCP 

were then taken as the starting values to refine the data of Mn-doped ?-TCP 

powders. An example for Mn1TCP sample shown in Fig. 3 confirms that this 

powder almost consists of single ?-TCP phase. Similar observations were made 

for the other samples and the results of quantitative phase analysis presented in 



Capítulo 4 

 163 

Table 3 confirm ?-TCP as the main crystalline phase together with 1.7?5% of ?-

CPP. 

 

 

 

 

 

 

 

 

Fig. 3. Rietveld analysis patterns of powder diffraction data for Mn1TCP powder. The blue line is 

calculated intensities and the red one is observed intensities. The difference between the observed 

and calculated intensities is plotted below the profile. 

 

The refined lattice parameters for all the compositions are represented graphically 

in Fig. 4. The plots show clear decreasing trends in both lattice parameters along 

a-axis and c-axis with increasing incorporated amounts of Mn.  

 

 

 

 

 

 

 

 

 

 

Fig. 4. Influence of Mn content on lattice a- and c-axis parameters and on unit cell volume of ?-

tricalciumphosphate (?-TCP) struture. Lattice parameters measured for Mn0TCP: a = 10.4492 Å; 

c = 37.3709 Å and for Mn10TCP (with 9.02 mol% of Mn): a = 10.3925 Å; c = 37.2892 Å. 



Capítulo 4 

 164 

Fig. 5 shows the morphological features of Mn0TCP, Mn1TCP, Mn5TCP and 

Mn10TCP (Fig. 5a, b, c and d, respectively) as observed by SEM.  

 

 

 

 

 

 

 

 

 

 

 

Fig. 5. Scanning electron micrographs of Mn0TCP (a), Mn1TCP (b), Mn5TCP (c) and Mn10TCP 

(d) powders with 0 mol%, 0.76 mol%, 3.54 mol% and 9.02 mol% of Mn content respectively. 

 

The micrographs clearly show that the added amounts of Mn exert a strong 

influence on the overall morphological aspects. The primary particles appear less 

agglomerated for Mn1TCP. The presence of porous agglomerates confirmed by 

SEM analysis (Fig. 5) are likely to account for the opposite trends observed in 

particle size distribution for lower and higher Mn contents, and the apparently 

ambiguous SSA results (Table 1). 

 

3.2. Biological properties 

3.2.1 Mn0.5-1TCP powders increase MC3T3 cellular proliferation 

Cell viability and proliferation of 1 x 104 cells cm?2 MC3T3-E1 osteoblastic-like 

cells cultured on doped MnTCP powders for various days in culture (2, 7, 14, 21 



Capítulo 4 

 165 

and 30), were evaluated by the non-destructive and non-toxic resazurin metabolic 

assay (Fig. 6).  

 

 

 

 

 

 

 

 

 

 

Fig. 6. Cell viability assays of MC3T3-E1 osteoblastic-like cells exposed to ?-TCP powders 

substituted with increasing amounts of Mn (Mn0-10TCP). The resazurin metabolic assay was used 

to determine the powders cytotoxic and proliferative effects in MC3T3-E1 cells. 1x104 cells were 

seeded in 24 well plates containing medium supplemented with 1 mg mL-1 of the respective 

powder. Upon 30 days of incubation (days in vitro), cellular viability was indirectly measured by 

their efficiency in reducing resazurin, expressed as O.D.f mean ± SE, of three independent 

experiments. 

 

This is a proved method to measure MC3T3-E1 cell proliferation and viability, with 

a linear response between 1 and 4 x 104 cells cm?2 [12, 34]. During the normal 

proliferation period (first 14 div), no cytotoxic effects were observed for any of the 

powders used and the cells final O.D. (O.D.f) was not significantly decreased. Mn-

doping generally maintained or increased proliferation over Mn0TCP values, 

having the following positive effects: (i) for Mn0.5?1TCP, cells proliferation 

increased over Mn0TCP values immediately at early time points (p&lt;0.05 

and&amp;lt;0.01 vs Mn0TCP values, respectively, at 7 div); (ii) cellular proliferation also 

increased for Mn5-10TCP powders, but only at 14 div, a period when all Mn-doped 

powders are significantly higher than control and Mn0TCP (with significance 



Capítulo 4 

 166 

different of p&lt;0.01 and&amp;lt;0.05). Along the subsequent two weeks in 

culture (14-30 div), Mn5-10TCP powders greatly decreased the number of viable 

cells (O.D.f significantly lower than control or Mn0TCP, p&lt;0.01), while 

Mn0.5?1TCP powders behave similarly as control cells, with steady comparable 

decreases (Fig. 6, 21 and 30 div).  

In summary, Mn0.5-1TCP powders did not decrease MC3T3 viability during 30 

days in culture, and were even able to significantly induce pre-osteoblastic 

proliferation at the proliferative period (1-14 div), or even longer (21 div) in the 

case of Mn1TCP (p&lt;0.05 vs Mn0TCP values). For Mn5-10TCP powders, 

significant increased proliferation was only observed at 14 div, and cell viability 

was greatly decreased in the subsequent differentiation period (14-30 div). Further 

analyses concerned the effects of the powders on pre-osteoblastic cells 

differentiation, namely their effects on procollagen protein synthesis, secretion and 

deposition into collagen fibrils.  

 

3.2.2 MnTCP powders greatly decrease intracellular procollagen (I) levels 

and increase its maturation and secretion  

Cells exposed to the powders for 30 days (and their corresponding conditioned 

media) were collected into 1% SDS solutions, and subjected to SDS-PAGE. In 

terms of immunoblot bands profile, monomeric Type-I procollagen consists of ?1 

(~140 kDa); and ?2 (~130 kDa) chains, which are intracellularly 

processed/matured by post-translational modifications (as proline and lysine 

hydroxylation, lysine glycosylation). Alpha chains can intracellularly associate into 

dimers (?, ~270 kDa) and trimers (?, ~400 kDa), forms that are not breakable in 

SDS-PAGE denaturing conditions [12, 40]. All these cell-associated Type-I 

procollagen forms were present in control and in Mn0-1TCP cell lysates, but barely 

visible in the Mn5-10TCP lysates (Fig. 7a). This may relate to their lower cell 

proliferation at 30 div (Fig. 6) but only partially, since this decrease in intracellular 

procollagen is even more pronounced. All MnTCP powders decreased intracellular 

procollagen (I) levels, with Mn1TCP powder presenting a less pronounced 



Capítulo 4 

 167 

decrease. Analyses of medium secreted procollagen (Fig. 7b) revealed that 

Mn0-1TCP powders increased the total amounts of soluble ?1 and ?2 procollagen 

(immature, arrowheads; mature, arrows). Further, all MnTCP powders increased 

procollagen maturation and/or the secretion of these processed procollagen 

forms (arrows), thus potentially inducing extracellular collagen fibrillar deposition 

[9, 12]. 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fig. 7. Immunoblot analysis of cell-associated (a) and medium secreted (b) Type-I collagen upon 

30 days in vitro. MC3T3 cells lysates (a) and conditioned media (b) were resolved under reducing 

conditions, and Type-I collagen was immunodetected. C, control cells; Mn TCP 0-10, cells grown in 

media with TCP substituted with various concentrations of Mn. ?1(I) and ?2(I), procollagen 

monomeric chains; arrowheads, immature; arrows, matured. ?(I), procollagen dimeric forms. ?(I), 

procollagen trimeric forms. Migration of molecular weight markers is indicated to the right. Below 

each immunoblot is a representative sample of the membrane Ponceau S staining, shown as a 

loading control. 

 

b) Secreted Type I Collagen

MnTCP

- 200

- 150

C        0         0.5        1           5         7      10

a) Intracellular Type I Collagen 

MnTCP

?2(I)

?(I)

?2(I)

?1(I)

?1(I)

?(I)

ponceau S

ponceau S

C         0         0.5        1        5         7       10
- 200 

- 150

b) Secreted Type I Collagen

MnTCP

- 200

- 150

C        0         0.5        1           5         7      10

a) Intracellular Type I Collagen 

MnTCP

?2(I)

?(I)

?2(I)

?1(I)

?1(I)

?(I)

ponceau S

ponceau S

C         0         0.5        1        5         7       10
- 200 

- 150



Capítulo 4 

 168 

In essence, while the Mn5-10TCP powders greatly decrease procollagen (I) 

formation and process and secrete the few cellular procollagen they contain, the 

Mn0-1TCP powders highly induce procollagen (I) maturation and further secretion, 

resulting in higher extracellular collagen and most probably in their lower 

intracellular contents. 

 

3.2.3 Mn1TCP induces osteoblastic differentiation  

Intracellular procollagen is secreted into the media, after which it is enzymatically 

processed into tropocollagen, promoting their aggregation into cell layer-

associated collagen fibrils [12, 41]. To investigate if the observed higher amounts 

of secreted procollagen resulted in increased number of collagen fibrils, MnTCP 

exposed cells were fixed at 30 days in vitro and subject to immunocytochemistry 

analysis of Type-I collagen cellular distribution (Fig. 8). Conditions chosen were: 

control non-exposed cells, Mn0-1TCP (that induced higher procollagen secretion) 

and Mn10TCP, for comparison purposes. While for control cells procollagen 

mainly accumulated inside intracellular secretory granule-like densities (Fig. 8, 

arrowheads), as expected [12], MnTCP-exposed cells presented less intracellular 

procollagen and higher levels of extracellular forms. Further, in accordance with 

the immunoblot results, cells incubated with Mn10TCP for 30 days had generally 

less procollagen type I. Extracellular secreted collagen levels were in the following 

order: Mn10TCP &amp;lt;Mn0TCP &amp;lt;Mn0.5TCP &amp;lt;Mn1TCP. F-actin, stained with red 

fluorescing phalloidin, denoted that, in general, all Mn0-10TCP powders induce 

higher osteoblastic elongation and even alignment (Mn0.5TCP and Mn1TCP), with 

these being particular evident for the Mn1TCP powder.  

 

 

 

 

 

 



Capítulo 4 

 169 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fig.8. Confocal microscopy analysis of Type-I collagen cellular distribution after cells in 

vitro incubation for 30 days in the absence (Ctrl) or presence of 1 mg mL-1 of the MnTCP 

powders. Cells were subjected to immunocytochemistry procedures in order to detect 

Type-I collagen distribution (green fluorescence), F-actin (red labelled phalloidin), and the 

nuclei (DAPI blue fluorescence). Arrowheads, intracellular granule-like densities. Arrows, 

extracellular cell-associated collagen (I) fibrils. Bar, 20 µm. 



Capítulo 4 

 170 

4. Discussion 

4.1 Influence of Mn-doping on the structure of ? ? ? ?-TCP  

The gradual accentuation of the pink colour presented by the heat-treated 

powders, characteristic of the oxidation state (II) of manganese [33] indicates its 

gradual incorporation into the ?-TCP lattice. This hypothesis is supported by the 

shifting of ?-TCP reflection plane (0 0 8) at 2? = 29.57º to higher angles with 

increasing Mn contents (Fig. 1b-c), and by the refinement of XRD data (Fig. 3) 

[32, 38]. The gradual incorporation of Mn into the ?-TCP lattice is also supported 

by the changes in the unit cell parameters reported in Fig. 4. The measured cell 

parameters for Mn0TCP are in good agreement with those reported by Yashima et 

al. [39] and other authors [5, 29]. The clear decreasing trends for both a-axis and 

c-axis refined lattice parameters with increasing Mn contents (Fig. 4) are 

consistent with the lower ionic radii of Mn2+ (0.83 Å for sixfold coordination with O) 

in comparison to Ca2+ (1.00 Å for sixfold coordination with O) [46], and with the 

observed contraction in the unit cell volume (Fig. 4) when compared with the 

Mn0TCP, as expected from other literature reports [23].  

The elementary analysis data reported in Table 2 offer further support to this 

interpretation. The Ca/P molar decreases as expected with increasing added 

amounts of Mn, but the (Ca+Mn)/P ratio is kept almost constant, meaning that 

most of the added Mn has been incorporated in Ca sites of the crystalline lattice. 

This is confirmed by the measured Mn concentrations in the synthesized powders. 

The amount of Mn concentration calculated from experimental data was found to 

be 70 to 90 % of Mn concentration calculated from planned compositions (as 

shown in Table 1 &amp;amp; 2). This variation in Mn concentrations reveals higher 

proneness of Mn to stay in solution. This is according to the solubility products of 

the Ca and Mn precursor, clearly indicating manganese nitrate as the most soluble 

of them [42]. The experimental fluctuations of pH values (between 6.3 and 7) may 

also account for the small deviations between the planned (Ca+Mn)/P = 1.48 and 

the measured values equal, or near to 1.49 (Table 2) [32]. The planned Ca/P and 

(Ca+Mn)/P molar rations slightly below the stoichiometric value justify the 



Capítulo 4 

 171 

formation of calcium pyrophosphate as secondary phase [43] identified in Fig. 

1b-c. The small fluctuations in the synthesis conditions are likely bound to the 

variations observed in the quantitative phase analysis (Table 3). The expected 

predominance of ?-TCP phase is in close agreement with findings reported 

elsewhere [30, 44] for powders prepared via aqueous precipitation. On the other 

hand, small amount of calcium pyrophosphate CPP up to 5% would be expected 

for Ca/P values equal to that planned [37, 38].  

The increased degeneracy of the FT-IR absorption bands caused by partial 

replacement of Ca by Mn in the ?-TCP lattice (Fig. 2) is similar to that reported for 

zinc-doped ?-TCP [5, 45]. This similarity can be understood considering that both 

Mn and Zn ions are smaller that the Ca ion. On the other hand, the intensity of the 

FT-IR absorption bands at 726 cm?1 and 1208 cm?1 due to pyrophosphate (P2O7
4-) 

groups, particularly to the P–O–P bonding, showing a close agreement with the 

quantitative phase analysis data reported in Table 3. The more and less intense 

bands are observed for Mn10TCP and Mn1TCP powders, respectively, which 

contain the higher and the smaller amounts of ?-CPP formed for 

Ca/P ratios &amp;lt;1.500 [37, 38]. 

Therefore, the results gathered by the different characterization techniques 

converge toward confirming the formation of small amounts of ?-CPP together with 

the main ?-TCP phase.  

The SEM micrographs of heat treated powders shown in Fig. 5 reveal a 

decreasing trend of the size of primary particles with increasing levels of Mn-

doping, probably due to the size mismatch (0.17 Å) between Ca and Mn ions. This 

decrease is likely to enhance the tendency of primary particles to form 

agglomerates during the synthesis and heat treatment processes. Moreover, 

during the precipitation (3 h) and maturation periods (15 h), 

dissolution/precipitations reactions will occur, driven by kinetics (stirring, or rest 

conditions) and thermodynamic reasons according to the well-known Ostwald 

ripening effect [47]. This mechanism predicts that smaller particles with a higher 

surface curvature will preferentially dissolve, contributing to supersaturation of the 



Capítulo 4 

 172 

liquid media. The excess concentration of ionic species in solution will then be 

resolved by deposition of these species at the surface of the larger particles, as 

well as within the necks between them. All these phenomena will contribute to the 

fusion of the primary particles, a process that will be exacerbated with increasing 

Mn contents. The SEM observations (Fig. 5) roughly corroborate this 

interpretation, with the finest and less agglomerated powder being observed for 

the Mn1TCP sample. This conclusion is well supported by the particle size 

distributions data (Table 2). However, straightforward relationships the 

morphological changes of the powders (Fig. 5) and BET results (Table 2) with 

varying Mn contents are difficult to establish due to the complex phenomena 

occurring along maturation stage. 

 

4.2 Biological properties 

Doping ?-TCP powders with Mn had a dual effect on MC3T3 in vitro viability and 

proliferation (Fig. 6). Mn0.5TCP and Mn1TCP powders slightly but significantly 

induced pre-osteoblastic proliferation at the second proliferative week (7-14 div), 

while Mn5-10TCP powders only increased proliferation at 14 div and greatly 

decreased cell viability at the differentiation period (14-30 div). A decrease in pre-

osteoblastic proliferation with increasing Mn concentration has already been 

reported [7]. 

A response duality was also observed in procollagen intracellular content and 

medium secretion (Fig. 7), with Mn5-10TCP compositions ultimately leading to 

less procollagen (I) and Mn0-1TCP powders inducing higher matured 

procollagen (I) secretion. Interestingly, this duality in behaviour of pre-osteoblasts 

viability/proliferation and procollagen(I) production and secretion, appears to 

accompany the trends observed for particle and agglomerates size denoted in 

Table 2 and in SEM micrographs (Fig. 5), with the Mn1TCP powder representing 

the turning point. The subsequent observation that Mn1TCP induces the highest 

induction of osteoblastic differentiation highlights its key properties. All MnTCP 

powders enhanced extracellular collagen (I), concordant with previous reports of 

enhanced osteoblast differentiation for Mn-doped carbonated CaP [20] and in CaP 



Capítulo 4 

 173 

coatings on Ti substrates [7], but osteoblasts grown on Mn1TCP powders were 

longer and more aligned, presenting longer intracellular F-actin fibres and 

increased extracellular collagen (I) fibrilar structures (Fig. 8).  

In agreement with that previously postulated [7, 20, 22] our data indicates that the 

biological benefits of Mn-doped ?-TCP are indeed limited to certain Mn 

incorporation levels, and potentially related to their surface microstructure and 

morphology. One or both may be occurring: MC3T3 pre-osteoblasts prefer the 

Mn1TCP finest and less agglomerated powder topology to grow on, and/or the 

amounts of the Mn trace element being released into the solution by this powder 

are closer to the optima for its biological activities. Indeed, in either case, Mn1TCP 

appears to be able to positively influence the cells´ ECM remodelling, an important 

event in organic matrix formation and osteoblasts differentiation. This is denoted 

by the high alignment and apparent tight coordination between the intracellular 

cytoskeleton of filamentous actin and the ECM collagen (I) fibrils. ECM is not only 

a component of bone but also a key element in osteoblasts differentiation and 

osteoregeneration [48, 49] as it bridges the extracellular milieu to the cell, via cell 

surface integrins and their binding to the intracellular F-actin. We believe that the 

Mn released by, or at the surface of Mn1TCP powders, is at a key concentration or 

position to function as cofactor of glycosyltransferases enzymes [13], so as to 

increase integrins activation (via enhancing its ligand-binding [15]), ultimately 

favoring ECM remodeling and osteoblasts differentiation.  

 

5. Conclusions 

Given the various studies suggesting that Mn positively affects bone growth and 

repair and that its deficiencies may be at the genesis of osteoporosis, the aim of 

the present study was develop and characterize Mn-doped ?-TCP compositions, 

including their biological effects. The results presented and discussed along this 

work enable the following conclusions to be drawn:  



Capítulo 4 

 174 

1. Well crystalline ?-TCP phase with trace amounts of ?-CPP could be 

obtained for all investigated compositions as detected from XRD and FT-IR 

analysis. 

2. Elemental analyses showed a reasonable coincidence between the planned 

Mn concentrations and the measured incorporation levels for all the 

powders. 

3. Rietveld refinement of the XRD data confirmed a decreasing trend of the 

lattice parameters a and c with the increasing concentrations of Mn into the 

?-TCP structure, providing a solid evidence about the successful 

incorporation of Mn in the ?-TCP lattice.  

4. The varying concentrations of Mn caused significant morphological changes 

in the Mn-doped ?-TCP powders, with Mn1TCP presenting smaller primary 

particles aggregated in finest agglomerates.  

5. The Mn1TCP powder presented the best set of positive effects on 

MC3T3-E1 in vitro pre-osteoblastic proliferation and differentiation. The 

incorporation of small amount (0.76 mol%) of Mn into ?-TCP proved to be 

effective in accelerating of bone mineralization, making the sample 

Mn1TCP a good candidate for future studies in bone repair applications. 

 

Acknowledgements 

Thanks are due to the Portuguese Foundation for Science and Technology for the 

fellowship grants of P.M.C. Torres (SFRH/BD/62021/2009) and S. Pina 

(SFRH/BPD/64119/2009), and to the Centre for Cell Biology (PEst-

OE/SAU/UI0482/2011, REEQ/1023/BIO/2005). The XRD facility was funded by 

FEDER Funds through QREN–Aviso SAIECT-IEC/2/2010, Operação NORTE-07–

0162-FEDER-000050. 

 



Capítulo 4 

 175 

References 

[1] S.V. Dorozhkin, Bioceramics of calcium orthophosphates, Biomaterials 31 

(2010) 1465-1485. 

[2] M. Bohner, Resorbable biomaterials as bone graft substitutes, Mater. Today, 

13 (2010) 24-30. 

[3] J. Aaseth, G. Boivin, O. Andersen, Osteoporosis and trace elements – An 

overview, J. Trace Elem. Med. Biol. 26 (2012) 149-152. 

[4] J.C. Elliott, Structure and chemistry of the apatites and other calcium 

orthophosphates, Elsevier, London; 1994. 

[5] A. Bigi, E. Foresti, M. Gandolfi, M. Gazzano, N. Roveri, Isomorphous 

substitutions in beta-tricalcium phosphate: The different effects of zinc and 

strontium, J. Inorg. Biochem. 66 (1997) 259-265. 

[6] E. Boanini, M. Gazzano, A. Bigi, Ionic substitutions in calcium phosphates 

synthesized at low temperature, Acta Biomater. 6(2010)1882-1894. 

[7] B. Bracci, P. Torricelli, S. Panzavolta, E. Boanini, R. Giardino, A. Bigi, Effect of 

Mg2+, Sr2+, and Mn2+ on the chemico-physical and in vitro biological properties of 

calcium phosphate biomimetic coatings, J. Inorg. Biochem. 103 (2009) 1666-1674. 

[8] S. Kannan, F. Goetz-Neunhoeffer, J. Neubauer, S. Pina, P.M.C. Torres, J.M.F. 

Ferreira, Synthesis and structural characterization of strontium- and magnesium-

co-substituted ?-tricalcium phosphate, Acta Biomater. 6 (2010) 571-576. 

[9] S. Kannan, S.I. Vieira, S.M. Olhero, P.M.C. Torres, S. Pina, O.A.B. Da Cruz E 

Silva, J.M.F. Ferreira, Synthesis, mechanical and biological characterization of 

ionic doped carbonated hydroxyapatite/?-tricalcium phosphate mixtures, Acta 

Biomater. 7 (2011) 1835-1843. 



Capítulo 4 

 176 

[10] I. Mayer, F.J.G. Cuisinier, S. Gdalya, I. Popov, TEM study of the morphology 

of Mn2+-doped calcium hydroxyapatite and ?-tricalcium phosphate, J. Inorg. 

Biochem. 102 (2008) 311-317. 

[11] S. Pina, P.M. Torres, J.M. Ferreira, Injectability of brushite-forming Mg-

substituted and Sr-substituted alpha-TCP bone cements, J. Mater. Sci. Mater. 

Med. 21 (2010) 431-438. 

[12] S. Pina, S.I. Vieira, P. Rego, P.M.C. Torres, O.A.B. da Cruz e Silva, E.F. da 

Cruz e Silva, J.M.F. Ferreira, Biological responses of brushite-forming Zn- and 

ZnSr- substituted beta-tricalcium phosphate bone cements, Eur. Cell. Mater. 20 

(2010) 162-177. 

[13] P.D. Saltman, L.G. Strause, The role of trace minerals in osteoporosis, J. Am. 

Coll. Nutr. 12 (1993) 384-389. 

[14] K. Cashman, A. Flynn, Trace elements and bone metabolism, Bibl. Nutr Dieta 

(1998) 150-164. 

[15] A. Armulik, G. Svineng, K. Wennerberg, R. Fässler, S. Johansson, Expression 

of Integrin Subunit ?1B in Integrin ?1-Deficient GD25 Cells Does Not Interfere with 

?V?3 Functions, Exp. Cell. Res. 254 (2000) 55-63. 

[16] B.J. Friedman, J.H. Freeland-Graves, C.W. Bales, F. Behmardi, R.L. Shorey-

Kutschke, R.A. Willis, J.B. Crosby, P.C. Trickett, S.D. Houston, Manganese 

balance and clinical observations in young men fed a manganese-deficient diet, J. 

Nutr. 117 (1987) 133-143. 

[17] H. Rico, N. Gómez-Raso, M. Revilla, E.R. Hernández, C. Seco, E. Páez, E. 

Crespo, Effects on bone loss of manganese alone or with copper supplement in 

ovariectomized rats A morphometric and densitomeric study, Eur. J. Obstet. 

Gynecol. Reprod. Biol. 90 (2000) 97-101. 

[18] T. Landete-Castillejos, I. Molina-Quilez, J.A. Estevez, F. Ceacero, A.J. Garcia, 

L. Gallego, Alternative hypothesis for the origin of osteoporosis: The role of Mn, 

Front Biosci. E4 (2012) 1385-1390. 



Capítulo 4 

 177 

[19] T. Landete-Castillejos, J.D. Currey, J.A. Estevez, Y. Fierro, A. Calatayud, F. 

Ceacero, A.J. Garcia, L. Gallego, Do drastic weather effects on diet influence 

changes in chemical composition, mechanical properties and structure in deer 

antlers? Bone 47 (2010) 815-825. 

[20] A. Bigi, B. Bracci, F. Cuisinier, R. Elkaim, M. Fini, I. Mayer, I.N. Mihailescu, G. 

Socol, L. Sturba, P. Torricelli, Human osteoblast response to pulsed laser 

deposited calcium phosphate coatings, Biomaterials 26 (2005) 2381-2389. 

[21] M. Jia, Y. Hong, S. Duan, Y. Liu, B. Yuan, F. Jiang, The influence of transition 

metal ions on collagen mineralization,  Mater. Sci. Eng: C 33 (2013) 2399-2406. 

[22] M.B. Pabbruwe, O.C. Standard, C.C. Sorrell, C.R. Howlett, Bone formation 

within alumina tubes: effect of calcium, manganese, and chromium dopants, 

Biomaterials 25 (2004) 4901-4910. 

[23] I. Mayer, F.J.G. Cuisinier, I. Popov, Y. Schleich, S. Gdalya, O. Burghaus, D. 

Reinen, Phase Relations Between ?-Tricalcium Phosphate and Hydroxyapatite 

with Manganese(II): Structural and Spectroscopic Properties, Eur. J. Org. Chem. 

2006 (2006) 1460-1465. 

[24] I. Mayer, O. Jacobsohn, T. Niazov, J. Werckmann, M. Iliescu, M. Richard-

Plouet, O. Burghaus, D. Reinen, Manganese in Precipitated Hydroxyapatites, Eur. 

J. Org. Chem. 2003 (2003) 1445-1451. 

[25] E.-S.Y. Lee, M. Sidoryk, H. Jiang, Z. Yin, M. Aschner, Estrogen and tamoxifen 

reverse manganese-induced glutamate transporter impairment in astrocytes, J. 

Neurochem. 110 (2009) 530-544. 

[26] G.F. Carl, L.K. Blackwell, F.C. Barnett, L.A. Thompson, C.J. Kissinger, K.L. 

Olin, J.W. Critchfield, C.L. Keen, B.B. Gallagher, Manganese and Epilepsy: Brain 

Glutamine Synthetase and Liver Arginase Activities in Genetically Epilepsy Prone 

and Chronically Seizured Rats, Epilepsia 34 (1993) 441-446. 



Capítulo 4 

 178 

[27] D.J. Sánchez, M. Gómez, J.M. Llobet, J. Corbella, J.L. Domingo, Effects of 

Aluminium on the Mineral Metabolism of Rats in Relation to Age, Pharmacol. 

Toxicol. 80 (1997) 11-17. 

[28] M. Bohner, Reactivity of calcium phosphate cements, J. Mater. Chem. 17 

(2007) 3980-3986. 

[29] S. Kannan, J.M. Ventura, J.M.F. Ferreira, Aqueous precipitation method for 

the formation of Mg-stabilized ?-tricalcium phosphate: An X-ray diffraction study, 

Ceram. Inter. 33 (2007) 637-641. 

[30] S. Kannan, S. Pina, J.M.F. Ferreira, Formation of strontium-stabilized 

?-tricalcium phosphate from calcium-deficient apatite, J. Am. Ceram. Soc. 89 

(2006) 3277-3280. 

[31] M. Descamps, J.C. Hornez, A. Leriche, Effects of powder stoichiometry on the 

sintering of ?-tricalcium phosphate, J. Eur. Ceram. Soc. 27 (2007) 2401-2406. 

[32] A. Destainville, E. Champion, D. Bernache-Assollant, E. Laborde, Synthesis, 

characterization and thermal behavior of apatitic tricalcium phosphate, Mater. 

Chem. Phys. 80 (2003) 269-277. 

[33] G. Rayner-Canham, Descriptive inorganic chemistry, Macmillan, 2009. 

[34] S. Pina, S.I. Vieira, P.M. Torres, F. Goetz-Neunhoeffer, J. Neubauer, E.S.O.A. 

da Cruz, E.S.E.F. da Cruz, J.M. Ferreira, In vitro performance assessment of new 

brushite-forming Zn- and ZnSr-substituted beta-TCP bone cements, J. Biomed. 

Mater. Res. Part B, Appl. Biomat. 94 (2010) 414-420. 

[35] A. Ueno, Y. Miwa, K. Miyoshi, T. Horiguchi, H. Inoue, I. Ruspita, K. Abe, K. 

Yamashita, E. Hayashi, T. Noma, Constitutive expression of thrombospondin 1 in 

MC3T3-E1 osteoblastic cells inhibits mineralization, J. Cell. Physiol. 209 (2006) 

322-332. 



Capítulo 4 

 179 

[36] S. Vieira, S. Rebelo, S. Domingues, E. Cruz e Silva, O.B. Cruz e Silva, S655 

phosphorylation enhances APP secretory traffic, Mol. Cell. Biochem. 328 (2009) 

145-154. 

[37] E.R. Kreidler, F.A. Hummel, Phase relationships in the system SrO-P2O5 and 

the influence of water vapor on the formation of Sr4P2O9, Inorg. Chem. 6 (1967) 

884-891. 

[38] S. Raynaud, E. Champion, D. Bernache-Assollant, P. Thomas, Calcium 

phosphate apatites with variable Ca/P atomic ratio I. Synthesis, characterisation 

and thermal stability of powders, Biomaterials 23 (2002) 1065-1072. 

[39] M. Yashima, A. Sakai, T. Kamiyama, A. Hoshikawa, Crystal structure analysis 

of ?-tricalcium phosphate Ca3(PO4)2 by neutron powder diffraction, J. Solid. State 

Chem. 175 (2003) 272-277. 

[40] R.R. Lareu, I. Arsianti, K.S. Harve, Y. Peng, M. Raghunath, in: F. Ibrahim, N. 

Osman, J. Usman, In Vitro Augmentation of Collagen Matrix Formation — 

Applications in Tissue Engineering, N. Kadri (Eds.), 3rd Kuala Lumpur 

International Conference on Biomedical Engineering 2006, 15, IFMBE 

Proceedings, Springer Berlin Heidelberg, 2007, pp 696-699. 

[41] S.M. Sweeney, J.P. Orgel, A. Fertala, J.D. McAuliffe, K.R. Turner, G.A. Di 

Lullo, S. Chen, O. Antipova, S. Perumal, L. Ala-Kokko, A. Forlino, W.A. Cabral, 

A.M. Barnes, J.C. Marini, J.D.S. Antonio, Candidate Cell and Matrix Interaction 

Domains on the Collagen Fibril, the Predominant Protein of Vertebrates, J. Biol. 

Chem. 283 (2008) 21187-21197. 

[42] Perry DL. Handbook of inorganic compounds, Taylor &amp;amp; Francis, Second ed., 

2011. 

[43] M. Maciejewski, T.J. Brunner, S.F. Loher, W.J. Stark, A. Baiker, Phase 

transitions in amorphous calcium phosphates with different Ca/P ratios, 

Thermochim. Acta 468 (2008) 75-80. 



Capítulo 4 

 180 

[44] S. Kannan, A.F. Lemos, J.H.G. Rocha, J.M.F. Ferreira, Characterization and 

Mechanical Performance of the Mg-Stabilized ?-Ca3(PO4)2 Prepared from Mg-

Substituted Ca-Deficient Apatite, J. Am. Ceram. Soc. 89 (2006) 2757-2761. 

[45] S. Kannan, F. Goetz-Neunhoeffer, J. Neubauer, J.M.F. Ferreira, Synthesis 

and structure refinement of zinc-doped ?-tricalcium phosphate powders, J. Am. 

Ceram. Soc. 92 (2009) 1592-1595. 

[46] R.D. Shannon, Revised effective ionic radii and systematic studies of 

interatomic distances in halides and chalcogenides, Acta Crystallogr. Sect A 32 

(1976) 751-767. 

[47] P. Dagtepe, V. Chikan, Quantized Ostwald Ripening of Colloidal 

Nanoparticles, J. Phys. Chem. C 114 (2010) 16263-16269. 

[48] S.F. Badylak, D.O. Freytes, T.W. Gilbert, Extracellular matrix as a biological 

scaffold material: Structure and function, Acta Biomater. 5 (2009) 1-13. 

[49] N.R. Gandavarapu, P.D. Mariner, M.P. Schwartz, K.S. Anseth, Extracellular 

matrix protein adsorption to phosphate-functionalized gels from serum promotes 

osteogenic differentiation of human mesenchymal stem cells, Acta Biomater. 9 

(2013) 4525-4534. 

 

 



 

 181 

 

 

Capítulo 5 

 

Cimentos ósseos formados por brushite 

adoçados e dopados com estrôncio e 

manganês: a receita para fomentar a 

injectabilidade e o desempenho biológico in 

vitro 
 

 

 



 

 182 

 

 



Capítulo 5 

 183 

 

 

 

Sweetened and MnSr-doped brushite-forming bone cements: the 

recipe for fostering injectability and in vitro biological 

performance  

 

P. M. C. Torres a,*, A. Marote b, R. Cerqueira b, A. Calado c, J. C. C. Abrantes a,d, 

 S. Olhero a, O. A. B. Cruz e Silva, S. I. Vieira b,#, J. M. F. Ferreira a,# 

 

a Department of Materials and Ceramic Engineering, CICECO, University of Aveiro, 3810-

193 Aveiro, Portugal 

b Neurociences and Cellular Signaling Group, Institute for Biomedicine (iBiMED), SACS, 

University of Aveiro, 3810-193 Aveiro, Portugal 

c Department of Biology, GeoBioTec, University of Aveiro, 3810-193 Aveiro, Portugal   

d UIDM, ESTG, Polytechnic Institute of Viana do Castelo, 4900 Viana do Castelo, Portugal 

 

# Equally contributing authors 

 

 

Submitted to Biomaterials 

 

 

 

*Corresponding authors.  
E-mail addresses: ptorres@ua.pt (P.M.C. Torres) and sivieira@ua.pt (S. I. Vieira) 



Capítulo 5 

 184 

 

 

 

Abstract 

Calcium phosphate cements (CPCs) are widely used in osteoregeneration due to 

their biocompatibility and biomimicking compositions. The general weak 

performance in terms of injectability and mechanical properties are the major 

drawbacks preventing widerspread applications of CPCs, but enhancements in 

cell adhesion and osteoconductivity would also be advantageous. This study 

presents innovative solutions to improve the handling ability (setting time, 

injectability), the mechanical strength and the biological performance of brushite 

CPCs. The improvements were achieved via: (i) doping the starting ?-tricalcium 

phosphate (?-TCP) powders with Sr and Mn; (ii) adding sugar (sucrose or 

fructose) to the setting-liquid solution. The combination of these two strategies 

enabled increasing the setting time from ~3 min to ~9 min, and to reach wet 

compressive strengths of ~17 MPa at 48 h, much higher than those registered for 

sugar-free CPCs derived from non-doped ?-TCP (5 MPa) or from Sr-doped ?-TCP 

(10 MPa). Doping with Sr alone, or combined with low levels of Mn, also improved 

the proliferative response of human osteoblastic-like MG63 cells to CPCs, and 

increased their rate of type-I collagen secretion. The Sr/Mn co-doped CPCs, 

particularly when kneaded with sucrose-containing setting liquid, allowed very 

good levels of cell adhesion and growth on its surface, as observed by scanning 

electron microscopy. The characteristics of co-doped CPCs with added sucrose 

were greatly improved, including extended working times, excellent injectability, 

mechanical and biological performances, rendering them very promising materials 

for bone regeneration and tissue engineering. 

 

Keywords: Strontium and manganese; Brushite cements; Sucrose as retardant; 

Compressive strength; Osteocompatible features 

 



Capítulo 5 

 185 

1. Introduction  

Calcium phosphates (CaP) bioceramics are among the most appropriate bone 

graft materials due to their close chemical similarity with the mineral bone 

composition [1-4]. These biocompatible, bioresorbable, bioactive and 

osteoconductive materials are commercially available in various forms, i.e. 

granules, blocks, non-hardening pastes and hydraulic cements [5-9]. The 

injectable forms of CPCs combine the optimal bone defect filling capacity via 

minimally invasive surgeries with the ability to harden in vivo at body temperature, 

and low exothermicity setting reactions [7, 10-14]. Based on their final hardened 

compositions, calcium phosphate cements (CPCs) are usually grouped in two 

types: brushite (dicalcium phosphate dihydrate, or calcium monohydrogen 

phosphate dihydrate, CaHPO4·2H2O; DCPD) or apatite, such as hydroxyapatite 

[Ca10 (PO4)6 (OH)2; HA] or calcium-deficient hydroxyapatite (CDHA) [15]. Brushite 

and its non-hydrated version, monetite (dicalcium phosphate anhydrous, CaHPO4; 

DCPA), are the most stable calcium orthophosphate phases at pH&amp;lt;4.2, while 

apatite is the most stable phase at pH ?4.2 (although brushite-based cements may 

subsist up to pH 6.5) [16]. The better mechanical performance of apatite cements, 

in comparison to brushite-type ones, is counterbalanced by low resorption rates in 

vivo due to the superior stability of apatite under physiological conditions, 

influencing the bone regeneration process. The higher solubility of brushite-based 

CPCs brushite in vivo induces faster resorption rates, making them more attractive 

biomaterials.  

Calcium and some minor ion constituents of teeth and bone, including Sr and Mn, 

are known to play essential and specific roles in the normal growth and 

metabolism of hard tissues [17, 18]. Thence, doping CaPs with trace elements 

existing in bone composition has been a widespread research topic aiming for 

closer matches between the compositions of bone grafts and hard tissues [18-25]. 

One of the benefits of doping elements in CaPs after implantation consists on 

fostering bone apposition through mechanisms that are still not well understood. 

Sr exerts beneficial effects in the treatment of osteoporosis, as it maintains bone 

formation. Sr increases osteoclast apoptosis, inhibiting bone resorption, and 



Capítulo 5 

 186 

enhances preosteoblastic cell proliferation and collagen synthesis [26]. While 

certain levels of Mn exert positive effects on bone growth and repair, its deficiency 

might be at the genesis of osteoporosis [27, 28]. Numerous literature reports are 

available on the properties of Sr-substituted CPCs [29], but published works on 

Mn-doping of CaP materials for biomedical applications are scarce, and none was 

found on CPCs. Our previous in vitro study revealed that low Mn-doping levels in 

??tricalcium phosphate (?-TCP) powders exerted various positive effects on 

proliferation and differentiation of MC3T3-E1 osteoblastic-like cells, making the 

CPCs derived thereof attractive as osteoregenerative materials [30].  

However, widespread clinical applications of CPCs require overcoming some 

critical drawbacks: (i) poor injectability, characterized by the occurrence of phase 

separation between the liquid and solid (filter pressing effect) [31, 32]; (ii) tendency 

to disintegrate upon early contact with blood or other physiological solutions, due 

to weak cohesion [33, 34]; and (iii) low mechanical properties after hardening that 

limit its application to non-load-bearing locations [35, 36]. CPCs pastes should not 

migrate to undesirable sites and must have adequate setting time and acceptable 

mechanical strength after hardening. Unfortunately, brushitic CPCs set faster and 

are more difficult to handle in comparison to apatitic ones. 

Many additives have been attempted aiming at improving the handling and/or 

mechanical properties of CPC pastes. Hydroxypropyl methylcellulose (HPMC) [37, 

38], citric acid (CA) [39-41], polyethylene glycol (PEG) [38, 42, 43] are a few 

examples. Adding sugar to Portland mortars was found to significantly delay the 

hydration rate and induce microstructural changes in the hardened cements [44]. 

This suggests sucrose (consisting of two monosaccharides, glucose and fructose) 

as an interesting candidate to extend the setting time for CPCs. The ubiquitous 

presence of sucrose in the human body, as fuel to generate heat and form 

adenosine triphosphate (ATP) [45], makes it a safe and innocuous additive.  

The main aim of this study was to evaluate the combined effects of doping the 

starting ?-TCP powders with Sr and Mn and adding sucrose or fructose into the 

setting liquid on the overall properties of brushite-forming Mn- and 



Capítulo 5 

 187 

MnSr-substituted CPCs. The relevant properties for biomedical applications 

include handling, injectability, setting time, mechanic, and biological in vitro 

performance. 

 

2. Materials and Methods 

2.1 Preparation of starting powders and cements 

2.1.1 Preparation and characterisation of the powders 

The synthesis of doped [?-Ca3-x-yMnxSry(PO4)2] powders with solely 0.5 and 1 

mol% Mn (x=0.015 and x=0.030, respectively, and y=0), solely 5 mol% Sr (x=0 

and y=0.150), or co-doped with all combinations of these elements (Table 1) was 

carried out by the aqueous precipitation [30, 46]. The concentrations of precursors 

were set to have a fixed total molar ratio (Ca+Sr+Mn)/P=1.48 to ensure no 

hydroxyapatite formation [47]. For comparison purposes, non-doped ?-TCP was 

also prepared and used as reference (Ref?TCP). The precipitates were vacuum 

filtrated, dried at 110ºC and finally heat treated for 2 h at 800ºC.  

 

Table 1. Planned and experimentally obtained molar concentrations of Mn and Sr in the starting 

?-TCP powders. 

 

 

 

 

 

 

 

Concentrations of the Sr and Mn (mol%) 

Experimentally planned  
ICP elemental analysis  

(±0.03) 
Sample code   

Mn Sr  Mn Sr 

Sr5????TCP  0 5  0.00 5.02 
Mn0.5????TCP  0.5 0  0.33 0.04 
Mn1????TCP  1 0  0.69 0.03 

Mn0.5Sr5????TCP  0.5 5  0.32 5.03 
Mn1Sr5????TCP  1 5  0.70 5.02 



Capítulo 5 

 188 

All calcined formulations were ground under dry conditions for different time 

periods in order to obtain powders with similar particle size distributions (PSDs) 

(Coulter LS 230, UK, Fraunhofer optical model) after being passed through a 

40 µm mesh sieve. Inductively coupled plasma spectrometry (ICP-OES Jobin 

Yvon Activa M., USA) was used to determine the elemental concentrations of Ca, 

P, Mn and Sr by dissolving the required amounts of powders in 1 vol% of nitric 

acid (HNO3) in deionised water. Qualitative phase analysis was performed by X-

ray powder diffraction (XRD) using a high-resolution Bruker D8 Advance DaVinci 

diffractometer with Cu K? radiation (? = 1.5406 Å) produced at 40 kV and 40 mA. 

Data sets were recorded in the 2? range of 20 ? 50º with a step size of 0.015º 

2? s–1. The XRD information was complemented by infrared spectra obtained by 

Fourier Transform Infrared Spectrometry (FT-IR model Mattson Galaxy S-7000, 

USA). For this purpose each powder was mixed with KBr in the proportion of 1/150 

(by weight) for 15 min and pressed into a pellet. Each infrared spectrum is the 

average of 32 scans collected at 2 cm?1 resolution at room temperature (RT). 

 

2.1.2 Preparation of cement pastes 

The starting powders were firstly dry blended with equimolar amounts of 

monocalcium phosphate monohydrate (MCPM, Sigma–Aldrich, Germany) for 20 s, 

followed by hand mixing for 1 min with the reacting liquid at constant 

liquid-to-powder ratio (LPR=0.28 mL?g?1) to produce the CPC pastes. Three 

different setting liquids were tested: A, AS and AF. Liquid A, an aqueous solution 

containing 15 wt.% citric acid (CA) (Sigma Aldrich, Germany) + 10 wt.% 

poly(ethylene glycol) (PEG) (400, Sigma) + 0.5% wt.% hydroxyl propyl 

methylcellulose (HPMC) (3.5–5.6 mPa?s at 2 wt.% in water, Sigma Aldrich, 

Germany). The liquids AS and AF derived from liquid A by further adding 10 wt.% 

of sucrose (S, C12H22O11, MW=342.30 g?mol
?1), or fructose (F, C6H12O6, 

MW=180.12 g?mol?1), respectively (Sigma Aldrich, Germany). Table 2 summarizes 

all the CPCs studied and their respective sample codes.  



Capítulo 5 

 189 

Table 2. For simplification purposes, the sample codes of CPCs were built by affixing the liquid 

designation to the codes of starting ?-TCP powders. 

 Setting liquids  ????????TCP powders  
 

 A AS AF 

Ref????TCP  RefCPC?A RefCPC?AS RefCPC?AF 
Sr5????TCP  Sr5CPC?A Sr5CPC?AS Sr5CPC?AF 

Mn0.5????TCP  Mn0.5CPC?A Mn0.5CPC?AS Mn0.5CPC?AF 

Mn1????TCP  Mn1CPC?A Mn1CPC?AS Mn1CPC?AF 

Mn0.5Sr5????TCP  Mn0.5Sr5CPC?A Mn0.5Sr5CPC?AS Mn0.5Sr5CPC?AF 

Mn1Sr5????TCP  Mn1Sr5CPC?A Mn1Sr5CPC?AS Mn1Sr5CPC?AF 
 

As an example, RefCPC?A denotes a CPC prepared from the starting pure ?-TCP 

powder (Ref?TCP) and liquid A. 

 

2.2 Characterisation of cement pastes 

2.2.1 Setting time 

The initial setting time (IST) of cement pastes was determined using the Vicat 

needle technique as described elsewhere (n=3) [29]. One minute after placing the 

cement paste into a glass plate stored at 37ºC in 100% humidity box, the indenter 

(100 g in mass, 1 mm needle diameter) was lowered vertically and dropped onto 

the cement surface. Indentations were repeated at ~30 s intervals until no more 

penetration was possible, taking this time point as IST. The CPC specimens were 

kept under controlled conditions (37ºC, 100% relative humidity) for a further 48 h 

and setting reaction was then stopped by crushing and mixing them with acetone. 

The powdered samples were dried at 40ºC and used for qualitative and 

quantitative phase analyses by XRD.  

 

 



Capítulo 5 

 190 

2.2.2 Injectability  

A protocol described previously [46] was used to test the injectability of CPC 

pastes. The cement pastes hand-mixed for 1 min were placed into a 6 ml syringe 

(12.50 mm inner diameter; 67 mm in length) fitted with a cannula (2.2 mm inner 

diameter; 91 mm in length). The extrusion set consisted of a homemade fixture 

device adapted to a testing machine (Shimadzu Autograph, trapezium 2, Japan). 

The tests were performed at 20ºC, 2.5 min after mixing the powders with liquid. 

The crosshead speed and the maximum load were fixed at 15 mm min?1 up and 

300 N, respectively. The percentage of injectability was determined as the ratio 

between the mass of the paste that could be expelled from the syringe and the 

initial mass of the paste inside the syringe (n=3) [24, 32, 46].   

 

2.2.3 Mechanical properties and porosity  

For compressive strength (CS) and porosity measurements, cement pastes were 

cast into PTFE-moulds (? 6 × 12 mm3) and stored in 100% humidity at 37ºC for 

1 h. The CPC specimens were then removed from the moulds, the surfaces 

polished to obtain flat and parallel faces, and immersed in phosphate-buffered 

saline (PBS) solution (Pierce, Perbio) at 37ºC for further 48 h. Following, the 

cements were immediately loaded to failure at a crosshead displacement rate of 

1 mm?min?1 using a universal materials testing machine (Shimadzu Autograph, 

Trapezium 2, Japan) equipped with a 10 kN load cell (n=7). The entire remaining 

specimens were completely dried at 37ºC for several days, and used for total 

porosity and crystalline phase composition determinations. Total porosity (n=3-5) 

was calculated as: Total porosity (vol%) = [(?calc? ?app)/?calc]*100, where ?calc is the 

density of fully dense CPCs (calculated from quantitative XRD phase analysis) and 

?app the sample’s apparent density (determined through the Archimedes’ method 

with Hg-immersion). The specific surface areas (SSA) of the mechanically 

strongest cements were determined by the BET method using a Micromeritics 

Gemini 2370 V5.00 (Norcross, USA) after degassing the samples in a 

Micromeritics Flow Prep 060 (Norcross, USA). 



Capítulo 5 

 191 

2.2.4 X-ray diffraction and structural analysis by the Rietveld refinement 

method  

The crystalline phase composition of the powdered CPCs was assessed using a 

Panalytical X'Pert Diffractometer with Ni filtered Cu-K? radiation (voltage 45 kV 

and intensity 40 mA) in a continuous scanning mode with spinning by recording 

X-ray diffraction data within the 2? range = 4–70º (step size 0.013º, 198.645 s for 

each step). The software TOPAS version 4.2 (Bruker AXS, Karlsruhe, Germany) 

with the fundamental parameter approach was used for Rietveld refinements, by 

using the following structural model of ICDD cards numbers: #04-001-7104 for 

?-TCP, #04-011-5377 for MCPM, #04-013-3344 for brushite, #04-009-3755 for 

monetite and #04-013-3883 for octacalcium phosphate  (Ca8H2(PO4)6.5H2O;  

OCP). 

 

2.3 Characterisation of cement/osteoblastic-like cells interactions 

2.3.1 Cultures of MG63 cells with cements  

The osteosarcoma cell line MG-63 (ATCC CRL-1427) was maintained in 2 mM 

Glutamine-containing Minimum Essential ?-Medium in EBSS (Eagle's balanced 

salt solution) supplemented with 10% (v/v) foetal bovine serum (FBS), 1% (v/v) of 

a 100 U m?L?1 penicillin and 100 mg?mL?1 streptomycin solution (Gibco BRL, 

Invitrogen), and 2.2 g?L?1 NaHCO3, at 37 ºC/5% CO2, and passaged using a 0.05% 

trypsin/EDTA solution (Gibco BRL, Invitrogen). Disc-shaped cements (10 mm 

diameter and ~1 mm height), prepared in liquids A and AS, were stored in 

100% humidity/37ºC for 48 h, air dried, sterilized by low-temperature hydrogen 

peroxide gas plasma, washed [3-4 times in PBS (Pierce, Perbio) and twice in cell 

media at 37ºC], and finally placed in 24-well plates. 1x104 cells?cm?2 MG-63 cells 

were seeded on the cement-containing wells and incubated at 37ºC/5% CO2 for 

specified days. Control cells were seeded directly on the polystyrene well bottom 

or on glass coverslips placed on the well (microscopy assays).  

 



Capítulo 5 

 192 

2.3.2 Viability and proliferation assays 

The resazurin metabolic assay was used to determine the cements’ effects on 

MG63 cells viability and proliferation [39]. Cells were grown on cement-containing 

wells for 28 days, and at 1, 4, 7, 14, 28 days in vitro (DIV) incubated for 4 h with 

fresh medium containing 10% of a resazurin solution [0.1 mg?mL?1 resazurin 

(Sigma Aldrich) in PBS]. Resazurin reduction was spectrophotometrically 

measured (Infinite M200 PRO, Tecan) at 570 and 600 nm, the ratio OD 570/OD 

600 nm calculated for each time point, and the OD 570/OD 600 nm ratio of the 

blank (cell-free resazurin medium) subtracted. The resulting final ODs (fOD) were 

converted to fold increases over the fOD value of control cells at 1 DIV (taken 

as 1), and plotted against time of incubation. As another indirect measure of total 

cell number, at the final time point (28 DIV), cells were collected and their total 

protein content analysed via the BCA protein assay kit (Pierce’s, Thermo 

Scientific), following the manufacturers’ instructions.  

 

2.3.3 Chemical and phase composition of cements after 28DIV with MG63 

cells 

The culture medium was substituted after the first 24 h and every 3 days 

thereafter. The pH values of the medium removed at 1, 7, 14 and 28 DIV were 

registered. The chemical variations of CPCs (Sr5CPC?AS, Mn0.5Sr5CPC?AS and 

Mn1Sr5CPC?AS) induced by the in vitro cell assay medium were assessed by ICP 

determination (section 2.1.1) of the Mn and Sr contents in the samples before and 

after the 28 DIV in the presence of cells (n=3). Qualitative and quantitative phase 

analyses were also performed by XRD for all cement samples prepared with 

liquids A and AS after 28 DIV. 

 

 

 



Capítulo 5 

 193 

2.3.4 Immunoblot analyses of type-I collagen  

At 4 DIV, cells’ conditioned media were collected, centrifuged at 1000 g/5 min to 

clear from cell debris, the supernatant collected into 1% SDS solutions and boiled 

for 10 min. Volume-normalized aliquots were subjected to 7.5% SDS-PAGE in 

Tris-Glycine buffer, the proteins electrophoretically transferred onto nitrocellulose 

membranes, and immunoblotted as previously described [48] using 

anti-type-I collagen (Novus Biologicals, Germany) and horseradish peroxidase-

linked anti-rabbit (GE Healthcare, Chalfont St. Giles, UK) antibodies for enhanced 

chemiluminescence detection. Previous to the immunoblotting, Ponceau S 

detection of all proteins was performed as a loading control [49]. Ponceau-S 

stained membranes and immunoblot autoradiograms were scanned (GS-800 

imaging densitometer, Bio-Rad) and protein bands quantified (Quantity One 

densitometry software, Bio-Rad). Immunoblot data was corrected to the respective 

Ponceau loading control. 

 

2.3.5 Confocal microscopy and scanning electron microscopy analyses of 

cells  

MG63 cells were seeded at 1x104 cells?cm?2 onto 24-well plates containing 

cement discs of RefCPC?A, Sr5CPC?A, Mn0.5Sr5CPC?A and Mn0.5Sr5CPC?AS 

over glass coverslips. Control cells were seeded only on the coverslip. At 7 DIV, 

confocal microscopy was used to analyse the cells grown in the vicinity of the 

cements, and scanning electron microscopy was used to visualize cells grown on 

cements. 

Immunocytochemistry (ICC) and confocal microscopy ? cells grown on coverslips 

were fixed with a 4% paraformaldehyde/PBS solution for 30 min, and 

permeabilised with a 0.2% Triton/PBS solution. Non-specific sites were blocked 

with a 3% bovine serum albumin (BSA)-PBS solution for 1 h, and coverslips 

submitted to ICC procedures as before [25] using the anti-type-I collagen I 

antibody (1:250 in 3% BSA-PBS), a FITC-conjugated secondary antibody (1:300 in 



Capítulo 5 

 194 

3% BSA-PBS) and red fluorescing Alexa 568-labelled Phalloidin (1:500) to stain 

filamentous actin. Images were acquired with a LSM 510 META confocal 

microscope (Zeiss, Jena, Germany) through a Plan-Neofluor 40×/1.30 oil objective 

and using an Argon 488 nm laser line (FITC channel), a Diode 405-430 laser 

(DAPI channel) and a 561 nm DPSS laser (Alexa 568 channel). 

Scanning electron microscopy (SEM) ? cells grown on cement disks were fixed by 

immersing the discs in 2.5% glutaraldehyde in PBS for 40 min at RT. After three 

washes in PBS the samples were dehydrated through a graded ethanol series 

(15%, 30%, 50%, 70%, 90%, 96%, 3×100%). The disks were critical-point-dried in 

a BAL-TEC CDC 030 (Balzers, Liechtenstein) and glued onto stubs, 

sputter-coated with gold-palladium and examined with a Hitachi S-4100 scanning 

electron microscope (Hitachi High-Technologies Corp., Tokyo, Japan) operated at 

15 kV. 

  

2.4 Statistical analysis 

Data relative to the characterization of the cements are expressed as mean±SD 

(standard deviation) of the mean; cellular in vitro data are expressed as mean±SE 

(standard error) of the mean. A minimum of three independent experiments was 

performed for each quantitative analysis. Statistical significance analysis was 

conducted using one- (cements composition) and two-way (cements composition 

and type of setting liquid) analysis of variance (ANOVA), followed by the 

Greenhouse-Geisser test, with the level of statistical significance set at 0.05. 

Symbols used: (*) for comparison between different CPCs and the Ref-CPC data, 

in a given liquid; (+) for comparison between data from different setting liquids for 

each cement composition; cellular in vitro data: (º) for comparison between control 

cells data and data from different CPCs in a set liquid.  

 

 



Capítulo 5 

 195 

3. Results  

3.1 Characterisation of ????-TCP powders  

Table 1 presents Sr and Mn contents of starting powders obtained by ICP 

analysis. For Sr, a good agreement is observed between the planned and the 

experimentally obtained contents, while the measured Mn concentrations were 

64?70% of the planned ones.  

From the XRD patterns displayed in Fig. 1a, all starting powders apparently 

consist of pure ??TCP phase (ICDD PDF 04-001-7104). This apparent close 

matching suggests that lattice distortions in ??TCP caused by the atomic 

replacement of Ca by Sr [21, 50, 51] or/and by Mn [30] are too small to be 

detected. The (Ca+Mn+Sr)/P ratios (1.485?1.496) obtained from ICP analyses 

suggest the formation of small amounts of calcium pyrophosphate (Ca2P2O7, CPP) 

[52, 53].  

The noticeable vibrational modes of PO4 tetrahedra in FT-IR patterns of Fig. 1b 

confirm the formation of ??TCP as the predominant phase. The absorption bands 

at 726 cm?1 and 1208 cm?1, ascribed to pyrophosphate groups (P2O7
4?), 

particularly to P?O?P bonds, are almost imperceptible being slightly more evident 

for Ref-TCP.  

The results of particle size analysis displayed in Fig. 1c reveal that all starting 

powders exhibit analogous bimodal PSD curves, including size parameters Dmean 

(1.02 ± 0.05 µm) and D50 (0.67 ± 0.03 µm). This feature is of crucial importance to 

ensure comparability between the different cement formulations prepared thereof. 

The most intense populations of fine particles appear centred at ~0.6 µm, while 

smaller populations of coarser ones are centred at ~2 µm. 

 

 

 



Capítulo 5 

 196 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fig. 1. a) X-ray diffraction patterns, b) FT-IR spectra and c) particle size distributions (including 

Dmean and D50 values) of non-doped (Ref-TCP) and doped ?-TCP starting powders (after heat-

treating at 800ºC for 2 h and dry-milling) used in CPC preparation. Dmean (mean diameter) is the 

‘‘average’’ size of particles and D50 (median diameter) the size for which 50 vol.% of the particles 

are finer. 

 

0

4

8

12

16

0.01 0.1 1 10 100
Particle size (µµµµm)

V
ol

u
m

e 
(%

)

Mn1Sr5-TCP

Mn0.5Sr5-TCP 

Mn1-TCP

Mn0.5-TCP

Sr5-TCP

Ref-TCP

,

(c) ????-TCP Dmean D50
powders  (µ (µ (µ (µm)  (µµµµm)

Mn1Sr5-TCP 1.01 0.69

Mn0.5Sr5-TCP 1.07 0.71

Mn1-TCP 0.97 0.62

Mn0.5-TCP 1.09 0.67

Sr5????TCP 0.96 0.68
Ref????TCP 0.99 0.67

0

4

8

12

16

0.01 0.1 1 10 100
Particle size (µµµµm)

V
ol

u
m

e 
(%

)

Mn1Sr5-TCP

Mn0.5Sr5-TCP 

Mn1-TCP

Mn0.5-TCP

Sr5-TCP

Ref-TCP

,

(c) ????-TCP Dmean D50
powders  (µ (µ (µ (µm)  (µµµµm)

Mn1Sr5-TCP 1.01 0.69

Mn0.5Sr5-TCP 1.07 0.71

Mn1-TCP 0.97 0.62

Mn0.5-TCP 1.09 0.67

Sr5????TCP 0.96 0.68
Ref????TCP 0.99 0.67



Capítulo 5 

 197 

3.2 Characterisation of cement pastes 

The properties of CPCs pastes listed in Table 2 are displayed in Fig. 2, including 

the initial setting time (IST, Fig. 2a), compressive strength (CS, Fig. 2b) and 

porosity (Fig. 2c).  

The combined effects of doping the starting powders and adding sugars to the 

setting liquid induced interesting changes in IST and CS. In comparison to the 

reference system RefCPC?A, the IST of Mn0.5CPC?A did not change and only a 

slight increase was noticed for Mn1CPC?A (Fig. 2a), while higher values of IST 

were registered for Sr5CPC?A. The higher values were measured for co-doped 

cements (Mn0.5Sr5CPC?A and Mn1Sr5CPC?A). Similar trends are observed for 

IST upon replacing setting liquid A by liquids AS and AF, but variation is greater 

irrespective of the type of sugar used. The same experimental variables induced 

similar synergetic effects on CS (Fig. 2b) and porosity (Fig. 2c) of hardened 

cements, with fructose being less effective in enhancing the mechanical 

properties. Mn0.5Sr5CPC?AS proved to be the strongest (CS ~17 MPa) and 

consistently the less porous cement. Liquid AS (and in a lesser extent liquid AF) 

favours CS and decreases porosity in comparison to liquid A. Irrespective of the 

setting liquid used, all doped cements were less porous than RefCPC, the lowest 

porosity values (~32%) being achieved for Mn0.5SrCPC-A and –AS. Interestingly, 

Mn0.5SrCPC cements prepared with sugars containing liquids exhibit higher 

specific surface area (SSA), with the highest value obtained for Mn0.5Sr5CPC?AS 

(Fig. 2c).   

 

 

 

 

 

 



Capítulo 5 

 198 

c)

****

**

**

***

***

++++

++

+ +++
+

+

++
++

a)

*

*

*** **

++
++ ++

++
++

++

+
+

+ +
++

+

b)

****

****

****

****

**
++++

+

+++
+ ++

+++

++++

+++

++++

+++

++

1.41.91.2

AFASA

SSA (m2 g????1)

1.41.91.2

AFASA

SSA (m2 g????1)c)

****

**

**

***

***

++++

++

+ +++
+

+

++
++

a)

*

*

*** **

++
++ ++

++
++

++

+
+

+ +
++

+

b)

****

****

****

****

**
++++

+

+++
+ ++

+++

++++

+++

++++

+++

++

1.41.91.2

AFASA

SSA (m2 g????1)

1.41.91.2

AFASA

SSA (m2 g????1)c)

****

**

**

***

***

++++

++

+ +++
+

+

++
++

a)a)

*

*

*** **

++
++ ++

++
++

++

+
+

+ +
++

+

b)

****

****

****

****

**
++++

+

+++
+ ++

+++

++++

+++

++++

+++

++

b)

****

****

****

****

**
++++

+

+++
+ ++

+++

++++

+++

++++

+++

++

1.41.91.2

AFASA

SSA (m2 g????1)

1.41.91.2

AFASA

SSA (m2 g????1)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fig. 2. Effects Effects of doping-ions (Sr and/or Mn in TCP powders) and of adding sugars, sucrose or 

fructose to setting liquids (AS or AF, respectively) on: a) initial setting time; b) compressive strength of wet 

CPC samples after 48 h of immersion in PBS solution at 37ºC; c) total porosity on CPCs prepared with a LPR 

of 0.28 mL?g?1. The inset in (c) reports SSA values of Mn0.5Sr5CPC prepared with different setting liquids. 

Symbol (*) denotes significantly different data for the doped CPCs?A with respect to RefCPC?A; symbol (+) 

denotes significant differences between data from CPCs in ?AS and ?AF liquids and CPCs?A data, for each 

cement composition. */+, p&lt;0.05; **/++, p&lt;0.01; ***/+++, p&lt;0.001; ****/++++, p&lt;0.0001). 



Capítulo 5 

 199 

The results of quantitative phase analysis of cements immersed in PBS at 37ºC for 

48 h or stored at 37ºC and 100% humidity for the same period are displayed in 

Fig. 3a and 3b, respectively. 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fig. 3. Quantitative phase analysis data (wt.%) obtained by Rietveld refinement of cement samples 

after: a) 48 h of immersion in PBS solution at 37ºC; b) 48 h storage at 37ºC under 100% humidity. 

DCPD = brushite; DCPA = monetite; ?-TCP = ?-tricalcium phosphate; MCPM = monocalcium 

phosphate monohydrate. 

 

All doped samples kept in PBS consisted predominantly of brushite (DCPD) 

together with small amounts of monetite (DCPA) and unreacted ??TCP, 

0

20

40

60

80

100

A AS AF A AS AF A AS AF A AS AF A AS AF A AS AF

Ref Sr5 Mn0.5 Mn1 Mn0.5Sr5 Mn1Sr5

CPC

X
R

D
 c

om
p

os
it

io
n

 (
w

t.
%

)

DCPD DCPA    -TCP????
a) 

0

20

40

60

80

100

A AS AF A AS AF A AS AF A AS AF A AS AF A AS AF

Ref Sr5 Mn0.5 Mn1 Mn0.5Sr5 Mn1Sr5

CPC

X
R

D
 c

om
p

os
it

io
n

 (
w

t.
%

)

MCPM DCPD DCPA
b) 



Capítulo 5 

 200 

irrespective of the setting liquid used. In contrast, in non-doped cements unreacted 

??TCP was absent and much higher monetite amounts formed, being this the 

main phase in RefCPC?A and RefCPC?AF samples (Fig. 3a). Under 100% 

humidity (Fig. 3b), remains of unreacted MCPM appeared instead of ??TCP; 

doped cements exhibited brushite as the main phase, together with very small 

amounts of monetite, contrasting with non-doped cements, in which monetite 

predominates. 

The effects of doping starting powders and adding sugars to setting liquid A on 

injectability (Fig. 4a) and extrusion force versus syringe plunger displacement 

curves (Fig. 4b) were studied for the higher CS cements (Sr5CPC, Mn0.5Sr5CPC, 

Mn1Sr5CPC). Mn-doping noticeably increased injectability from ~4% (Sr5CPC) to 

~80% (Mn0.5Sr5CPC?A, Mn1Sr5CPC?A). Adding sugars to setting liquid A 

drastically enhanced the injectability of the least performing paste (Sr5CPC) to 

~97.5% (AS) or ~96% (AF). Sugars also enabled co-doped Mn0.5Sr5CPC and 

Mn1Sr5CPC pastes to be fully extruded. The combined benefits of co-doping and 

adding sugars are also evident from Fig. 4b. The fully injectable pastes exhibited 

typical extrusion curves [31, 32, 54], characterized by an initial fast increase of the 

applied force, followed by a plateau and a marked increase up to the maximal 

extrusion force. Instead of plateau, the intermediate segments of the extrusion 

curves of partially injectable pastes (Sr5CPC?A, Mn0.5Sr5CPC?A, Mn1Sr5CPC?A 

and Sr5CPC?AF) became gradually inclined as injectability worsened, being 

accompanied by an increasing filter pressing effect [32, 46] (Supplementary Table 

S1). The force required to extrude the Sr5CPC?A paste sharply increased and 

quickly reached the set maximum value of 300 N [32]. Co-doping noticeably 

reduced the extruding force (Fig. 4b), while adding sugars clearly enhanced the 

extrusion ability of Sr5CPC?A in the order Sr5CPC?AS &gt;Sr5CPC?AF and further 

improved the reasonable injectability of co-doped cements (Fig. 4a and 4b).  

 

 

 



Capítulo 5 

 201 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fig. 4. a) Percentage of injectability and b) extrusion force curves versus syringe plunger 

displacement for Sr5CPC, Mn0.5Sr5CPC and Mn1Sr5CPC pastes prepared with sugar free liquid 

(A) and liquids containing sucrose (AS) and fructose (AF) with LPR = 0.28 mL?g?1, extruded 2.5 min 

after mixing the powders with the setting liquid. Symbol (*) denotes significantly different 

injectability values for the co-doped CPCs-A with respect to Sr5CPC-A; symbol (+) denotes 

significantly different injectability values for CPCs in ?AS and ?AF liquids with respect to CPCs?A, 

for each cement composition. ++, p&lt;0.01; ***/+++, p&lt;0.001; ****/++++, p&lt;0.0001). 

 

 



Capítulo 5 

 202 

Table S1. Evaluation of the homogeneity of the CPC pastes [initial liquid to powder ratio 

(LPR) = 0.28 mL?g?1] upon extrusion. To evaluate filter pressing effects, paste samples were 

collected every 30 ± 2 s counted from the beginning of the extrusion process. Any remaining paste 

in the syringe (when complete extrusion did not occur) was also collected. These samples were 

weighed before and after complete drying at 120ºC for 24 h, to determine their LPR values. The 

filter pressing effect was evaluated by the significance of the variations in LPR (three independent 

experiments) undergone upon the extrusion of each paste and quantified from repeated measures. 

ANOVA with Greenhouse Geisser correction was used to determine statistical significance (p &amp;lt;

0.05). 

LPR of A1 a LPR of A2 a LPR of A3 a 

LPR of  

Remaining paste 

 not extruded 

p-value b 

Cement Pastes 

(± 0.01)  
(mL g????1) 

(± 0.01)  
(mL g????1) 

(± 0.01)  
(mL g????1) 

(± 0.01)  
(mL g????1) 

 

Sr5CPC????A 0.3 - - 0.26 0.029b 

Sr5CPC????AS 0.27 0.28 0.29 - 0.156 

Sr5CPC????AF 0.27 0.29 0.28 - 0.103 

Mn0.5Sr5CPC????A 0.28 0.3 - 0.25 0.011b 

Mn0.5Sr5CPC????A 0.27 0.28 0.28 - 0.055 

Mn0.5Sr5CPC????A 0.28 0.29 0.29 - 0.100 

Mn1Sr5CPC????A 0.28 0.3 - 0.26 0.029b 

Mn1Sr5CPC????A 0.28 0.28 0.29 - 0.065 

Mn1Sr5CPC????A 0.27 0.29 0.29 - 0.057 

a A1, A2 and A3 – samples of paste injected during the extrusion. 
b Presence of filter pressing effect (p &amp;lt;0.05). 
 

 

 

 

 



Capítulo 5 

 203 

The phase compositional changes derived from aging CPCs for 28 days in vitro 

(DIV) in the presence of the MG63 pre-osteoblastic cells are shown in Fig. 5.  

 

 

 

 

 

 

 

 

 

 

 

Fig. 5. Quantitative phase analysis data (wt.%) obtained by Rietveld refinement of cement samples 

after immersion during 28 days in vitro (DIV) in the presence of MG63 pre-osteoblastic cells. 

DCPD = brushite; DCPA = monetite; OCP = octacalcium phosphate. 

 

The predominant monetite phase in RefCPCs (Fig. 3b) transformed into brushite 

and octacalcium phosphate (OCP); brushite remained as one of the main phases 

in the other cements, (Figs. 3b vs 5). Monetite, formed only in doped CPCs, tends 

to disappear in the presence of sucrose. Interestingly, significant fractions of OCP 

were formed in all the non-doped and doped cement formulations, except Sr5CPC 

that consisted of brushite alone (Sr5CPC?AS) or accompanied with monetite 

(Sr5CPC?A). These results suggest that Sr tends to hinder the formation of OCP 

from brushite cements.  

 

 

0

20

40

60

80

100

A AS A AS A AS A AS A AS A AS

Ref Sr5 Mn0.5 Mn1 Mn0.5Sr5 Mn1Sr5

CPC

X
R

D
 c

om
p

os
it

io
in

 (
w

t.
%

)

DCPD DCPA OCP



Capítulo 5 

 204 

The amounts of doping Sr and Mn ions released into the culture medium during 

incubation with MG63 cells for 28 DIV from Sr5CPC?AS, Mn0.5Sr5CPC?AS and 

Mn1Sr5CPC?AS samples obtained by ICP analysis (section 2.3.3) are reported in 

Fig. 6.  

 

 

 

 

 

 

 

 

 

 

Fig. 6. Total released amounts of Sr and Mn ions from Sr5CPC-AS, Mn0.5Sr5CPC?AS and 

Mn1Sr5CPC?AS samples during 28 days in vitro (DIV) in the presence of MG63 pre-osteoblastic 

cells (mg per g of cement, grey bars), and percentages (wt.%, values in brackets) relative to their 

contents in cement samples before starting the in vitro test (after washing in PBS and in cell media 

at 37ºC).  

 

It can be seen that (i) a higher Mn content (Mn1Sr5CPC) released a higher dose 

(~0.4 mg?g?1); (ii) co-doping decreased the Sr release (Sr5CPC?AS &gt; 

Mn0.5Sr5CPC?AS &gt; Mn1Sr5CPC?AS); (iii) the released percentage of Mn was 

much higher than that of Sr, suggesting a preferential leaching of the smaller Mn 

(ionic radius = 0.83 Å) in comparison to Sr (ionic radius = 1.13 Å); (iv) ionic 

leaching from co-doped cements is likely to continue beyond the 28 days if longer 

time periods are allowed. 

 

(44.6 %)

(7.4 %)

(47.0 %)

( 9.9 %)

(17.2 %)

0

1

2

3

Sr Mn Sr Mn Sr Mn

Sr5CPC Mn0.5Sr5CPC Mn1Sr5CPC

R
el

ea
se

d
 i

on
 c

on
te

n
t 

(m
g 

g-
1 )



Capítulo 5 

 205 

3.3 Characterisation of in vitro osteoconductive properties 

3.3.1 Effects of Mn- and Sr-doping on cell viability and type-I collagen 
secretion 

The reversible metabolic resazurin assay, an indirect measure of the number of 

viable cells and their proliferation, was used to assess MG63 pre-osteoblastic cell 

viability at various time points of incubation with the CPCs (1, 4, 7, 14 and 28 DIV) 

(Fig. 7).  

Resazurin data was expressed as fold increases of control cells’ values at 1 DIV 

(taken as 1). The time-dependent resazurin profiles obtained varied as expected 

for these pre-osteobastic cells, with control cells growing exponentially during the 

first week in culture and maintaining their number thereafter (Fig. 7; [25]). 

Regardless of the setting liquids tested (A, AS), cell numbers decreased in the 

presence of cements, except for Sr5CPC (A and AS) at the latest time point 

(Fig. 7a and 7b, 28 DIV). Non-doped and Mn-doped cements strongly inhibited 

MG63 proliferation (Fig. 7a and b), while Sr stimulated the number of viable cells, 

contributing for the increased resazurin fOD levels observed in co-doped cements 

(Mn0.5Sr5CPC, Mn1Sr5CPC) over solely Mn-doped ones (Mn0.5CPC, Mn1CPC). 

This is especially true for Mn0.5Sr5CPC, which presented metabolic levels more 

similar to the Sr5CPC ones, whilst Mn1Sr5CPC strongly induced growth arrest 

(and potentially some cell death) at the latest DIV (Fig. 7a and 7b). The cells 

time-dependent growth profile was similar when liquid AS (CPCs?AS) was used, 

with fOD fold-increases being generally higher than for CPCs?A although not 

always significant (Fig. 7a and 7b). Quantification of the total protein content of 

MG63 cell lysates at 28 DIV in CPCs?A, another indirect measure of the final 

number of cells, revealed a similar profile of cell growth (Fig. 7c). While protein 

contents of cell grown with Sr5CPC?A and Mn0.5Sr5CPC?A were less distant 

than the one of control cells, the yielded protein content was very small 

(~0.1 µg?µL?1) for the non-doped (RefCPC?A) and Mn-doped (Mn0.5CPC?A, 

Mn1CPC?A) cements. 

 



Capítulo 5 

 206 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fig. 7. Cell viability and secretion of type-I collagen in human MG63 osteoblast-like cells exposed 

to non-doped and doped CPC discs. a) and b) Resazurin assay of MG63 cells cultured for 28 days 

in vitro (DIV) without cement discs (control ‘Ctrl’ cells) and with non-doped (RefCPC) or doped 

(Mn0.5CPC, Mn1CPC, Sr5CPC, Mn0.5Sr5CPC, Mn1Sr5CPC) cement discs prepared with setting 

liquids A (a) and AS (b). c) Total protein concentration of the lysates of cells cultured for 28 days 

with CPC-A cements. d) Medium secreted type-I collagen levels were detected by immunoblot and 

quantified in conditioned media collected at 4 DIV; type-I procollagen a(I) and a(II) bands were 

quantified, data normalized to loading control (Ponceau staining). Symbol (*) and (º) denote 

significant differences between doped CPC?A data, and RefCPC?A or Control cells (‘Ctrl’) data, 

respectively; symbol (+) denotes significant differences between CPCs?AS and CPCs?A data, for 

each cement composition. */º/+, p&lt;0.05; **/ºº/++, p&lt;0.01; ***/ººº/+++, p&lt;0.001; ºººº/++++, p&lt;0.0001). 

 



Capítulo 5 

 207 

Type-I collagen is the major protein constituent of the organic bone matrix, and its 

precursor chains are secreted by osteoblasts to form extracellular collagen fibrils. 

Cellular monomeric type-I pro-collagen consists of  ?1 (~140 kDa) and ?2 (~130 

kDa) chains, which can suffer a high number of post-translational modifications, 

before aggregating into oligomers and fibres [25]. The effects of the cements on 

secreted pro-collagen protein levels were analysed in cells conditioned media 

collected at 4 DIV, a time point of high pro-collagen secretion by pre-osteoblastic 

cells in culture (Fig. 7d); [25]). The results obtained were similar using either liquid 

A or AS (Fig. 7d, upper and lower graphs, respectively). As expected from their 

very low resazurin levels (Fig. 7a and 7b), RefCPC and Mn-doped cements had 

severely decreased amounts of secreted pro-collagen. In contrast, Sr-containing 

cements (Sr5CPC, Mn0.5Sr5CPC, Mn1Sr5CPC) induced cells to secrete pro-

collagen at levels very similar to control cells (Fig. 7d; non-statistically significant 

from control cells), even though their viability levels at 4 DIV are only half of the 

control (Fig. 7a and 7b). Therefore, cells grown in the presence of Sr-containing 

CPCs had increased rates of pro-collagen secretion (at 4 DIV). 

 

3.3.2 Mn0.5Sr5CPC potential to be an osteoconductive scaffold 

Metabolic activity and secreted pro-collagen are bulk biochemical evaluations of 

the biological responses of MG63 cells grown with the CPC samples. Upon 

seeding, cells have either grown on top of the cements or in their surroundings. To 

discriminate between the two cell populations, the compositions that exhibited the 

best proliferation and differentiation results (Sr5CPC and Mn0.5Sr5CPC), in 

comparison with RefCPC and regardless of the setting liquid used, were further 

analysed using imaging techniques. Confocal microscopy was first used to monitor 

the cells that did not adhere to cement discs and instead grew on their 

surroundings at 7 DIV (Fig. 8). Fluorescent staining of cellular nuclei, 

type-I collagen and filamentous-actin (F-actin) allowed the analysis of the cellular 

distribution and collagen content in the various conditions (Fig. 8).  

 



Capítulo 5 

 208 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fig. 8. Confocal microscopy analysis of MG63 osteoblasts cultured for 7 days on the surroundings 

of RefCPC, Sr5CPC and Mn0.5Sr5CPC discs. MG63 cells were seeded on RefCPC, Sr5CPC or 

Mn0.5Sr5CPC (prepared with setting liquid(s) A and/or AS) discs placed on glass coverslips; cells 

that did not adhere to the surface of the discs but grew on the top of the coverslip (in the cement 

disks’ vicinity) were probed for type-I collagen (green fluorescence), DAPI (blue nuclear staining), 

and filamentous actin (F-actin, probed with red-labeled phalloidin). Control (Ctrl) cells were grown 

on a glass coverslip in the absence of any cement disk. Arrowheads, intracellular granule-like 

densities. Scale bar = 50 µm. 



Capítulo 5 

 209 

As expected, control cells grown on a coverslip in the absence of cements had a 

tissue-like spreading (pervasive cell-to-cell contacts in the F-actin staining), and 

presented homogeneous pools of granular intracellular type-I collagen (Fig. 8, 

Ctrl cells) [25]. Contrastingly, very few cells grew in the presence of  RefCPC?A 

(approximately one cell was visible per 20x imaged field) (Fig. 8, RefCPC?A). 

Agreeing with its high metabolic activity, the majority of the Sr5CPC coverslips 

showed high cell density (higher number of DAPI-positive nuclei per imaged area) 

and cells were often smaller than control ones, a characteristic of high growth 

rates in a limited area (Fig. 8, Sr5CPC?A). Further, intracellular collagen staining 

decreased in cells exposed to every doped cement, suggesting that collagen had 

been partially secreted in the earlier days. Particularly for Mn0.5Sr5CPCs, the 

intensity of intracellular collagen staining was not homogeneous throughout the 

cell population (Fig. 8, Mn0.5Sr5CPC?A and ?AS). The number of cells grown for 

7 DIV in the presence of the Mn0.5SrCPC cements was also smaller, in 

comparison to Sr5CPC and control cell conditions (Fig. 8, Mn0.5Sr5CPC?A and 

?AS). Remarkably, cells cultured in the presence of cements often grew in more 

disorganized overlapping layers, potentially due to dislocations of the cement disks 

over the coverslips during time in culture. At first glance, these data on cell 

population numbers do not agree with the metabolic activity data of Fig. 7, where 

Sr5CPC and Mn0.5Sr5CPC have similar metabolic activity at 7 DIV, about half of 

control cells levels. SEM analysis of the MG63 cells that have grown on the top of 

the cement discs for 7 DIV shed further light on this apparent contradiction (Fig. 9, 

and supplementary Figs. S1 and S2). Low cell density is detected on the surface 

of RefCPC?A (Supplementary Fig. S1) and Sr5CPC?A discs (Fig. 9a). In contrast, 

high cell densities are clearly observed on the surface of Mn0.5Sr5CPC?A and 

?AS cements, with the latter presenting the highest cell density (Fig. 9d and 9g; 

cell scores in supplementary Fig. S1d). Moreover, cells grown on RefCPC?A and 

Sr5CPC?A appeared less adherent to the substrate than cells grown on the 

Mn0.5Sr5CPC (compare supplementary Fig. S1c and Fig. 9b-c with Fig. 9e-f and 

9h-i).  

 



Capítulo 5 

 210 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fig. 9. Representative aspects of MG63 cells cultured for 7 days on the cement discs of Sr5CPC, 

Mn0.5Sr5CPC-A and Mn0.5Sr5CPC-AS, SEM. An area of 0.5 mm2 is shown for each of the 

compositions in a), d) and g), accompanied on the right column by a medium and a higher 

magnification of the same material. a)-c) Low cell density on the surface of Sr5CPC disk. The 

arrows in a) and b) indicate the cells. As shown in c), most cells on this material appeared less 

closely appressed to the substrate than those shown in e), f) and h)-i). d)-i): Cell coverage on 

Mn0.5Sr5CPC-A (d-f) and Mn0.5Sr5CPC-AS (g-i). In both cases, cell shape and distribution on the 

surface of the material suggest great division and migratory activity. Most cells are rather flat on the 

substrate. 



Capítulo 5 

 211 

Indeed, cells grown on Mn0.5Sr5CPC are rather flat denoting good spreading and 

adhesion to the substrate, and exhibit numerous pseudopodia extensions (more 

evidenced in supplementary Fig. S2). Further, cell shape and distribution over 

Mn0.5Sr5CPC-A and -AS surfaces suggest high cell division and migratory activity 

(Fig. 9d-i). 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fig. S1. SEM images of MG63 human osteoblasts on disc surface of RefCPC after 7 days of 

culturing (a-c). The area shown in a) is 0.5 mm2. a)-b) Surface texture at two magnifications. No 

cells are visible in the area displayed. c) Detail of one of the rare cells found on the disk surface, 

showing numerous thin pseudopodia extending toward surface particles from a relatively thick, 

elongated cell body (compare with Fig. 8). d) Plot of cell densities obtained under each of the four 

experimental conditions, estimated from cell counts over at least 3 mm2 of disk surface visualized 

as in a). Symbol (*) denotes significantly different values for co-doped CPCs?A and ?AS with 

respect to RefCPC?A; **, p&lt;0.01; ***, p&lt;0.001; ****, p&lt;0.0001). Statistic significances in-between 

doped CPCs: Sr5CPC?A vs Mn0.5Sr5CPC?A p&lt;0.0001; Sr5CPC?A vs Mn0.5Sr5CPC?AS 

p&lt;0.0002; Mn0.5Sr5CPC?A vs Mn0.5Sr5CPC?AS p = 0.0518. 



Capítulo 5 

 212 

 

 

 

 

 

 

 

 

Fig. S2. Details of MG63 cells colonizing the disc surface of Mn0.5Sr5CPC?A (a) and 

Mn0.5Sr5CPC-AS (b), SEM. Both cell-to-cell and cell-to-substrate connections by thin 

pseudopodia are abundant. The cells are rather flat and somewhat electron-translucent, allowing 

the distinction of underlying substrate particles. 

 

4. Discussion 

4.1. Effects of MnSr-doping and sugars addition on the properties of 

cements 

The beneficial effects of Sr on preventing bone resorption and enhancing bone 

apposition in vivo are well known [55, 56], and Sr incorporation into CPCs became 

a hot topic tackled in various recent studies [25, 29, 57-65]. In contrast, the 

osteogenic effects of Mn did not arise much interest so far, and only a few studies 

disclosed benefits in terms of bone growth and repair when it is present at low 

levels in metallic implants [20], while its deficiency in the body may lead to 

osteoporosis [27, 28]. This work aims at fulfilling this gap by incorporating Sr and 

Mn in CPCs and assessing their roles in determining relevant handling, physical 

and in vitro biological properties. The results of XRD (Fig. 1a) and ICP analysis 

(Table 2) confirmed that Ca has been partially replaced by doping elements in the 

crystalline lattice of the starting ?-TCP powders [21, 50, 51].  



Capítulo 5 

 213 

The incorporation of species with different ionic radii (0.83 Å for Mn and 

1.13 Å for Sr) is likely to affect the chemical stability of doped powders and induce 

changes in dissolution/precipitation reactions with the setting liquid. According to 

the results displayed in (Fig. 2a), one can conclude that: (i) doping ions have 

enhanced the chemical stability, as the setting reactions have been delayed; (ii) in 

this regard, there was a clear synergetic effect when both ions were present 

(Mn0.5Sr5CPC and Mn1Sr5CPC). The IST increased more than 2.5 times upon 

changing from RefCPC?A to Mn1Sr5CPC?A. These observations are in 

agreement with the Sr retarding effect reported for the setting of Sr-containing 

brushite cements [24, 66, 67]. Slower setting reaction rates are likely to favour 

more uniform spatial arrangements of crystals and lead to more packed and less 

porous structures. This would help explaining why doped cements exhibit higher 

wet CS, with the highest value being observed for Mn0.5Sr5CPC. While these 

results agree with those reported by Pina et al. [24, 25, 29], they disagree with the 

ones reported for Sr-doped cements by Alkhraisat et al. [63], who did not find any 

influence of doping on the mechanical properties.   

Noticeable increases in IST were also obtained when sugars were added to the 

setting liquid, confirming their well-known roles as setting retardants in cement 

building materials [44, 68-70]. However, the retarding mechanism is not yet 

completely understood even for Portland type cements [44, 70] and the subject 

deserves to be further investigated, particularly in the case of CPCs systems 

[71, 72]. Considering that more time is allowed for handling the cement pastes 

when IST is longer, the enhanced flowing ability of the Sr5CPC?AS, 

Mn0.5Sr5CPC?AS and Mn1Sr5CPC?AS pastes demonstrated in Fig. 4a and 4b is 

not surprising. The poor injectability of Sr5CPC?A can be partially understood as 

extrusion was initiated at about 50% of IST. The enhanced injectability of 

Mn0.5Sr5CPC?A and Mn1Sr5CPC?A can also be partially attributed to the 

increase of IST by ~2 min, in comparison to Sr5CPC?A. The significant 

improvements in flowing ability of Sr-doped cements upon adding sugars 

(Sr5CPC?AS, Sr5CPC?AF) cannot be dissociated from the induced increments in 

IST (Fig. 2a). In comparison to sucrose, fructose shows slightly less performance 



Capítulo 5 

 214 

in terms of injectability, and its extrusion curve along the intermediate stage is 

always above in comparison to that of paste with added sucrose. In both cases, 

extrusion stopped at ~3.9 min after beginning mixing the paste, not much after 

achieving ~50% of IST (6.3 ± 0.2 min).  

However, the overall effects of doping and adding sugars on injectability are more 

complex than conveyed by this simplistic appraisal. At least three other factors are 

likely to shed further light and have an impact on this issue: (i) the composition and 

intrinsic viscosity of the setting liquid; (ii) the structural changes induced in the 

starting powders upon doping; (iii) the effects of additives on the kinetics of setting 

reactions. Sugars are expected to enhance the intrinsic viscosity of the liquid 

beyond that conferred by other additives (PEG, HPMC), which alone would favour 

the flow by hindering particles from agglomeration under shear [37, 38]. On the 

other hand, the retarding effects of sugars can be exerted through their specific 

interactions with the surface of the particles.  

The electrophoretic curves displayed in supplementary Fig. S3a reveal that adding 

sugars to the background electrolyte decreased the absolute values of zeta 

potential, with more evident changes in the case of sucrose. These results confirm 

that the positively charged polyatomic species derived from sugars dissociation 

[73] have been specifically adsorbed onto the surface of the particles. It is likely 

that the adsorbed polyatomic ions will exert a certain hindrance towards the setting 

liquid species, decreasing the dissolution rate of solid particles and delaying 

formation of supersaturated concentration levels of species necessary for the 

precipitation of reaction products. The possible formation of complexes involving 

the polyatomic ions from sugars and ionic species derived from dissolution of 

solids would also contribute for the observed increases in IST [68], and cannot be 

discarded. In any case, the presence of sugar-derived species will also directly 

interfere with the formation kinetics of phases in the hardened cements by 

adsorbing at the surfaces of nuclei and conditioning their growth. As hypothesised 

above, slower growing kinetics is likely to favour a more uniform spatial 

arrangement of crystals and lead to more packed and less porous structures. 

 



Capítulo 5 

 215 

(a) (b) 

 

 

 

 

 

 

 

 

Fig. S3. Since Sr5CPC cements presented the most significant differences of injectability 

percentage when sugars were added to the setting liquids, the Sr5-TCP powder was selected to 

investigate the effects of liquids’ composition on their dispersing ability. The influences of different 

aqueous electrolyte solutions and pH on a) Zeta Potential (ZP) and b) Electrical conductivity (EC) 

were therefore surveyed. Except for molar concentration in KCl (M), the other numerical 

coefficients in the sample codes stand for weight percent concentration (wt.%) in the electrolyte in 

solution. The error bars of standard deviations are almost imperceptible in some cases, meaning 

excellent reproducibility of data.  

The measurements were carried out at several pH values using a Zeta Sizer (Nano ZS, Malvern, 

Worcestershire, UK). For this, 13 mg of powder was ultrasonically dispersed for 15 min into 50 mL 

of the background electrolyte solution (1 mM KCl) and adding the other additives. Each dilute 

suspension was divided into two equal parts, one for increasing and the other for decreasing pH 

runs, and the pH values were adjusted using 0.1 M NaOH or 0.1 M HCl solutions, respectively. 

Results revealed that ZP is significantly affected by pH and the type of additive, while EC is mostly 

dependent on pH (except in the presence of PEG).  

The results for 15 wt.% CA in a) are not shown because fast dissolution of particles hindered any 

reliable measurement, in agreement with observations reported elsewhere [46]. The ZP curves for 

the Sr5-TCP powders suspended in 0.5 wt.% HPMC, 10 wt.% of fructose and KCl 10?3 M as 

electrolytes, showed a decreasing trend as pH increases, more pronounced for KCl 10?3 M. ZP 

curves in the presence of 10 wt.% PEG or 10 wt.% sucrose present minima of ~12 mV at pH range 

5?6 and of ~17 mV at pH?8, respectively. In the presence of fructose, higher absolute ZP values 

were registered in comparison to sucrose. High EC values b) were measured when particles are 

dispersed in the complete setting liquids, irrespective of their additive contents. When the same 

additives were dissolved in the KCl 10?3 M used for electrophoretic measurements, EC decreased 

for about 1.5 order of magnitude.  

 



Capítulo 5 

 216 

This is consistent with the lower values of porosity observed in Fig. 2c for 

co-doped cements containing sugars. The same reasoning helps explaining why 

these cements are mechanically stronger (Fig. 2b). The superior performance of 

sucrose in comparison to fructose can be attributed to its stronger affinity to the 

surface of solid particles (of reactants and reaction products) and more extensive 

adsorption as deduced from the lower zeta potential values (supplementary 

Fig. S3a). Sucrose should exert a more effective initial retarding effect, while its 

higher molecular weight (almost double than fructose) is expected to enhance 

more the intrinsic viscosity of the liquid and facilitate extrusion. Oppositely, 

fructose being less effective in preventing hydrolysis reactions is likely to allow 

earlier nuclei formation of reaction products. This might explain why the 

intermediate stage of the extrusion curves appears inclined in the present of 

fructose (Fig. 4b, Sr5CPC?AF). In fact, although similar IST values were 

measured for sugar-containing pastes (Fig. 2a), the setting reactions seem to 

occur more gradually in the presence of fructose, with viscosity progressively 

increasing, leading to slightly less packed and more porous structures than in 

sucrose-containing cements. This is consistent with the porosity data reported in 

Fig. 2c and the lower CS values displayed in Fig. 2b for all cements containing 

fructose, in comparison to those with added sucrose.  

Although the roles attributed to MnSr-doping and sugars bring a better 

understanding of their effects on the handling and physical properties of CPCs, 

some apparent inconsistencies noticed in this work still need to be further clarified: 

(i) The expected relationship between porosity and CS [74] is not observed for 

Mn0.5Sr5CPC and Mn1Sr5CPC samples in Fig. 2b and c. A significantly higher 

CS was obtained when liquid A was replaced by liquid AS, but the hardened 

cements exhibited similar porosities. This apparent inconsistency could be 

attributed to different pore size distributions. This hypothesis is supported by the 

higher SSA of Mn0.5Sr5CPC?AS, the strongest cement among the most 

mechanically performing cements. The increase in SSA could result either from: 

(1) a volume increase of open porosity (not determined in this study) and/or (2) a 

large number of smaller pores formed in Mn0.5Sr5CPC?AS than in 



Capítulo 5 

 217 

Mn0.5Sr5CPC?A, as hypothesised above. However, only the latter justifies the 

observed increase in CS for Mn0.5Sr5CPC?AS (Fig. 2b). This hypothesis is also 

supported by SEM observations of hardened cements (Fig. 9d and g).  

(ii) Although Mn/Sr co-doping generally enhanced the IST (Fig. 2a), handling time, 

injectability (Fig. 4a and b), and CS (Fig. 2b), the Mn1Sr5CPC deviates from this 

trend. The lower injectability of Mn1Sr5CPC?A (78%) in comparison to that of 

Mn0.5Sr5CPC?A (82%) is consistent with the lower CS of hardened 

Mn1Sr5CPC?A cement (Fig. 2b), and with its highest porosity values (Fig. 2c). All 

these differences between these two cements [which have similar IST values (Fig. 

2a)] might be related to the slight differences observed in PSDs of the powders 

(Fig. 1c) [46].  

There is abundant experimental evidence demonstrating the influence of doping 

ions on the PSD of the synthesised powders. The lattice strains induced by doping 

with ions of different radii are likely to determine different milling behaviours under 

a given set of experimental conditions. A previous study [30] showed that the 

Mn-doping and its content exert a strong effect on the starting ??TCP powders’ PS 

and PSD. It was also shown that small variations in PS and PSD could strongly 

affected the injectability [46] and the kinetics of setting reaction of CPCs [75], with 

fine particles accelerating the setting, and shortening both initial and final setting 

times. Therefore, a perfect comparability among different samples is only possible 

when starting from exactly coincident PSDs. Strangely, little attention has been 

given to this cornstone factor [24, 60, 63, 76]. Thence, using fixed milling 

conditions for doped and non-doped powders is not the most suitable criterion for 

enhancing the comparability among different cement samples. In this work, an 

attempt was made to accomplish this condition, by using differentiated milling 

conditions for each starting ??TCP powder (illustrated in Fig. 1c). 

 

 



Capítulo 5 

 218 

4.2 Effects of MnSr-doping and adding sucrose on the in vitro biological 

behaviour 

The resazurin assay for metabolic active cells and the analyses of the rate of 

type-I collagen secretion revealed that Sr-containing CPCs are the most 

osteoconductive. While RefCPC and only Mn-doped CPCs are not permissive to 

pre-osteoblastic proliferation (Fig. 7a and b), Sr-containing CPCs maintain cell 

proliferation levels closer to control ones, during the first proliferative week (Fig. 7a 

and b, Sr5CPC, Mn0.5Sr5CPC and Mn1Sr5CPC at 1-7 DIV). These three CPCs 

mainly delayed proliferation, having performed in the following order: Mn1Sr5CPC 

&amp;lt;Mn0.5Sr5CPC &amp;lt;Sr5CPC, with the latter roughly equalling control levels at 

28 DIV. During the maturation period, the levels of active cells seriously decreased 

for Mn1Sr5CPC, independently of the setting-liquid used (Fig. 7a and b, 

Mn1Sr5CPC at 14-28 DIV). Mn0.5Sr5CPC?A only presented this decrease 

punctually, and adding sucrose to the setting liquid prevented it (Fig. 7a and b, 

Mn0.5Sr5CPC?A and ?AS at 14 DIV). Indeed, and although only punctually 

significantly different, cements set in AS generally performed better in terms of 

osteoblastic proliferation (higher f.ODs in Fig. 7b than in Fig. 7a). Sr-containing 

CPCs were also able to maintain good levels of type-I pro-collagen secretion 

(Fig. 7d). Pro-collagen is secreted to further acquire the quaternary fibrillary 

collagen conformation that is the most abundant proteic constituent of the 

extracellular bone matrix. Given that at 4 DIV these cements have roughly half of 

the number of cells relative to control conditions (Fig. 7a and b), this clearly 

indicates that the Sr-containing CPCs increase the rate of cellular pro-collagen 

secretion. Accordingly, the MG63 cells grown for 7 DIV in the vicinity of these 

cements generally presented less intracellular pro-collagen (Fig. 8), indicating that 

pro-collagen secretion occurs earlier. Particularly, cells cultured in the presence of 

co-doped Mn/Sr-CPCs are even more depleted than when in the presence of only 

Sr-doped CPCs (Fig. 8, Mn0.5Sr5CPC vs Sr5CPC), confirming that Mn 

accelerates osteoblastic differentiation, as previously reported [30]. Regarding the 

effects of the biological 28 DIV incubation on the A and AS cements, significant 

fractions of OCP were formed in the non-doped and Mn-doped cement 

formulations Fig. 5. Mandel and Tas [77] demonstrated that brushite powders 



Capítulo 5 

 219 

soaked in commercial DMEM solutions, at 36.6 ºC for about 1 week, were able to 

completely transform into OCP. A consistent pH decrease in the cell culture 

medium was observed at day 7 for all these cements except for SrCPCs 

(supplementary Fig. S4), presenting OCP phase in their composition after 28 DIV 

(Fig. 5, compare with Fig. 3b).  

 

 

 

 

 

 

 

 

 

 

Fig. S4. pH evolution of the cell culture medium in the presence of cement samples at different 

time points up to 28 days of immersion in vitro conditions (28 DIV) in presence of the MG63 pre-

osteoblastic cells. Data for the cement-free control (Ctrl) are also presented for comparison. The 

culture medium was substituted after the first 24 h and every 3 days further on. The pH values of 

the medium removed at 1, 7, 14 and 28 DIV were registered. 

 

In fact, when brushite transforms into OCP (more basic), the reaction generates 

H2PO4
? ions in solution, acidifying the medium [77]. The higher pH values for 

Sr-doped only cements (Fig. S4) suggest that this transformation did not occur as 

shown in Fig. 5 and that Sr tends to hinder the formation of OCP. 

The interactions between the MG63 cells and CPCs are mediated by a number of 

complex factors (e.g. surface chemistry and topography, porosity, SSA, 

composition of the culture medium, etc.); the role of each of these is not easy to 

0

2

4

6

8

10

A AS A AS A AS A AS A AS A AS

Ctrl Ref Sr5 Mn0.5 Mn1 Mn0.5Sr5 Mn1Sr5

CPC 

p
H

1d 7d 14d 28d 



Capítulo 5 

 220 

discriminate due to their interdependencies. The adsorption of proteins from the 

cell culture medium on the cement surface is likely affected by ionic composition of 

the medium, namely by the concentration of Mn ions [78-81]. But surface 

topography (roughness, porosity, pore sizes and pore size distribution) also 

influences the absorption of proteins that help regulate cement-cells interactions 

[82, 83]. The smoother surface topographies of Mn0.5Sr5CPC (?A and ?AS) 

cements (Fig. 9, supplementary Fig. S1a-c) after 7 DIV are consistent with the 

enhanced attachment of osteoblastic cells. The higher cell density observed on the 

surface of Mn0.5Sr5CPC?AS, in comparison with Mn0.5Sr5CPC?A (Fig. 9d and g, 

supplementary Fig. S1d), is also consistent with residual cell nutrition effects from 

eventual remains of sucrose, although slight differences in porosity might also play 

a role (Fig. 9d and g). However, surface topography effects can hardly be 

separated from those of doping ions released to the culture medium during 

incubation with MG63 cells for 28 DIV (Fig. 6). It is known that Mn increases the 

ligand binding affinity of integrins, increasing integrin activation. This essential 

transmembrane protein is involved in osteoblastic adhesion, increasing the 

cell-extracellular matrix interaction, cell adhesion, and consequently cell 

spreading/flattening and migration on the substrate [78-81]. Therefore, the Mn 

release most likely promotes cell attachment to the surface of the Mn0.5Sr5CPC, 

as shown in Fig. 9d-i and supplementary Fig. S2, in which the cells appeared even 

more flattened and better spread across the surface, in comparison to cells grown 

on SrCPC?A (Fig. 9a-c) and RefCPC?A (supplementary Fig. S1c). Altogether, 

these results indicate that the incorporation of Mn can be a promising approach to 

improve the osteointegration of CPCs [79, 80]. 

 

5. Conclusions 

The treatment of bone defects via minimally invasive surgical techniques such as 

vertebroplasty requires considerable overall improvements to be achieved in the 

properties of injectable CPC, in terms of handling, mechanical and biological 

performances. The results presented and discussed along this article clearly 

indicate that handling (setting time and injectability), microstructure, mechanical 



Capítulo 5 

 221 

and biological properties of brushite cements are strongly dependent on ionic 

substitutions in the starting powders and on setting liquid composition (without or 

with added sugars). Both independent approaches caused retarding effects in 

setting reactions and enhanced injectability. Mn and Sr co-doping produced more 

benefits in comparison to single doping. Concerning the influence of sugars, 

sucrose was more effective than fructose. However, the combined effects of Mn 

and Sr co-doping with the presence of sucrose in the setting liquid led to cements 

with overall greatly improved properties, including extended working times, 

excellent injectability, mechanical and biological performances, therefore rendering 

them very promising materials for bone regeneration and tissue engineering. 

Moreover, small amounts of Mn promoted the adhesion of MG63 cells and may be 

a promising way to improve the integration of brushite cements in future in vivo 

experiments. 

 

Acknowledgments 

This work was developed in the scope of the CICECO-Aveiro Institute of Materials 

(Ref. UID/CTM/50011/2013) and the Institute for Biomedicine iBiMED (Ref. 

UID/BIM/04501/2013) projects, and funded by FEDER funds through the 

Operational Programme Competitiveness Factors (COMPETE 2020) and the 

Portuguese Foundation for Science and Technology (FCT). P.M.C. Torres also 

acknowledges the FCT for the doctoral grant (SFRH/BD/62021/2009). 

The XRD facility was funded by FEDER funds through QREN-Aviso SAIECT-

IEC/2/2010 and Operação NORTE-07-0162-FEDER-000050. The authors are very 

thankful to the Hospital Infante D. Pedro of Aveiro, namely to the team involved in 

the process of sterilization of samples, especially to the Chief Nurse Aurea Simões 

and to the responsible for sterilization service, Nurse Margarida Vilarinho. 

 

 



Capítulo 5 

 222 

References 

[1] LeGeros RZ, Calcium phosphate materials in restorative dentistry: a review, 

Adv. Dent. Res. 2 (1988) 164?80. 

[2] P.S. Eggli, W. Muller, R.K. Schenk, Porous hydroxyapatite and tricalcium 

phosphate cylinders with two different pore size ranges implanted in the 

cancellous bone of rabbits. A comparative histomorphometric and histologic study 

of bone ingrowth and implant substitution, Clin. Orthop. Relat. Res. 232 (1988) 

127?38. 

[3] N. Kondo, A. Ogose, K. Tokunaga, T. Ito, K. Arai, N. Kudo, H. Inoue, H. Irie, N.  

Endo, Bone formation and resorption of highly purified ?-tricalcium phosphate in 

the rat femoral condyle, Biomaterials 26 (2005) 5600?8. 

[4] S.V. Dorozhkin, Bioceramics of calcium orthophosphates, Biomaterials  

31.(2010) 1465?85. 

[5] M. Bohner, Resorbable biomaterials as bone graft substitutes, Mater Today 13 

(2010) 24?30. 

[6] R.W. Bucholz, Nonallograft osteoconductive bone graft substitutes, Clin. 

Orthop. 395 (2002) 44?52. 

[7] B. von Rechenberg, O.R. Génot, K. Nuss, L. Galuppo, M. Fulmer, E. Jacobson, 

P. Kronen, K. Zlinszky, J.A. Auer, Evaluation of four biodegradable, injectable 

bone cements in an experimental drill hole model in sheep, Eur. J. Pharm. 

Biopharm. 85 (2013) 130?8. 

[8] M.A. Lopez-Heredia, M. Bongio, M. Bohner, V. Cuijpers, L.A.J.A. Winnubst, N. 

Van Dijk, J.G.C.Wolke, J.J.J.P. Van Den Beucken, J.A. Jansen, Processing and in 

vivo evaluation of multiphasic calcium phosphate cements with dual tricalcium 

phosphate phases, Acta Biomater. 8 (2012) 3500?8. 



Capítulo 5 

 223 

[9] M.P. Ginebra, M. Espanol, E.B. Montufar, R.A. Perez, G. Mestres, New 

processing approaches in calcium phosphate cements and their applications in 

regenerative medicine, Acta Biomater. 6 (2010) 2863?73. 

[10] K.L. Low, S.H. Tan, S.H.S. Zein, J.A. Roether, V. Mourino, A.R. Boccaccini. 

Calcium phosphate-based composites as injectable bone substitute materials. J 

Biomed Mater Res B. 94B (2010) 273?86. 

[11] S. V. Dorozhkin. Calcium Orthophosphate Cements and Concretes. Mat Sci 

Eng C-Mater. 2 (2009) 221?91. 

[12] F Tamimi, J Torres, E Lopez-Cabarcos, D Bassett, P Habibovic, E Luceron, J. 

E. Barralet, Minimally invasive maxillofacial vertical bone augmentation using 

brushite based cements, Biomaterials 30 (2009) 208?16. 

[13] M. Bohner. Calcium orthophosphates in medicine: from ceramics to calcium 

phosphate cements. Injury. 31 (2000) 37?47. 

[14] M. Bohner, Design of ceramic-based cements and putties for bone graft 

substitution, Eur. Cell. Mater. 20 (2010) 1?12. 

[15] M. Bohner, Calcium phosphate emulsions: possible applications, Key Eng. 

Mater. 192-195 (2001)765?8. 

[16] U. Gbureck, S. Dembski, R. Thull, J.E. Barralet, Factors influencing calcium 

phosphate cement shelf-life, Biomaterials 26( 2005) 3691?7. 

[17] J. Aaseth, G. Boivin, O. Andersen. Osteoporosis and trace elements – An 

overview, J. Trace Elem. Med. Bio. 26 (2012) 149?52. 

[18] E. Boanini, M. Gazzano, A. Bigi, Ionic substitutions in calcium phosphates 

synthesized at low temperature, Acta Biomater. 6 (2010)1882?94. 

[19] A. Bigi, E. Foresti, M. Gandolfi, M. Gazzano, N. Roveri, Isomorphous 

substitutions in ?-tricalcium phosphate: The different effects of zinc and strontium, 

J. Inorg. Biochem. 66 (1997) 259?65. 



Capítulo 5 

 224 

[20] B. Bracci, P. Torricelli, S. Panzavolta, E. Boanini, R. Giardino, A. Bigi, Effect 

of Mg2+, Sr2+, and Mn2+ on the chemico-physical and in vitro biological properties 

of calcium phosphate biomimetic coatings, J. Inorg. Biochem. 103 (2009) 

1666?74. 

[21] S. Kannan, F. Goetz-Neunhoeffer, J. Neubauer, S. Pina, P.M.C. Torres, 

J.M.F. Ferreira, Synthesis and structural characterization of strontium- and 

magnesium-co-substituted ?-tricalcium phosphate, Acta Biomater. 6 (2010) 571?6. 

[22] S. Kannan, S.I. Vieira, S.M. Olhero, P.M.C. Torres, S. Pina, O.A.B. Da Cruz e 

Silva, J.M. Ferreira, Synthesis, mechanical and biological characterization of ionic 

doped carbonated hydroxyapatite/?-tricalcium phosphate mixtures, Acta Biomater. 

7 (2011) 1835?43. 

[23] I. Mayer, F.J.G. Cuisinier, S. Gdalya, I. Popov, TEM study of the morphology 

of Mn2+-doped calcium hydroxyapatite and ?-tricalcium phosphate, J. Inorg. 

Biochem. 102 (2008) 311?7. 

[24] S. Pina, P.M. Torres, J.M. Ferreira, Injectability of brushite-forming Mg-

substituted and Sr-substituted alpha-TCP bone cements, J. Mater. Sci. Mater. 

Med. 21 (2010) 431?8. 

[25] S. Pina, S.I. Vieira, P. Rego, P.M.C. Torres, O.A.B. da Cruz e Silva, E.F. da 

Cruz e Silva, J.M.F. Ferreira, Biological Responses of Brushite forming Zn- and 

ZnSr- substituted beta-tricalcium phosphate bone Cements, Eur. Cells Mater. 20 

(2010) 162?77. 

 

[26] E. Rokita, C. Hermes, H.F. Nolting, J. Ryczek, Substitution of Calcium by 

Strontium within Selected Calcium Phosphates, J Crystal Growth 130 (1993) 

543?52. 

[27] T. Landete-Castillejos, I. Molina-Quilez, J.A. Estevez, F. Ceacero, A.J. Garcia, 

L. Gallego, Alternative hypothesis for the origin of osteoporosis: The role of Mn, 

Front Biosci. E4 (2012) 1385?90. 



Capítulo 5 

 225 

[28] H. Rico, N. Gómez-Raso, M. Revilla, E.R. Hernández, C. Seco, E. Páez, E. 

Crespo, Effects on bone loss of manganese alone or with copper supplement in 

ovariectomized rats A morphometric and densitomeric study, Eur. J. Obstet. Gyn. 

R. B. 90 (2000) 97?101. 

[29] S. Pina, P.M. Torres, F. Goetz-Neunhoeffer, J. Neubauer, J.M.F. Ferreira, 

Newly developed Sr-substituted alpha-TCP bone cements, Acta Biomater. 6 

(2010) 928?35. 

[30] P.M.C. Torres, S.I. Vieira, A.R. Cerqueira, S. Pina, O.A.B. da Cruz Silva, 

J.C.C. Abrantes, J.M. Ferreira, Effects of Mn-doping on the structure and 

biological properties of ?-tricalcium phosphate, J. Inorg. Biochem. 136 (2014) 

57?66. 

[31] G. Baroud, E. Cayer, M. Bohner. Rheological characterization of concentrated 

aqueous ?-tricalcium phosphate suspensions: The effect of liquid-to-powder ratio, 

milling time, and additives. Acta Biomater. 1(2005) 357?63. 

[32] M. Bohner, G. Baroud. Injectability of calcium phosphate pastes. Biomaterials. 

26 (2005) 1553?63. 

[33] G. Chen, W. Li, X. Yu, K. Sun, Study of the cohesion of TTCP/DCPA 

phosphate cement through evolution of cohesion time and remaining percentage, 

J. Mater. Sci. 44 (2009) 828?34. 

[34] I. Khairoun, F.C.M. Driessens, M.G. Boltong, J.A. Planell, R. Wenz, Addition 

of cohesion promoters to calcium phosphate cements, Biomaterials. 20 (1999) 

393?8. 

[35] C. Canal, M.P. Ginebra, Fibre-reinforced calcium phosphate cements: A 

review, J. Mech. Behav. Biomed. Mater. 4 (2011) 1658?71. 

[36] R. Krüger, J. Groll, Fiber reinforced calcium phosphate cements – On the way 

to degradable load bearing bone substitutes? Biomaterials 33 (2012) 5887?900. 



Capítulo 5 

 226 

[37] W. Liu, J. Zhang, P. Weiss, F. Tancret, J.-M. Bouler, The influence of different 

cellulose ethers on both the handling and mechanical properties of calcium 

phosphate cements for bone substitution, Acta Biomater. 9 (2013) 5740?50. 

[38] S. Pina, S.M. Olhero, S. Gheduzzi, A.W. Miles, J.M. Ferreira, Influence of 

setting liquid composition and liquid-to-powder ratio on properties of a Mg-

substituted calcium phosphate cement, Acta Biomater. 5 (2009) 1233?40. 

[39] S. Pina, S.I. Vieira, P.M. Torres, F. Goetz-Neunhoeffer, J. Neubauer, O. A. da 

Cruz e Silva, E. F. da Cruz e Silva. J. M. Ferreira, In vitro performance 

assessment of new brushite-forming Zn- and ZnSr-substituted beta-TCP bone 

cements, J. Biomed. Mater. Res B. Appl. Biomater. 94 (2010) 414?20. 

[40] S. Sarda, E. Fernandez, M. Nilsson, M. Balcells, J.A. Planell, Kinetic study of 

citric acid influence on calcium phosphate bone cements as water-reducing agent, 

J. Biomed. Mater. Res. 61(2002) 653?9. 

[41] J.E. Barralet, L.M. Grover, U. Gbureck, Ionic modification of calcium 

phosphate cement viscosity. Part II: hypodermic injection and strength 

improvement of brushite cement, Biomaterials 25 (2004) 2197?203. 

[42] B. Han, P.-W. Ma, L.-L. Zhang, Y.-J. Yin, K.-D. Yao, F.-J. Zhang, Y.-D. Zhang, 

X.-L. Li, W. Nie, Beta-TCP/MCPM-based premixed calcium phosphate cements, 

Acta Biomater. 5 (2009) 3165?77. 

[43] M. Roy, K. Devoe, A. Bandyopadhyay, S. Bose, Mechanical property and in 

vitro biocompatibility of brushite cement modified by polyethylene glycol, Mater. 

Sci. Eng. C 32 (2012) 2145?52. 

[44] M.C. Garci Juenger, H.M. Jennings, New insights into the effects of sugar on 

the hydration and microstructure of cement pastes, Cement Concrete Res.. 

32(2002) 393?9. 



Capítulo 5 

 227 

[45] G. Eggleston. Sucrose and Related OligosaccharidesOligosaccharides. In: B. 

Fraser-Reid, K. Tatsuta, J. Thiem, (eds.), Glycoscience, Springer Berlin 

Heidelberg, 2008, pp. 1163?83. 

[46] P.M. Torres, S. Gouveia, S. Olhero, A. Kaushal, J.M. Ferreira, Injectability of 

calcium phosphate pastes: Effects of particle size and state of aggregation of beta-

tricalcium phosphate powders, Acta Biomater. 21 (2015) 204?216. 

[47] M. Descamps, J.C. Hornez, A. Leriche, Effects of powder stoichiometry on the 

sintering of ?-tricalcium phosphate, J. Eur. Ceram. Soc. 27 (2007) 2401?6. 

[48] A.G. Henriques, S.I. Vieira, S. Rebelo, S.C. Domingues, E.F. da Cruz e Silva, 

O.A. da Cruz e Silva. Isoform specific amyloid-beta protein precursor metabolism. 

J Alzheimer's dis. 11 (2007) 85?95. 

[49] J.F. da Rocha, O.A. da Cruz e Silva, S.I. Vieira, Analysis of the amyloid 

precursor protein role in neuritogenesis reveals a biphasic SH-SY5Y neuronal cell 

differentiation model, J. Neurochem. 134 (2015) 288?301. 

[50] S. Kannan, S. Pina, J.M.F. Ferreira, Formation of strontium-stabilized ?-

tricalcium phosphate from calcium-deficient apatite, J. Am. Ceram. Soc. 89 (2006) 

3277?80. 

[51] S Kannan, F Goetz-Neunhoeffer, J Neubauer, J.M.F. Ferreira, Cosubstitution 

of zinc and strontium in ?-tricalcium phosphate: Synthesis and characterization, J. 

Am. Ceram. Soc. 94 (2011) 230?5. 

[52] S. Raynaud, E. Champion, D. Bernache-Assollant, P. Thomas, Calcium 

phosphate apatites with variable Ca/P atomic ratio I. Synthesis, characterisation 

and thermal stability of powders, Biomaterials 23(2002) 1065?72. 

[53] E.R. Kreidler, F.A. Hummel, Phase relationships in the system SrO-P2O5 and 

the influence of water vapor on the formation of Sr4P2O9, Inorg. chem. 6 (1967) 

884?91. 



Capítulo 5 

 228 

[54] C. Liu, H. Shao, F. Chen, H. Zheng, Rheological properties of concentrated 

aqueous injectable calcium phosphate cement slurry, Biomaterials 27 (2006) 

5003?13. 

[55] J.Y. Reginster, O. Bruyère, A. Sawicki, A. Roces-Varela, P. Fardellone, A. 

Roberts J. P. Devogelaer, Long-term treatment of postmenopausal osteoporosis 

with strontium ranelate: Results at 8 years, Bone 45 (2009) 1059?64. 

[56] P.J. Marie, Strontium ranelate: a novel mode of action optimizing bone 

formation and resorption, Osteoporosis international: a journal established as 

result of cooperation between the European Foundation for Osteoporosis and the 

National Osteoporosis Foundation of the USA.;16 Suppl 1 (2005) S7?10. 

[57] Schumacher M, Gelinsky M. Strontium modified calcium phosphate cements - 

Approaches towards targeted stimulation of bone turnover, J. Mat. Chem. B. 3 

(2015) 4626?40. 

[58] U. Thormann, S. Ray, U. Sommer, T. ElKhassawna, T. Rehling, M. 

Hundgeburth, A. Henß, M. Rohnke, J Janek, L. Jürgen, S. Katrin, C. Heiss, G. 

Schlewitz, G. Szalay, M. Schumacher, M. Gelinsky, R. Schnettler, V. Alt, Bone 

formation induced by strontium modified calcium phosphate cement in critical-size 

metaphyseal fracture defects in ovariectomized rats, Biomaterials 34 (2013) 

8589?98. 

[59] M. Schumacher, A. Lode, A. Helth, M. Gelinsky, A novel strontium(II)-modified 

calcium phosphate bone cement stimulates human-bone-marrow-derived 

mesenchymal stem cell proliferation and osteogenic differentiation in vitro, Acta 

Biomater. 9 (2013) 9547?57. 

[60] M. Schumacher, A. Henß, M. Rohnke, M. Gelinsky, A novel and easy-to-

prepare strontium(II) modified calcium phosphate bone cement with enhanced 

mechanical properties, Acta Biomater. 9 (2013) 7536?44. 

[61] M. Baier, P. Staudt, R. Klein, U. Sommer, R. Wenz, I. Grafe, P.J. Meeder, 

P.P. Nawroth, C. Kasperk, Strontium enhances osseointegration of calcium 



Capítulo 5 

 229 

phosphate cement: a histomorphometric pilot study in ovariectomized rats, J. 

Orthop. Surg. Res. 8 (2013) 16. 

[62] M.H. Alkhraisat, C. Rueda, E. Lopez Cabarcos, Strontium ions substitution in 

brushite crystals: the role of strontium chloride, J. Funct. Biomater. 2 (2011) 31?8. 

[63] M.H. Alkhraisat, C. Moseke, L. Blanco, J.E. Barralet, E. Lopez-Carbacos, U. 

Gbureck, Strontium modified biocements with zero order release kinetics, 

Biomaterials 29 (2008) 4691?7. 

[64] E. Boanini, S. Panzavolta, K. Rubini, M. Gandolfi, A. Bigi, Effect of strontium 

and gelatin on the reactivity of alpha-tricalcium phosphate, Acta Biomater. 6 

(2010) 936?42. 

[65] S. Tadier, R. Bareille, R. Siadous, O. Marsan, C. Charvillat, S. Cazalbou, J. 

Amédée, C. Rey, C. Combes, Strontium-loaded mineral bone cements as 

sustained release systems: Compositions, release properties, and effects on 

human osteoprogenitor cells, J. Biomed. Mater. Res. B – Appl. Biomater. 100 B 

(2012) 378?90. 

[66] S. Panzavolta, P. Torricelli, L. Sturba, B. Bracci, R. Giardino, A. Bigi, Setting 

properties and in vitro bioactivity of strontium-enriched gelatin–calcium phosphate 

bone cements, J. Biomed. Mater. Res. A 84A (2008) 965?72. 

[67] M.H. Alkhraisat, F.T. Mariño, C.R. Rodríguez, LB Jerez, E.L. Cabarcos, 

Combined effect of strontium and pyrophosphate on the properties of brushite 

cements, Acta Biomater. 4 (2008) 664?70. 

[68] M. Bishop, A.R. Barron, Cement hydration inhibition with sucrose, tartaric 

acid, and lignosulfonate: Analytical and spectroscopic study, Ind. Eng. Chem. Res. 

45 (2006) 7042?9. 

[69] N.L. Thomas, J.D. Birchall, The retarding action of sugars on cement 

hydration, Cement Concrete Res. 13 (1983) 830?42. 



Capítulo 5 

 230 

[70] J. Cheung, A. Jeknavorian, L. Roberts, D. Silva, Impact of admixtures on the 

hydration kinetics of Portland cement, Cement Concrete Res. 41 (2011)1289?309. 

[71] G. Cama, B. Gharibi, J.C. Knowles, S. Romeed, L. DiSilvio, S. Deb, Structural 

changes and biological responsiveness of an injectable and mouldable monetite 

bone graft generated by a facile synthetic method, J. Roy. Soc. Interface 11 ( 

2014) 07?27. 

[72] S. Takagi, L.C. Chow, Formation of macropores in calcium phosphate cement 

implants, J. Mater. Sci. Mater. Med. 12 (2001) 135?9. 

[73] V.F. Taylor, R.E. March, H.P. Longerich, C.J. Stadey, A mass spectrometric 

study of glucose, sucrose, and fructose using an inductively coupled plasma and 

electrospray ionization, Inter. J. Mass. Spectrom. 243 (2005) 71?84. 

[74] J. Zhang, W. Liu, V. Schnitzler, F. Tancret, J.M. Bouler, Calcium phosphate 

cements for bone substitution: Chemistry, handling and mechanical properties, 

Acta Biomater. 10 (2014) 1035?49. 

[75] M.P. Ginebra, F.C.M. Driessens, J.A. Planell, Effect of the particle size on the 

micro and nanostructural features of a calcium phosphate cement: a kinectic 

analysis, Biomaterials 25 (2004) 3453?62. 

[76] X. Wang, J. Ye, Y. Wang, Influence of a novel radiopacifier on the properties 

of an injectable calcium phosphate cement, Acta Biomater. 3 (2007) 757?63. 

[77] S. Mandel, A.C. Tas, Brushite (CaHPO4•2H2O) to octacalcium phosphate 

(Ca8(HPO4)2(PO4)4•5H2O) transformation in DMEM solutions at 36.5ºC, Mater. Sci. 

Eng. C 30 (2010) 245?54. 

[78] D.W. Hamilton, D.M. Brunette, The effect of substratum topography on 

osteoblast adhesion mediated signal transduction and phosphorylation, 

Biomaterials 28 (2007) 1806?19. 



Capítulo 5 

 231 

[79] Z. Zhang, B. Gu, W. Zhu, L. Zhu, Integrin-mediated osteoblastic adhesion on 

a porous manganese-incorporated TiO coating prepared by plasma electrolytic 

oxidation, Exper. Ther. med. 6 (2013) 707?14. 

[80] F. Lüthen, U. Bulnheim, P.D. Müller, J. Rychly, H. Jesswein, J.G.B. Nebe, 

Influence of manganese ions on cellular behavior of human osteoblasts in vitro, 

Biomol. Eng. 24(2007) 531?6. 

[81] D.T. Bridgen, C.L. Gilchrist, W.J. Richardson, R.E. Isaacs, C.R. Brown, K.L. 

Yang, J. Chen, L.A. Setton, Integrin-mediated interactions with extracellular matrix 

proteins for nucleus pulposus cells of the human intervertebral disc, J. Orthopaed. 

Res. 31 (2013)1661?7. 

[82] K. Anselme, Osteoblast adhesion on biomaterials, Biomaterials 21 (2000) 

667-81. 

[83] X.D. Zhu, H.J. Zhang, H.S. Fan, W. Li, X.D. Zhang, Effect of phase 

composition and microstructure of calcium phosphate ceramic particles on protein 

adsorption, Acta Biomater.6 (2010) 1536?41. 

 

 

 



 

 232 

 

 

 

 

 



 

 233 

 

 

Capítulo 6 

 

Conclusões gerais e perspetivas futuras 

 

 

 

 

 

 

 

 

 



 

 234 

 

 



Capítulo 6 

 235 

O trabalho apresentado nesta tese tinha como objetivo principal desenvolver 

cimentos de fosfatos de cálcio com injectabilidade e propriedades mecânicas 

melhoradas para aplicações em procedimentos cirúrgicos minimamente invasivos. 

A eventual aplicação dos cimentos em vertebroplastia, o procedimento cirúrgico 

minimamente invasivo mais exigente no que concerne a estas propriedades 

específicas, foi encarada como um grande desafio não necessariamente 

alcançável, mas mantido como uma motivação inspiradora para maximizar 

resultados. Os resultados obtidos ao longo das várias fases do estudo 

culminaram na obtenção de um cimento de brushite co-dopado com Mn e Sr com 

propriedades gerais muito promissoras. Com base nestes resultados, pode 

concluir-se que os objetivos inicialmente estabelecidos foram alcançados com um 

grau de satisfação relativamente elevado. 

A combinação da co-dopagem de 0.5 mol% Mn e 5 mol% dos pós de ?-TCP com 

a adição de sucrose no líquido de presa, como agente retardador, resultou em 

cimentos de brushite com propriedades de manuseamento (tempo inicial de 

presa, injectabilidade), de microestrutura (porosidade), mecânicas e biológicas 

bastante melhoradas: Para uma LPR de 0.28 mL g?1, o tempo inicial de presa 

passou de ~3 min a ~9 min; a injectabilidade das pastas foi completa sem 

apresentar efeito de separação de fases; a resistência à compressão de amostras 

de cimento molhadas (após 48 h numa solução de PBS) foi de ~17 MPa, valor 

muito superior ao que foi obtido para os cimentos sem açúcar não dopados 

(5 MPa) ou dopados só com Sr (10 MPa). Numerosos estudos estão disponíveis 

na literatura acerca das propriedades dos cimentos de fosfato de cálcio dopados 

com Sr, mas trabalhos publicados sobre fosfatos de cálcio dopados com Mn para 

aplicações biomédicas são escassos, e nenhum foi encontrado no caso de 

cimentos de fosfato de cálcio. A presença de Mn (combinado com Sr) neste tipo 

de cimentos e a utilização de sucrose são, portanto, duas novidades que tornam 

este trabalho original. Seu uso combinado não só melhorou muito o desempenho 

biológico, tais como a adesão e crescimento de células osteoblásticas na 

superfície do cimento, como também aumentou o tempo de manuseamento, 

promoveu uma excelente injectabilidade e uma melhoria significativa das 

propriedades mecânicas, tornando assim estes cimentos materiais muito 



Capítulo 6 

 236 

promissores para regeneração óssea e engenharia de tecidos e, eventualmente, 

para aplicação em vertebroplastia. 

Todos os pós de fosfatos tricálcicos usados ao longo deste estudo foram obtidos 

pelo processo de precipitação em meio aquoso. Esta técnica mostrou-se 

adequada para preparar pós de ?-TCP dopados com Mg, Sr, Mn e co-dopados 

com Mn e Sr, como já tinha sido demostrado em estudos anteriores para o caso 

da dopagem com Mg, Sr e outros elementos. Os precipitados obtidos à 

temperatura de 30ºC foram calcinados à temperatura de 800ºC originando 

composições apatíticas ligeiramente deficientes em cálcio. A incorporação dos 

elementos dopantes na estrutura do ??TCP foi confirmada pelas alterações dos 

valores dos parâmetros de rede que podem ser relacionados com: (i) os 

tamanhos dos raios iónicos dos elementos dopantes relativamente ao do cálcio; 

(ii) o grau de dopagem (quantidades incorporadas). Além das alterações nos 

parâmetros de rede, a incorporação dos elementos dopantes têm implicações em 

termos de estabilidade térmica da fase ?-TCP (deslocando a transformação 

?-TCP ? ?-TCP para temperaturas superiores). Os resultados mostraram ainda 

que as transformações de fase alotrópicas ???-TCP são fortemente 

influenciadas por variáveis experimentais como a taxa de arrefecimento, a 

presença de impurezas de CPP e a extensão do grau de dopagem com Mg. A 

obtenção de um pó de ?-fosfato tricálcico puro (sem outras fases presentes) é 

tanto mais dificultada quanto maior for o teor de iões dopantes e a presença de 

impurezas de CPP. A presença de CPP promove a formação de fase amorfa, 

aspeto que pode ser interessante explorar com vista a obter pós reativos ricos em 

?-TCP com um certo grau de dopagem e com algum teor de fase amorfa para 

aplicação em cimentos de fosfatos de cálcio. 

Os conhecimentos adquiridos no estudo dos efeitos das características dos pós 

(PS, PSD, estado de agregação) na injectabilidade de pastas não reativas, não 

podem ser diretamente transpostos para as pastas cimentícias preparadas a partir 

dos mesmos pós. No caso destas pastas, o aumento significativo da força iónica 

(causado pelos aditivos presentes no líquido de presa e pelo MCPM) leva ao 

colapso da dupla camada elétrica em torno das partículas, diminuindo assim o 



Capítulo 6 

 237 

tamanho aparente das partículas e a sua maior aproximação. Desta forma, as 

interações entre as partículas são medidas pelas forças de lubrificação de curto 

alcance. Além disso, os resultados revelaram que a distribuição de tamanho de 

partícula/agregado é um fator determinante na injectabilidade de pastas 

cimentícias. De facto, a injectabilidade destas pastas mostrou ser muito mais 

sensível a pequenas variações da distribuição granulométrica do que a mudanças 

de viscosidade. Foi possível injetar completamente pastas reativas com LPR de 

0.28 mL g?1 preparadas com pós com a mesma distribuição de tamanhos de 

partícula/agregado mas com partículas com morfologia distinta (significativamente 

diferentes em área superficial específica) sem apresentar o filter pressing effect 

durante a sua extrusão. 

 
Perspetivas futuras 

A realização de testes in vivo com as formulações de cimentos mais promissoras 

é fundamental para aquilatar acerca da necessidade de outras melhorias na sua 

composição ou processo de preparação. 

As análises histológicas dos explantes serão de grande importância na avaliação 

das propriedades osteogénicas do cimento implantado. Assim, a existência ou 

não de tecido inflamado dentro dos defeitos criados e preenchidos com o cimento, 

a biocompatibilidade, a osteocondutividade, como também a taxa de reabsorção 

do cimento e da formação do novo osso poderiam ser avaliadas. 

Além disso, o estudo in vivo permitiria ainda: 

• Avaliar se a pasta tem tendência a dispersar-se (falta de coesão) em 

contacto com o fluido biológico;  

• Avaliar a permeabilidade óssea visando otimizar os parâmetros de 

injeção e de infiltração do cimento no osso, condição essencial quando se 

trata de aplicações em vertebroplastia percutânea. De facto, sendo 

dependente da porosidade óssea e da viscosidade do cimento, esta 

propriedade afeta o processo de injeção; 



Capítulo 6 

 238 

• Verificar se os cimentos apresentam contraste suficiente (radiopacidade) 

aos Raios X para assistir no processo de injeção e permitir acompanhar a 

sua evolução depois de implantado;  

• Confirmar se os resultados das análises físicas e químicas feitas aos 

explantes após determinados períodos de implantação (7 e 28 dias, e 

tempos mais longos) vão ao encontro dos resultados medidos para as 

amostras testadas in vitro neste trabalho; 

• Avaliar a capacidade do cimento para induzir formação de osso quando 

implantado num local heterotópico (capacidade osteoindutora). 

 

Outros estudos complementares também poderiam ser feitos: 

? A implementação de condições de mistura diferentes das usadas neste 

trabalho (manual e a pressão atmosférica), como uma mistura mecânica 

e sob vácuo, de modo a garantir graus superiores de homogeneidade e 

de desarejamento das pastas cimentícias, com o intuito de melhorar 

ainda mais o manuseamento/injectabilidade e propriedades mecânicas. 

? A adição de um agente antibacteriano no cimento e/ou de um antibiótico, 

com o objetivo de limitar ou prevenir riscos de infeção pós-operatória. 

? A adição de outras espécies iónicas, existentes como elementos 

vestigiais na composição do osso, aos cimentos co-dopado de Mn e Sr 

tornando-os cimentos poli-dopados para posteriormente avaliar as suas 

propriedades. 

? A adição de outros aditivos no líquido de presa e estudar a sua influência 

nas propriedades de manuseamento, mecânicas e biológicas dos 

cimentos. 

 
 
 
 



 

 239 

 

 

Anexos 

 



 

 240 

 

 



Anexos 

 241 

 

Anexo 1. Diagrama de equilíbrio de fases do sistema Mg3(PO4)2-Ca3(PO4)2  

Anexo 1.1 Segundo Enderle et al. 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diagrama de equilíbrio de fases do sistema Mg3(PO4)2-Ca3(PO4)2 (TCP = fosfato tricálcico) 

segundo Enderle et al. ([31] do Capítulo 2). 

 

 

 

 

 

 

 

 



Anexos 

 242 

 

Anexo 1.2 Segundo Carrodeguas et al. 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diagrama de equilíbrio de fases do sistema Mg3(PO4)2-Ca3(PO4)2 (TCP = fosfato tricálcico) 

segundo Carrodeguas et al.([23] do Capítulo 2). 

 

 

 

 

 

 

 

 

 

 

 



Anexos 

 243 

 

Anexo 2. Diagrama de equilíbrio de fases do sistema CaO-P2O5  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diagrama de equilíbrio de fases do sistema CaO-P2O5 (C = CaO; P = P2O5) segundo Kreidler e 

Hummel ([45] do Capítulo 2). 

 

 

 

 

 



Anexos 

 244 

 

Anexo 3. Diagrama de equilíbrio de fases do sistema CaO-P2O5-H2O  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diagrama de equilíbrio de fases do sistema CaO-P2O5-H2O (C=CaO; P=P2O5; 

Ap=apatite/hidroxiapatite) segundo Ribaud ([46] do Capítulo 2). 

 

 

 

T
e

m
p

e
ra

tu
re

 (
ºC

) 


</field>
	</doc>
</add>